id,adj.P.Val.xBirACre.over.NoBirA,AveExpr.xBirACre.over.NoBirA,Log.P.Value.xBirACre.over.NoBirA,logFC.xBirACre.over.NoBirA,P.Value.xBirACre.over.NoBirA,t.xBirACre.over.NoBirA,PlexesSearchedTogether_correct..126.126.127.128.129.130.131..NoBirA_6Combo.multimedian,PlexesSearchedTogether_correct..128.126.127.128.129.130.131..NoBirA_4Combo.multimedian,PlexesSearchedTogether_correct..129.126.127.128.129.130.131..NoBirA_5Combo.multimedian,PlexesSearchedTogether_correct..127.126.127.128.129.130.131..BirA.Cre_3Combo.multimedian,PlexesSearchedTogether_correct..130.126.127.128.129.130.131..BirA.Cre_2Combo.multimedian,PlexesSearchedTogether_correct..131.126.127.128.129.130.131..BirA.Cre_1Combo.multimedian,id.query,id.mapped,id.concat,accession_number,geneSymbol,numColumnsProteinObserved,numSpectraProteinObserved,numPepsUnique,numPepsUniqueSubgroupSpecificCI,accession_numbers,species,protein_mw,percentCoverage,groupNum,subgroupNum,scoreUnique,scoreUniqueSubgroupSpecificCI,orfCategory,sequenceLength,entry_name,cellular_component,biological_process,molecular_function,PlexesSearchedTogether_correct.unique_peptides,PlexesSearchedTogether_correct.numSpectra,PlexesSearchedTogether_correct.totalIntensity,PlexesSearchedTogether_correct.pct_cov
E9Q414,1.0426e-4,-1.0185,50.46101528,4.295666667,8.99287e-6,10.63278084,-3.717,-2.784,-2.998,1.353,0.912,1.123,E9Q414,Apob,E9Q414_Apob,E9Q414,Apob,1,2206,277,277,E9Q414,MOUSE,510791.9,55.2,1,1.1,4364.47,4364.47,,4505,Apolipoprotein B-100,extracellular region|cytoplasm|endoplasmic reticulum|Golgi apparatus|plasma membrane|vesicle membrane|actin cytoskeleton|vesicle lumen|mature chylomicron|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|chylomicron|neuronal cell body|extracellular exosome|,in utero embryonic development|lipid metabolic process|triglyceride mobilization|spermatogenesis|nervous system development|cholesterol metabolic process|fertilization|response to virus|response to carbohydrate|post-embryonic development|response to selenium ion|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|positive regulation of lipid storage|positive regulation of cholesterol storage|lipid catabolic process|triglyceride catabolic process|cholesterol transport|sperm motility|response to lipopolysaccharide|cholesterol efflux|low-density lipoprotein particle remodeling|low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|cholesterol homeostasis|lipoprotein transport|regulation of cholesterol biosynthetic process|artery morphogenesis|cellular response to tumor necrosis factor|cellular response to prostaglandin stimulus|,phospholipid binding|heparin binding|cholesterol transporter activity|lipase binding|low-density lipoprotein particle receptor binding|,277,2206,2740000000000,55.2%
P01027,1.0426e-4,-1.061833333,49.00568511,4.511666667,1.25728e-5,10.13781395,-4.049,-2.806,-3.098,1.259,0.923,1.4,P01027,C3,P01027_C3,P01027,C3,1,2121,185,162,P01027|P01027-2|Q2UVX4|G3X7A5,MOUSE,188021,90.3,2,2.1,3125.9,2801.99,,1663,Complement C3,extracellular space|extracellular exosome|blood microparticle|,"positive regulation of type IIa hypersensitivity|positive regulation of protein phosphorylation|positive regulation of activation of membrane attack complex|tolerance induction|fatty acid metabolic process|inflammatory response|complement activation|complement activation, alternative pathway|complement activation, classical pathway|blood coagulation|positive regulation of vascular endothelial growth factor production|positive regulation of glucose transport|regulation of triglyceride biosynthetic process|positive regulation of lipid storage|negative regulation of endopeptidase activity|response to magnesium ion|response to estradiol|response to progesterone|positive regulation of G-protein coupled receptor protein signaling pathway|positive regulation of angiogenesis|positive regulation of developmental growth|positive regulation of phagocytosis|response to glucocorticoid|positive regulation of ERK1 and ERK2 cascade|positive regulation of apoptotic cell clearance|",endopeptidase inhibitor activity|protein binding|lipid binding|C5L2 anaphylatoxin chemotactic receptor binding|cofactor binding|,186,2121,6900000000000,90.3%
Q61838,1.0426e-4,-1.049,46.69646995,4.296666667,2.1397e-5,9.393865295,-4.033,-2.664,-2.895,1.133,1.166,0.999,Q61838,NotFound,Q61838_NotFound,Q61838,Pzp,1,4113,148,143,Q61838,MOUSE,167218.8,75.7,3,3.1,2782.24,2702.38,,1495,Pregnancy zone protein,extracellular region|extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|protein complex binding|,148,4113,191000000000000,75.7%
A0A087WSN6,0.002281433,-0.128833333,27.52963818,3.663,0.001766185,4.812491675,-0.763,-1.973,-3.145,1.991,2.597,0.52,A0A087WSN6,Fn1,A0A087WSN6_Fn1,A0A087WSN6,Fn1,1,1003,120,120,A0A087WSN6|B9EHT6|A0A087WR50|Q3UHL6|P11276|B7ZNJ1|A0A087WS56|Q4KL80,MOUSE,256658.4,60.7,4,4.1,1990.99,1990.99,,2296,Fibronectin,fibrinogen complex|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|apical plasma membrane|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,"regulation of protein phosphorylation|cell-substrate junction assembly|cell adhesion|cell-matrix adhesion|calcium-independent cell-matrix adhesion|positive regulation of cell proliferation|positive regulation of gene expression|positive regulation of peptidase activity|peptide cross-linking|integrin activation|substrate adhesion-dependent cell spreading|endodermal cell differentiation|wound healing|positive regulation of axon extension|positive regulation of fibroblast proliferation|regulation of ERK1 and ERK2 cascade|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of transforming growth factor-beta secretion|",protease binding|integrin binding|protein binding|peptidase activator activity|,120,1003,956000000000,60.7%
P06684,1.0426e-4,-1.156833333,48.99099206,4.518333333,1.26154e-5,10.13292232,-3.961,-2.685,-3.602,1.368,1,0.939,P06684,Hc,P06684_Hc,P06684,C5,1,1072,131,131,P06684|A0A0J9YUU3,MOUSE,190586.2,61,5,5.1,1982.7,1982.7,,1680,Complement C5,membrane attack complex|extracellular space|extracellular exosome|,"in utero embryonic development|inflammatory response|complement activation, alternative pathway|complement activation, classical pathway|positive regulation of vascular endothelial growth factor production|negative regulation of macrophage chemotaxis|negative regulation of endopeptidase activity|cytolysis|positive regulation of angiogenesis|positive regulation of chemokine secretion|activation of mitophagy in response to mitochondrial depolarization|",endopeptidase inhibitor activity|,131,1072,1800000000000,61.0%
P28665,1.10858e-4,-1.039666667,45.56277301,4.314,2.77794e-5,9.046238818,-4.033,-2.53,-3.027,1.4,1,0.952,P28665,Mug1,P28665_Mug1,P28665,Mug1,1,1351,108,52,P28665,MOUSE,166721,62.1,6,6.1,1825.68,971.3,,1476,Murinoglobulin-1,extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,108,1351,3130000000000,62.1%
P28666,1.0426e-4,-1.043,55.34681111,4.271333333,2.91957e-6,12.45699338,-3.306,-3.068,-3.162,1,1.033,1.245,P28666,Mug2,P28666_Mug2,P28666,Mug2,1,30,63,15,P28666,MOUSE,163805.4,39.2,6,6.2,912.37,179.67,,1451,Murinoglobulin-2,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,15,30,1470000000,11.5%
A0A0N4SVU1,1.0426e-4,-1.105333333,47.14357143,4.464,1.93038e-5,9.534082687,-4.155,-2.717,-3.14,1.394,1.028,0.958,A0A0N4SVU1,NotFound,A0A0N4SVU1_NotFound,A0A0N4SVU1,Gm7298,1,6,40,2,A0A0N4SVU1,MOUSE,166767.7,24.3,6,6.3,566.2,14.9,,1476,Predicted gene 7298,,,,2,6,99800000,1.2%
P01029,1.0426e-4,-0.913333333,47.12443807,4.058666667,1.9389e-5,9.528045382,-3.612,-2.752,-2.464,1.284,0.924,1.14,P01029,C4b,P01029_C4b,P01029,C4b,1,1089,116,116,P01029|E1BH06|F1MVK1|P01030,MOUSE,194566.4,62.3,7,7.1,1704.26,1704.26,,1738,Complement C4-B,extracellular space|,"inflammatory response|complement activation, classical pathway|negative regulation of endopeptidase activity|innate immune response|",endopeptidase inhibitor activity|,116,1089,1630000000000,62.3%
Q921I1,1.0838e-4,-1.069666667,45.83073397,4.626666667,2.61172e-5,9.127394203,-4.196,-2.494,-3.459,1.454,1.363,0.914,Q921I1,Trf,Q921I1_Trf,Q921I1,Tf,1,1784,90,87,Q921I1|E9Q035|Q29443|E9Q939,MOUSE,78890.5,82.2,8,8.1,1669.13,1617.66,,697,Serotransferrin,extracellular space|endosome|early endosome|late endosome|coated pit|basal plasma membrane|cell surface|membrane|cytoplasmic membrane-bounded vesicle|apical plasma membrane|vesicle coat|endocytic vesicle|vesicle|basal part of cell|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|blood microparticle|dense body|,"iron ion transport|cellular iron ion homeostasis|actin filament organization|activation of JUN kinase activity|ferric iron transport|osteoclast differentiation|positive regulation of phosphorylation|positive regulation of bone resorption|positive regulation of transcription, DNA-templated|SMAD protein signal transduction|ERK1 and ERK2 cascade|positive regulation of cell motility|",protein binding|ferric iron binding|ferric iron transmembrane transporter activity|,90,1784,29000000000000,82.2%
E9Q8I0,1.0426e-4,-1.085833333,50.46752357,4.426333333,8.97941e-6,10.63504162,-3.903,-2.921,-3.073,1,0.963,1.419,E9Q8I0,Cfh,E9Q8I0_Cfh,E9Q8I0,Cfh,1,939,95,77,E9Q8I0|P06909|D6RGQ0|E9Q8H9|A0A0A6YVP8,MOUSE,145947.1,76.1,9,9.1,1615.22,1330.82,,1252,Complement factor H,extracellular exosome|blood microparticle|,regulation of complement activation|,complement component C3b binding|heparin binding|heparan sulfate proteoglycan binding|,95,939,3140000000000,76.1%
E9Q8B5,1.22826e-4,-1.09,44.34768734,4.619333333,3.67478e-5,8.685872068,-3.284,-2.53,-4.385,1.376,0.88,1.403,E9Q8B5,Gm4788,E9Q8B5_Gm4788,E9Q8B5,Gm4788,1,23,50,4,E9Q8B5|E9Q8B6,MOUSE,102688.5,63.9,9,9.2,834.24,71.86,,879,Predicted gene 4788,,,,4,23,20200000000,6.8%
P20918,2.25378e-4,-0.901833333,39.51106844,4.631666667,1.11916e-4,7.366895773,-3.944,-2.004,-3.705,2.182,1.188,0.872,P20918,Plg,P20918_Plg,P20918,Plg,1,1250,87,87,P20918,MOUSE,93544.9,86.3,10,10.1,1482.37,1482.37,,812,Plasminogen,extracellular region|extracellular space|cell surface|extrinsic component of plasma membrane|extrinsic component of external side of plasma membrane|plasma lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood coagulation|negative regulation of cell-substrate adhesion|negative regulation of angiogenesis|extracellular matrix disassembly|tissue regeneration|fibrinolysis|myoblast differentiation|muscle cell cellular homeostasis|tissue remodeling|proteolysis involved in cellular protein catabolic process|negative regulation of fibrinolysis|positive regulation of fibrinolysis|trophoblast giant cell differentiation|labyrinthine layer blood vessel development|mononuclear cell migration|,fibronectin binding|serine-type endopeptidase activity|receptor binding|protein domain specific binding|apolipoprotein binding|,87,1250,8920000000000,86.3%
E9PZD8,1.53223e-4,-0.8915,42.22791711,4.199666667,5.98699e-5,8.085953,-4.033,-2.451,-2.49,1.392,1.327,0.906,E9PZD8,Cp,E9PZD8_Cp,E9PZD8,Cp,1,1067,79,1,E9PZD8|Q61147,MOUSE,125007.5,59.3,11,11.1,1447.9,17.49,,1086,Ceruloplasmin,extracellular space|lysosomal membrane|extracellular exosome|blood microparticle|,copper ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|chaperone binding|,79,1067,3690000000000,59.3%
B8JJN0,1.0426e-4,-0.958666667,46.75296224,4.235333333,2.11205e-5,9.411483289,-3.748,-2.57,-2.911,1.591,0.952,0.934,B8JJN0,NotFound,B8JJN0_NotFound,B8JJN0,Gm20547,1,769,90,64,B8JJN0|B8JJM5|P04186|B8JJM6|F6XQ00|Q9WTX6,MOUSE,144605,52.5,12,12.1,1423.12,1012.9,,1276,Predicted gene 20547,,proteolysis|,serine-type endopeptidase activity|,90,769,1390000000000,52.5%
P21180,1.0426e-4,-0.836833333,48.85643264,3.993666667,1.30124e-5,10.08822102,-3.149,-2.501,-2.851,1.596,0.884,1,P21180,C2,P21180_C2,P21180,C2,1,54,37,11,P21180|P21180-2|B8JJN2|B8JJM9,MOUSE,85995.1,47.3,12,12.2,553.32,143.1,,760,Complement C2,extracellular exosome|,"proteolysis|complement activation|complement activation, classical pathway|response to nutrient|innate immune response|positive regulation of apoptotic cell clearance|",serine-type endopeptidase activity|metal ion binding|,11,54,42600000000,16.7%
P07724,1.0426e-4,-1.023833333,47.04291205,4.162333333,1.97564e-5,9.502357837,-3.871,-2.746,-2.698,1.148,1.045,0.979,P07724,Alb,P07724_Alb,P07724,Alb,1,1273,73,70,P07724,MOUSE,70745.2,92.5,13,13.1,1292.24,1238.24,,608,Serum albumin,extracellular region|extracellular space|nucleus|cytoplasm|myelin sheath|protein complex|extracellular exosome|blood microparticle|,retina homeostasis|transport|cellular response to starvation|hemolysis by symbiont of host erythrocytes|negative regulation of apoptotic process|maintenance of mitochondrion location|,DNA binding|fatty acid binding|drug binding|toxic substance binding|pyridoxal phosphate binding|metal ion binding|chaperone binding|oxygen binding|,73,1273,16000000000000,92.5%
O88783,1.0426e-4,-0.871833333,47.88695187,4.165,1.62669e-5,9.77123031,-3.489,-2.412,-2.962,1.523,1.221,0.888,O88783,F5,O88783_F5,O88783,F5,1,434,83,83,O88783,MOUSE,248366.9,36,14,14.1,1234.51,1234.51,,2183,Coagulation factor V,extracellular space|membrane|platelet alpha granule|extracellular vesicle|,blood coagulation|blood circulation|platelet activation|,copper ion binding|,83,434,124000000000,36.0%
Q5SWU9,0.009207727,0.089333333,21.09502722,2.322666667,0.007771364,3.606777765,-1.766,-0.562,-0.888,2.548,0.39,0.814,Q5SWU9,Acaca,Q5SWU9_Acaca,Q5SWU9,Acaca,1,269,83,71,Q5SWU9|Q5SWU9-2,MOUSE,266849.4,35,15,15.1,1069.38,899.93,,2345,Acetyl-CoA carboxylase 1,nucleolus|cytoplasm|mitochondrion|cytosol|actin cytoskeleton|extracellular exosome|,tissue homeostasis|acetyl-CoA metabolic process|lipid metabolic process|fatty acid biosynthetic process|multicellular organismal protein metabolic process|protein homotetramerization|lipid homeostasis|cellular response to prostaglandin E stimulus|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|protein binding|ATP binding|metal ion binding|,83,269,34200000000,35.0%
E9Q4Z2,0.007092511,0.096833333,22.31323552,2.738333333,0.005870518,3.850942055,-2.187,-0.479,-1.151,2.801,0.506,1.091,E9Q4Z2,Acacb,E9Q4Z2_Acacb,E9Q4Z2,Acacb,1,14,21,9,E9Q4Z2,MOUSE,278141.4,9.8,15,15.2,256.63,87.18,,2448,Acetyl-CoA carboxylase 2,nucleus|mitochondrion|endomembrane system|membrane|,acetyl-CoA metabolic process|fatty acid biosynthetic process|positive regulation of lipid storage|negative regulation of fatty acid oxidation|protein homotetramerization|positive regulation of heart growth|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|ATP binding|metal ion binding|,9,14,171000000,4.2%
Q80YQ1,0.009169997,-0.681166667,21.11885393,3.323,0.007728845,3.702145757,-0.375,-2.688,-3.965,1.454,1.176,0.311,Q80YQ1,Thbs1,Q80YQ1_Thbs1,Q80YQ1,Thbs1,1,508,68,68,Q80YQ1|P35441|Q03350,MOUSE,133681.8,57.6,16,16.1,1068.46,1068.46,,1171,Thrombospondin-1,fibrinogen complex|extracellular space|external side of plasma membrane|cell surface|secretory granule|extracellular matrix|platelet alpha granule|extracellular exosome|extracellular matrix|,activation of MAPK activity|negative regulation of endothelial cell proliferation|negative regulation of cell-matrix adhesion|sprouting angiogenesis|chronic inflammatory response|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|negative regulation of dendritic cell antigen processing and presentation|outflow tract morphogenesis|endocardial cushion development|growth plate cartilage development|inflammatory response|immune response|cell cycle arrest|cell adhesion|response to glucose|positive regulation of endothelial cell migration|negative regulation of endothelial cell migration|negative regulation of plasma membrane long-chain fatty acid transport|negative regulation of nitric oxide mediated signal transduction|negative regulation of cGMP-mediated signaling|negative regulation of plasminogen activation|positive regulation of fibroblast migration|positive regulation of cell-substrate adhesion|cell migration|negative regulation of angiogenesis|peptide cross-linking|positive regulation of blood coagulation|positive regulation of cell migration|positive regulation of transforming growth factor beta receptor signaling pathway|regulation of cGMP metabolic process|response to magnesium ion|negative regulation of interleukin-12 production|negative regulation of fibroblast growth factor receptor signaling pathway|positive regulation of phosphorylation|response to drug|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|engulfment of apoptotic cell|positive regulation of translation|positive regulation of angiogenesis|blood vessel morphogenesis|positive regulation of chemotaxis|response to calcium ion|positive regulation of protein kinase B signaling|negative regulation of fibrinolysis|cellular response to nitric oxide|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of endothelial cell apoptotic process|positive regulation of reactive oxygen species metabolic process|negative regulation of endothelial cell chemotaxis|,phosphatidylserine binding|fibronectin binding|integrin binding|calcium ion binding|heparin binding|fibroblast growth factor binding|low-density lipoprotein particle binding|laminin binding|extracellular matrix binding|fibrinogen binding|collagen V binding|,69,508,541000000000,57.6%
A6X935,1.0426e-4,-0.980833333,50.35353296,4.219666667,9.21821e-6,10.59550664,-3.416,-2.641,-3.215,1.494,0.952,0.941,A6X935,Itih4,A6X935_Itih4,A6X935,Itih4,1,539,63,1,A6X935|A6X935-2|E9Q5L2,MOUSE,104828.7,70.5,17,17.1,1027.99,24.1,,942,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|hyaluronan metabolic process|response to cytokine|,serine-type endopeptidase inhibitor activity|protein binding|calcium ion binding|hyaluronic acid binding|,63,539,1050000000000,70.5%
Q9DBD0,1.0426e-4,-0.8935,46.63554289,4.224333333,2.16993e-5,9.37489609,-3.741,-2.536,-2.74,1.508,1.252,0.896,Q9DBD0,1300017J02Rik,Q9DBD0_1300017J02Rik,Q9DBD0,Ica,1,602,60,60,Q9DBD0|D3YY36,MOUSE,78761.2,67.5,18,18.1,982.11,982.11,,700,Inhibitor of carbonic anhydrase,extracellular space|,negative regulation of catalytic activity|,enzyme inhibitor activity|iron ion binding|,60,602,1380000000000,67.5%
P06728,1.0426e-4,-1.180666667,50.45567634,4.626,9.00394e-6,10.63092658,-4.02,-2.792,-3.669,1.161,1.3,0.936,P06728,Apoa4,P06728_Apoa4,P06728,Apoa4,1,1119,51,51,P06728,MOUSE,45028.2,85.8,19,19.1,900.53,900.53,,395,Apolipoprotein A-IV,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|cell surface|,innate immune response in mucosa|cholesterol biosynthetic process|lipid transport|response to lipid hydroperoxide|leukocyte cell-cell adhesion|cholesterol metabolic process|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|removal of superoxide radicals|triglyceride catabolic process|regulation of intestinal cholesterol absorption|neuron projection regeneration|regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|negative regulation of plasma lipoprotein particle oxidation|response to stilbenoid|lipoprotein metabolic process|cholesterol homeostasis|hydrogen peroxide catabolic process|reverse cholesterol transport|multicellular organismal lipid catabolic process|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipoprotein lipase activity|lipid homeostasis|protein-lipid complex assembly|triglyceride homeostasis|,copper ion binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|phosphatidylcholine binding|protein homodimerization activity|phosphatidylcholine-sterol O-acyltransferase activator activity|,51,1119,22400000000000,85.8%
Q91ZX7,1.0426e-4,-0.886333333,48.85850499,3.762,1.30062e-5,10.08890815,-3.206,-2.614,-2.482,1.039,1.018,0.927,Q91ZX7,Lrp1,Q91ZX7_Lrp1,Q91ZX7,Lrp1,1,191,73,73,A0A0R4J0I9|Q91ZX7|Q3U5J2|Q9JI18|A2API5|E9Q202|D3Z5M3|Q3TES0|A0A0N4SWH8|D6RHQ8,MOUSE,523675.1,18.1,20,20.1,891.37,891.37,,4545,Prolow-density lipoprotein receptor-related protein 1,nucleolus|cytoplasm|lysosomal membrane|integral component of plasma membrane|coated pit|focal adhesion|membrane|receptor complex|perinuclear region of cytoplasm|,receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of cholesterol efflux|negative regulation of smooth muscle cell migration|negative regulation of Wnt signaling pathway|positive regulation of lipid transport|regulation of cholesterol transport|regulation of phospholipase A2 activity|regulation of actin cytoskeleton organization|aorta morphogenesis|apoptotic cell clearance|beta-amyloid clearance|negative regulation of platelet-derived growth factor receptor-beta signaling pathway|,calcium ion binding|protein binding|protein complex binding|apolipoprotein binding|poly(A) RNA binding|,73,191,20100000000,18.1%
P21614,1.33041e-4,-1.009,43.59759078,4.469333333,4.36758e-5,8.469500974,-4.219,-2.446,-3.066,1.583,1.212,0.882,P21614,Gc,P21614_Gc,P21614,Gc,1,442,49,49,P21614,MOUSE,55196.9,89.2,21,21.1,887,887,,476,Vitamin D-binding protein,extracellular space|cytosol|axon|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|,female pregnancy|lactation|response to nutrient levels|response to estradiol|vitamin D metabolic process|vitamin transport|,actin binding|vitamin transporter activity|calcidiol binding|,49,442,654000000000,89.2%
P32261,1.10032e-4,-0.8205,45.68191867,4.359666667,2.70276e-5,9.082247307,-3.755,-2.371,-2.875,1.644,1.552,0.882,P32261,Serpinc1,P32261_Serpinc1,P32261,Serpinc1,1,682,57,57,P32261|A0A0A6YX49|A0A0A6YXS8,MOUSE,52516.1,72.4,22,22.1,885.21,885.21,,465,Antithrombin-III,extracellular space|extracellular exosome|blood microparticle|,"response to nutrient|blood coagulation|negative regulation of endopeptidase activity|negative regulation of inflammatory response|regulation of blood coagulation, intrinsic pathway|",protease binding|serine-type endopeptidase inhibitor activity|heparin binding|,57,682,2570000000000,72.4%
Q8K0E8,0.047709698,-0.1625,13.61624737,2.976333333,0.043488584,2.464836367,0.515,-2.704,-2.763,0.847,3.398,-0.268,Q8K0E8,Fgb,Q8K0E8_Fgb,Q8K0E8,Fgb,1,380,52,52,Q8K0E8|F1MAV0|P02676,MOUSE,55436.4,79.6,23,23.1,855.45,855.45,,481,Fibrinogen beta chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"cell-matrix adhesion|signal transduction|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|cellular protein complex assembly|cellular response to leptin stimulus|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-1|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|chaperone binding|receptor binding|cell adhesion molecule binding|",52,380,372000000000,79.6%
P19221,1.11935e-4,-1.096666667,45.20330306,4.566,3.01766e-5,8.938333973,-3.947,-2.446,-3.746,1.662,0.918,0.979,P19221,F2,P19221_F2,P19221,F2,1,554,50,50,P19221|H7BX99,MOUSE,71693.8,58.5,24,24.1,841.78,841.78,,618,Prothrombin,extracellular space|cytosol|extracellular matrix|extracellular exosome|blood microparticle|,positive regulation of protein phosphorylation|proteolysis|acute-phase response|cell surface receptor signaling pathway|positive regulation of cell proliferation|regulation of cell shape|response to wounding|regulation of gene expression|positive regulation of phosphatidylinositol 3-kinase signaling|response to inactivity|platelet activation|positive regulation of blood coagulation|positive regulation of cell growth|positive regulation of collagen biosynthetic process|fibrinolysis|negative regulation of proteolysis|negative regulation of astrocyte differentiation|positive regulation of release of sequestered calcium ion into cytosol|cytosolic calcium ion homeostasis|thrombin receptor signaling pathway|cellular response to mechanical stimulus|positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|receptor binding|calcium ion binding|protein binding|peptidase activity|thrombospondin receptor activity|,50,554,1590000000000,58.5%
Q60841,1.0426e-4,-0.935666667,48.3253933,4.137333333,1.47049e-5,9.913491401,-3.63,-2.83,-2.553,0.931,1.308,1.16,Q60841,Reln,Q60841_Reln,Q60841,Reln,1,229,61,61,Q60841|Q60841-2|Q60841-3,MOUSE,394505.8,19.3,25,25.1,835.78,835.78,,3461,Reelin,proteinaceous extracellular matrix|extracellular space|cytoplasm|dendrite|,"cell morphogenesis involved in differentiation|neuron migration|proteolysis|cell adhesion|axon guidance|central nervous system development|brain development|learning|long-term memory|associative learning|glial cell differentiation|regulation of gene expression|positive regulation of neuron projection development|positive regulation of phosphatidylinositol 3-kinase signaling|dendrite development|cell migration|peptidyl-tyrosine phosphorylation|spinal cord patterning|ventral spinal cord development|hippocampus development|cerebral cortex tangential migration|layer formation in cerebral cortex|cerebral cortex development|forebrain development|positive regulation of TOR signaling|positive regulation of CREB transcription factor activity|protein localization to synapse|reelin-mediated signaling pathway|positive regulation of protein kinase activity|response to pain|positive regulation of peptidyl-tyrosine phosphorylation|regulation of behavior|regulation of synaptic transmission|positive regulation of small GTPase mediated signal transduction|positive regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|positive regulation of dendritic spine morphogenesis|positive regulation of protein tyrosine kinase activity|positive regulation of synapse maturation|postsynaptic density assembly|N-methyl-D-aspartate receptor clustering|postsynaptic density protein 95 clustering|receptor localization to synapse|lateral motor column neuron migration|positive regulation of long-term synaptic potentiation|positive regulation of lateral motor column neuron migration|regulation of N-methyl-D-aspartate selective glutamate receptor activity|positive regulation of excitatory postsynaptic membrane potential|positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity|",protein binding|serine-type peptidase activity|metal ion binding|lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,61,229,20200000000,19.3%
E9PV24,0.059478079,-0.244333333,12.64213683,2.737333333,0.054423481,2.311515024,0.686,-2.531,-2.994,0.646,2.967,-0.24,E9PV24,Fga,E9PV24_Fga,E9PV24,Fga,1,429,61,61,E9PV24|E9PV24-2|P02672|A5PJE3,MOUSE,88169.4,60.2,26,26.1,826.72,826.72,,789,Fibrinogen alpha chain,fibrinogen complex|extracellular space|rough endoplasmic reticulum|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"protein complex assembly|acute-phase response|cell-matrix adhesion|signal transduction|blood coagulation|plasminogen activation|response to estradiol|response to genistein|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|response to morphine|cellular protein complex assembly|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|response to cycloheximide|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-6|cellular response to organic cyclic compound|blood coagulation, common pathway|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|liver regeneration|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|cellular response to granulocyte colony-stimulating factor|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|receptor binding|cell adhesion molecule binding|",61,429,785000000000,60.2%
P26262,1.84037e-4,-0.889833333,40.97928518,4.363666667,7.98126e-5,7.748801621,-4.238,-2.596,-2.381,1.551,1.421,0.904,P26262,Klkb1,P26262_Klkb1,P26262,Klkb1,1,478,49,49,P26262|P04187,MOUSE,73492.3,68.1,27,27.1,824.46,824.46,,638,Plasma kallikrein,extracellular space|extracellular exosome|,inflammatory response|blood coagulation|plasminogen activation|fibrinolysis|positive regulation of fibrinolysis|liver regeneration|,serine-type endopeptidase activity|,49,478,888000000000,68.1%
Q61702,1.05478e-4,-1.021666667,46.06691652,4.53,2.47348e-5,9.199439657,-4.038,-2.472,-3.35,1.576,1.256,0.898,Q61702,Itih1,Q61702_Itih1,Q61702,Itih1,1,420,47,2,Q61702,MOUSE,101521.5,50.8,28,28.1,820.26,31.83,,907,Inter-alpha-trypsin inhibitor heavy chain H1,extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,47,420,574000000000,50.8%
E9PUU8,1.34728e-4,-1.217833333,43.32185892,4.581666667,4.65387e-5,8.391102942,-3.259,-2.647,-4.62,1.111,1.201,0.907,E9PUU8,NotFound,E9PUU8_NotFound,E9PUU8,Pkhd1l1,1,155,59,59,E9PUU8|Q80ZA4|F8WH29|Q80ZA4-2,MOUSE,469488.1,16.6,29,29.1,763.01,763.01,,4249,Fibrocystin-L,cilium|,,protein binding|,59,155,12200000000,16.6%
P42703,1.0426e-4,-0.985166667,49.79380817,5.120333333,1.04862e-5,10.40326659,-3.743,-2.833,-4.06,0.921,1.844,1.96,P42703,Lifr,P42703_Lifr,P42703,Lifr,1,431,49,3,P42703,MOUSE,123883.7,40.1,30,30.1,755.34,45.04,,1092,Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,49,431,903000000000,40.1%
P42703-2,4.11068e-4,-0.196833333,35.92538365,3.409,2.55542e-4,6.495448714,-2.516,-1.006,-2.182,0.915,1.652,1.956,P42703,Lifr,P42703-2_Lifr,P42703-2,Lifr,1,26,47,2,P42703-2,MOUSE,82255.7,58.4,30,30.2,723.76,28,,1092,Isoform 2 of Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,2,26,25200000000,3.7%
A0A0R4J0I1,1.0426e-4,-1.054166667,49.26623384,4.242333333,1.18407e-5,10.22490209,-3.79,-2.67,-3.066,1.044,1.199,0.958,A0A0R4J0I1,Serpina3k,A0A0R4J0I1_Serpina3k,A0A0R4J0I1,Serpina3k,1,1670,37,25,A0A0R4J0I1|P07759,MOUSE,46900.1,68.1,31,31.1,748.6,504.18,,418,MCG1051009,,,,37,1670,19600000000000,68.1%
G3X8T9,1.95315e-4,-1.070666667,40.58337812,4.356666667,8.74303e-5,7.644303036,-3.414,-2.13,-4.203,1.459,1,0.864,G3X8T9,Serpina3n,G3X8T9_Serpina3n,G3X8T9,Serpina3n,1,29,31,2,G3X8T9|Q6P4P1|D3Z451,MOUSE,46936.4,55.5,31,31.2,508.69,43.82,,418,"Serine (Or cysteine) peptidase inhibitor, clade A, member 3N, isoform CRA_a",extracellular region|extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,2,29,31900000000,6.6%
Q03734,1.10858e-4,-0.5325,45.49378624,3.675666667,2.82242e-5,9.025445101,-2.736,-2.387,-1.988,1.661,1.387,0.868,Q03734,Serpina3m,Q03734_Serpina3m,Q03734,Serpina3m,1,102,29,16,Q03734,MOUSE,47234.5,58.8,31,31.4,507.95,239.1,,418,Serine protease inhibitor A3M,extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,16,102,71600000000,39.2%
A0A0R4J038,1.0426e-4,-1.075166667,48.61117396,4.586333333,1.37684e-5,10.00719017,-3.933,-2.607,-3.565,1.491,1.24,0.923,A0A0R4J038,Kng1,A0A0R4J038_Kng1,A0A0R4J038,Kng1,1,536,42,8,A0A0R4J038|D3YTY9|O08677|O08677-3|B99909|P01044|P01045,MOUSE,74183.9,51.5,32,32.1,742.38,151.88,,661,Kininogen-1,,,,42,536,3970000000000,51.5%
O08677-2,3.75323e-4,-0.795,36.44420842,3.517333333,2.26767e-4,6.616457182,-3.183,-1.46,-3.018,1.218,0.779,0.894,O08677,Kng1,O08677-2_Kng1,O08677-2,Kng1,1,39,33,3,O08677-2,MOUSE,48981.4,64.3,32,32.2,591.75,35.5,,661,Isoform LMW of Kininogen-1,extracellular space|cytosol|extracellular exosome|blood microparticle|,inflammatory response|blood coagulation|negative regulation of endopeptidase activity|vasodilation|,cysteine-type endopeptidase inhibitor activity|receptor binding|,3,39,50100000000,6.2%
Q6S9I3,1.31635e-4,-0.918,43.66116372,4.212,4.30411e-5,8.487662652,-3.836,-2.272,-2.964,1.606,1.063,0.895,Q6S9I3,Kng2,Q6S9I3_Kng2,Q6S9I3,Kng2,1,163,32,25,Q6S9I3|Q6S9I2|E0CYI5,MOUSE,72355.1,37.1,32,32.3,505.69,421.91,,644,HMW kininogen-II,extracellular space|cytosol|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|receptor binding|,25,163,98600000000,35.2%
Q61129,1.0426e-4,-1.016666667,49.24319221,4.31,1.19037e-5,10.21717399,-3.822,-2.697,-2.996,1.243,1.235,0.937,Q61129,Cfi,Q61129_Cfi,Q61129,Cfi,1,416,42,42,Q61129,MOUSE,69541.5,59.8,33,33.1,732.18,732.18,,603,Complement factor I,extracellular space|membrane|extracellular exosome|,"proteolysis|receptor-mediated endocytosis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|scavenger receptor activity|metal ion binding|,42,416,773000000000,59.8%
Q00623,1.11935e-4,-1.1,45.23864052,4.604666667,2.9932e-5,8.948892801,-4.362,-2.614,-3.231,1.465,1.206,0.936,Q00623,Apoa1,Q00623_Apoa1,Q00623,Apoa1,1,1753,44,44,Q00623,MOUSE,30615,81.4,34,34.1,730.74,730.74,,264,Apolipoprotein A-I,extracellular region|extracellular space|nucleus|cytosol|cell surface|endocytic vesicle|cytoplasmic vesicle|very-low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,regulation of protein phosphorylation|endothelial cell proliferation|negative regulation of cytokine secretion involved in immune response|phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol biosynthetic process|G-protein coupled receptor signaling pathway|integrin-mediated signaling pathway|response to nutrient|cholesterol metabolic process|glucocorticoid metabolic process|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|negative regulation of very-low-density lipoprotein particle remodeling|protein oxidation|peptidyl-methionine modification|triglyceride catabolic process|lipid storage|regulation of intestinal cholesterol absorption|cholesterol transport|adrenal gland development|organ regeneration|regulation of Cdc42 protein signal transduction|cholesterol efflux|phospholipid efflux|negative regulation of heterotypic cell-cell adhesion|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|positive regulation of Rho protein signal transduction|lipoprotein biosynthetic process|response to drug|cholesterol homeostasis|blood vessel endothelial cell migration|response to estrogen|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|negative regulation of interleukin-1 beta secretion|negative regulation of inflammatory response|protein stabilization|negative chemotaxis|positive regulation of lipoprotein lipase activity|vitamin transport|positive regulation of hydrolase activity|negative regulation of hydrolase activity|positive regulation of stress fiber assembly|phospholipid homeostasis|negative regulation of lipase activity|negative regulation of cell adhesion molecule production|negative regulation of response to cytokine stimulus|triglyceride homeostasis|cholesterol import|positive regulation of substrate adhesion-dependent cell spreading|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|phospholipid transporter activity|high-density lipoprotein particle binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|apolipoprotein receptor binding|apolipoprotein A-I receptor binding|identical protein binding|chemorepellent activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|lipoprotein particle binding|cholesterol transporter activity|,44,1753,305000000000000,81.4%
P20029,1.0426e-4,-1.1375,46.97651665,4.543,2.00608e-5,9.481481954,-3.852,-2.524,-3.851,1.416,1.102,0.884,P20029,Hspa5,P20029_Hspa5,P20029,Hspa5,1,339,46,43,P20029,MOUSE,72534.8,57.7,35,35.1,726.45,687.53,,655,78 kDa glucose-regulated protein,extracellular region|nucleus|mitochondrion|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|smooth endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|plasma membrane|focal adhesion|cell surface|membrane|integral component of endoplasmic reticulum membrane|midbody|endoplasmic reticulum chaperone complex|melanosome|myelin sheath|extracellular exosome|COP9 signalosome|,ER overload response|activation of signaling protein activity involved in unfolded protein response|cerebellum structural organization|cerebellar Purkinje cell layer development|substantia nigra development|positive regulation of cell migration|negative regulation of transforming growth factor beta receptor signaling pathway|positive regulation of protein ubiquitination|response to endoplasmic reticulum stress|maintenance of protein localization in endoplasmic reticulum|positive regulation of embryonic development|cellular response to glucose starvation|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|cellular response to antibiotic|cellular response to interleukin-4|toxin transport|,glycoprotein binding|protein binding|ATP binding|ATPase activity|enzyme binding|protein domain specific binding|ubiquitin protein ligase binding|ribosome binding|unfolded protein binding|misfolded protein binding|,46,339,257000000000,57.7%
P63017,1.44347e-4,-0.747166667,42.73524098,3.515,5.32692e-5,8.226310927,-3.155,-2.342,-2.017,1.271,0.844,0.916,P63017,Hspa8,P63017_Hspa8,P63017,Hspa8,1,53,24,21,P63017|Q504P4|P17156|P16627|P17879|Q61696,MOUSE,71098,34,35,35.2,291.49,252.57,,646,Heat shock cognate 71 kDa protein,Prp19 complex|extracellular space|intracellular|nucleus|spliceosomal complex|nucleolus|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|melanosome|myelin sheath|extracellular exosome|blood microparticle|ubiquitin ligase complex|,"transcription, DNA-templated|mRNA processing|protein folding|RNA splicing|protein refolding|negative regulation of transcription, DNA-templated|ATP metabolic process|positive regulation of mRNA splicing, via spliceosome|chaperone mediated protein folding requiring cofactor|regulation of cell cycle|clathrin coat disassembly|negative regulation of fibril organization|","G-protein coupled receptor binding|protein binding|ATP binding|ATPase activity|enzyme binding|MHC class II protein complex binding|heat shock protein binding|ubiquitin protein ligase binding|ATPase activity, coupled|poly(A) RNA binding|unfolded protein binding|C3HC4-type RING finger domain binding|",21,53,1300000000,31.2%
Q8K182,1.54772e-4,-0.869333333,42.14023295,4.032666667,6.10909e-5,8.061894183,-3.697,-2.968,-1.992,1.183,0.925,1.333,Q8K182,C8a,Q8K182_C8a,Q8K182,C8a,1,371,45,45,Q8K182|A2A997|A2A998,MOUSE,67733.7,65.4,36,36.1,697.14,697.14,,587,Complement component C8 alpha chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation|complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|protein complex binding|,45,371,477000000000,65.4%
P06683,1.0426e-4,-1.079333333,49.50655197,4.394,1.12033e-5,10.30581205,-3.964,-2.856,-3.009,1.147,1.277,0.929,P06683,C9,P06683_C9,P06683,C9,1,338,43,43,A0A0R4J032|P06683,MOUSE,63256.4,66.2,37,37.1,696.87,696.87,,548,Complement component C9,membrane attack complex|cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",,43,338,609000000000,66.2%
E9Q6D8,1.0426e-4,-0.919833333,47.34751396,4.373,1.84183e-5,9.598640394,-3.784,-2.938,-2.597,1.16,1.712,0.928,E9Q6D8,NotFound,E9Q6D8_NotFound,E9Q6D8,C6,1,226,41,41,E9Q6D8|Q91X70,MOUSE,108049.4,49.5,38,38.1,682.27,682.27,,931,Complement component 6,membrane attack complex|extracellular exosome|,in utero embryonic development|immune response|,,41,226,66600000000,49.5%
P01872,1.0426e-4,-0.882,48.06459932,4.529333333,1.56149e-5,9.828655429,-3.394,-2.715,-3.331,1.09,2.127,0.931,P01872,NotFound,P01872_NotFound,P01872,Ighm,1,455,38,37,P01872|P01872-2|P04221,MOUSE,50655.7,62.7,39,39.1,655.86,636.11,,454,Ig mu chain C region,"extracellular space|plasma membrane|external side of plasma membrane|integral component of membrane|B cell receptor complex|immunoglobulin complex, circulating|perinuclear region of cytoplasm|",activation of MAPK activity|humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antigen processing and presentation|positive regulation of B cell proliferation|positive regulation of MAPK cascade|early endosome to late endosome transport|positive regulation of endocytosis|positive regulation of peptidyl-tyrosine phosphorylation|defense response to Gram-negative bacterium|B cell receptor signaling pathway|positive regulation of B cell activation|,antigen binding|transmembrane signaling receptor activity|protein binding|immunoglobulin receptor binding|identical protein binding|,38,455,1790000000000,62.7%
P08113,1.0426e-4,-1.212833333,51.37811648,4.503666667,7.28096e-6,10.95561136,-4.059,-2.97,-3.365,1.016,1.175,0.926,P08113,Hsp90b1,P08113_Hsp90b1,P08113,Hsp90b1,1,198,48,46,P08113|E9PX27,MOUSE,92759.4,48.7,40,40.1,654.48,615.54,,802,Endoplasmin,extracellular region|nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|cytosol|plasma membrane|focal adhesion|membrane|midbody|extracellular matrix|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"response to hypoxia|protein folding|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|actin rod assembly|negative regulation of apoptotic process|regulation of phosphoprotein phosphatase activity|cellular response to ATP|",RNA binding|protein binding|ATP binding|protein phosphatase binding|virion binding|low-density lipoprotein particle receptor binding|unfolded protein binding|,48,198,47600000000,48.7%
Q07968,1.0426e-4,-0.959166667,48.56308187,4.225666667,1.39217e-5,9.991368181,-3.728,-2.777,-2.711,1.178,1.367,0.916,Q07968,F13b,Q07968_F13b,Q07968,F13b,1,382,41,41,Q07968,MOUSE,78476.1,54.8,41,41.1,650.8,650.8,,669,Coagulation factor XIII B chain,extracellular region|,blood coagulation|,,41,382,341000000000,54.8%
P09103,1.09993e-4,-1.31,45.74566133,4.985333333,2.66338e-5,9.10156188,-3.913,-2.756,-4.739,1.371,1.274,0.903,P09103,P4hb,P09103_P4hb,P09103,P4hb,1,202,46,46,P09103|P05307|A6H7J6|E9Q8G8,MOUSE,57456.8,66.6,42,42.1,641.23,641.23,,509,Protein disulfide-isomerase,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|focal adhesion|external side of plasma membrane|procollagen-proline 4-dioxygenase complex|endoplasmic reticulum chaperone complex|melanosome|extracellular exosome|,protein folding|peptidyl-proline hydroxylation to 4-hydroxy-L-proline|response to endoplasmic reticulum stress|cell redox homeostasis|cellular response to hypoxia|regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|integrin binding|protein binding|enzyme binding|poly(A) RNA binding|protein heterodimerization activity|procollagen-proline 4-dioxygenase activity|peptidyl-proline 4-dioxygenase activity|,46,202,70700000000,66.6%
Q91WP0,1.0426e-4,-1.087333333,51.36964058,4.384,7.29518e-6,10.95258808,-3.82,-2.848,-3.17,1.251,1.129,0.934,Q91WP0,Masp2,Q91WP0_Masp2,Q91WP0,Masp2,1,366,44,44,Q91WP0|Q91WP0-2,MOUSE,76998.6,63.5,43,43.1,640.87,640.87,,685,Mannan-binding lectin serine protease 2,extracellular exosome|,"complement activation, lectin pathway|proteolysis|complement activation, classical pathway|",complement component C4b binding|serine-type endopeptidase activity|calcium ion binding|protein binding|peptidase activity|calcium-dependent protein binding|,45,366,449000000000,63.5%
D3YXF5,1.0426e-4,-1.317833333,49.42943196,4.827666667,1.1404e-5,10.27978606,-4.237,-2.861,-4.097,1.061,1.298,0.929,D3YXF5,C7,D3YXF5_C7,D3YXF5,C7,1,210,39,39,D3YXF5,MOUSE,96587.9,43.6,44,44.1,622.19,622.19,,845,Complement component 7,membrane attack complex|extracellular exosome|,immune response|,,39,210,50500000000,43.6%
G3X977,1.11935e-4,-0.982333333,45.25304103,4.445333333,2.98329e-5,8.953198705,-3.914,-2.365,-3.336,1.634,1.201,0.886,G3X977,Itih2,G3X977_Itih2,G3X977,Itih2,1,413,38,38,G3X977|Q61703,MOUSE,106758.8,40.5,45,45.1,617.02,617.02,,950,"Inter-alpha trypsin inhibitor, heavy chain 2",extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,38,413,1240000000000,40.5%
P98064,1.0426e-4,-1.146333333,52.09545032,4.36,6.17241e-6,11.21420791,-3.819,-2.894,-3.266,1,1.101,1,P98064,Masp1,P98064_Masp1,P98064,Masp1,1,245,40,19,P98064,MOUSE,81621.4,55.8,46,46.1,605.46,269.73,,704,Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,40,245,86200000000,55.8%
P98064-2,1.0426e-4,-1.232833333,49.54690527,4.586333333,1.10997e-5,10.3194534,-4.307,-3.156,-3.115,1,1.228,0.953,P98064,Masp1,P98064-2_Masp1,P98064-2,Masp1,1,39,29,8,P98064-2,MOUSE,83984.9,41,46,46.2,457.29,121.56,,704,Isoform 2 of Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,8,39,7570000000,10.2%
Q8BH35,1.0426e-4,-1.205666667,50.50818436,4.634,8.89573e-6,10.64917558,-3.737,-2.804,-4.027,1.218,0.928,1.188,Q8BH35,C8b,Q8BH35_C8b,Q8BH35,C8b,1,270,37,37,Q8BH35|Q8BH35-2,MOUSE,68053.9,58,47,47.1,601.62,601.62,,589,Complement component C8 beta chain,membrane attack complex|extracellular space|extracellular exosome|extracellular vesicle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",protein complex binding|,37,270,161000000000,58.0%
Q00897,1.0426e-4,-0.969833333,47.31408458,4.351,1.85606e-5,9.588032506,-3.875,-2.554,-3.007,1.47,1.227,0.92,Q00897,Serpina1d,Q00897_Serpina1d,Q00897,Serpina1d,1,465,33,10,Q00897,MOUSE,46168.7,66.8,48,48.1,596.99,189.57,,413,Alpha-1-antitrypsin 1-4,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,33,465,3740000000000,66.8%
P22599,3.12666e-4,-1.029166667,37.44306866,4.387666667,1.80174e-4,6.8541458220000004,-4.678,-2.425,-2.566,1.436,1.169,0.889,P22599,Serpina1b,P22599_Serpina1b,P22599,Serpina1b,1,80,31,9,P22599,MOUSE,46145,65.8,48,48.2,570.79,166.93,,413,Alpha-1-antitrypsin 1-2,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,in utero embryonic development|protein N-linked glycosylation|acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,9,80,256000000000,21.7%
Q00898,2.0518e-4,-0.501333333,40.11197721,3.989333333,9.74546e-5,7.521349516,-3.253,-1.734,-2.501,0.794,1.913,1.773,Q00898,Serpina1e,Q00898_Serpina1e,Q00898,Serpina1e,1,21,23,3,Q00898,MOUSE,46118.8,34.6,48,48.5,360.92,47.56,,413,Alpha-1-antitrypsin 1-5,extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,3,21,2240000000,8.7%
J3QQ16,1.0426e-4,-0.960666667,50.51845688,3.888666667,8.87471e-6,10.65274903,-3.254,-2.571,-2.89,0.928,0.985,1.038,J3QQ16,Col6a3,J3QQ16_Col6a3,J3QQ16,Col6a3,1,122,48,48,J3QQ16|E9PWQ3|A0A087WS16,MOUSE,290173.5,19.3,49,49.1,587.73,587.73,,2677,"Collagen, type VI, alpha 3",proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|extracellular exosome|extracellular vesicle|extracellular matrix|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,48,122,6630000000,19.3%
Q91X72,1.0426e-4,-0.692,46.68172459,4.039333333,2.14698e-5,9.389271403,-2.353,-2.796,-2.986,1.215,1.927,0.841,Q91X72,Hpx,Q91X72_Hpx,Q91X72,Hpx,1,314,36,36,Q91X72,MOUSE,52058.5,53,50,50.1,583.84,583.84,,460,Hemopexin,extracellular space|extracellular exosome|blood microparticle|,positive regulation of immunoglobulin production|positive regulation of humoral immune response mediated by circulating immunoglobulin|transport|hemoglobin metabolic process|heme metabolic process|positive regulation of tyrosine phosphorylation of Stat1 protein|regulation of protein metabolic process|positive regulation of response to interferon-gamma|positive regulation of interferon-gamma-mediated signaling pathway|,heme binding|metal ion binding|,36,314,312000000000,53.0%
E9QPD7,0.007140302,0.202,22.27796562,2.205333333,0.005918388,3.804986527,-1.073,-0.62,-1.009,2.524,0.414,0.976,E9QPD7,Pcx,E9QPD7_Pcx,E9QPD7,Pcx,1,159,42,42,E9QPD7|G5E8R3|Q05920,MOUSE,130571.1,37.7,51,51.1,577.87,577.87,,1179,Pyruvate carboxylase,mitochondrion|,pyruvate metabolic process|gluconeogenesis|negative regulation of gene expression|viral RNA genome packaging|positive regulation by host of viral release from host cell|,DNA binding|biotin carboxylase activity|pyruvate carboxylase activity|ATP binding|biotin binding|metal ion binding|,42,159,24400000000,37.7%
O08601-2,1.04475e-4,-0.886833333,46.54909146,4.104333333,2.21356e-5,9.348036648,-3.478,-2.317,-3.022,1.531,1.085,0.88,O08601,Mttp,O08601-2_Mttp,O08601-2,Mttp,1,131,38,38,O08601-2|O08601,MOUSE,101433.7,36.6,52,52.1,572.28,572.28,,894,Isoform 2 of Microsomal triglyceride transfer protein large subunit,endoplasmic reticulum|rough endoplasmic reticulum|Golgi apparatus|basolateral plasma membrane|brush border membrane|microvillus membrane|membrane-bounded vesicle|receptor complex|,protein lipidation|lipid metabolic process|triglyceride metabolic process|lipid transport|circadian rhythm|cholesterol metabolic process|lipoprotein metabolic process|cholesterol homeostasis|lipoprotein transport|response to calcium ion|,lipid transporter activity|protein binding|lipid binding|apolipoprotein binding|protein heterodimerization activity|,38,131,17300000000,36.6%
Q8CG16,1.06798e-4,-0.959833333,45.94964743,4.082333333,2.54118e-5,9.163607204,-3.744,-2.731,-2.528,1.365,0.95,0.929,Q8CG16,C1ra,Q8CG16_C1ra,Q8CG16,C1ra,1,183,35,32,Q8CG16|Q8CFG9,MOUSE,81555.2,59.2,53,53.1,556.65,517.34,,707,Complement C1r-A subcomponent,extracellular exosome|blood microparticle|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|calcium ion binding|,35,183,65500000000,59.2%
Q3UZ09,1.0426e-4,-0.625833333,47.1129551,3.339,1.94404e-5,9.524423653,-2.385,-2.099,-2.402,1.252,0.958,0.921,Q3UZ09,C1rl,Q3UZ09_C1rl,Q3UZ09,C1rl,1,48,19,16,Q3UZ09,MOUSE,54233.1,36.7,53,53.2,221.9,182.59,,482,Complement C1r subcomponent-like protein,extracellular space|extracellular exosome|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|,16,48,3370000000,32.3%
E9Q6C2,1.78163e-4,-0.910833333,41.18527137,4.026333333,7.61155e-5,7.803623048,-3.95,-2.556,-2.266,1.367,1,0.94,E9Q6C2,C1s1,E9Q6C2_C1s1,E9Q6C2,C1s1,1,215,33,2,E9Q6C2,MOUSE,79039.3,51.4,54,54.1,554,17.67,,694,"Complement component 1, s subcomponent 1",extracellular exosome|blood microparticle|,proteolysis|complement activation|,serine-type endopeptidase activity|calcium ion binding|identical protein binding|,33,215,68500000000,51.4%
Q8CG14,4.90869e-4,-1.2025,34.99518049,4.698333333,3.16579e-4,6.409906648,-3.652,-1.991,-5.012,1.32,1.199,0.921,Q8CG14,C1s1,Q8CG14_C1s1,Q8CG14,C1sa,1,17,32,2,Q8CG14,MOUSE,78396.6,51.7,54,54.2,543.88,27.94,,688,Complement C1s-A subcomponent,extracellular exosome|blood microparticle|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|calcium ion binding|identical protein binding|,2,17,2820000000,3.9%
Q06890,1.05478e-4,-0.619166667,46.2842407,3.699666667,2.35275e-5,9.266161943,-2.369,-2.302,-2.736,1.735,1.123,0.834,Q06890,Clu,Q06890_Clu,Q06890,Clu,1,361,34,34,Q06890,MOUSE,52282.3,48.4,55,55.1,551.91,551.91,,448,Clusterin,extracellular space|intracellular|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|extracellular matrix|mitochondrial membrane|spherical high-density lipoprotein particle|chromaffin granule|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|neurofibrillary tangle|apical dendrite|extracellular matrix|,cell morphogenesis|microglial cell activation|response to virus|protein import|central nervous system myelin maintenance|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of protein homooligomerization|positive regulation of tumor necrosis factor production|positive regulation of apoptotic process|positive regulation of nitric oxide biosynthetic process|protein stabilization|positive regulation of NF-kappaB transcription factor activity|chaperone-mediated protein complex assembly|response to misfolded protein|chaperone-mediated protein folding|microglial cell proliferation|intrinsic apoptotic signaling pathway|regulation of beta-amyloid clearance|regulation of neuron death|positive regulation of neuron death|positive regulation of beta-amyloid formation|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|negative regulation of beta-amyloid formation|regulation of neuronal signal transduction|positive regulation of tau-protein kinase activity|positive regulation of neurofibrillary tangle assembly|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of intrinsic apoptotic signaling pathway|,protein binding|ubiquitin protein ligase binding|misfolded protein binding|ATPase activity|,34,361,1070000000000,48.4%
Q01339,1.41391e-4,-0.846166667,42.96054758,4.166333333,5.05761e-5,8.289284417,-3.881,-2.428,-2.479,1.553,1.261,0.897,Q01339,Apoh,Q01339_Apoh,Q01339,Apoh,1,386,34,34,Q01339,MOUSE,39930.4,70.7,56,56.1,542.84,542.84,,345,Beta-2-glycoprotein 1,extracellular space|cell surface|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|extracellular matrix|,"negative regulation of endothelial cell proliferation|triglyceride metabolic process|blood coagulation, intrinsic pathway|negative regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of blood coagulation|negative regulation of blood coagulation|organ regeneration|plasminogen activation|negative regulation of myeloid cell apoptotic process|negative regulation of smooth muscle cell apoptotic process|positive regulation of lipoprotein lipase activity|regulation of fibrinolysis|negative regulation of fibrinolysis|",glycoprotein binding|phospholipid binding|heparin binding|lipid binding|identical protein binding|lipoprotein lipase activator activity|,34,386,1990000000000,70.7%
O89020,1.0426e-4,-1.122166667,50.98364493,4.499666667,7.97325e-6,10.81569544,-3.762,-2.748,-3.606,1.333,1.139,0.911,O89020,Afm,O89020_Afm,O89020,Afm,1,260,38,38,O89020|O89020-3|O89020-2,MOUSE,71317.7,53.7,57,57.1,542,542,,608,Afamin,extracellular space|extracellular exosome|blood microparticle|,vitamin transport|,vitamin E binding|,38,260,160000000000,53.7%
B2RPV6,1.12595e-4,-0.646666667,45.06674631,3.772,3.11405e-5,8.897630055,-1.99,-2.856,-2.752,1.348,1.569,0.801,B2RPV6,Mmrn1,B2RPV6_Mmrn1,B2RPV6,Mmrn1,1,145,40,40,B2RPV6|G3UVV6|A0A0N4SVL8,MOUSE,137358.3,33.4,58,58.1,527.42,527.42,,1210,Multimerin-1,extracellular region|,,,40,145,14700000000,33.4%
P13020,1.0426e-4,-0.890666667,46.71884241,3.954666667,2.12871e-5,9.40083909,-3.539,-2.555,-2.51,1.168,1.192,0.9,P13020,Gsn,P13020_Gsn,P13020,Gsn,1,168,37,37,P13020|P13020-2,MOUSE,86339.4,38.9,59,59.1,523.23,523.23,,780,Gelsolin,ruffle|podosome|extracellular region|extracellular space|cytoplasm|cytosol|plasma membrane|focal adhesion|sarcoplasm|lamellipodium|actin cap|cortical actin cytoskeleton|myelin sheath|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|nucleus|focal adhesion|cortical actin cytoskeleton|,"phagocytosis, engulfment|aging|positive regulation of gene expression|oligodendrocyte development|striated muscle atrophy|vesicle-mediated transport|actin filament polymerization|protein destabilization|tissue regeneration|sequestering of actin monomers|actin nucleation|response to ethanol|negative regulation of viral entry into host cell|phosphatidylinositol-mediated signaling|actin filament severing|barbed-end actin filament capping|positive regulation of actin nucleation|response to folic acid|actin filament capping|cilium morphogenesis|cellular response to cadmium ion|regulation of podosome assembly|actin filament reorganization|renal protein absorption|hepatocyte apoptotic process|positive regulation of keratinocyte apoptotic process|regulation of wound healing, spreading of epidermal cells|regulation of establishment of T cell polarity|regulation of plasma membrane raft polarization|regulation of receptor clustering|positive regulation of protein processing in phagocytic vesicle|amyloid fibril formation|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|",actin binding|calcium ion binding|protein binding|protein domain specific binding|myosin II binding|,37,168,136000000000,38.9%
Q61508,4.59505e-4,-0.331,35.33715811,4.223333333,2.92607e-4,6.360226936,-1.868,-2.211,-3.249,1.528,3.037,0.777,Q61508,Ecm1,Q61508_Ecm1,Q61508,Ecm1,1,188,34,34,Q61508|F8WI14|Q61508-2,MOUSE,64485.6,67.2,60,60.1,509.54,509.54,,559,Extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|,ossification|angiogenesis|positive regulation of endothelial cell proliferation|negative regulation of cytokine-mediated signaling pathway|regulation of type 2 immune response|regulation of transcription from RNA polymerase II promoter|inflammatory response|signal transduction|negative regulation of peptidase activity|negative regulation of bone mineralization|biomineral tissue development|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of angiogenesis|regulation of T cell migration|,protease binding|signal transducer activity|interleukin-2 receptor binding|protein C-terminus binding|enzyme binding|laminin binding|,34,188,95700000000,67.2%
Q8VCU2,6.11179e-4,-0.874666667,33.85145948,3.96,4.11959e-4,6.027724073,-4.081,-3.02,-1.463,1.374,1.01,0.932,Q8VCU2,Gpld1,Q8VCU2_Gpld1,Q8VCU2,Gpld1,1,206,33,33,Q8VCU2|O70362,MOUSE,94192.4,45.9,61,61.1,501.16,501.16,,842,Glycosylphosphatidylinositol specific phospholipase D1,proteinaceous extracellular matrix|extracellular space|intracellular|cytoplasm|lysosomal membrane|intracellular membrane-bounded organelle|extracellular exosome|,cell migration involved in sprouting angiogenesis|complement receptor mediated signaling pathway|GPI anchor release|negative regulation of cell proliferation|insulin receptor signaling pathway|response to glucose|positive regulation of endothelial cell migration|cellular response to insulin stimulus|cellular response to drug|positive regulation of apoptotic process|positive regulation of cytolysis|positive regulation of membrane protein ectodomain proteolysis|cellular response to calcium ion|cellular response to cholesterol|cellular response to triglyceride|cellular response to pH|regulation of cellular response to insulin stimulus|,glycosylphosphatidylinositol phospholipase D activity|phospholipase D activity|protein binding|,33,206,98900000000,45.9%
Q19LI2,0.001357334,-0.243166667,29.99902566,4.363666667,0.001000224,5.327013543,-3.078,-2.379,-1.818,1,3.816,1,Q19LI2,A1bg,Q19LI2_A1bg,Q19LI2,A1bg,1,353,30,30,Q19LI2,MOUSE,57237.7,66,62,62.1,495.2,495.2,,512,Alpha-1B-glycoprotein,extracellular region|extracellular space|extracellular exosome|blood microparticle|,,,30,353,1520000000000,66.0%
P50446,0.281239185,-0.436166667,5.647940076,1.404333333,0.272399303,1.192185758,0.432,0.199,-4.046,-0.028,-0.101,0.927,P50446,Krt6a,P50446_Krt6a,P50446,Krt6a,1,16,24,7,P50446|Q9Z331|Q3UV11|Q6IFZ8,MOUSE,59676.4,32.9,63,63.2,288.53,75.09,,553,"Keratin, type II cytoskeletal 6A",keratin filament|extracellular exosome|,morphogenesis of an epithelium|Wnt signaling pathway|keratinization|wound healing|intermediate filament organization|,structural molecule activity|,7,16,5580000000,11.0%
Q3TTY5,0.004717678,-0.7015,24.22045629,2.662333333,0.003784028,4.140013911,-1.45,-1.13,-3.518,0.552,0.607,0.73,Q3TTY5,Krt2,Q3TTY5_Krt2,Q3TTY5,Krt2,1,74,15,9,Q3TTY5,MOUSE,71377.9,12.3,63,63.3,180.69,106.76,,707,"Keratin, type II cytoskeletal 2 epidermal",extracellular space|nucleus|Golgi apparatus|membrane|keratin filament|extracellular exosome|,keratinization|keratinocyte activation|keratinocyte proliferation|keratinocyte migration|,structural molecule activity|,9,74,52600000000,9.0%
Q6IFZ6,0.045957745,-0.669,13.7898342,1.980666667,0.041784632,2.471048105,0.09,-1.859,-3.209,0.566,0.514,-0.116,Q6IFZ6,Krt77,Q6IFZ6_Krt77,Q6IFZ6,Krt77,1,8,10,5,Q6IFZ6|Q6IFZ9,MOUSE,61414.7,12,63,63.6,120.32,45.95,,572,"Keratin, type II cytoskeletal 1b",cytoskeleton|keratin filament|extracellular exosome|,,structural molecule activity|,5,8,1010000000,5.7%
P04104,0.088027604,-0.968166667,10.86827505,2.627,0.081878993,2.033592059,-0.191,-1.121,-5.533,0.327,0.333,0.376,P04104,Krt1,P04104_Krt1,P04104,Krt1,1,29,9,5,P04104,MOUSE,66118.3,7.2,63,63.7,116.77,67.2,,637,"Keratin, type II cytoskeletal 1",extracellular space|nucleus|plasma membrane|membrane|extracellular matrix|keratin filament|extracellular exosome|blood microparticle|,"complement activation, lectin pathway|retina homeostasis|negative regulation of inflammatory response|establishment of skin barrier|",structural molecule activity|carbohydrate binding|,5,29,88900000000,3.9%
Q6NXH9,0.056593632,-0.514,12.86909534,2.330666667,0.051652395,2.347165138,-0.73,-0.209,-4.099,0.281,0.652,1.021,Q6NXH9,Krt73,Q6NXH9_Krt73,Q6NXH9,Krt73,1,9,9,3,Q6NXH9,MOUSE,59538,11.1,63,63.8,101.29,24.01,,539,"Keratin, type II cytoskeletal 73",nucleus|keratin filament|extracellular exosome|,activation of mitophagy in response to mitochondrial depolarization|,structural molecule activity|,3,9,17100000000,4.0%
Q8BPB5,1.0426e-4,-0.842833333,50.56622331,3.985,8.77764e-6,10.66937928,-3.216,-2.726,-2.564,1.181,1.331,0.937,Q8BPB5,Efemp1,Q8BPB5_Efemp1,Q8BPB5,Efemp1,1,190,27,27,Q8BPB5,MOUSE,57234.1,59.2,64,64.1,473.28,473.28,,493,EGF-containing fibulin-like extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,"regulation of transcription, DNA-templated|epidermal growth factor receptor signaling pathway|peptidyl-tyrosine phosphorylation|negative regulation of chondrocyte differentiation|",epidermal growth factor-activated receptor activity|epidermal growth factor receptor binding|calcium ion binding|growth factor activity|,27,190,132000000000,59.2%
Q9ESB3,1.99242e-4,-0.9675,40.46901772,4.673,8.97632e-5,7.614328832,-3.754,-2.183,-3.975,2.204,1.018,0.885,Q9ESB3,Hrg,Q9ESB3_Hrg,Q9ESB3,Hrg,1,282,26,26,A0A0R4J039|Q9ESB3,MOUSE,60131.6,42.8,65,65.1,429.95,429.95,,525,Histidine-rich glycoprotein,extracellular region|vesicle|endolysosome|phagolysosome membrane|,angiogenesis|positive regulation of immune response to tumor cell|chemotaxis|negative regulation of cell adhesion|negative regulation of cell proliferation|regulation of gene expression|regulation of platelet activation|negative regulation of lamellipodium assembly|negative regulation of endopeptidase activity|response to organic cyclic compound|heme transport|negative regulation of angiogenesis|platelet activation|regulation of blood coagulation|negative regulation of cell growth|regulation of actin cytoskeleton organization|negative regulation of cell adhesion mediated by integrin|regulation of transcription from RNA polymerase II promoter in response to iron|fibrinolysis|positive regulation of apoptotic process|regulation of protein complex assembly|negative regulation of blood vessel endothelial cell migration|regulation of peptidyl-tyrosine phosphorylation|defense response to fungus|positive regulation of focal adhesion assembly|negative regulation of fibrinolysis|heme export|negative regulation of vascular endothelial growth factor signaling pathway|positive regulation of blood vessel remodeling|negative regulation of endothelial cell chemotaxis|,serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity|receptor binding|protein binding|heparin binding|zinc ion binding|immunoglobulin binding|heme binding|heparan sulfate proteoglycan binding|metal ion binding|,26,282,747000000000,42.8%
Q01279,1.0426e-4,-0.877333333,48.26285473,4.218,1.49181e-5,9.893089589,-3.586,-2.817,-2.556,0.928,1.572,1.195,Q01279,Egfr,Q01279_Egfr,Q01279,Egfr,1,159,30,30,Q01279|Q9WVF5,MOUSE,138274.2,23.2,66,66.1,411.11,411.11,,1210,Epidermal growth factor receptor,"Golgi membrane|intracellular|nucleus|cytoplasm|endosome|endoplasmic reticulum membrane|plasma membrane|focal adhesion|cell surface|endosome membrane|membrane|integral component of membrane|basolateral plasma membrane|endocytic vesicle|early endosome membrane|nuclear membrane|receptor complex|membrane raft|perinuclear region of cytoplasm|multivesicular body, internal vesicle lumen|",cell morphogenesis|embryonic placenta development|positive regulation of protein phosphorylation|hair follicle development|signal transduction|cell surface receptor signaling pathway|epidermal growth factor receptor signaling pathway|salivary gland morphogenesis|learning or memory|cell proliferation|positive regulation of cell proliferation|epidermis development|single organismal cell-cell adhesion|peptidyl-tyrosine phosphorylation|cerebral cortex cell migration|signal transduction by protein phosphorylation|positive regulation of cell migration|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle|positive regulation of catenin import into nucleus|regulation of cell proliferation|negative regulation of protein catabolic process|positive regulation of phosphorylation|negative regulation of apoptotic process|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of DNA repair|positive regulation of DNA replication|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|positive regulation of fibroblast proliferation|digestive tract morphogenesis|positive regulation of epithelial cell proliferation|regulation of peptidyl-tyrosine phosphorylation|regulation of nitric-oxide synthase activity|positive regulation of protein kinase B signaling|morphogenesis of an epithelial fold|response to UV-A|positive regulation of ERK1 and ERK2 cascade|cellular response to amino acid stimulus|cellular response to epidermal growth factor stimulus|cellular response to estradiol stimulus|,chromatin binding|protein tyrosine kinase activity|receptor signaling protein tyrosine kinase activity|signal transducer activity|transmembrane signaling receptor activity|epidermal growth factor-activated receptor activity|protein binding|ATP binding|kinase activity|enzyme binding|protein phosphatase binding|ubiquitin protein ligase binding|identical protein binding|protein heterodimerization activity|actin filament binding|nitric-oxide synthase regulator activity|,30,159,60000000000,23.2%
A2A7A7,1.0426e-4,-0.945333333,50.28022526,3.943333333,9.37513e-6,10.57015067,-3.319,-2.575,-2.857,1.116,0.905,1.058,A2A7A7,H6pd,A2A7A7_H6pd,A2A7A7,H6pd,1,130,28,28,A2A7A7|Q8CF,MOUSE,90478.8,36.2,67,67.1,409.25,409.25,,797,GDH/6PGL endoplasmic bifunctional protein,mitochondrion|,glucose metabolic process|pentose-phosphate shunt|oxidation-reduction process|response to alcohol|,glucose-6-phosphate dehydrogenase activity|6-phosphogluconolactonase activity|carbohydrate binding|NADP binding|,28,130,35700000000,36.2%
P97290,1.28279e-4,-0.907833333,43.91751786,4.117666667,4.0574e-5,8.561228435,-3.847,-2.649,-2.404,1.438,1.111,0.904,P97290,Serping1,P97290_Serping1,P97290,Serping1,1,234,27,27,P97290|A2ATR8,MOUSE,55868.8,39.2,68,68.1,405.64,405.64,,504,Plasma protease C1 inhibitor,extracellular space|extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|complement activation, classical pathway|aging|blood coagulation|negative regulation of endopeptidase activity|fibrinolysis|innate immune response|",serine-type endopeptidase inhibitor activity|,27,234,222000000000,39.2%
Q8R121,1.0426e-4,-0.942333333,50.40818202,4.269333333,9.10294e-6,10.61444405,-3.598,-2.71,-2.923,1.308,1.368,0.901,Q8R121,Serpina10,Q8R121_Serpina10,Q8R121,Serpina10,1,155,27,27,Q8R121|Q8R121-2,MOUSE,51910.6,53.7,69,69.1,404.14,404.14,,448,Protein Z-dependent protease inhibitor,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,27,155,71700000000,53.7%
Q9JKR6,1.0426e-4,-1.196166667,50.51440847,4.409666667,8.88299e-6,10.6513406,-3.744,-2.741,-3.718,1.002,1.092,0.932,Q9JKR6,Hyou1,Q9JKR6_Hyou1,Q9JKR6,Hyou1,1,127,29,29,Q9JKR6|E0CYZ2,MOUSE,111407.3,31.8,70,70.1,403.28,403.28,,999,Hypoxia up-regulated protein 1,extracellular region|endoplasmic reticulum lumen|focal adhesion|membrane|endoplasmic reticulum chaperone complex|extracellular exosome|,response to ischemia|response to endoplasmic reticulum stress|negative regulation of apoptotic process|cellular response to hypoxia|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway|negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway|,ATP binding|,29,127,14700000000,31.8%
Q61247,1.0426e-4,-1.085666667,46.9907793,4.751333333,1.9995e-5,9.485963038,-3.87,-2.526,-3.988,1.507,1.47,0.893,Q61247,Serpinf2,Q61247_Serpinf2,Q61247,Serpinf2,1,272,25,25,Q61247,MOUSE,55199.1,41.1,71,71.1,402.22,402.22,,491,Alpha-2-antiplasmin,fibrinogen complex|extracellular space|cell surface|extracellular exosome|blood microparticle|,regulation of blood vessel size by renin-angiotensin|acute-phase response|response to organic substance|negative regulation of plasminogen activation|negative regulation of endopeptidase activity|collagen fibril organization|positive regulation of collagen biosynthetic process|positive regulation of cell differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of JNK cascade|blood vessel morphogenesis|positive regulation of smooth muscle cell proliferation|positive regulation of stress fiber assembly|negative regulation of fibrinolysis|positive regulation of ERK1 and ERK2 cascade|positive regulation of transforming growth factor beta production|,protease binding|serine-type endopeptidase inhibitor activity|protein homodimerization activity|,25,272,906000000000,41.1%
Q3UER8,0.029148945,0.009,15.86845782,3.108,0.025891322,2.823965301,0.145,-2.462,-2.318,0.96,3.694,0.035,Q3UER8,Fgg,Q3UER8_Fgg,Q3UER8,Fgg,1,212,28,28,Q3UER8|Q8VCM7|P12799|F1MGU7|Q3SZZ9,MOUSE,51033.2,59.1,72,72.1,401.01,401.01,,443,Fibrinogen gamma chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|,"cell-matrix adhesion|signal transduction|protein secretion|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|cellular protein complex assembly|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","receptor binding|structural molecule activity|protein binding, bridging|cell adhesion molecule binding|",28,212,237000000000,59.1%
F8VQ07,1.0426e-4,-1.013333333,49.24770647,4.333333333,1.18913e-5,10.21868765,-3.733,-2.664,-3.143,1.492,1.072,0.896,F8VQ07,5830473C10Rik,F8VQ07_5830473C10Rik,F8VQ07,5830473C10Rik,1,120,30,30,F8VQ07|A0A0J9YV75,MOUSE,72340.4,41.7,73,73.1,396.62,396.62,,620,RIKEN cDNA 5830473C10 gene,extracellular space|,transport|,,30,120,15900000000,41.7%
Q8BH61,0.003795431,0.151666667,25.20947678,3.919333333,0.003013369,4.43217355,-1.231,-1.473,-2.72,1.675,4,0.659,Q8BH61,F13a1,Q8BH61_F13a1,Q8BH61,F13a1,1,148,26,26,Q8BH61,MOUSE,83719.2,32.9,74,74.1,392.34,392.34,,732,Coagulation factor XIII A chain,cytoplasm|blood microparticle|,blood coagulation|peptide cross-linking|,protein-glutamine gamma-glutamyltransferase activity|metal ion binding|,26,148,30000000000,32.9%
Q9QWK4,1.0426e-4,-0.725833333,47.53939504,4.015,1.76222e-5,9.65972563,-2.888,-2.605,-2.707,1.003,1.933,0.909,Q9QWK4,Cd5l,Q9QWK4_Cd5l,Q9QWK4,Cd5l,1,209,26,26,Q9QWK4,MOUSE,40345.4,60.7,75,75.1,390.37,390.37,,352,CD5 antigen-like,membrane|extracellular exosome|blood microparticle|,receptor-mediated endocytosis|apoptotic process|,scavenger receptor activity|,26,209,457000000000,60.7%
Q8BHN3-2,1.0426e-4,-1.010166667,50.16635913,4.122333333,9.62419e-6,10.53087307,-3.473,-2.569,-3.172,1.162,1.098,0.893,Q8BHN3,Ganab,Q8BHN3-2_Ganab,Q8BHN3-2,Ganab,1,112,33,33,Q8BHN3-2|Q8BHN3|Q8BHN3-3,MOUSE,109858.4,33.6,76,76.1,387.82,387.82,,944,Isoform 2 of Neutral alpha-glucosidase AB,endoplasmic reticulum|Golgi apparatus|membrane|glucosidase II complex|melanosome|extracellular exosome|,N-glycan processing|,"protein binding|glucosidase activity|carbohydrate binding|glucan 1,3-alpha-glucosidase activity|poly(A) RNA binding|",33,112,15800000000,33.6%
P49182,1.0426e-4,-1.168833333,48.89190726,4.775666667,1.29065e-5,10.09998901,-3.569,-2.849,-4.252,1.627,1.106,0.924,P49182,Serpind1,P49182_Serpind1,P49182,Serpind1,1,210,26,26,P49182,MOUSE,54781,49.3,77,77.1,384.86,384.86,,478,Heparin cofactor 2,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,26,210,202000000000,49.3%
P26928,1.28279e-4,-1.2935,43.90621989,4.741666667,4.06797e-5,8.557975087,-3.641,-2.649,-4.703,1.293,1.016,0.923,P26928,Mst1,P26928_Mst1,P26928,Mst1,1,138,29,29,P26928|E0CXN0,MOUSE,83185.1,40,78,78.1,378.2,378.2,,716,Hepatocyte growth factor-like protein,extracellular exosome|,proteolysis|spermatogenesis|embryo implantation|sperm motility|,serine-type endopeptidase activity|,29,138,31300000000,40.0%
A2AS37,1.0426e-4,-1.008166667,48.31742692,4.519,1.47319e-5,9.910890506,-3.77,-2.571,-3.462,1.662,1.199,0.893,A2AS37,AI182371,A2AS37_AI182371,A2AS37,AI182371,1,158,23,23,A2AS37,MOUSE,40887.3,52.2,79,79.1,374.1,374.1,,356,Expressed sequence AI182371,extracellular region|,inflammatory response|complement activation|negative regulation of endopeptidase activity|,endopeptidase inhibitor activity|,23,158,161000000000,52.2%
P14211,1.0426e-4,-1.247,47.7481624,4.592,1.67951e-5,9.726569745,-4.432,-3.006,-3.191,1.205,1.015,0.927,P14211,Calr,P14211_Calr,P14211,Calr,1,141,26,26,P14211,MOUSE,48164.8,54.3,80,80.1,368.72,368.72,,416,Calreticulin,acrosomal vesicle|extracellular region|extracellular space|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|Golgi apparatus|cytosol|polysome|focal adhesion|external side of plasma membrane|membrane|extracellular matrix|sarcoplasmic reticulum lumen|MHC class I peptide loading complex|phagocytic vesicle|perinuclear region of cytoplasm|extracellular exosome|,"negative regulation of transcription from RNA polymerase II promoter|peptide antigen assembly with MHC class I protein complex|protein export from nucleus|cell cycle arrest|spermatogenesis|positive regulation of cell proliferation|positive regulation of gene expression|negative regulation of translation|cortical actin cytoskeleton organization|response to estradiol|negative regulation of intracellular steroid hormone receptor signaling pathway|response to testosterone|protein localization to nucleus|regulation of meiotic nuclear division|response to drug|negative regulation of neuron differentiation|positive regulation of DNA replication|positive regulation of cell cycle|negative regulation of transcription, DNA-templated|negative regulation of retinoic acid receptor signaling pathway|positive regulation of phagocytosis|protein stabilization|cardiac muscle cell differentiation|chaperone-mediated protein folding|cellular response to lithium ion|cellular response to organic substance|cellular senescence|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of dendritic cell chemotaxis|",glycoprotein binding|mRNA binding|integrin binding|iron ion binding|calcium ion binding|protein binding|carbohydrate binding|ubiquitin protein ligase binding|peptide binding|hormone binding|poly(A) RNA binding|androgen receptor binding|unfolded protein binding|,26,141,79700000000,54.3%
Q8BK48,1.0426e-4,-0.9885,49.99140278,4.245,1.00198e-5,10.4707751,-3.643,-2.643,-3.047,1.262,1.239,0.901,Q8BK48,Ces2e,Q8BK48_Ces2e,Q8BK48,Ces2e,1,140,23,18,Q8BK48|F6Z9B9|Q08ED5|Q149K3,MOUSE,62716,44.5,81,81.1,358.53,287.37,,559,Pyrethroid hydrolase Ces2e,endoplasmic reticulum|,metabolic process|,carboxylic ester hydrolase activity|,23,140,32400000000,44.5%
Q91WG0,1.12515e-4,-0.979833333,45.11715068,4.119666667,3.07812e-5,8.91263592,-3.817,-2.455,-2.847,1.401,0.95,0.889,Q91WG0,Ces2c,Q91WG0_Ces2c,Q91WG0,Ces2c,1,32,16,9,Q91WG0,MOUSE,62753.8,31.3,81,81.2,239.59,134.84,,561,Acylcarnitine hydrolase,endoplasmic reticulum|intracellular membrane-bounded organelle|,metabolic process|,acylcarnitine hydrolase activity|,9,32,1270000000,16.2%
Q8QZR3,1.0426e-4,-1.2445,51.59426805,4.546333333,6.92745e-6,11.03296392,-3.894,-2.89,-3.769,1.21,0.956,0.92,Q8QZR3,Ces2a,Q8QZR3_Ces2a,Q8QZR3,Ces2a,1,23,10,5,Q8QZR3|Q8QZR3-2,MOUSE,62395.6,17.7,81,81.3,143.29,73.57,,558,Pyrethroid hydrolase Ces2a,,,carboxylic ester hydrolase activity|,5,23,1120000000,10.2%
E9PV38,2.9252e-4,-1.071166667,37.87501739,4.001666667,1.63117e-4,6.958903718,-3.387,-1.866,-3.963,1.19,0.812,0.787,E9PV38,Ces2g,E9PV38_Ces2g,E9PV38,Ces2g,1,3,9,3,E9PV38,MOUSE,63005,19.6,81,81.4,113.08,24.29,,560,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,3,3,334000000,7.1%
P00920,1.52167e-4,-0.737,42.27925473,3.854,5.91663e-5,8.100066277,-3.479,-2.511,-2.002,1.47,0.911,1.189,P00920,Car2,P00920_Car2,P00920,Ca2,1,108,19,19,P00920|A0A0A6YX78|P00921,MOUSE,29146.1,66.5,82,82.1,349.71,349.71,,260,Carbonic anhydrase 2,extracellular space|cytoplasm|cytosol|plasma membrane|microvillus|basolateral plasma membrane|axon|myelin sheath|apical part of cell|extracellular exosome|,"kidney development|morphogenesis of an epithelium|one-carbon metabolic process|regulation of pH|response to pH|response to zinc ion|carbon dioxide transport|positive regulation of synaptic transmission, GABAergic|positive regulation of cellular pH reduction|angiotensin-activated signaling pathway|odontogenesis of dentin-containing tooth|response to estrogen|regulation of anion transport|positive regulation of osteoclast differentiation|positive regulation of bone resorption|secretion|regulation of intracellular pH|cellular response to fluid shear stress|positive regulation of dipeptide transmembrane transport|regulation of chloride transport|",arylesterase activity|carbonate dehydratase activity|zinc ion binding|,19,108,26100000000,66.5%
P35917,1.0426e-4,-1.076333333,52.89272272,4.288666667,5.13721e-6,11.50805987,-3.282,-2.846,-3.534,1.045,1.252,0.907,P35917,Flt4,P35917_Flt4,P35917,Flt4,1,70,26,26,P35917,MOUSE,155124.7,19,83,83.1,349.12,349.12,,1363,Vascular endothelial growth factor receptor 3,nucleus|cytoplasm|plasma membrane|integral component of plasma membrane|receptor complex|,positive regulation of protein phosphorylation|positive regulation of endothelial cell proliferation|vasculature development|lymph vessel development|lymphangiogenesis|sprouting angiogenesis|positive regulation of cell proliferation|positive regulation of vascular endothelial growth factor production|positive regulation of endothelial cell migration|peptidyl-tyrosine phosphorylation|cellular response to vascular endothelial growth factor stimulus|vascular endothelial growth factor signaling pathway|negative regulation of apoptotic process|positive regulation of MAPK cascade|positive regulation of JNK cascade|protein autophosphorylation|vascular endothelial growth factor receptor signaling pathway|blood vessel morphogenesis|regulation of blood vessel remodeling|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein kinase C signaling|,transmembrane receptor protein tyrosine kinase activity|vascular endothelial growth factor-activated receptor activity|protein binding|ATP binding|growth factor binding|protein phosphatase binding|,26,70,7120000000,19.0%
E9Q557,0.10517643,-0.650666667,10.04126217,1.941333333,0.099054403,1.903880386,-0.433,-0.267,-4.164,0.159,0.395,0.406,E9Q557,Dsp,E9Q557_Dsp,E9Q557,Dsp,1,71,37,37,E9Q557|E9PZW0,MOUSE,335359.7,11.5,84,84.1,348.98,348.98,,2883,Desmoplakin,cornified envelope|nucleus|cytoplasm|plasma membrane|cell-cell junction|fascia adherens|intercalated disc|membrane|basolateral plasma membrane|desmosome|extracellular exosome|intermediate filament|,desmosome organization|ventricular compact myocardium morphogenesis|single organismal cell-cell adhesion|peptide cross-linking|keratinocyte differentiation|adherens junction organization|wound healing|skin development|intermediate filament cytoskeleton organization|intermediate filament organization|protein localization to adherens junction|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,"protein kinase C binding|structural molecule activity|protein binding|protein binding, bridging|poly(A) RNA binding|cell adhesion molecule binding|scaffold protein binding|",37,71,2010000000,11.5%
P39039,1.0426e-4,-1.098333333,47.5670308,4.419333333,1.75104e-5,9.668551194,-3.987,-2.552,-3.385,1.271,1.102,0.961,P39039,Mbl1,P39039_Mbl1,P39039,Mbl1,1,222,22,22,P39039|P39039-2|A0A2C9F2B6,MOUSE,25852,66.9,85,85.1,344.34,344.34,,239,Mannose-binding protein A,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|positive regulation of phagocytosis|defense response to Gram-positive bacterium|protein homotetramerization|killing by host of symbiont cells|protein homotrimerization|",protease binding|calcium ion binding|mannose binding|polysaccharide binding|protein homodimerization activity|calcium-dependent protein binding|phosphatidylinositol-4-phosphate binding|,22,222,1330000000000,66.9%
Q3U3V1,1.0426e-4,-1.252666667,48.45864395,4.816666667,1.42605e-5,9.957084216,-3.933,-2.786,-4.264,1.47,1.088,0.909,Q3U3V1,F10,Q3U3V1_F10,Q3U3V1,F10,1,144,23,23,Q3U3V1|O88947|D3Z215|D3Z521,MOUSE,56680.8,42.7,86,86.1,337.76,337.76,,493,Coagulation factor X,extracellular region|membrane|intracellular membrane-bounded organelle|,proteolysis|blood coagulation|positive regulation of protein kinase B signaling|,serine-type endopeptidase activity|calcium ion binding|phospholipid binding|,23,144,143000000000,42.7%
A11111,1.0426e-4,-1.234166667,46.87269659,4.543,2.05461e-5,9.448918481,-4.271,-2.671,-3.575,1.21,0.994,0.908,A11111,NotFound,A11111_NotFound,A11111,,1,100,21,21,A11111|P06709,MOUSE,39099.5,69.3,87,87.1,336.4,336.4,,,BirAG3ER,,,,21,100,414000000000,69.3%
P63260,0.001422306,-1.072166667,29.77543039,4.090333333,0.001053069,5.261688058,-2.985,-1.56,-4.807,1.165,0.741,1.013,P63260,Actg1,P63260_Actg1,P63260,Actg1,1,114,23,1,P63260|G3UYG0|B1ATY1|V9GXQ2,MOUSE,42134.4,58.9,88,88.1,331.02,23.1,,375,"Actin, cytoplasmic 2",extracellular space|nucleus|cytosol|plasma membrane|focal adhesion|actin cytoskeleton|membrane|myofibril|filamentous actin|costamere|myelin sheath|extracellular exosome|blood microparticle|dense body|,retina homeostasis|sarcomere organization|response to calcium ion|platelet aggregation|,structural constituent of cytoskeleton|protein binding|ATP binding|ubiquitin protein ligase binding|identical protein binding|,23,114,41600000000,58.9%
Q02819,1.0426e-4,-1.215666667,46.96248011,4.526666667,2.01257e-5,9.477073694,-3.668,-2.608,-4.161,0.932,1.211,1,Q02819,Nucb1,Q02819_Nucb1,Q02819,Nucb1,1,79,25,25,Q02819|A0A1C7CYU3,MOUSE,53407.7,54.4,89,89.1,327.11,327.11,,459,Nucleobindin-1,extracellular space|nucleus|early endosome|rough endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi-associated vesicle|cis-Golgi network|trans-Golgi network|microtubule cytoskeleton|membrane|Golgi cisterna membrane|extracellular exosome|extrinsic component of Golgi membrane|lumenal side of Golgi membrane|,response to cisplatin|regulation of protein targeting|,G-protein alpha-subunit binding|DNA binding|calcium ion binding|,25,79,8150000000,54.4%
Q61704,1.0426e-4,-0.9955,47.87364647,4.250333333,1.63168e-5,9.766941091,-3.03,-2.572,-3.76,1.433,1.055,0.901,Q61704,Itih3,Q61704_Itih3,Q61704,Itih3,1,131,24,24,Q61704,MOUSE,99698.3,27.3,90,90.1,326.79,326.79,,889,Inter-alpha-trypsin inhibitor heavy chain H3,extracellular exosome|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,24,131,54300000000,27.3%
O70570,1.0426e-4,-1.039833333,49.04953593,4.080333333,1.24465e-5,10.15242518,-3.305,-2.502,-3.433,1.176,0.896,0.929,O70570,Pigr,O70570_Pigr,O70570,Pigr,1,77,21,21,O70570,MOUSE,86309.5,30,91,91.1,322.65,322.65,,771,Polymeric immunoglobulin receptor,extracellular space|plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|epidermal growth factor receptor signaling pathway|Fc receptor signaling pathway|receptor clustering|,polymeric immunoglobulin receptor activity|,21,77,12800000000,30.0%
P97298,1.0426e-4,-1.2375,47.24292757,4.760333333,1.88672e-5,9.565486607,-3.929,-2.666,-4.258,1.377,1.138,0.913,P97298,Serpinf1,P97298_Serpinf1,P97298,Serpinf1,1,122,19,19,P97298|E9PWS2,MOUSE,46290.3,52.9,92,92.1,319.45,319.45,,417,Pigment epithelium-derived factor,extracellular region|basement membrane|extracellular space|melanosome|axon hillock|perinuclear region of cytoplasm|extracellular exosome|extracellular matrix|,kidney development|aging|short-term memory|response to acidic pH|negative regulation of endothelial cell migration|negative regulation of gene expression|negative regulation of endopeptidase activity|positive regulation of neuron projection development|negative regulation of angiogenesis|ovulation cycle|response to arsenic-containing substance|negative regulation of inflammatory response|positive regulation of neurogenesis|retina development in camera-type eye|negative regulation of epithelial cell proliferation involved in prostate gland development|cellular response to cobalt ion|cellular response to retinoic acid|cellular response to glucose stimulus|cellular response to dexamethasone stimulus|negative regulation of neuron death|,serine-type endopeptidase inhibitor activity|,19,122,30700000000,52.9%
P08226,1.0426e-4,-1.046666667,51.40288975,4.332,7.23954e-6,10.96445206,-3.666,-2.731,-3.241,0.932,1.26,1.166,P08226,Apoe,P08226_Apoe,P08226,Apoe,1,149,24,24,P08226,MOUSE,35923,58.8,93,93.1,318.79,318.79,,311,Apolipoprotein E,extracellular region|extracellular space|nucleus|endoplasmic reticulum|Golgi apparatus|cytosol|membrane|extracellular matrix|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,negative regulation of endothelial cell proliferation|response to dietary excess|lipid metabolic process|triglyceride metabolic process|cholesterol biosynthetic process|cholesterol catabolic process|cellular calcium ion homeostasis|receptor-mediated endocytosis|response to oxidative stress|G-protein coupled receptor signaling pathway|nitric oxide mediated signal transduction|cholesterol metabolic process|regulation of gene expression|negative regulation of platelet activation|positive regulation of cholesterol esterification|positive regulation of cholesterol efflux|long-chain fatty acid transport|protein import|virion assembly|triglyceride catabolic process|cGMP-mediated signaling|negative regulation of blood coagulation|regulation of axon extension|positive regulation of cGMP biosynthetic process|regulation of cholesterol transport|regulation of Cdc42 protein signal transduction|positive regulation of low-density lipoprotein particle receptor catabolic process|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|chylomicron remnant clearance|high-density lipoprotein particle clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|vasodilation|cholesterol homeostasis|negative regulation of MAP kinase activity|negative regulation of neuron apoptotic process|negative regulation of blood vessel endothelial cell migration|reverse cholesterol transport|positive regulation by host of viral process|negative regulation of cholesterol biosynthetic process|positive regulation of lipid biosynthetic process|artery morphogenesis|negative regulation of inflammatory response|positive regulation of nitric-oxide synthase activity|positive regulation of membrane protein ectodomain proteolysis|negative regulation of lipid biosynthetic process|maintenance of location in cell|lipid homeostasis|fatty acid homeostasis|positive regulation of dendritic spine development|negative regulation of dendritic spine development|cardiovascular system development|negative regulation of cholesterol efflux|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering|N-methyl-D-aspartate receptor clustering|regulation of beta-amyloid clearance|regulation of neuron death|negative regulation of neuron death|positive regulation of neuron death|negative regulation of postsynaptic membrane organization|positive regulation of postsynaptic membrane organization|negative regulation of presynaptic membrane organization|positive regulation of presynaptic membrane organization|positive regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|regulation of tau-protein kinase activity|negative regulation of dendritic spine maintenance|positive regulation of dendritic spine maintenance|positive regulation of phospholipid efflux|positive regulation of neurofibrillary tangle assembly|negative regulation of phospholipid efflux|negative regulation of lipid transport across blood brain barrier|positive regulation of lipid transport across blood brain barrier|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|heparin binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|identical protein binding|protein homodimerization activity|metal chelating activity|tau protein binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|very-low-density lipoprotein particle receptor binding|lipoprotein particle binding|,24,149,85800000000,58.8%
Q03311,1.0426e-4,-1.088833333,49.77057826,4.478333333,1.05425e-5,10.39535543,-3.994,-2.82,-3.17,1.345,1.198,0.908,Q03311,Bche,Q03311_Bche,Q03311,Bche,1,103,20,20,Q03311,MOUSE,68974.5,30,94,94.1,317.53,317.53,,603,Cholinesterase,nuclear envelope lumen|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|blood microparticle|,learning|negative regulation of cell proliferation|neuroblast differentiation|choline metabolic process|response to drug|response to alkaloid|negative regulation of synaptic transmission|response to glucocorticoid|response to folic acid|,acetylcholinesterase activity|cholinesterase activity|choline binding|identical protein binding|,20,103,41000000000,30.0%
P23953,1.04681e-4,-1.237166667,46.41095614,4.686333333,2.2851e-5,9.305256968,-3.936,-2.608,-4.197,1.402,1,0.916,P23953,Ces1c,P23953_Ces1c,P23953,Ces1c,1,115,21,13,P23953|Q8VCT4|E9PYP1,MOUSE,61339.9,35.3,95,95.1,317.22,199.45,,554,Carboxylesterase 1C,extracellular space|endoplasmic reticulum lumen|,metabolic process|,"hydrolase activity, acting on ester bonds|carboxylic ester hydrolase activity|",21,115,41900000000,35.3%
D3Z5G7,1.0426e-4,-0.816666667,48.58103541,3.849333333,1.38643e-5,9.997272217,-3.157,-2.513,-2.554,1.417,1,0.907,D3Z5G7,Ces1b,D3Z5G7_Ces1b,D3Z5G7,Ces1b,1,28,17,8,D3Z5G7,MOUSE,62538.2,33.1,95,95.2,256.39,122,,567,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,8,28,2100000000,19.4%
Q07456,1.0426e-4,-1.210833333,48.41197134,4.799666667,1.44146e-5,9.941796272,-3.732,-2.78,-4.32,1.465,1.183,0.919,Q07456,Ambp,Q07456_Ambp,Q07456,Ambp,1,126,19,19,Q07456,MOUSE,39941.4,50.1,96,96.1,312.84,312.84,,349,Protein AMBP,extracellular space|plasma membrane|cell surface|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|protein-chromophore linkage|protein catabolic process|protein maturation|,serine-type endopeptidase inhibitor activity|IgA binding|heme binding|small molecule binding|protein homodimerization activity|,19,126,139000000000,50.1%
Q06194,1.10075e-4,-1.269833333,45.65968251,4.620333333,2.71664e-5,9.075517787,-3.44,-2.761,-4.539,1.041,1.18,0.9,Q06194,F8,Q06194_F8,Q06194,F8,1,68,25,25,Q06194|B2RRC9,MOUSE,267560.2,9.4,97,97.1,311.53,311.53,,2319,Coagulation factor VIII,extracellular space|,acute-phase response|platelet activation|oxidation-reduction process|,copper ion binding|oxidoreductase activity|,25,68,4600000000,9.4%
Q8CG19,1.10023e-4,-0.533333333,45.71845589,3.482,2.68012e-5,9.093314116,-2.329,-2.494,-2,1.204,1.572,0.847,Q8CG19,Ltbp1,Q8CG19_Ltbp1,Q8CG19,Ltbp1,1,54,20,20,Q8CG19|Q8CG19-2|Q8CG19-3|Q61810|F8VQ06|Q61810-2,MOUSE,195158.2,14.4,98,98.1,309.5,309.5,,1712,Latent-transforming growth factor beta-binding protein 1,microfibril|proteinaceous extracellular matrix|extracellular matrix|protein complex|extracellular matrix|,transforming growth factor beta receptor signaling pathway|,calcium ion binding|transforming growth factor beta binding|microfibril binding|,20,54,3140000000,14.4%
Q64726,1.10858e-4,-0.941166667,45.47110461,4.456333333,2.8372e-5,9.018617386,-3.439,-2.314,-3.755,1.693,1.292,0.876,Q64726,Azgp1,Q64726_Azgp1,Q64726,Azgp1,1,125,21,21,Q64726,MOUSE,35559.5,53.7,99,99.1,309.44,309.44,,307,Zinc-alpha-2-glycoprotein,extracellular space|nucleus|plasma membrane|MHC class I protein complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|antigen processing and presentation of peptide antigen via MHC class I|immune response|cell adhesion|regulation of multicellular organism growth|,glycoprotein binding|peptide antigen binding|,21,125,63500000000,53.7%
P70389,1.0426e-4,-0.743166667,47.22835191,3.443,1.89306e-5,9.560874019,-2.788,-2.158,-2.448,0.961,1,0.974,P70389,Igfals,P70389_Igfals,P70389,Igfals,1,88,22,22,A0A0R4J0S2|P70389,MOUSE,67757.5,40.1,100,100.1,304.56,304.56,,603,Insulin-like growth factor-binding protein complex acid labile subunit,nucleoplasm|insulin-like growth factor ternary complex|extracellular exosome|,cell adhesion|,,22,88,10600000000,40.1%
Q9DBB9,1.0426e-4,-1.147833333,52.85737079,4.513,5.1792e-6,11.49488422,-3.806,-2.902,-3.505,1.258,1.124,0.944,Q9DBB9,Cpn2,Q9DBB9_Cpn2,Q9DBB9,Cpn2,1,145,19,19,Q9DBB9,MOUSE,61333.9,45.5,101,101.1,303.11,303.11,,547,Carboxypeptidase N subunit 2,extracellular exosome|blood microparticle|,,,19,145,104000000000,45.5%
A0A0A6YXW6,1.52167e-4,-1.2405,42.28471808,5.218333333,5.90919e-5,8.101569397,-3.511,-2.936,-5.102,0.999,0.975,2.132,A0A0A6YXW6,NotFound,A0A0A6YXW6_NotFound,A0A0A6YXW6,Igha,1,126,15,4,A0A0A6YXW6,MOUSE,42869.8,48.8,103,103.1,294.53,68.76,,389,Immunoglobulin heavy constant alpha (Fragment),,,,15,126,191000000000,48.8%
P41317,1.34595e-4,-1.521166667,43.49162957,5.3223333330000004,4.47545e-5,8.439301613,-4.502,-2.806,-5.239,1.343,1.151,0.926,P41317,Mbl2,P41317_Mbl2,P41317,Mbl2,1,168,17,17,P41317,MOUSE,26356,60.2,104,104.1,292.13,292.13,,244,Mannose-binding protein C,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|innate immune response|negative regulation of viral process|positive regulation of phagocytosis|defense response to Gram-positive bacterium|killing by host of symbiont cells|",receptor binding|calcium ion binding|mannose binding|calcium-dependent protein binding|,17,168,401000000000,60.2%
Q6GQT1,1.0426e-4,-1.275,53.94159989,4.798666667,4.03497e-6,11.90526246,-3.752,-3.117,-4.154,1.029,1.228,1.116,Q6GQT1,A2m,Q6GQT1_A2m,Q6GQT1,A2m,1,148,25,21,Q6GQT1|K4JBR5|K4JF13|K4JB97,MOUSE,165776,18.5,105,105.1,290.94,244.16,,1474,Alpha-2-macroglobulin-P,extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|female pregnancy|negative regulation of endopeptidase activity|stem cell differentiation|",protease binding|serine-type endopeptidase inhibitor activity|receptor binding|protein binding|growth factor binding|enzyme binding|interleukin-8 binding|interleukin-1 binding|peptidase inhibitor activity|tumor necrosis factor binding|calcium-dependent protein binding|,27,148,14100000000000,18.5%
Q9R1E6-2,1.61029e-4,-0.935333333,41.90531726,4.322666667,6.44864e-5,7.997725872,-3.412,-2.133,-3.745,1.839,0.974,0.865,Q9R1E6,Enpp2,Q9R1E6-2_Enpp2,Q9R1E6-2,Enpp2,1,61,21,21,Q9R1E6-2|G3UXY9|Q9R1E6-3|Q9R1E6,MOUSE,106969.5,26.9,106,106.1,286.37,286.37,,862,Isoform 2 of Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,extracellular space|integral component of plasma membrane|,receptor-mediated endocytosis|chemotaxis|immune response|phospholipid catabolic process|positive regulation of epithelial cell migration|regulation of cell migration|phosphatidylcholine catabolic process|regulation of angiogenesis|positive regulation of peptidyl-tyrosine phosphorylation|nucleic acid phosphodiester bond hydrolysis|positive regulation of lamellipodium morphogenesis|,nucleic acid binding|phosphodiesterase I activity|nucleotide diphosphatase activity|lysophospholipase activity|scavenger receptor activity|calcium ion binding|zinc ion binding|polysaccharide binding|alkylglycerophosphoethanolamine phosphodiesterase activity|,21,61,7050000000,26.9%
P29699,1.0426e-4,-1.154833333,47.16079562,4.531,1.92274e-5,9.539520408,-4.206,-2.668,-3.387,1.334,1.083,0.915,P29699,Ahsg,P29699_Ahsg,P29699,Ahsg,1,167,18,18,P29699,MOUSE,38123.7,63.1,107,107.1,284.6,284.6,,345,Alpha-2-HS-glycoprotein,extracellular space|extracellular exosome|blood microparticle|,ossification|acute-phase response|negative regulation of endopeptidase activity|negative regulation of bone mineralization|regulation of inflammatory response|positive regulation of phagocytosis|,cysteine-type endopeptidase inhibitor activity|,18,167,485000000000,63.1%
O70165,1.35226e-4,-1.108166667,43.21338346,4.510333333,4.77157e-5,8.360426066,-4.489,-2.734,-2.867,1.206,1.331,0.904,O70165,Fcna,O70165_Fcna,O70165,Fcn1,1,132,18,18,O70165,MOUSE,36868.4,38.9,108,108.1,283.49,283.49,,334,Ficolin-1,collagen trimer|extrinsic component of external side of plasma membrane|blood microparticle|,cell surface pattern recognition receptor signaling pathway|G-protein coupled receptor signaling pathway|recognition of apoptotic cell|negative regulation of viral entry into host cell|defense response to virus|negative regulation of RNA biosynthetic process|positive regulation of interleukin-8 secretion|,antigen binding|protein binding|signaling pattern recognition receptor activity|carbohydrate binding|metal ion binding|carbohydrate derivative binding|,18,132,133000000000,38.9%
P70375,1.34728e-4,-0.958666667,43.373036,4.126666667,4.59935e-5,8.405608216,-3.929,-2.856,-2.281,1.207,1.178,0.929,P70375,F7,P70375_F7,P70375,F7,1,138,20,20,P70375,MOUSE,51701.8,40.3,109,109.1,283.43,283.43,,446,Coagulation factor VII,extracellular region|extracellular space|vesicle|,positive regulation of leukocyte chemotaxis|proteolysis|blood coagulation|circadian rhythm|positive regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of blood coagulation|organ regeneration|response to vitamin K|response to estrogen|positive regulation of positive chemotaxis|positive regulation of protein kinase B signaling|response to growth hormone|,glycoprotein binding|serine-type endopeptidase activity|receptor binding|calcium ion binding|,20,138,73500000000,40.3%
Q9Z0Z4,4.27725e-4,-1.464333333,35.74475145,5.003333333,2.66394e-4,6.588220554,-3.436,-2.708,-5.754,1.159,1.04,0.913,Q9Z0Z4,Heph,Q9Z0Z4_Heph,Q9Z0Z4,Heph,1,63,22,22,Q9Z0Z4|Q9Z0Z4-2|A2AI62,MOUSE,130576.7,22.3,110,110.1,280.49,280.49,,1157,Hephaestin,intracellular|integral component of membrane|basolateral plasma membrane|perinuclear region of cytoplasm|,copper ion transport|iron ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|ferrous iron binding|,22,63,5720000000,22.3%
Q08761,2.0518e-4,-0.881833333,40.22480256,3.990333333,9.49554e-5,7.550632978,-3.887,-2.718,-2.026,1.357,1.08,0.903,Q08761,Pros1,Q08761_Pros1,Q08761,Pros1,1,89,23,23,Q08761,MOUSE,76987.1,31.1,111,111.1,278.78,278.78,,675,Vitamin K-dependent protein S,extracellular space|protein complex|extracellular exosome|blood microparticle|,blood coagulation|response to lipopolysaccharide|fibrinolysis|positive regulation of phagocytosis|,calcium ion binding|protein complex binding|,23,89,23700000000,31.1%
Q61730-2,1.0426e-4,-0.951833333,47.3096107,4.147666667,1.85797e-5,9.586613615,-3.682,-2.683,-2.712,1.483,0.916,0.967,Q61730,Il1rap,Q61730-2_Il1rap,Q61730-2,Il1rap,1,79,20,20,Q61730-2|Q61730-3|E9Q6I2|Q61730|G3UY13,MOUSE,42194.2,44.1,112,112.1,276.48,276.48,,570,Isoform 2 of Interleukin-1 receptor accessory protein,extracellular region|plasma membrane|membrane|integral component of membrane|,inflammatory response|cytokine-mediated signaling pathway|interleukin-2 biosynthetic process|innate immune response|,signal transducer activity|interleukin-1 receptor activity|protein binding|,20,79,13900000000,44.1%
Q9JHH6,1.0426e-4,-0.918333333,50.39779465,4.493333333,9.12474e-6,10.61084222,-3.34,-2.621,-3.534,1.534,1.564,0.887,Q9JHH6,Cpb2,Q9JHH6_Cpb2,Q9JHH6,Cpb2,1,117,18,18,Q9JHH6,MOUSE,49269,36.7,114,114.1,274.75,274.75,,422,Carboxypeptidase B2,extracellular space|cell|extracellular exosome|,positive regulation of extracellular matrix constituent secretion|proteolysis|blood coagulation|response to heat|negative regulation of plasminogen activation|response to drug|fibrinolysis|negative regulation of fibrinolysis|cellular response to glucose stimulus|liver regeneration|negative regulation of hepatocyte proliferation|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,18,117,59500000000,36.7%
P27773,1.0426e-4,-1.155,51.60764916,4.418,6.90614e-6,11.03776857,-3.664,-2.783,-3.645,1.12,1.14,0.902,P27773,Pdia3,P27773_Pdia3,P27773,Pdia3,1,53,20,20,P27773|A5D7E8|P38657,MOUSE,57133.7,40,115,115.1,273.3,273.3,,505,Protein disulfide-isomerase A3,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|cell surface|melanosome|myelin sheath|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|positive regulation of extrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|protein binding|poly(A) RNA binding|,20,53,4430000000,40.0%
P82198,1.0426e-4,-1.08,51.87357898,4.308666667,6.49594e-6,11.13364445,-3.547,-2.778,-3.378,0.996,0.903,1.324,P82198,Tgfbi,P82198_Tgfbi,P82198,Tgfbi,1,66,20,20,P82198|Q3UXJ2,MOUSE,75223.3,26.6,116,116.1,273.23,273.23,,683,Transforming growth factor-beta-induced protein ig-h3,proteinaceous extracellular matrix|basement membrane|extracellular space|trans-Golgi network|extracellular exosome|extracellular matrix|,angiogenesis|chondrocyte differentiation|cell adhesion|extracellular matrix organization|,collagen binding|cell adhesion molecule binding|extracellular matrix binding|,20,66,3370000000,26.6%
P08607,1.0426e-4,-1.110333333,52.5082633,4.336666667,5.61272e-6,11.36550244,-3.728,-2.905,-3.203,1.118,0.916,1.14,P08607,C4bp,P08607_C4bp,P08607,C4bpa,1,126,16,16,P08607|E9PUZ8,MOUSE,53006.2,33.9,117,117.1,271.53,271.53,,469,C4b-binding protein,extracellular region|,"complement activation, classical pathway|innate immune response|",protein binding|,16,126,68600000000,33.9%
Q5I012-3,1.50949e-4,-1.126,42.38873369,4.241333333,5.76935e-5,8.130230632,-3.31,-2.277,-4.153,1.131,0.946,0.907,Q5I012,Slc38a10,Q5I012-3_Slc38a10,Q5I012-3,Slc38a10,1,48,18,18,Q5I012-3|Q5I012-4|Q5I012|J3QNE8|Q5I012-2,MOUSE,116909.1,26.2,118,118.1,266.08,266.08,,1090,Isoform 3 of Putative sodium-coupled neutral amino acid transporter 10,Golgi apparatus|integral component of membrane|,amino acid transmembrane transport|sodium ion transport|bone development|,amino acid transmembrane transporter activity|,18,48,21700000000,26.2%
Q9CQF9,1.0426e-4,-1.063166667,51.73728373,4.249666667,6.70304e-6,11.08441281,-3.316,-2.719,-3.529,1.177,1.106,0.902,Q9CQF9,Pcyox1,Q9CQF9_Pcyox1,Q9CQF9,Pcyox1,1,70,17,17,Q9CQF9|A0A0N4SWD3,MOUSE,56721.9,40.3,119,119.1,265.71,265.71,,505,Prenylcysteine oxidase,lysosome|vacuolar membrane|plasma membrane|very-low-density lipoprotein particle|extracellular exosome|,prenylated protein catabolic process|prenylcysteine catabolic process|oxidation-reduction process|chloride transmembrane transport|,prenylcysteine oxidase activity|chloride-transporting ATPase activity|,17,70,6920000000,40.3%
Q9EQH2,1.0426e-4,-1.2325,48.99914078,4.579,1.25917e-5,10.13563495,-3.537,-2.826,-4.203,1.294,0.939,0.938,Q9EQH2,Erap1,Q9EQH2_Erap1,Q9EQH2,Erap1,1,53,23,23,Q9EQH2,MOUSE,107167.8,25.3,120,120.1,263.58,263.58,,930,Endoplasmic reticulum aminopeptidase 1,extracellular region|extracellular space|cytoplasm|endoplasmic reticulum lumen|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,immune system process|proteolysis|membrane protein ectodomain proteolysis|positive regulation of angiogenesis|,aminopeptidase activity|interleukin-6 receptor binding|tumor necrosis factor receptor binding|peptidase activity|metalloexopeptidase activity|zinc ion binding|,23,53,3270000000,25.3%
A0A0A6YVP0,2.11828e-4,-1.088,39.86457181,4.429333333,1.03167e-4,7.457451379,-2.631,-2.654,-4.623,1.218,1.267,0.895,A0A0A6YVP0,NotFound,A0A0A6YVP0_NotFound,A0A0A6YVP0,Ighg2b,1,82,18,16,A0A0A6YVP0|P01867|P01867-2|P01865|P01863,MOUSE,45094.4,47.1,121,121.1,256.71,214.61,,405,Immunoglobulin heavy constant gamma 2B (Fragment),"extracellular space|immunoglobulin complex, circulating|","positive regulation of type IIa hypersensitivity|positive regulation of type I hypersensitivity|humoral immune response mediated by circulating immunoglobulin|phagocytosis, recognition|phagocytosis, engulfment|complement activation, classical pathway|immunoglobulin mediated immune response|positive regulation of phagocytosis|positive regulation of immune response|",antigen binding|,18,82,17600000000,47.1%
F6TQW2,0.006649005,-1.987,22.60590286,6.164,0.005487945,3.971808918,-3.537,-2.641,-9.029,1.186,1.201,0.898,F6TQW2,NotFound,F6TQW2_NotFound,F6TQW2,Ighg2c,1,56,13,11,F6TQW2|P01864,MOUSE,44892.5,32.9,121,121.2,230.3,188.2,,404,Immunoglobulin heavy constant gamma 2C (Fragment),"extracellular space|immunoglobulin complex, circulating|",humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antibacterial humoral response|defense response to bacterium|,antigen binding|,11,56,14000000000,28.2%
Q9QWL7,0.113470542,-0.489333333,9.695540048,1.527333333,0.107262026,1.839772657,-0.059,-0.419,-3.281,0.147,0.235,0.441,Q9QWL7,Krt17,Q9QWL7_Krt17,Q9QWL7,Krt17,1,116,21,6,Q9QWL7|Q9D312|Q8CCX5|Q8CCX5-2|Q99PS0,MOUSE,48446.3,33.9,122,122.1,256.44,73.93,,433,"Keratin, type I cytoskeletal 17",cytoplasm|intermediate filament|extracellular exosome|cell periphery|,morphogenesis of an epithelium|signal transduction|positive regulation of cell growth|hair follicle morphogenesis|keratinization|intermediate filament organization|positive regulation of translation|positive regulation of hair follicle development|,structural molecule activity|protein binding|MHC class II receptor activity|MHC class II protein binding|,22,116,520000000000,33.9%
Q61781,5.51273e-4,-0.479333333,34.41347019,2.474,3.61954e-4,6.152011764,-1.685,-1.222,-2.242,0.801,0.606,0.866,Q61781,Krt14,Q61781_Krt14,Q61781,Krt14,1,3,21,3,Q61781|Q9Z320|Q8VCW2,MOUSE,53208.4,35.7,122,122.2,254.8,29.07,,484,"Keratin, type I cytoskeletal 14",intracellular|nucleus|cytoplasm|intermediate filament|keratin filament|extracellular exosome|cell periphery|,aging|response to zinc ion|response to ionizing radiation|epithelial cell differentiation|hair cycle|intermediate filament bundle assembly|,structural molecule activity|protein binding|keratin filament binding|,3,3,13800000,7.2%
Q6IFX2,0.139291043,-1.152666667,8.778479157,2.985333333,0.132480538,1.704523473,0.044,-0.847,-7.133,-0.045,0.48,0.585,Q6IFX2,Krt42,Q6IFX2_Krt42,Q6IFX2,Krt42,1,12,21,6,Q6IFX2,MOUSE,50474.5,30.5,122,122.3,229.96,61.98,,452,"Keratin, type I cytoskeletal 42",cytoplasm|intermediate filament|,,structural molecule activity|,6,12,1460000000,8.8%
P08730,0.005824,-0.355333333,23.2305375,4.144666667,0.004752764,4.08597827,-1.957,-1.286,-4.04,0.733,0.784,3.634,P08730,Krt13,P08730_Krt13,P08730,Krt13,1,4,16,3,P08730|P08730-2|A6BLY7,MOUSE,48095.6,21.9,122,122.4,163.4,25.83,,437,"Keratin, type I cytoskeletal 13",nucleus|keratin filament|intermediate filament cytoskeleton|extracellular exosome|,cytoskeleton organization|response to radiation|tongue morphogenesis|cellular response to retinoic acid|,structural molecule activity|protein binding|,3,4,462000000,5.9%
Q9Z2K1,0.130032042,-0.547166667,9.087851728,1.669666667,0.123371495,1.753577352,0.146,-0.624,-3.668,-0.03,0.247,0.646,Q9Z2K1,Krt16,Q9Z2K1_Krt16,Q9Z2K1,Krt16,1,12,15,6,Q9Z2K1,MOUSE,52004.9,23.6,122,122.5,183.42,82.81,,469,"Keratin, type I cytoskeletal 16",nucleus|cytoskeleton|intermediate filament|extracellular exosome|,morphogenesis of an epithelium|inflammatory response|aging|keratinocyte differentiation|negative regulation of cell migration|keratinization|hair cycle|innate immune response|intermediate filament cytoskeleton organization|keratinocyte migration|establishment of skin barrier|,structural constituent of cytoskeleton|protein binding|,6,12,2910000000,11.5%
P02535,0.011623641,-0.6915,20.0059461,2.379666667,0.009986318,3.446090563,-1.127,-1.003,-3.514,0.479,0.641,0.375,P02535,Krt10,P02535_Krt10,P02535,Krt10,1,57,12,7,P02535|P02535-2|A2A513|P02535-3,MOUSE,57940,17,122,122.7,175.58,109.55,,570,"Keratin, type I cytoskeletal 10",keratin filament|,epithelial cell differentiation|cellular response to calcium ion|,structural molecule activity|protein binding|,7,57,144000000000,11.7%
P29788,1.05478e-4,-0.720166667,46.25606292,3.731666667,2.36807e-5,9.257487546,-2.902,-2.746,-2.11,1.521,1,0.916,P29788,Vtn,P29788_Vtn,P29788,Vtn,1,184,16,16,P29788,MOUSE,55646.8,34.5,123,123.1,255.79,255.79,,478,Vitronectin,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,receptor-mediated endocytosis|immune response|cell-matrix adhesion|positive regulation of cell-substrate adhesion|negative regulation of endopeptidase activity|positive regulation of smooth muscle cell migration|extracellular matrix organization|positive regulation of protein binding|cell adhesion mediated by integrin|endodermal cell differentiation|positive regulation of receptor-mediated endocytosis|oligodendrocyte differentiation|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell-matrix adhesion|,scavenger receptor activity|integrin binding|heparin binding|polysaccharide binding|extracellular matrix binding|,16,184,432000000000,34.5%
P29533,1.0426e-4,-1.137833333,52.58217509,4.303666667,5.51801e-6,11.39278437,-3.613,-2.84,-3.416,0.994,1.129,0.919,P29533,NotFound,P29533_NotFound,P29533,Vcam1,1,58,19,19,P29533|Q3UPN1|P29533-2,MOUSE,82457.1,27.8,124,124.1,253.07,253.07,,739,Vascular cell adhesion protein 1,podosome|extracellular space|early endosome|endoplasmic reticulum|Golgi apparatus|microvillus|external side of plasma membrane|cell surface|integral component of membrane|filopodium|anchored component of membrane|apical part of cell|extracellular exosome|alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex|cell periphery|,cell adhesion|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell-matrix adhesion|heart development|amine metabolic process|viral process|positive regulation of T cell proliferation|leukocyte tethering or rolling|oxidation-reduction process|embryonic placenta morphogenesis|chorio-allantoic fusion|visceral serous pericardium development|cellular response to glucose stimulus|,integrin binding|primary amine oxidase activity|cell adhesion molecule binding|,19,58,8400000000,27.8%
Q3U9N4,1.30405e-4,-1.021,43.77789383,4.202,4.18997e-5,8.521094925,-3.146,-2.27,-3.95,1.131,1.219,0.89,Q3U9N4,Grn,Q3U9N4_Grn,Q3U9N4,Grn,1,71,18,18,Q3U9N4|P28798,MOUSE,70037.8,29.9,125,125.1,252.36,252.36,,602,Granulins,extracellular space|mitochondrion|cell surface|intracellular membrane-bounded organelle|extracellular exosome|,blastocyst hatching|embryo implantation|response to estradiol|chondrocyte proliferation|synaptic vesicle endocytosis|positive regulation of epithelial cell proliferation|male mating behavior|positive regulation of dendritic spine development|neural precursor cell proliferation|,poly(A) RNA binding|,18,71,4540000000,29.9%
Q9R098,1.05478e-4,-1.006666667,46.26711422,4.204666667,2.36205e-5,9.260888806,-3.092,-2.415,-3.82,1.192,1.212,0.883,Q9R098,Hgfac,Q9R098_Hgfac,Q9R098,Hgfac,1,62,17,17,Q9R098,MOUSE,72905.8,26.6,126,126.1,248.86,248.86,,653,Hepatocyte growth factor activator,extracellular space|cytoplasm|rough endoplasmic reticulum|,proteolysis|,serine-type endopeptidase activity|,17,62,13200000000,26.6%
P70663,1.0426e-4,-0.880833333,47.9456659,3.821,1.60485e-5,9.790177371,-2.774,-2.339,-3.261,1.101,1.094,0.894,P70663,Sparcl1,P70663_Sparcl1,P70663,Sparcl1,1,64,19,19,P70663,MOUSE,73141.8,33,127,127.1,245.26,245.26,,650,SPARC-like protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|,signal transduction|,calcium ion binding|,19,64,9130000000,33.0%
P28653,7.49815e-4,-0.357,32.83064865,2.237333333,5.21117e-4,5.806464126,-0.996,-1.568,-1.863,0.743,0.873,0.669,P28653,Bgn,P28653_Bgn,P28653,Bgn,1,50,17,17,P28653,MOUSE,42094.9,53.6,128,128.1,244.49,244.49,,369,Biglycan,proteinaceous extracellular matrix|intracellular|cell surface|transport vesicle|sarcolemma|extracellular exosome|extracellular matrix|,blood vessel remodeling|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|extracellular matrix binding|,17,50,13100000000,53.6%
Q06770,1.0426e-4,-1.077333333,47.41007153,4.5,1.81549e-5,9.618518643,-3.994,-2.593,-3.395,1.529,1.093,0.896,Q06770,Serpina6,Q06770_Serpina6,Q06770,Serpina6,1,99,15,15,Q06770,MOUSE,44939.5,35,129,129.1,242.09,242.09,,397,Corticosteroid-binding globulin,extracellular space|extracellular exosome|,transport|glucocorticoid metabolic process|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|steroid binding|,15,99,117000000000,35.0%
Q9R0E2,1.0426e-4,-0.919166667,47.81867238,3.886333333,1.65247e-5,9.749236644,-3.436,-2.492,-2.659,1.076,1.085,0.911,Q9R0E2,Plod1,Q9R0E2_Plod1,Q9R0E2,Plod1,1,66,21,20,Q9R0E2|A8Y5E6,MOUSE,84164,31,130,130.1,240.07,227.56,,728,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",rough endoplasmic reticulum membrane|extracellular exosome|,response to hypoxia|epidermis development|peptidyl-lysine hydroxylation|cellular response to hormone stimulus|oxidation-reduction process|,ferrous iron binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|peptide binding|,21,66,2840000000,31.0%
Q9R0E1,1.15041e-4,-1.116166667,44.89326393,4.432333333,3.24096e-5,8.846146044,-4.165,-3.4,-2.432,1.074,1.269,0.957,Q9R0E1,Plod3,Q9R0E1_Plod3,Q9R0E1,Plod3,1,20,8,7,Q9R0E1,MOUSE,85491.3,12.8,130,130.2,73.53,61.02,,741,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",rough endoplasmic reticulum membrane|extracellular exosome|,in utero embryonic development|endothelial cell morphogenesis|protein localization|neural tube development|collagen fibril organization|cellular response to hormone stimulus|vasodilation|epidermis morphogenesis|oxidation-reduction process|lung morphogenesis|basement membrane assembly|,iron ion binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|procollagen glucosyltransferase activity|,7,20,2020000000,11.4%
P01898,3.91225e-4,-0.752666667,36.2223555,3.864666667,2.38652e-4,6.564511232,-3.795,-2.69,-1.57,1.456,1.179,0.904,P01898,H2-Q10,P01898_H2-Q10,P01898,H2-Q10,1,122,15,8,P01898|G3UXE9|E9Q0G4|A7VMS6|V9GXR0|V9GXI4|Q05A75|G3UZL7|A0A0B4J1G3,MOUSE,37478.5,40.6,131,131.1,240.04,134.39,,325,"H-2 class I histocompatibility antigen, Q10 alpha chain",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|integral component of lumenal side of endoplasmic reticulum membrane|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,15,122,43800000000,40.6%
Q8HWB2,1.50217e-4,-1.364166667,42.42727691,4.900333333,5.71837e-5,8.1408722,-3.692,-2.71,-5.041,1.255,1.106,0.897,Q8HWB2,H2-Q4,Q8HWB2_H2-Q4,Q8HWB2,H2-Q4,1,20,15,6,Q8HWB2|P01899|O19441|E9PX63|P01900|P14427|P01895-2,MOUSE,39902.4,37,131,131.2,205.53,80.74,,354,"Histocompatibility 2, Q region locus 4",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,6,20,774000000,16.1%
P33587,1.06798e-4,-1.116166667,45.93678017,4.613,2.54872e-5,9.159682791,-3.415,-2.608,-4.245,1.58,1.094,0.897,P33587,Proc,P33587_Proc,P33587,Proc,1,59,15,15,P33587,MOUSE,53186.4,38,132,132.1,239.95,239.95,,460,Vitamin K-dependent protein C,extracellular space|,proteolysis|blood coagulation|negative regulation of blood coagulation|negative regulation of apoptotic process|,calcium ion binding|peptidase activity|,15,59,7720000000,38.0%
Q61207,1.0426e-4,-1.413666667,48.00541514,5.088,1.58292e-5,9.809491355,-4.091,-2.994,-4.788,1,1.417,0.974,Q61207,Psap,Q61207_Psap,Q61207,Psap,1,78,16,16,Q61207|J3QPG5|K3W4L3|Q8BFQ1|E9PZ00,MOUSE,63303.9,36.2,133,133.1,237.18,237.18,,557,Prosaposin,extracellular space|nucleoplasm|nucleolus|mitochondrion|lysosome|Golgi apparatus|intracellular membrane-bounded organelle|extracellular exosome|,sphingolipid metabolic process|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway|regulation of lipid metabolic process|regulation of MAPK cascade|positive regulation of MAPK cascade|developmental growth|prostate gland growth|epithelial cell differentiation involved in prostate gland development|cellular response to organic substance|negative regulation of hydrogen peroxide-induced cell death|,G-protein coupled receptor binding|,16,78,23600000000,36.2%
Q9R097,1.22235e-4,-0.832,44.45398418,4.056,3.58593e-5,8.716905552,-3.616,-2.753,-2.211,1.465,1.233,0.89,Q9R097,Spint1,Q9R097_Spint1,Q9R097,Spint1,1,50,18,18,Q9R097,MOUSE,58358.6,37.8,134,134.1,237.12,237.12,,507,Kunitz-type protease inhibitor 1,extracellular space|plasma membrane|extracellular exosome|,neural tube closure|embryonic placenta development|negative regulation of endopeptidase activity|extracellular matrix organization|branching involved in labyrinthine layer morphogenesis|placenta blood vessel development|,serine-type endopeptidase inhibitor activity|,18,50,3050000000,37.8%
P46412,1.0426e-4,-1.480833333,50.14858724,5.133666667,9.66365e-6,10.52475445,-4.246,-3.145,-4.752,1.287,1,0.971,P46412,Gpx3,P46412_Gpx3,P46412,Gpx3,1,180,17,17,P46412|P21765,MOUSE,25581.2,48.2,135,135.1,236.26,236.26,,226,Glutathione peroxidase 3,extracellular space|extracellular exosome|,response to oxidative stress|hydrogen peroxide catabolic process|protein homotetramerization|oxidation-reduction process|,glutathione peroxidase activity|selenium binding|,17,180,345000000000,48.2%
P55065,1.0426e-4,-0.8475,47.27047392,4.073666667,1.87479e-5,9.574209137,-3.464,-2.866,-2.323,1.266,1.39,0.912,P55065,Pltp,P55065_Pltp,P55065,Pltp,1,74,16,16,P55065|A2A5K2,MOUSE,54680.3,41.7,136,136.1,235.85,235.85,,493,Phospholipid transfer protein,extracellular space|,lipid metabolic process|lipid transport|vitamin E biosynthetic process|positive regulation of cholesterol efflux|sperm motility|high-density lipoprotein particle remodeling|,lipid binding|,16,74,14100000000,41.7%
E0CZ58,3.45278e-4,-0.967333333,36.90264605,4.028,2.04049e-4,6.724766228,-2.055,-2.63,-4.259,1.354,0.958,0.828,E0CZ58,Prg4,E0CZ58_Prg4,E0CZ58,Prg4,1,55,17,17,E0CZ58|Q9JM99|Q9JM99-2|E9QQ17|Q9JM99-3|E9QQ18|Q9JM99-4|A0A0R4J207|Q9JM99-5,MOUSE,135831.6,15.3,137,137.1,229.33,229.33,,1221,Proteoglycan 4,extracellular space|cytoplasm|,receptor-mediated endocytosis|immune response|peptide cross-linking|regulation of cell proliferation|negative regulation of interleukin-6 biosynthetic process|hematopoietic stem cell proliferation|,scavenger receptor activity|polysaccharide binding|,17,55,10000000000,15.3%
Q9JJN5,0.005401434,-0.439166667,23.57006932,3.175666667,0.004395346,4.07537828,-3.4,-2.458,-0.223,1.348,1.184,0.914,Q9JJN5,Cpn1,Q9JJN5_Cpn1,Q9JJN5,Cpn1,1,83,15,15,Q9JJN5|Q2KJ83,MOUSE,52129.7,37.4,138,138.1,227.96,227.96,,457,Carboxypeptidase N catalytic chain,extracellular space|,proteolysis|bradykinin catabolic process|response to glucocorticoid|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,15,83,17500000000,37.4%
G3X8T3,1.63648e-4,-1.234666667,41.76014902,4.742,6.66784e-5,7.958281002,-3.708,-2.411,-4.698,1.283,1.235,0.891,G3X8T3,Ctsa,G3X8T3_Ctsa,G3X8T3,Ctsa,1,85,16,16,G3X8T3|P16675,MOUSE,56352.8,30.2,139,139.1,224.44,224.44,,492,Carboxypeptidase,nucleoplasm|mitochondrion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis|,serine-type carboxypeptidase activity|protein binding|,16,85,436000000000,30.2%
P68368,3.07843e-4,-0.735,37.55467776,3.795333333,1.75603e-4,6.881098068,-2.587,-1.685,-3.626,1.462,0.756,1.27,P68368,Tuba4a,P68368_Tuba4a,P68368,Tuba4a,1,35,18,4,P68368|Q9JJZ2|Q3U0,MOUSE,50665.2,42.1,140,140.1,222.89,45.52,,448,Tubulin alpha-4A chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,18,35,3300000000,42.1%
P05213,0.018041693,-1.169833333,17.99768929,4.173666667,0.015857367,3.172562108,-2.887,-0.585,-6.298,1.295,0.415,1.041,P05213,Tuba1b,P05213_Tuba1b,P05213,Tuba1b,1,7,17,3,P05213|P68369|P68373|P05214,MOUSE,50835.4,39.6,140,140.2,219.15,41.78,,451,Tubulin alpha-1B chain,cytosol|microtubule|cytoplasmic microtubule|myelin sheath|extracellular exosome|,microtubule cytoskeleton organization|protein folding|protein polymerization|cellular response to interleukin-4|,double-stranded RNA binding|GTPase activity|structural constituent of cytoskeleton|protein binding|GTP binding|ubiquitin protein ligase binding|,3,7,120000000,9.7%
A8DUK4,3.99267e-4,-0.784166667,36.11555669,3.927666667,2.44593e-4,6.539612564,-4.038,-2.157,-2.049,1.549,0.796,1.194,A8DUK4,Hbb-bs,A8DUK4_Hbb-bs,A8DUK4,Hbb-bs,1,148,12,4,A8DUK4|P02081|P02104|D4QBB3|P02070|P06642|P06643,MOUSE,15804.8,89.7,141,141.1,222.66,67.24,,147,Beta-globin,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,13,148,231000000000,89.7%
P02088,1.59273e-4,-0.529,41.96556361,3.477333333,6.3598e-5,8.014142577,-2.36,-1.793,-2.65,1.767,0.862,1,P02088,Hbb-b1,P02088_Hbb-b1,P02088,Hbb-b1,1,36,12,3,P02088,MOUSE,15954,89.7,141,141.2,218.6,54.62,,147,Hemoglobin subunit beta-1,hemoglobin complex|myelin sheath|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,3,36,38800000000,27.8%
O09164,1.0426e-4,-0.822333333,46.71699759,3.786,2.12961e-5,9.400263865,-3.142,-2.172,-2.832,1.279,1.029,0.904,O09164,Sod3,O09164_Sod3,O09164,Sod3,1,59,14,14,O09164,MOUSE,27733.7,51.3,142,142.1,222.2,222.2,,251,Extracellular superoxide dismutase [Cu-Zn],extracellular space|nucleus|cytoplasm|Golgi lumen|trans-Golgi network|extracellular exosome|extracellular matrix|,response to hypoxia|removal of superoxide radicals|response to copper ion|oxidation-reduction process|,superoxide dismutase activity|copper ion binding|protein binding|zinc ion binding|,14,59,23900000000,51.3%
O35930,1.0426e-4,-1.007166667,50.10555655,4.250333333,9.75988e-6,10.50995262,-3.312,-2.566,-3.519,1.258,1.201,0.895,O35930,Gp1ba,O35930_Gp1ba,O35930,Gp1ba,1,61,14,14,O35930,MOUSE,80567.4,20.2,143,143.1,221.97,221.97,,734,Platelet glycoprotein Ib alpha chain,plasma membrane|integral component of plasma membrane|cell surface|membrane|extracellular exosome|anchored component of external side of plasma membrane|,cell morphogenesis|cell adhesion|blood coagulation|hemostasis|fibrinolysis|,,14,61,8590000000,20.2%
P45700,1.0426e-4,-1.038166667,50.70986142,4.255,8.49208e-6,10.71952741,-3.672,-2.726,-3.099,1.153,1.218,0.897,P45700,Man1a,P45700_Man1a,P45700,Man1a1,1,53,20,20,P45700|A0A1W2P6N0,MOUSE,73502.6,30.6,144,144.1,220.83,220.83,,655,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA",Golgi membrane|cytoplasm|endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|extracellular exosome|,N-glycan processing|,"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",20,53,3000000000,30.6%
P07309,9.31914e-4,-1.66,31.7928761,5.878666667,6.61778e-4,5.837990538,-4.152,-2.709,-6.937,1.596,1.338,0.904,P07309,Ttr,P07309_Ttr,P07309,Ttr,1,112,15,15,P07309,MOUSE,15889.7,77.5,145,145.1,220.74,220.74,,147,Transthyretin,extracellular space|protein complex|extracellular exosome|,retinol metabolic process|thyroid hormone transport|,hormone activity|protein binding|identical protein binding|protein heterodimerization activity|thyroid hormone binding|,15,112,139000000000,77.5%
P00687,1.0426e-4,-1.008833333,46.66236576,4.261,2.15657e-5,9.383243131,-3.616,-2.341,-3.461,1.31,1.16,0.895,P00687,Amy1,P00687_Amy1,P00687,Amy1,1,57,16,16,P00687|P00688|E9PV85|Q3MHH8,MOUSE,58327.3,34.4,146,146.1,220.56,220.56,,511,Alpha-amylase 1,extracellular space|extracellular exosome|,carbohydrate catabolic process|,alpha-amylase activity|calcium ion binding|amylase activity|chloride ion binding|,16,57,11900000000,34.4%
G5E8J0,1.0426e-4,-1.139,53.06832058,4.318666667,4.93365e-6,11.57370794,-3.691,-2.919,-3.285,1.069,1.045,0.947,G5E8J0,Notch2,G5E8J0_Notch2,G5E8J0,Notch2,1,47,17,17,G5E8J0|O35516|O35516-2,MOUSE,279492.6,8.4,147,147.1,219.73,219.73,,2473,Neurogenic locus notch homolog protein 2,nucleus|integral component of plasma membrane|cell surface|receptor complex|,pulmonary valve morphogenesis|cell cycle arrest|Notch signaling pathway|negative regulation of cell proliferation|cell growth|cell differentiation|positive regulation of Ras protein signal transduction|bone remodeling|regulation of developmental process|atrial septum morphogenesis|,calcium ion binding|,17,47,1370000000,8.4%
Q9QXC1,0.001080635,-0.7225,31.09325711,3.717,7.77453e-4,5.471992033,-3.897,-2.662,-1.184,1.5,0.939,0.969,Q9QXC1,Fetub,Q9QXC1_Fetub,Q9QXC1,Fetub,1,92,14,14,Q9QXC1|Q6YJU1,MOUSE,43567.8,28.6,149,149.1,213.1,213.1,,388,Fetuin-B,extracellular region|extracellular space|extracellular exosome|,single fertilization|binding of sperm to zona pellucida|negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|metalloendopeptidase inhibitor activity|,14,92,59300000000,28.6%
Q99M74,0.549486111,0.340333333,2.671797353,-0.446,0.540530575,-0.641789982,0.155,2.138,-0.603,0.059,0.367,-0.074,Q99M74,Krt82,Q99M74_Krt82,Q99M74,Krt82,1,2,4,2,Q99M74,MOUSE,58736.9,9.3,150,150.4,29.34,9.45,,516,"Keratin, type II cuticular Hb2",keratin filament|,,structural molecule activity|,2,2,1240000000,5.6%
Q3UTR7,1.34728e-4,-0.768166667,43.36073673,3.897666667,4.61239e-5,8.402120299,-3.415,-2.153,-2.583,1.65,0.986,0.906,Q3UTR7,Agt,Q3UTR7_Agt,Q3UTR7,Agt,1,83,13,13,Q3UTR7|P11859,MOUSE,52954.5,34,151,151.1,207.63,207.63,,482,Angiotensinogen,extracellular space|cytoplasm|extracellular exosome|blood microparticle|,"ovarian follicle rupture|blood vessel development|branching involved in ureteric bud morphogenesis|kidney development|regulation of systemic arterial blood pressure by circulatory renin-angiotensin|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure|renin-angiotensin regulation of aldosterone production|regulation of renal output by angiotensin|regulation of heart rate|brain renin-angiotensin system|renal system process|angiotensin-mediated drinking behavior|positive regulation of extracellular matrix constituent secretion|cellular sodium ion homeostasis|cell-matrix adhesion|G-protein coupled receptor signaling pathway|activation of phospholipase C activity|activation of NF-kappaB-inducing kinase activity|female pregnancy|aging|excretion|establishment of blood-nerve barrier|regulation of blood pressure|negative regulation of cell proliferation|response to cold|response to salt stress|regulation of gene expression|positive regulation of activation of JAK2 kinase activity|positive regulation of endothelial cell migration|positive regulation of cardiac muscle hypertrophy|positive regulation of gene expression|positive regulation of cholesterol esterification|negative regulation of endopeptidase activity|regulation of norepinephrine secretion|positive regulation of phosphatidylinositol 3-kinase signaling|artery smooth muscle contraction|response to muscle activity involved in regulation of muscle adaptation|negative regulation of angiogenesis|extracellular matrix organization|negative regulation of cell growth|peristalsis|positive regulation of cellular protein metabolic process|positive regulation of superoxide anion generation|positive regulation of peptidyl-serine phosphorylation|negative regulation of tissue remodeling|catenin import into nucleus|positive regulation of renal sodium excretion|positive regulation of multicellular organism growth|vasodilation|hormone metabolic process|drinking behavior|regulation of apoptotic process|positive regulation of MAPK cascade|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of fatty acid biosynthetic process|positive regulation of epidermal growth factor receptor signaling pathway|positive regulation of transcription, DNA-templated|positive regulation of vasodilation|positive regulation of organ growth|astrocyte activation|fibroblast proliferation|positive regulation of fibroblast proliferation|regulation of long-term neuronal synaptic plasticity|smooth muscle cell proliferation|cytokine secretion|regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell differentiation|negative regulation of neurotrophin TRK receptor signaling pathway|stress-activated MAPK cascade|regulation of calcium ion transport|regulation of transmission of nerve impulse|cell growth involved in cardiac muscle cell development|positive regulation of protein tyrosine kinase activity|ERK1 and ERK2 cascade|uterine smooth muscle contraction|cellular response to mechanical stimulus|positive regulation of branching involved in ureteric bud morphogenesis|positive regulation of protein kinase C activity|regulation of extracellular matrix assembly|positive regulation of membrane hyperpolarization|positive regulation of gap junction assembly|regulation of cardiac conduction|positive regulation of extrinsic apoptotic signaling pathway|",serine-type endopeptidase inhibitor activity|hormone activity|sodium channel regulator activity|type 1 angiotensin receptor binding|type 2 angiotensin receptor binding|,13,83,35500000000,34.0%
Q8VDD5,0.087912563,-0.430166667,10.87939329,1.547666667,0.081669646,2.021049791,0.452,-2.69,-1.374,0.401,-0.01,0.64,Q8VDD5,Myh9,Q8VDD5_Myh9,Q8VDD5,Myh9,1,24,20,18,Q8VDD5|Q6URW6-3|Q6URW6|K3W4R2|Q6URW6-2|Q3UH59|Q5SV64|Q61879|F2Z494,MOUSE,227566.2,12.1,152,152.1,205.65,178.31,,1960,Myosin-9,stress fiber|ruffle|uropod|nucleus|cytoplasm|actomyosin contractile ring|cytosol|plasma membrane|brush border|cell-cell adherens junction|cell cortex|actin cytoskeleton|membrane|myosin complex|myosin II complex|cortical cytoskeleton|cell leading edge|cleavage furrow|actomyosin|protein complex|extracellular exosome|myosin II filament|immunological synapse|spindle|plasma membrane|focal adhesion|COP9 signalosome|integrin complex|neuromuscular junction|,"meiotic spindle organization|cell morphogenesis involved in differentiation|cytokinesis|angiogenesis|in utero embryonic development|establishment of T cell polarity|membrane protein ectodomain proteolysis|phagocytosis, engulfment|cell adhesion|myoblast fusion|regulation of cell shape|protein transport|single organismal cell-cell adhesion|actin filament-based movement|platelet formation|monocyte differentiation|actomyosin structure organization|actin cytoskeleton reorganization|uropod organization|blood vessel endothelial cell migration|establishment of meiotic spindle localization|platelet aggregation|negative regulation of actin filament severing|positive regulation of protein processing in phagocytic vesicle|actin filament polymerization|actin filament capping|",microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein domain specific binding|actin-dependent ATPase activity|protein homodimerization activity|protein anchor|ADP binding|poly(A) RNA binding|actin filament binding|,20,24,421000000,12.1%
O54782,1.0426e-4,-0.846666667,47.11314874,3.984,1.94395e-5,9.524484716,-3.465,-2.416,-2.635,1.129,1.37,0.937,O54782,Man2b2,O54782_Man2b2,O54782,Man2b2,1,54,16,16,O54782,MOUSE,115835.7,18.3,153,153.1,205.38,205.38,,1018,Epididymis-specific alpha-mannosidase,extracellular exosome|,mannose metabolic process|,alpha-mannosidase activity|zinc ion binding|carbohydrate binding|,16,54,11000000000,18.3%
P28654,0.009931562,-0.297333333,20.74844225,1.508666667,0.00841697,3.549469539,-0.358,-1.403,-1.394,0.448,0.617,0.306,P28654,Dcn,P28654_Dcn,P28654,Dcn,1,72,16,16,P28654,MOUSE,40150.6,35.8,154,154.1,204.64,204.64,,354,Decorin,collagen type VI trimer|extracellular space|extracellular matrix|,kidney development|placenta development|skeletal muscle tissue development|aging|response to mechanical stimulus|positive regulation of autophagy|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|response to lipopolysaccharide|wound healing|,collagen binding|glycosaminoglycan binding|poly(A) RNA binding|protein N-terminus binding|extracellular matrix binding|,16,72,19300000000,35.8%
P16858,9.22682e-4,-0.7195,31.84324005,3.932333333,6.54148e-4,5.651766969,-2.578,-1.411,-4.068,1.785,0.713,1.242,P16858,Gapdh,P16858_Gapdh,P16858,Gapdh,1,51,14,14,A0A0A0MQF6|P16858|A0A1D5RLD8|S4R1W1|P10096|Q64467|S4R2G5|A0A0R4J0X7|V9GX06|V9GXA7,MOUSE,36094.6,44.7,155,155.1,202.93,202.93,,333,Glyceraldehyde-3-phosphate dehydrogenase,nucleus|cytoplasm|cytosol|microtubule cytoskeleton|myelin sheath|GAIT complex|,microtubule cytoskeleton organization|glucose metabolic process|glycolytic process|negative regulation of translation|peptidyl-cysteine S-trans-nitrosylation|protein stabilization|neuron apoptotic process|oxidation-reduction process|,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity|protein binding|microtubule binding|enzyme binding|peptidyl-cysteine S-nitrosylase activity|NADP binding|NAD binding|,14,51,3300000000,44.7%
P11680,1.0426e-4,-1.041333333,48.55776146,4.705333333,1.39388e-5,9.989619146,-3.572,-2.622,-3.988,1.418,1.6,0.916,P11680,Cfp,P11680_Cfp,P11680,Cfp,1,120,14,14,P11680,MOUSE,52836.7,34.6,156,156.1,202.34,202.34,,464,Properdin,extracellular region|extracellular matrix|,"complement activation, alternative pathway|",,14,120,205000000000,34.6%
Q8VCG4,1.0426e-4,-1.3055,47.3531665,4.824333333,1.83943e-5,9.600435077,-3.716,-2.845,-4.592,1.221,0.929,1.17,Q8VCG4,C8g,Q8VCG4_C8g,Q8VCG4,C8g,1,113,12,12,Q8VCG4|Q9DAC2,MOUSE,22678.7,63.3,157,157.1,200.2,200.2,,202,Complement component C8 gamma chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|retinol binding|protein complex binding|,12,113,63700000000,63.3%
P18242,1.0426e-4,-1.042666667,51.37390254,4.253333333,7.28802e-6,10.95410819,-3.384,-2.65,-3.474,1.094,1.195,0.963,P18242,Ctsd,P18242_Ctsd,P18242,Ctsd,1,45,14,14,P18242|F8WIR1,MOUSE,45409.4,32.6,158,158.1,199.28,199.28,,410,Cathepsin D,extracellular space|mitochondrion|lysosome|melanosome|membrane raft|extracellular exosome|extracellular matrix|,autophagosome assembly|proteolysis|autophagy|protein catabolic process|epithelial tube branching involved in lung morphogenesis|,aspartic-type endopeptidase activity|peptidase activity|peptide binding|,14,45,9550000000,32.6%
O55111,1.27982e-4,-1.449833333,44.01326568,4.949666667,3.96893e-5,8.58884138,-3.777,-2.902,-5.095,1.16,0.979,0.936,O55111,Dsg2,O55111_Dsg2,O55111,Dsg2,1,35,14,14,O55111|Q811I1|Q8VCE3,MOUSE,123181.5,15.2,159,159.1,198.95,198.95,,1122,Desmoglein-2,plasma membrane|cell surface|intercalated disc|integral component of membrane|apical plasma membrane|lateral plasma membrane|desmosome|extracellular exosome|,desmosome organization|Purkinje myocyte development|cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|response to progesterone|maternal process involved in female pregnancy|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,calcium ion binding|cell adhesion molecule binding|,14,35,718000000,15.2%
Q02257,0.088809562,-0.606333333,10.81900921,1.840666667,0.082813107,2.025874546,-0.592,-0.235,-3.753,0.187,0.363,0.392,Q02257,Jup,Q02257_Jup,Q02257,Jup,1,43,18,18,Q02257|Q02248|E9Q6A9,MOUSE,82541,29.1,160,160.1,197.88,197.88,,745,Junction plakoglobin,nucleus|cytoplasm|cytosol|intermediate filament|plasma membrane|cell-cell junction|cell-cell adherens junction|focal adhesion|intercalated disc|membrane|catenin complex|Z disc|desmosome|protein-DNA complex|extracellular exosome|gamma-catenin-TCF7L2 complex|,desmosome assembly|cell adhesion|signal transduction|single organismal cell-cell adhesion|cell migration|adherens junction assembly|regulation of cell proliferation|positive regulation of protein import into nucleus|regulation of cell fate specification|skin development|detection of mechanical stimulus|positive regulation of sequence-specific DNA binding transcription factor activity|cellular response to indole-3-methanol|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|establishment of protein localization to plasma membrane|regulation of ventricular cardiac muscle cell action potential|positive regulation of transcription from RNA polymerase II promoter|,transcription coactivator activity|signal transducer activity|structural molecule activity|protein binding|protein phosphatase binding|alpha-catenin binding|cadherin binding|cell adhesion molecule binding|nuclear hormone receptor binding|,18,43,1540000000,29.1%
Q9D154,1.14096e-4,-1.544666667,44.94704997,5.202,3.20107e-5,8.862080991,-4.006,-3.095,-5.336,0.953,1.264,0.952,Q9D154,Serpinb1a,Q9D154_Serpinb1a,Q9D154,Serpinb1a,1,42,18,18,Q9D154|Q8VHP7|Q5SV42|Q9JK88|I7HJI5|Q9DAV6|Q9D6A7,MOUSE,42745.3,39.5,161,161.1,197.68,197.68,,379,Leukocyte elastase inhibitor A,extracellular space|cytoplasm|membrane|extracellular exosome|,negative regulation of endopeptidase activity|regulation of protein catabolic process|,serine-type endopeptidase inhibitor activity|,18,42,1690000000,39.5%
P03987,1.0426e-4,-0.919666667,48.97343707,4.228666667,1.26665e-5,10.12708061,-2.68,-2.873,-3.549,1.101,1.609,0.874,P03987,NotFound,P03987_NotFound,P03987,,1,103,13,13,A0A1Y7VJN6|P03987|P03987-2,MOUSE,44498.8,29.8,162,162.1,197.62,197.62,,398,Ig gamma-3 chain C region,extracellular region|plasma membrane|integral component of membrane|,,antigen binding|immunoglobulin receptor binding|,13,103,35400000000,29.8%
Q63880,1.10858e-4,-0.985666667,45.52509088,3.961333333,2.80215e-5,9.034875773,-3.738,-2.62,-2.541,0.986,0.958,1.041,Q63880,Ces3a,Q63880_Ces3a,Q63880,Ces3a,1,81,14,7,Q63880|Q63880-2,MOUSE,63715.9,26.7,163,163.1,197.5,105.86,,571,Carboxylesterase 3A,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,14,81,18000000000,26.7%
Q8CIF4,2.0571e-4,-0.846666667,40.07953695,4.03,9.81853e-5,7.512946454,-3.886,-2.728,-1.971,1.371,1.22,0.914,Q8CIF4,Btd,Q8CIF4_Btd,Q8CIF4,Btd,1,91,12,12,A0A0R4J131|Q8CIF4,MOUSE,58952,26.1,164,164.1,196.87,196.87,,520,Biotinidase,extracellular space|nucleolus|perikaryon|apical part of cell|extracellular exosome|,biotin metabolic process|,biotinidase activity|,12,91,24800000000,26.1%
Q61805,1.65963e-4,-1.112333333,41.67439215,4.520666667,6.80081e-5,7.93505372,-3.153,-2.476,-4.489,1.582,0.922,0.94,Q61805,Lbp,Q61805_Lbp,Q61805,Lbp,1,55,15,15,Q61805|A2AC65,MOUSE,53282.7,29.3,165,165.1,196.62,196.62,,481,Lipopolysaccharide-binding protein,extracellular space|cell surface|extracellular exosome|,"liver development|leukocyte chemotaxis involved in inflammatory response|macrophage activation involved in immune response|acute-phase response|opsonization|lipopolysaccharide transport|lipopolysaccharide-mediated signaling pathway|detection of molecule of bacterial origin|response to lipopolysaccharide|negative regulation of tumor necrosis factor production|positive regulation of chemokine production|positive regulation of interleukin-6 production|positive regulation of interleukin-8 production|positive regulation of tumor necrosis factor production|positive regulation of toll-like receptor 4 signaling pathway|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of growth of symbiont in host|innate immune response|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|positive regulation of phagocytosis, engulfment|positive regulation of respiratory burst involved in inflammatory response|cellular response to lipopolysaccharide|cellular response to lipoteichoic acid|positive regulation of neutrophil chemotaxis|regulation of membrane permeability|",lipopolysaccharide binding|receptor binding|lipoteichoic acid binding|,15,55,5010000000,29.3%
E9QN70,1.10023e-4,-1.337833333,45.70288667,5.085,2.68975e-5,9.088596929,-3.969,-2.812,-4.86,0.925,1.231,1.458,E9QN70,Lamb1,E9QN70_Lamb1,E9QN70,Lamb1,1,34,18,18,E9QN70|P02469,MOUSE,209741,10.8,166,166.1,196.09,196.09,,1834,Laminin subunit beta-1,proteinaceous extracellular matrix|basement membrane|basal lamina|laminin-1 complex|laminin-2 complex|extracellular space|extracellular matrix|laminin complex|laminin-8 complex|laminin-10 complex|extracellular exosome|basement membrane|,embryo implantation|cell migration|neuronal-glial interaction involved in cerebral cortex radial glia guided migration|positive regulation of cell migration|neuron projection development|substrate adhesion-dependent cell spreading|endodermal cell differentiation|odontogenesis|,integrin binding|extracellular matrix structural constituent|protein binding|enzyme binding|glycosphingolipid binding|,18,34,967000000,10.8%
Q91Y47,1.0426e-4,-1.085333333,46.58198294,4.800666667,2.19686e-5,9.35824783,-3.484,-2.681,-4.292,0.911,1.792,1.242,Q91Y47,F11,Q91Y47_F11,Q91Y47,F11,1,59,15,15,Q91Y47,MOUSE,71784.4,24.1,167,167.1,195.25,195.25,,624,Coagulation factor XI,extracellular space|extracellular exosome|,blood coagulation|regulation of blood coagulation|plasminogen activation|positive regulation of fibrinolysis|,serine-type endopeptidase activity|heparin binding|,15,59,13600000000,24.1%
Q8K0D2,1.17305e-4,-1.005666667,44.74477483,4.325333333,3.35369e-5,8.802279481,-4.056,-2.524,-2.925,1.499,1.067,0.905,Q8K0D2,Habp2,Q8K0D2_Habp2,Q8K0D2,Habp2,1,58,17,17,Q8K0D2|E9QM92|E9Q092|Q8K0D2-2|Q3V1J8|E9Q0C5,MOUSE,64409.4,26.7,168,168.1,194.56,194.56,,558,Hyaluronan-binding protein 2,extracellular region|,proteolysis|,serine-type endopeptidase activity|peptidase activity|,17,58,5620000000,26.7%
Q3UEL9,1.46405e-4,-0.72,42.61063913,4.28,5.48196e-5,8.191654184,-2.351,-2.545,-3.684,2.063,0.828,1.369,Q3UEL9,Serpina7,Q3UEL9_Serpina7,Q3UEL9,Serpina7,1,62,15,15,Q3UEL9|P61939|Q8BII9,MOUSE,48364.8,34.7,169,169.1,194.55,194.55,,426,Thyroxine-binding globulin,extracellular space|extracellular exosome|,aging|post-embryonic development|negative regulation of endopeptidase activity|response to vitamin A|response to prostaglandin E|response to drug|response to peptide hormone|response to corticosterone|thyroid hormone transport|,serine-type endopeptidase inhibitor activity|hormone binding|,15,62,13400000000,34.7%
Q60590,1.0426e-4,-0.979666667,52.33273012,4.179333333,5.84423e-6,11.30094671,-3.257,-2.693,-3.258,1.084,1.304,0.942,Q60590,Orm1,Q60590_Orm1,Q60590,Orm1,1,65,13,7,Q60590|J3JRU4|Q63805,MOUSE,24008.9,34.7,170,170.1,193.29,111.95,,207,Alpha-1-acid glycoprotein 1,extracellular space|,regulation of immune system process|transport|acute-phase response|,,13,65,47000000000,34.7%
P07361,0.008689008,-1.239666667,21.37690458,3.932,0.007282987,3.751581781,-0.607,-4.528,-4.482,0.426,0.658,1.095,P07361,Orm2,P07361_Orm2,P07361,Orm2,1,17,10,4,P07361,MOUSE,23957.1,29.4,170,170.2,129.67,48.33,,207,Alpha-1-acid glycoprotein 2,extracellular space|,regulation of immune system process|transport|acute-phase response|,,4,17,2380000000,12.5%
P16301,1.34728e-4,-1.256833333,43.29830988,5.000333333,4.67917e-5,8.384435351,-4.121,-2.507,-4.643,1.601,1.234,0.895,P16301,Lcat,P16301_Lcat,P16301,Lcat,1,105,12,12,P16301,MOUSE,50088.2,31,171,171.1,191.56,191.56,,438,Phosphatidylcholine-sterol acyltransferase,extracellular space|high-density lipoprotein particle|extracellular exosome|,phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol metabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol esterification|lipoprotein biosynthetic process|cholesterol homeostasis|reverse cholesterol transport|response to copper ion|response to glucocorticoid|regulation of high-density lipoprotein particle assembly|,phosphatidylcholine-sterol O-acyltransferase activity|phospholipase A2 activity|apolipoprotein A-I binding|,12,105,165000000000,31.0%
Q8BND5,1.0426e-4,-1.065333333,53.48899032,4.48,4.47817e-6,11.7323602,-3.344,-2.922,-3.65,1.248,1.367,0.909,Q8BND5,Qsox1,Q8BND5_Qsox1,Q8BND5,Qsox1,1,43,17,2,Q8BND5|Q8BND5-2,MOUSE,83582.5,22.5,172,172.1,191.17,30.5,,748,Sulfhydryl oxidase 1,extracellular space|endoplasmic reticulum|Golgi apparatus|integral component of Golgi membrane|intracellular membrane-bounded organelle|intercellular bridge|extracellular exosome|,protein folding|negative regulation of macroautophagy|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity|,17,43,2630000000,22.5%
Q8BND5-3,2.59639e-4,-0.405333333,38.55922815,2.855333333,1.3934e-4,7.127342002,-1.379,-1.786,-2.334,1.248,0.843,0.976,Q8BND5,Qsox1,Q8BND5-3_Qsox1,Q8BND5-3,Qsox1,1,5,17,3,Q8BND5-3,MOUSE,64076.9,26.9,172,172.2,175.86,26.29,,748,Isoform 3 of Sulfhydryl oxidase 1,extracellular space|endoplasmic reticulum|Golgi apparatus|integral component of Golgi membrane|intracellular membrane-bounded organelle|intercellular bridge|extracellular exosome|,protein folding|negative regulation of macroautophagy|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity|,3,5,96000000,3.8%
Q922D8,1.0426e-4,-0.930333333,48.88854248,3.760666667,1.29165e-5,10.09887229,-3.125,-2.386,-2.921,1.026,0.924,0.9,Q922D8,Mthfd1,Q922D8_Mthfd1,Q922D8,Mthfd1,1,30,18,18,Q922D8|A0A1W2P733,MOUSE,101882.4,19.8,173,173.1,190.86,190.86,,935,"C-1-tetrahydrofolate synthase, cytoplasmic",mitochondrion|cytosol|membrane|extracellular exosome|,histidine biosynthetic process|neutrophil homeostasis|neural tube closure|purine nucleotide biosynthetic process|methionine metabolic process|one-carbon metabolic process|heart development|serine family amino acid metabolic process|serine family amino acid biosynthetic process|methionine biosynthetic process|10-formyltetrahydrofolate biosynthetic process|transsulfuration|tetrahydrofolate interconversion|oxidation-reduction process|somite development|,formate-tetrahydrofolate ligase activity|methenyltetrahydrofolate cyclohydrolase activity|methylenetetrahydrofolate dehydrogenase (NAD+) activity|methylenetetrahydrofolate dehydrogenase (NADP+) activity|ATP binding|,18,30,1270000000,19.8%
Q3TQC7,1.0426e-4,-0.948333333,46.77345569,4.104666667,2.10211e-5,9.417881521,-3.65,-2.519,-2.833,1.462,0.912,0.938,Q3TQC7,Entpd5,Q3TQC7_Entpd5,Q3TQC7,Entpd5,1,46,13,13,Q3TQC7|Q9WUZ9,MOUSE,50293.2,35.3,174,174.1,186.36,186.36,,452,Ectonucleoside triphosphate diphosphohydrolase 5,extracellular exosome|,metabolic process|,hydrolase activity|,13,46,5180000000,35.3%
Q62009,1.0426e-4,-1.0085,51.97695807,3.983,6.34314e-6,11.17111731,-3.246,-2.691,-3.063,0.916,1.063,0.97,Q62009,Postn,Q62009_Postn,Q62009,Postn,1,34,15,15,Q62009|Q62009-2|Q62009-3|Q62009-5|Q62009-4,MOUSE,93826.5,21.4,175,175.1,183.11,183.11,,838,Periostin,proteinaceous extracellular matrix|extracellular space|trans-Golgi network|extracellular matrix|,cell adhesion|regulation of Notch signaling pathway|tissue development|extracellular matrix organization|,heparin binding|cell adhesion molecule binding|,15,34,1470000000,21.4%
P47879,1.05478e-4,-0.801666667,46.09484977,4.136,2.45762e-5,9.207992531,-3.153,-2.17,-3.286,1.588,1.338,0.873,P47879,Igfbp4,P47879_Igfbp4,P47879,Igfbp4,1,82,13,13,P47879|H3BLB7,MOUSE,28947.5,48.8,176,176.1,181.41,181.41,,254,Insulin-like growth factor-binding protein 4,extracellular space|,regulation of cell growth|inflammatory response|regulation of glucose metabolic process|regulation of growth|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,13,82,36500000000,48.8%
Q91WU0,2.86085e-4,-1.2295,38.03331726,4.438333333,1.57278e-4,6.997599206,-3.602,-2.112,-4.632,1.118,1.015,0.836,Q91WU0,Ces1f,Q91WU0_Ces1f,Q91WU0,Ces1f,1,46,14,14,Q91WU0,MOUSE,62010.5,33.1,178,178.1,180.59,180.59,,561,Carboxylesterase 1F,lipid particle|cytosol|,short-chain fatty acid catabolic process|,hydrolase activity|,14,46,275000000000,33.1%
P01837,1.0426e-4,-0.915833333,52.54421227,4.373666667,5.56646e-6,11.37876436,-3.315,-3.062,-2.931,0.929,1.716,1.168,P01837,NotFound,P01837_NotFound,P01837,,1,104,11,11,P01837|A0A075B5P2,MOUSE,11948.8,94.3,179,179.1,180.18,180.18,,106,Ig kappa chain C region,plasma membrane|,,antigen binding|,11,104,336000000000,94.3%
P52480,2.85081e-4,-0.637333333,38.07852622,3.131333333,1.55649e-4,7.008680446,-2.292,-1.489,-2.828,1.144,0.774,0.867,P52480,Pkm,P52480_Pkm,P52480,Pkm,1,41,16,16,P52480|P52480-2|P53657|G3X925|E9Q509,MOUSE,58414.4,38.4,180,180.1,179.44,179.44,,531,Pyruvate kinase PKM,nucleus|cytoplasm|mitochondrion|plasma membrane|cilium|extracellular matrix|vesicle|myelin sheath|extracellular exosome|extracellular vesicle|,glycolytic process|programmed cell death|phosphorylation|,magnesium ion binding|pyruvate kinase activity|protein binding|ATP binding|MHC class II protein complex binding|potassium ion binding|poly(A) RNA binding|,19,41,5010000000,38.4%
P98086,2.01363e-4,-0.480333333,40.38815141,4.439333333,9.14502e-5,7.59319019,-2.351,-2.289,-3.46,1.729,2.668,0.821,P98086,C1qa,P98086_C1qa,P98086,C1qa,1,100,12,12,P98086,MOUSE,26202.1,41.6,181,181.1,179.23,179.23,,245,Complement C1q subcomponent subunit A,collagen trimer|extracellular exosome|,"complement activation, classical pathway|innate immune response|",protein binding|,12,100,179000000000,41.6%
P16882-2,1.0426e-4,-1.244166667,50.58762519,4.820333333,8.73449e-6,10.67683801,-3.991,-2.874,-4.098,1.21,1.376,0.912,P16882,Ghr,P16882-2_Ghr,P16882-2,Ghr,1,80,10,10,P16882-2|P16882|Q3UP14,MOUSE,34617.4,36.7,182,182.1,179.13,179.13,,650,Isoform 2 of Growth hormone receptor,extracellular region|extracellular space|nucleus|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extrinsic component of membrane|receptor complex|growth hormone receptor complex|,allantoin metabolic process|citrate metabolic process|2-oxoglutarate metabolic process|succinate metabolic process|oxaloacetate metabolic process|isoleucine metabolic process|valine metabolic process|creatine metabolic process|fatty acid metabolic process|endocytosis|cytokine-mediated signaling pathway|taurine metabolic process|response to estradiol|cellular response to hormone stimulus|regulation of multicellular organism growth|positive regulation of multicellular organism growth|multicellular organismal metabolic process|creatinine metabolic process|insulin-like growth factor receptor signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|growth hormone receptor signaling pathway|,growth hormone receptor activity|protein binding|peptide hormone binding|growth factor binding|protein homodimerization activity|,11,80,74700000000,36.7%
O08795-2,1.0426e-4,-1.034833333,50.36997443,4.393666667,9.18338e-6,10.6012009,-3.69,-2.659,-3.346,1.317,1.289,0.88,O08795,Prkcsh,O08795-2_Prkcsh,O08795-2,Prkcsh,1,54,14,14,O08795-2|O08795,MOUSE,60528.5,18.3,183,183.1,178.97,178.97,,521,Isoform 2 of Glucosidase 2 subunit beta,endoplasmic reticulum|,in utero embryonic development|liver development|N-glycan processing|nitrogen compound metabolic process|negative regulation of neuron projection development|protein heterooligomerization|renal system development|,RNA binding|protein kinase C binding|calcium ion binding|protein binding|ion channel binding|phosphoprotein binding|,14,54,7270000000,18.3%
Q80YC5,1.04511e-4,-0.967333333,46.52379423,4.366,2.22649e-5,9.340189628,-3.953,-2.799,-2.699,1.575,1.156,0.916,Q80YC5,F12,Q80YC5_F12,Q80YC5,F12,1,64,12,12,Q80YC5|E9Q698,MOUSE,67982.3,23.2,184,184.1,177.24,177.24,,597,Coagulation factor XII,extracellular space|extracellular exosome|,plasma kallikrein-kinin cascade|Factor XII activation|blood coagulation|positive regulation of plasminogen activation|protein processing|protein autoprocessing|regulation of blood coagulation|positive regulation of blood coagulation|zymogen activation|fibrinolysis|response to misfolded protein|positive regulation of fibrinolysis|,serine-type endopeptidase activity|peptidase activity|serine-type aminopeptidase activity|,12,64,17100000000,23.2%
G5E8Q8,2.25378e-4,-1.473166667,39.50654137,5.033,1.12033e-4,7.420080647,-3.593,-2.844,-5.532,1.073,1.139,0.918,G5E8Q8,Adgrf5,G5E8Q8_Adgrf5,G5E8Q8,Adgrf5,1,41,14,14,G5E8Q8,MOUSE,151723.4,11.5,185,185.1,176.79,176.79,,1348,Adhesion G protein-coupled receptor F5,,,,14,41,4440000000,11.5%
Q02566,0.278057098,-0.502166667,5.71304647,1.345666667,0.26834614,1.203288825,-2.579,1.635,-2.581,0.408,-0.034,0.138,Q02566,Myh6,Q02566_Myh6,Q02566,Myh6,1,25,17,4,Q02566|Q5SX39|Q5SX40|G3UW82|P13542|B1AR69,MOUSE,224360.2,9.4,186,186.1,176.78,43.64,,1938,Myosin-6,stress fiber|nucleoplasm|cytoplasm|mitochondrion|muscle myosin complex|focal adhesion|myosin complex|myofibril|Z disc|myosin filament|,in utero embryonic development|regulation of the force of heart contraction|regulation of heart rate|muscle contraction|striated muscle contraction|adult heart development|visceral muscle development|regulation of heart contraction|regulation of blood pressure|response to heat|actin filament-based movement|muscle filament sliding|myofibril assembly|BMP signaling pathway|regulation of ATPase activity|sarcomere organization|ATP metabolic process|cardiac muscle fiber development|atrial cardiac muscle tissue morphogenesis|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|canonical Wnt signaling pathway|regulation of heart growth|,microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein kinase binding|actin-dependent ATPase activity|calcium-dependent ATPase activity|protein homodimerization activity|protein heterodimerization activity|,18,25,9980000000,9.4%
A0A075B5T3,1.0426e-4,-1.110166667,48.56076343,4.660333333,1.39291e-5,9.990605983,-3.741,-2.654,-3.926,1.165,1.59,0.905,A0A075B5T3,NotFound,A0A075B5T3_NotFound,A0A075B5T3,Ighv6-6,1,88,12,7,A0A075B5T3,MOUSE,13464,81.5,187,187.1,175.85,110.12,,119,Immunoglobulin heavy variable 6-6 (Fragment),,,,12,88,127000000000,81.5%
A0A075B5T2,1.78163e-4,-1.405,41.18510458,5.336666667,7.61184e-5,7.864382147,-4.091,-2.703,-5.426,1,1.578,1.212,A0A075B5T2,NotFound,A0A075B5T2_NotFound,A0A075B5T2,Ighv6-3,1,38,10,5,A0A075B5T2,MOUSE,13430,56.7,187,187.2,151.63,82.48,,118,Immunoglobulin heavy variable 6-3 (Fragment),,,,5,38,29200000000,26.2%
Q07113,1.05478e-4,-0.98,46.13785039,3.942666667,2.43341e-5,9.221172186,-3.147,-2.253,-3.454,1.037,1.048,0.889,Q07113,Igf2r,Q07113_Igf2r,Q07113,Igf2r,1,35,16,16,Q07113,MOUSE,280828.2,6.8,188,188.1,174.5,174.5,,2483,Cation-independent mannose-6-phosphate receptor,nucleus|nuclear envelope lumen|lysosomal membrane|endosome|early endosome|late endosome|trans-Golgi network|focal adhesion|cell surface|membrane|integral component of membrane|endocytic vesicle|trans-Golgi network transport vesicle|extracellular exosome|,transport|,glycoprotein binding|transporter activity|insulin-like growth factor binding|mannose binding|identical protein binding|phosphoprotein binding|,16,35,3000000000,6.8%
P52430,1.34728e-4,-0.803333333,43.40288206,4.088666667,4.56785e-5,8.414077181,-3.716,-2.284,-2.543,1.527,1.326,0.87,P52430,Pon1,P52430_Pon1,P52430,Pon1,1,60,12,12,P52430|H3BLB8,MOUSE,39735.6,32.3,189,189.1,174.42,174.42,,355,Serum paraoxonase/arylesterase 1,extracellular space|high-density lipoprotein particle|spherical high-density lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood circulation|cholesterol metabolic process|response to toxic substance|positive regulation of cholesterol efflux|dephosphorylation|aromatic compound catabolic process|response to nutrient levels|positive regulation of transporter activity|carboxylic acid catabolic process|organophosphate catabolic process|phosphatidylcholine metabolic process|positive regulation of binding|response to fatty acid|response to fluoride|,aryldialkylphosphatase activity|arylesterase activity|calcium ion binding|phospholipid binding|high-density lipoprotein particle binding|protein homodimerization activity|,12,60,13200000000,32.3%
P12399,5.41412e-4,-1.6625,34.50729243,5.333666667,3.54218e-4,6.323141052,-3.626,-2.982,-6.38,1.055,1.004,0.954,P12399,Ctla2a,P12399_Ctla2a,P12399,Ctla2a,1,92,11,11,P12399|A0A286YDF0|A0A286YD17|P12400|A0A0R4J245,MOUSE,16053.8,59.8,190,190.1,172.89,172.89,,137,Protein CTLA-2-alpha,extracellular space|lysosome|dendrite|,negative regulation of protein processing|regulation of regulatory T cell differentiation|negative regulation of inflammatory response|proteolysis involved in cellular protein catabolic process|,cysteine-type endopeptidase activity|,11,92,111000000000,59.8%
P03953,1.70289e-4,-1.2085,41.53803897,4.551666667,7.01772e-5,7.898235737,-3.756,-2.265,-4.432,1,1.109,1.093,P03953,Cfd,P03953_Cfd,P03953,Cfd,1,79,9,9,P03953|P03953-2,MOUSE,28569.8,45.9,191,191.1,171.59,171.59,,259,Complement factor D,extracellular space|extracellular exosome|,"proteolysis|complement activation, alternative pathway|",serine-type endopeptidase activity|,9,79,73300000000,45.9%
Q9CQW3,1.0426e-4,-1.019666667,48.95345926,4.432666667,1.27249e-5,10.12043626,-3.817,-2.571,-3.32,1.319,1.343,0.928,Q9CQW3,Proz,Q9CQW3_Proz,Q9CQW3,Proz,1,84,9,9,Q9CQW3|Q8CI01,MOUSE,45615.9,33.8,192,192.1,167.8,167.8,,399,Vitamin K-dependent protein Z,extracellular region|extracellular exosome|,proteolysis|blood coagulation|,serine-type endopeptidase activity|calcium ion binding|,9,84,41500000000,33.8%
P98063,1.0426e-4,-1.295,54.53869669,4.576,3.51666e-6,12.13691207,-3.858,-3.117,-3.774,1.073,0.939,0.967,P98063,Bmp1,P98063_Bmp1,P98063,Bmp1,1,33,15,15,P98063|Q9WVM6|E9Q5B9|G3X9F5|Q62381|Q62381-2,MOUSE,113889.4,17.9,193,193.1,167.46,167.46,,991,Bone morphogenetic protein 1,proteinaceous extracellular matrix|extracellular space|Golgi apparatus|membrane-bounded vesicle|,ossification|proteolysis|cell differentiation|cartilage development|positive regulation of cartilage development|,metalloendopeptidase activity|cytokine activity|calcium ion binding|protein binding|growth factor activity|peptidase activity|zinc ion binding|,15,33,2550000000,17.9%
Q3SXB8-2,1.0426e-4,-1.1515,49.73710417,4.735666667,1.0624e-5,10.38396489,-3.441,-2.902,-4.215,1.185,1.551,0.913,Q3SXB8,Colec11,Q3SXB8-2_Colec11,Q3SXB8-2,Colec11,1,40,11,11,Q3SXB8-2|A0A1Y7VKG6|Q3SXB8|A0A0R4J0M6,MOUSE,29981.5,33,194,194.1,163.08,163.08,,272,Isoform 2 of Collectin-11,extracellular region|collagen trimer|,multicellular organismal development|developmental process|,mannose binding|,11,40,2960000000,33.0%
Q8CIT9,1.0426e-4,-1.054,48.32575739,4.15,1.47036e-5,9.913610285,-3.256,-2.494,-3.637,0.916,1.162,0.985,Q8CIT9,Sbsn,Q8CIT9_Sbsn,Q8CIT9,Sbsn,1,39,12,12,Q8CIT9|E9QPB2|S4R2I1|Q8CIT9-3|A0A0R4J2A5,MOUSE,72446.7,23.4,195,195.1,161.85,161.85,,700,Suprabasin,cytoplasm|extracellular exosome|,,,12,39,1910000000,23.4%
P47877,1.0426e-4,-1.135666667,49.38186862,4.679333333,1.15296e-5,10.26376361,-3.882,-2.739,-3.805,1.604,1.1,0.908,P47877,Igfbp2,P47877_Igfbp2,P47877,Igfbp2,1,46,11,11,P47877|D3YU40,MOUSE,33930.2,38.6,197,197.1,158.81,158.81,,305,Insulin-like growth factor-binding protein 2,extracellular region|extracellular space|apical plasma membrane|cytoplasmic vesicle|extracellular exosome|,regulation of cell growth|signal transduction|female pregnancy|aging|response to nutrient|response to mechanical stimulus|response to lithium ion|response to estradiol|response to retinoic acid|cellular response to hormone stimulus|positive regulation of activated T cell proliferation|response to drug|regulation of insulin-like growth factor receptor signaling pathway|response to glucocorticoid|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,11,46,6840000000,38.6%
P11627,1.0426e-4,-0.980666667,52.59358691,4.064666667,5.50353e-6,11.3970019,-3.122,-2.717,-3.2,1.136,1.125,0.894,P11627,NotFound,P11627_NotFound,P11627,L1cam,1,31,14,14,P11627|Q6PGJ3|A2AFG8|A2AFG7,MOUSE,141935.8,10.5,199,199.1,157.34,157.34,,1260,Neural cell adhesion molecule L1,plasma membrane|focal adhesion|external side of plasma membrane|cell surface|membrane|integral component of membrane|presynaptic membrane|terminal bouton|,homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell surface receptor signaling pathway|axon guidance|positive regulation of cell-cell adhesion|neuron projection development|cell-cell adhesion mediated by integrin|homotypic cell-cell adhesion|positive regulation of calcium-mediated signaling|,integrin binding|protein binding|sialic acid binding|identical protein binding|protein self-association|,14,31,860000000,10.5%
P31532,1.0426e-4,-0.928833333,47.89325601,4.462333333,1.62433e-5,9.773263129,-3.631,-2.441,-3.408,1.54,1.497,0.87,P31532,Saa4,P31532_Saa4,P31532,Saa4,1,52,10,10,P31532,MOUSE,15144.6,68.4,200,200.1,155,155,,130,Serum amyloid A-4 protein,extracellular space|high-density lipoprotein particle|,acute-phase response|positive chemotaxis|cell chemotaxis|,chemoattractant activity|,10,52,17100000000,68.4%
Q60994,1.0426e-4,-1.313166667,54.20418689,5.051666667,3.79823e-6,12.00663411,-4.101,-3.247,-4.169,0.957,1.568,1.113,Q60994,Adipoq,Q60994_Adipoq,Q60994,Adipoq,1,108,9,9,Q60994,MOUSE,26922.6,30.3,202,202.1,154.74,154.74,,247,Adiponectin,collagen trimer|extracellular space|endoplasmic reticulum|cell surface|perinuclear region of cytoplasm|extracellular exosome|cell periphery|,"response to hypoxia|positive regulation of protein phosphorylation|glucose metabolic process|fatty acid beta-oxidation|response to nutrient|circadian rhythm|response to sucrose|response to glucose|positive regulation of signal transduction|negative regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of protein kinase A signaling|negative regulation of macrophage derived foam cell differentiation|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol efflux|regulation of glucose metabolic process|response to activity|negative regulation of smooth muscle cell migration|fatty acid oxidation|negative regulation of cell migration|negative regulation of granulocyte differentiation|negative regulation of protein autophosphorylation|positive regulation of cellular protein metabolic process|negative regulation of tumor necrosis factor production|positive regulation of interleukin-8 production|cellular response to insulin stimulus|positive regulation of myeloid cell apoptotic process|adiponectin-activated signaling pathway|negative regulation of heterotypic cell-cell adhesion|low-density lipoprotein particle clearance|response to tumor necrosis factor|cellular response to drug|glucose homeostasis|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of MAP kinase activity|response to ethanol|negative regulation of fat cell differentiation|negative regulation of macrophage differentiation|negative regulation of low-density lipoprotein particle receptor biosynthetic process|negative regulation of gluconeogenesis|negative regulation of blood pressure|positive regulation of blood pressure|negative regulation of transcription, DNA-templated|positive regulation of fatty acid metabolic process|positive regulation of glucose import|negative regulation of hormone secretion|negative regulation of smooth muscle cell proliferation|negative regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|negative regulation of phagocytosis|negative regulation of synaptic transmission|brown fat cell differentiation|protein homooligomerization|response to glucocorticoid|membrane depolarization|membrane hyperpolarization|protein heterotrimerization|negative regulation of ERK1 and ERK2 cascade|response to linoleic acid|detection of oxidative stress|cellular response to cAMP|positive regulation of monocyte chemotactic protein-1 production|cellular response to epinephrine stimulus|protein localization to plasma membrane|negative regulation of intracellular protein transport|negative regulation of receptor binding|negative regulation of DNA biosynthetic process|positive regulation of glycogen (starch) synthase activity|positive regulation of metanephric glomerular visceral epithelial cell development|positive regulation of cAMP-dependent protein kinase activity|positive regulation of renal albumin absorption|negative regulation of platelet-derived growth factor receptor-alpha signaling pathway|negative regulation of metanephric mesenchymal cell migration|",receptor binding|hormone activity|protein binding|sialic acid binding|identical protein binding|protein homodimerization activity|,9,108,290000000000,30.3%
Q8C196,0.205073346,-0.8955,7.072121288,2.057666667,0.196240152,1.429872459,-2.641,1.567,-4.699,0.343,-0.016,0.073,Q8C196,Cps1,Q8C196_Cps1,Q8C196,Cps1,1,17,14,14,Q8C196,MOUSE,165813.2,10.9,203,203.1,153.36,153.36,,1500,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",nucleolus|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|protein complex|,urea cycle|glycogen catabolic process|'de novo' pyrimidine nucleobase biosynthetic process|proteolysis|arginine biosynthetic process|glutamine metabolic process|midgut development|response to toxic substance|response to zinc ion|response to amine|triglyceride catabolic process|response to food|response to lipopolysaccharide|response to drug|response to starvation|response to amino acid|cellular response to fibroblast growth factor stimulus|positive regulation of vasodilation|nitric oxide metabolic process|homocysteine metabolic process|anion homeostasis|response to growth hormone|hepatocyte differentiation|carbamoyl phosphate biosynthetic process|cellular response to cAMP|cellular response to glucagon stimulus|cellular response to oleic acid|response to dexamethasone|,carbamoyl-phosphate synthase (ammonia) activity|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|endopeptidase activity|calcium ion binding|protein binding|ATP binding|phospholipid binding|glutamate binding|protein complex binding|modified amino acid binding|,14,17,802000000,10.9%
Q07235,1.0426e-4,-0.947666667,49.02994699,4.256,1.25027e-5,10.1458958,-3.292,-2.607,-3.328,1.688,0.949,0.904,Q07235,Serpine2,Q07235_Serpine2,Q07235,Serpine2,1,33,12,12,Q07235|A2RSF9,MOUSE,44263.6,33.5,204,204.1,150.25,150.25,,397,Glia-derived nexin,extracellular region|extracellular space|cytosol|extracellular matrix|platelet alpha granule|extrinsic component of external side of plasma membrane|neuromuscular junction|neuronal cell body|extracellular vesicle|,"embryo implantation|blood coagulation|negative regulation of cell proliferation|response to radiation|response to wounding|negative regulation of peptidase activity|negative regulation of platelet activation|negative regulation of plasminogen activation|negative regulation of sodium ion transport|negative regulation of endopeptidase activity|negative regulation of protein processing|positive regulation of neuron projection development|negative regulation of phosphatidylinositol 3-kinase signaling|cerebellar granular layer morphogenesis|negative regulation of blood coagulation|negative regulation of cell growth|secretion by cell|secretory granule organization|negative regulation of protein catabolic process|mating plug formation|negative regulation of proteolysis|negative regulation of smoothened signaling pathway|regulation of timing of cell differentiation|positive regulation of astrocyte differentiation|detection of mechanical stimulus involved in sensory perception|regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|innervation|seminal vesicle epithelium development|dense core granule biogenesis|negative regulation of platelet aggregation|",serine-type endopeptidase inhibitor activity|receptor binding|glycosaminoglycan binding|heparin binding|,12,33,1010000000,33.5%
P11589,1.10858e-4,-1.328333333,45.43387832,5.213333333,2.86162e-5,9.007420901,-3.804,-2.995,-5.006,1.1,1.816,0.919,P11589,NotFound,P11589_NotFound,P11589,Mup2,1,39,10,10,P11589|Q4FZE8|A2BIN1|P04938|A2CEK7|P02762|P11588|A2CEL1|A2AKN8|Q58EV3|B5X0G2|A9C496|E9PVW0|A2CEL0|E9QA79|A9C497|A2AKN9|A9R9W0|A2CEK6|L7N222|A2BIN0|A2AV72|P11591|P04939|Q3KQQ2|Q80YX8|A2ANT6,MOUSE,20948.4,58.8,205,205.1,148.97,148.97,,180,Major urinary protein 2,extracellular space|nucleus|cytosol|,"energy reserve metabolic process|transport|insulin receptor signaling pathway|aerobic respiration|positive regulation of gene expression|negative regulation of lipid storage|positive regulation of glucose metabolic process|heat generation|glucose homeostasis|locomotor rhythm|negative regulation of gluconeogenesis|positive regulation of lipid metabolic process|negative regulation of transcription, DNA-templated|negative regulation of lipid biosynthetic process|positive regulation of protein kinase B signaling|negative regulation of insulin secretion involved in cellular response to glucose stimulus|mitochondrion morphogenesis|cellular response to lipid|",insulin-activated receptor activity|transporter activity|pheromone binding|small molecule binding|,10,39,3850000000,58.8%
Q9CWF2,3.80425e-4,-0.642333333,36.37721147,3.706,2.30292e-4,6.60073814,-2.499,-1.522,-3.465,1.574,0.72,1.338,Q9CWF2,Tubb2b,Q9CWF2_Tubb2b,Q9CWF2,Tubb2b,1,26,11,1,Q9CWF2|Q7TMM9|A0A1D5RM76,MOUSE,50408.6,28,206,206.1,148.86,16.49,,445,Tubulin beta-2B chain,nucleus|cytoplasm|microtubule|,neuron migration|microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,11,26,1050000000,28.0%
A2AQ07,6.65936e-4,-0.485,33.42663057,3.804666667,4.54294e-4,5.934948374,-2.01,-1.479,-3.673,1.801,0.722,1.729,A2AQ07,Tubb1,A2AQ07_Tubb1,A2AQ07,Tubb1,1,5,6,3,A2AQ07,MOUSE,51124.7,12.6,206,206.4,74.73,38.44,,451,Tubulin beta-1 chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,3,5,163000000,8.4%
B2RXS4,1.05478e-4,-1.0145,46.06124229,4.254333333,2.47671e-5,9.1977031,-2.861,-2.594,-3.97,1.173,1.273,0.892,B2RXS4,Plxnb2,B2RXS4_Plxnb2,B2RXS4,Plxnb2,1,32,12,12,B2RXS4,MOUSE,209079.3,7.7,207,207.1,146.74,146.74,,1842,Plexin-B2,integral component of plasma membrane|cell surface|extracellular exosome|,neural tube closure|regulation of protein phosphorylation|neuroblast proliferation|brain development|regulation of cell shape|regulation of GTPase activity|positive regulation of axonogenesis|semaphorin-plexin signaling pathway|regulation of neuron migration|,protein binding|semaphorin receptor activity|,12,32,1980000000,7.7%
O88968,2.07088e-4,-1.371666667,40.00482849,4.648666667,9.98889e-5,7.493622889,-3.53,-2.552,-5.006,0.95,0.995,0.913,O88968,Tcn2,O88968_Tcn2,O88968,Tcn2,1,44,11,11,O88968,MOUSE,48041.3,24.1,208,208.1,143.9,143.9,,430,Transcobalamin-2,extracellular space|extracellular exosome|,cobalt ion transport|cobalamin transport|,cobalamin binding|metal ion binding|,11,44,6940000000,24.1%
Q8CJH3,1.0426e-4,-0.914666667,51.16616783,4.018666667,7.6451e-6,10.88023493,-3.3,-2.655,-2.817,1.163,1.207,0.914,Q8CJH3,Plxnb1,Q8CJH3_Plxnb1,Q8CJH3,Plxnb1,1,38,11,11,Q8CJH3,MOUSE,234738.4,5.9,209,209.1,141.26,141.26,,2119,Plexin-B1,semaphorin receptor complex|integral component of plasma membrane|,negative regulation of cell adhesion|regulation of cell shape|positive regulation of phosphatidylinositol 3-kinase signaling|negative regulation of osteoblast proliferation|positive regulation of GTPase activity|ossification involved in bone maturation|neuron projection morphogenesis|positive regulation of axonogenesis|regulation of cytoskeleton organization|semaphorin-plexin signaling pathway|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis|,protein binding|semaphorin receptor activity|GTPase activating protein binding|,11,38,1540000000,5.9%
Q5MJS3,1.34728e-4,-0.847166667,43.28099034,3.711,4.69787e-5,8.379534363,-2.778,-1.996,-3.334,1.17,0.945,0.91,Q5MJS3,Fam20c,Q5MJS3_Fam20c,Q5MJS3,Fam20c,1,27,11,11,Q5MJS3|Q8CID3,MOUSE,66392.3,17.4,210,210.1,141.04,141.04,,579,Extracellular serine/threonine protein kinase FAM20C,extracellular space|Golgi apparatus|extracellular exosome|,skeletal system development|protein phosphorylation|positive regulation of bone mineralization|biomineral tissue development|osteoclast maturation|regulation of fibroblast growth factor receptor signaling pathway|positive regulation of osteoblast differentiation|regulation of phosphorus metabolic process|enamel mineralization|odontoblast differentiation|dentinogenesis|,protein serine/threonine kinase activity|calcium ion binding|manganese ion binding|,11,27,1570000000,17.4%
P70428,1.0426e-4,-0.785,46.85600628,3.598,2.06253e-5,9.443692528,-2.767,-2.121,-2.864,1.19,0.935,0.917,P70428,Ext2,P70428_Ext2,P70428,Ext2,1,28,11,11,P70428|V9GX32|E9Q1M5,MOUSE,82804.6,20.1,211,211.1,141.04,141.04,,718,Exostosin-2,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|membrane|integral component of membrane|UDP-N-acetylglucosamine transferase complex|extracellular exosome|,"ossification|mesoderm formation|glycosaminoglycan biosynthetic process|protein glycosylation|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|cell differentiation|cellular polysaccharide biosynthetic process|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|heparan sulfate N-acetylglucosaminyltransferase activity|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|acetylglucosaminyltransferase activity|",11,28,298000000,20.1%
P51885,1.0426e-4,-0.985833333,52.16774538,3.889666667,6.07051e-6,11.24057197,-3.038,-2.702,-3.052,1.003,0.996,0.878,P51885,Lum,P51885_Lum,P51885,Lum,1,29,10,10,P51885,MOUSE,38663.6,34.9,213,213.1,136.44,136.44,,338,Lumican,proteinaceous extracellular matrix|fibrillar collagen trimer|extracellular space|extracellular exosome|extracellular matrix|,visual perception|response to organic cyclic compound|collagen fibril organization|positive regulation of transforming growth factor beta1 production|positive regulation of transcription from RNA polymerase II promoter|cartilage development|response to growth factor|,collagen binding|,10,29,4620000000,34.9%
A0A075B5R5,0.001473376,-0.636666667,29.6085903,3.768666667,0.001094312,5.227462779,-4.011,-2.458,-1.094,1.48,1.387,0.876,A0A075B5R5,NotFound,A0A075B5R5_NotFound,A0A075B5R5,Ighv4-1,1,40,8,8,A0A075B5R5|P01807|P01808|P01812|P01806|P01809|P01810|A0A075B5Q2|A0A075B5P7|A0A0A6YWG4,MOUSE,13044.9,69.8,214,214.1,135.49,130.34,,116,Immunoglobulin heavy variable 4-1 (Fragment),,,,10,40,4350000000,69.8%
Q61406,1.0426e-4,-1.157333333,48.8082446,4.644,1.31576e-5,10.0722549,-3.684,-2.701,-4.053,1.455,0.909,1.13,Q61406,Cfhr1,Q61406_Cfhr1,Q61406,Cfhr1,1,40,10,10,Q61406,MOUSE,39640.4,34.6,215,215.1,135.19,135.19,,343,Complement factor H-related 1,extracellular exosome|blood microparticle|,,,10,40,5610000000,34.6%
Q04857,1.0426e-4,-1.032666667,50.39071661,4.186666667,9.13962e-6,10.60838853,-3.512,-2.593,-3.273,0.95,1.212,1.02,Q04857,Col6a1,Q04857_Col6a1,Q04857,Col6a1,1,21,11,11,Q04857,MOUSE,109628.6,12.4,216,216.1,134.47,134.47,,1025,Collagen alpha-1(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|lysosomal membrane|membrane|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular matrix|,osteoblast differentiation|cell adhesion|endodermal cell differentiation|protein heterotrimerization|cellular response to amino acid stimulus|,platelet-derived growth factor binding|,11,21,1090000000,12.4%
P01592,1.0426e-4,-1.044166667,52.3730322,4.233,5.79024e-6,11.31573926,-3.378,-2.734,-3.37,0.934,1.221,1.062,P01592,Jchain,P01592_Jchain,P01592,Jchain,1,70,10,10,P01592,MOUSE,18469.7,71.6,217,217.1,132.48,132.48,,159,Immunoglobulin J chain,extracellular space|extracellular exosome|monomeric IgA immunoglobulin complex|dimeric IgA immunoglobulin complex|secretory IgA immunoglobulin complex|secretory dimeric IgA immunoglobulin complex|pentameric IgM immunoglobulin complex|blood microparticle|,adaptive immune response|glomerular filtration|humoral immune response|antibacterial humoral response|positive regulation of protein oligomerization|innate immune response|positive regulation of respiratory burst|,antigen binding|IgA binding|protein homodimerization activity|single-stranded DNA binding|phosphatidylcholine binding|immunoglobulin receptor binding|peptidoglycan binding|,10,70,87300000000,71.6%
O08689,1.0426e-4,-0.985833333,50.69864012,4.168333333,8.51405e-6,10.71560219,-2.959,-2.704,-3.547,1.152,1.25,0.893,O08689,Mstn,O08689_Mstn,O08689,Mstn,1,31,11,11,O08689|A0A087WQL8|Q9Z1W4,MOUSE,43662.3,33.2,218,218.1,131.41,131.41,,376,Growth/differentiation factor 8,extracellular space|cytoplasm|,"positive regulation of defense response to virus by host|transforming growth factor beta receptor signaling pathway|response to heat|response to gravity|positive regulation of pathway-restricted SMAD protein phosphorylation|skeletal muscle atrophy|negative regulation of muscle hypertrophy|response to muscle activity|ovulation cycle process|response to testosterone|negative regulation of kinase activity|regulation of apoptotic process|skeletal muscle tissue regeneration|regulation of MAPK cascade|response to estrogen|response to ethanol|negative regulation of myoblast differentiation|positive regulation of transcription, DNA-templated|negative regulation of insulin receptor signaling pathway|muscle cell cellular homeostasis|cell development|negative regulation of skeletal muscle tissue growth|response to electrical stimulus|negative regulation of protein kinase B signaling|SMAD protein signal transduction|cellular response to dexamethasone stimulus|activation of mitophagy in response to mitochondrial depolarization|negative regulation of skeletal muscle satellite cell proliferation|negative regulation of satellite cell differentiation|negative regulation of myoblast proliferation|",receptor binding|cytokine activity|transforming growth factor beta receptor binding|protein binding|growth factor activity|heparin binding|identical protein binding|,11,31,1090000000,33.2%
P55284,1.0426e-4,-1.189166667,54.19942711,4.653666667,3.8024e-6,12.00478961,-3.743,-3.032,-3.773,1.226,1.276,0.911,P55284,Cdh5,P55284_Cdh5,P55284,Cdh5,1,24,11,11,P55284,MOUSE,88186.6,13.3,219,219.1,131.32,131.32,,784,Cadherin-5,plasma membrane|cell-cell junction|adherens junction|bicellular tight junction|integral component of membrane|cell junction|cell periphery|,blood vessel maturation|homophilic cell adhesion via plasma membrane adhesion molecules|negative regulation of cell proliferation|single organismal cell-cell adhesion|regulation of establishment of cell polarity|,receptor binding|calcium ion binding|protein binding|beta-catenin binding|protein phosphatase binding|ion channel binding|,11,24,13400000000,13.3%
P06330,1.0426e-4,-1.2525,46.59088017,4.846333333,2.19236e-5,9.361011629,-3.747,-2.776,-4.504,0.906,1.57,1.036,P06330,NotFound,P06330_NotFound,P06330,,1,40,9,2,P06330|P01757|P01756|A0A075B5U6,MOUSE,13048.2,72.8,220,220.1,131.3,28.53,,118,Ig heavy chain V region AC38 205.12,,,antigen binding|,10,40,12800000000,72.8%
A0A075B5V6,0.006190226,-1.283166667,22.94713978,4.929666667,0.005073247,4.033985855,-6.491,-3.585,-1.168,0.978,1.598,0.969,A0A075B5V6,NotFound,A0A075B5V6_NotFound,A0A075B5V6,Ighv1-42,1,8,6,2,A0A075B5V6|A0A075B5V7,MOUSE,10890,55.1,220,220.4,81.61,18.65,,98,Immunoglobulin heavy variable V1-42,,,,2,8,10500000000,15.3%
A0A075B5U5,1.0426e-4,-1.277333333,48.65683266,5.184666667,1.36244e-5,10.02223192,-4.61,-2.918,-4.081,0.953,1.652,1.34,A0A075B5U5,NotFound,A0A075B5U5_NotFound,A0A075B5U5,Ighv1-19,1,6,4,2,A0A075B5U5,MOUSE,12970.5,41.3,220,220.5,45.47,26.16,,116,Immunoglobulin heavy variable V1-19,,,,2,6,154000000,30.1%
E9QPK1,1.0426e-4,-1,46.91352126,4.156,2.03539e-5,9.461711726,-2.668,-2.737,-3.829,1.003,1.275,0.956,E9QPK1,Cgref1,E9QPK1_Cgref1,E9QPK1,Cgref1,1,37,9,9,E9QPK1|Q8R1U2,MOUSE,35428.9,36.9,222,222.1,129.25,129.25,,325,Cell growth regulator with EF hand domain protein 1,,negative regulation of cell growth|,calcium ion binding|,9,37,30000000000,36.9%
Q71KU9,1.0426e-4,-0.696666667,47.31825252,3.465333333,1.85428e-5,9.589354532,-2.609,-2.134,-2.545,0.895,1.26,0.953,Q71KU9,Fgl1,Q71KU9_Fgl1,Q71KU9,Fgl1,1,36,10,10,Q71KU9|A0A0R4J0E1|Q3SZZ7,MOUSE,36724.1,26.7,224,224.1,126.83,126.83,,314,Fibrinogen-like protein 1,extracellular exosome|,cholesterol metabolic process|regulation of glucose metabolic process|response to stilbenoid|adipose tissue development|,,10,36,1310000000,26.7%
P70274,1.49139e-4,-1.177166667,42.48517526,4.699,5.64264e-5,8.156879082,-3.365,-2.537,-4.678,1.418,1.193,0.906,P70274,Selenop,P70274_Selenop,P70274,Selenop,1,54,9,9,P70274,MOUSE,43595.1,20.7,225,225.1,126.38,126.38,,380,Selenoprotein P,extracellular region|extracellular space|extracellular exosome|,selenium compound metabolic process|brain development|locomotory behavior|post-embryonic development|sexual reproduction|growth|,selenium binding|,9,54,15100000000,20.7%
A0A075B5Y4,1.24757e-4,-0.646833333,44.22499675,3.923,3.78007e-5,8.650167842,-3.045,-2.568,-2.212,1.041,1.994,0.909,A0A075B5Y4,NotFound,A0A075B5Y4_NotFound,A0A075B5Y4,Ighv1-81,1,38,9,4,A0A075B5Y4|A0A0A6YVW3|P06327|A0A075B5X2|A0A075B5W5,MOUSE,13102.5,65.8,226,226.1,126.02,74.75,,117,Immunoglobulin heavy variable 1-81 (Fragment),,,,9,38,6510000000,65.8%
A0A0B4J1J7,1.0426e-4,-0.634666667,47.7898009,3.805333333,1.66349e-5,9.739949757,-2.556,-2.635,-2.421,0.885,1.786,1.133,A0A0B4J1J7,NotFound,A0A0B4J1J7_NotFound,A0A0B4J1J7,Ighv1-82,1,8,8,4,A0A0B4J1J7,MOUSE,10763.9,68.3,226,226.2,71.94,38.54,,98,Immunoglobulin heavy variable 1-82,,,,4,8,348000000,54.0%
Q9WUB3,5.58133e-4,-1.1615,34.35207237,4.207666667,3.67107e-4,6.178730633,-2.654,-2.28,-4.862,1.052,0.861,0.914,Q9WUB3,Pygm,Q9WUB3_Pygm,Q9WUB3,Pygm,1,23,13,13,Q9WUB3|E9PUM3|Q8CI94|Q9ET01|Q3UEJ6,MOUSE,97741,17.4,227,227.1,125.14,125.14,,842,"Glycogen phosphorylase, muscle form",cytoplasm|sarcoplasmic reticulum|Z disc|extracellular exosome|,response to hypoxia|glycogen catabolic process|cellular calcium ion homeostasis|response to cAMP|,drug binding|glycogen phosphorylase activity|AMP binding|pyridoxal phosphate binding|carbohydrate binding|,13,23,473000000,17.4%
A0A075B5R6,1.84583e-4,-0.660333333,40.9493056,4.338666667,8.03655e-5,7.740848714,-3.816,-2.131,-2.542,1.617,2.048,0.862,A0A075B5R6,NotFound,A0A075B5R6_NotFound,A0A075B5R6,Ighv11-1,1,26,9,9,A0A075B5R6|A0A075B5R8,MOUSE,13378.9,51.2,228,228.1,123.54,123.54,,117,Immunoglobulin heavy variable 11-1 (Fragment),,,,9,26,1180000000,51.2%
P10493,2.41179e-4,-0.712666667,39.04271304,3.210666667,1.2466e-4,7.24825126,-2.711,-1.525,-2.718,0.912,0.899,0.867,P10493,Nid1,P10493_Nid1,P10493,Nid1,1,25,12,12,P10493,MOUSE,139387.9,10.6,230,230.1,121.04,121.04,,1245,Nidogen-1,extracellular region|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular matrix|extracellular exosome|cell periphery|extracellular matrix|,cell-matrix adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|glomerular basement membrane development|,calcium ion binding|protein binding|collagen binding|laminin binding|laminin-1 binding|proteoglycan binding|extracellular matrix binding|,12,25,407000000,10.6%
P39876,1.0426e-4,-0.784666667,46.95757662,3.715333333,2.01485e-5,9.475534142,-3.136,-2.451,-2.34,1.317,1.014,0.888,P39876,Timp3,P39876_Timp3,P39876,Timp3,1,32,10,10,P39876,MOUSE,24923.3,42.1,231,231.1,119.98,119.98,,211,Metalloproteinase inhibitor 3,proteinaceous extracellular matrix|basement membrane|extracellular space|nucleus|cytoplasm|extracellular exosome|extracellular matrix|,central nervous system development|aging|response to mechanical stimulus|response to hormone|negative regulation of endopeptidase activity|response to cytokine|tissue regeneration|response to estrogen|negative regulation of metalloenzyme activity|negative regulation of membrane protein ectodomain proteolysis|response to folic acid|cellular response to organic substance|,protease binding|metalloendopeptidase inhibitor activity|metal ion binding|,10,32,1410000000,42.1%
Q91VB8,3.83431e-4,-0.884833333,36.33468473,3.971666667,2.32558e-4,6.590774757,-4.188,-2.136,-2.288,1.454,0.849,1,Q91VB8,Hba-a1,Q91VB8_Hba-a1,Q91VB8,Hba-a1,1,76,7,7,Q91VB8|P01942|P01966,MOUSE,15169,63.3,232,232.1,119.71,119.71,,142,Alpha globin 1,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,7,76,259000000000,63.3%
P27656,1.0426e-4,-1.123833333,48.59596295,4.456333333,1.38167e-5,10.00218348,-3.548,-2.6,-3.908,1.214,1.189,0.91,P27656,Lipc,P27656_Lipc,P27656,Lipc,1,34,8,8,P27656|Q3TYU0,MOUSE,58072.5,17.8,233,233.1,119.69,119.69,,510,Hepatic triacylglycerol lipase,extracellular space|high-density lipoprotein particle|,fatty acid biosynthetic process|cholesterol metabolic process|triglyceride catabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol homeostasis|triglyceride homeostasis|,triglyceride lipase activity|protein binding|heparin binding|lipase activity|,8,34,2510000000,17.8%
Q99K41,0.005667343,-0.409333333,23.35515602,3.374,0.004618324,4.047772874,-0.843,-1.543,-3.903,1.837,1.602,0.394,Q99K41,Emilin1,Q99K41_Emilin1,Q99K41,Emilin1,1,16,10,10,Q99K41,MOUSE,108895,12.6,234,234.1,118.03,118.03,,1017,EMILIN-1,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular matrix|extracellular exosome|extracellular matrix|,cell adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|,protein binding|extracellular matrix constituent conferring elasticity|identical protein binding|,10,16,158000000,12.6%
P43025,2.45192e-4,-1.315666667,38.92786774,4.655333333,1.28001e-4,7.219387683,-3.368,-2.502,-5.06,0.959,1.119,0.958,P43025,NotFound,P43025_NotFound,P43025,Clec3b,1,25,8,8,P43025|Q8CFZ6,MOUSE,22656.5,38.6,235,235.1,117.36,117.36,,202,Tetranectin,granular component|proteinaceous extracellular matrix|extracellular space|cytoplasm|extracellular exosome|,skeletal system development|ossification|positive regulation of plasminogen activation|bone mineralization|,calcium ion binding|protein binding|heparin binding|carbohydrate binding|kringle domain binding|,8,25,786000000,38.6%
Q02105,1.10858e-4,-0.471666667,45.48292038,4.344666667,2.82949e-5,9.022173667,-2.66,-2.588,-2.684,1.72,2.509,0.873,Q02105,C1qc,Q02105_C1qc,Q02105,C1qc,1,69,8,8,Q02105,MOUSE,26390.5,35.3,237,237.1,115.04,115.04,,246,Complement C1q subcomponent subunit C,collagen trimer|extracellular space|membrane|extracellular exosome|blood microparticle|,"complement activation, classical pathway|negative regulation of granulocyte differentiation|innate immune response|negative regulation of macrophage differentiation|",tumor necrosis factor receptor binding|,8,69,158000000000,35.3%
F8VQJ3,2.0518e-4,-1.382666667,40.2397569,4.804666667,9.4629e-5,7.554521119,-3.38,-2.763,-5.212,1.145,0.896,1.018,F8VQJ3,Lamc1,F8VQJ3_Lamc1,F8VQJ3,Lamc1,1,14,10,10,F8VQJ3|P02468,MOUSE,182889.8,8.2,238,238.1,113.75,113.75,,1607,Laminin subunit gamma-1,basement membrane|basal lamina|laminin-1 complex|extracellular matrix|laminin-10 complex|extracellular exosome|basement membrane|extracellular matrix|,protein complex assembly|cell adhesion|cell migration|extracellular matrix disassembly|neuron projection development|hemidesmosome assembly|substrate adhesion-dependent cell spreading|,extracellular matrix structural constituent|protein binding|glycosphingolipid binding|,10,14,326000000,8.2%
Q62356,6.38995e-4,-0.681166667,33.62827462,3.385666667,4.33683e-4,5.978859387,-3.469,-2.342,-1.311,1.015,1.071,0.949,Q62356,Fstl1,Q62356_Fstl1,Q62356,Fstl1,1,17,8,8,Q62356,MOUSE,35694.4,31.3,239,239.1,112.44,112.44,,306,Follistatin-related protein 1,extracellular space|extracellular exosome|,response to starvation|,calcium ion binding|protein binding|heparin binding|,8,17,476000000,31.3%
Q8VCS0,1.05478e-4,-0.810666667,46.14808515,3.973333333,2.42768e-5,9.22431151,-3.327,-2.22,-2.845,1.504,1.166,0.858,Q8VCS0,Pglyrp2,Q8VCS0_Pglyrp2,Q8VCS0,Pglyrp2,1,29,7,7,Q8VCS0|Q8VCS0-2|Q8VCS0-3,MOUSE,58219.2,18.3,241,241.1,111.3,111.3,,530,N-acetylmuramoyl-L-alanine amidase,membrane|extracellular exosome|,pattern recognition receptor signaling pathway|peptidoglycan catabolic process|detection of bacterium|negative regulation of interferon-gamma production|negative regulation of natural killer cell differentiation involved in immune response|growth of symbiont in host|regulation of inflammatory response|defense response to Gram-positive bacterium|,zinc ion binding|N-acetylmuramoyl-L-alanine amidase activity|peptidoglycan receptor activity|peptidoglycan binding|,7,29,1410000000,18.3%
Q91ZA3,0.008042931,-0.232833333,21.72454387,1.729666667,0.006722729,3.711741854,-0.506,-1.097,-1.69,1.157,0.19,0.549,Q91ZA3,Pcca,Q91ZA3_Pcca,Q91ZA3,Pcca,1,19,11,11,Q91ZA3,MOUSE,80547.9,17.8,242,242.1,110.69,110.69,,724,"Propionyl-CoA carboxylase alpha chain, mitochondrial",mitochondrion|mitochondrial matrix|,metabolic process|,biotin carboxylase activity|propionyl-CoA carboxylase activity|ATP binding|enzyme binding|metal ion binding|,11,19,160000000,17.8%
Q8QZR4,0.00269294,-1.689333333,26.77043954,5.718666667,0.002103566,4.764901466,-3.826,-2.376,-7.444,1.603,1.022,0.885,Q8QZR4,Oaf,Q8QZR4_Oaf,Q8QZR4,Oaf,1,16,8,8,Q8QZR4,MOUSE,32151.3,26.2,243,243.1,110.22,110.22,,282,Out at first protein homolog,extracellular exosome|,,,8,16,1510000000,26.2%
O88200,1.0426e-4,-0.915666667,49.75602858,3.770666667,1.05778e-5,10.39040312,-3.121,-2.462,-2.82,0.968,1.018,0.923,O88200,Clec11a,O88200_Clec11a,O88200,Clec11a,1,22,11,11,O88200,MOUSE,36793.1,38.4,244,244.1,110.07,110.07,,328,C-type lectin domain family 11 member A,extracellular region|extracellular space|cytoplasm|,positive regulation of cell proliferation|,growth factor activity|carbohydrate binding|,11,22,1330000000,38.4%
Q91XL1,1.04681e-4,-0.8885,46.47186742,3.716333333,2.25327e-5,9.32410004,-3.302,-2.641,-2.297,0.97,0.922,1.017,Q91XL1,Lrg1,Q91XL1_Lrg1,Q91XL1,Lrg1,1,55,8,8,Q91XL1,MOUSE,37829.6,23.9,245,245.1,109.05,109.05,,342,Leucine-rich HEV glycoprotein,extracellular space|extracellular exosome|,positive regulation of endothelial cell proliferation|positive regulation of transforming growth factor beta receptor signaling pathway|positive regulation of angiogenesis|brown fat cell differentiation|,transforming growth factor beta receptor binding|,8,55,14900000000,23.9%
Q99P87,1.12595e-4,-1.276333333,45.04075489,4.578666667,3.13274e-5,8.889900523,-3.373,-2.754,-4.57,1.097,0.938,1.004,Q99P87,Retn,Q99P87_Retn,Q99P87,Retn,1,28,7,7,Q99P87,MOUSE,13119,62.2,246,246.1,108.2,108.2,,114,Resistin,extracellular region|extracellular space|extracellular exosome|,,hormone activity|,7,28,8710000000,62.2%
A0A0B4J1H7,4.01427e-4,-1.1925,36.05292526,5.498333333,2.48146e-4,6.693264246,-3.38,-2.641,-5.804,0.899,1.875,1.896,A0A0B4J1H7,NotFound,A0A0B4J1H7_NotFound,A0A0B4J1H7,Igkv1-135,1,39,9,9,A0A0B4J1H7,MOUSE,13419.1,45.8,247,247.1,107.88,107.88,,120,Immunoglobulin kappa variable 1-135 (Fragment),,,,9,39,10100000000,45.8%
A0A0B4J1H9,6.1088e-4,-0.261166667,33.86109564,3.012333333,4.11046e-4,6.029840095,-1.226,-1.782,-2.294,0.977,0.722,2.036,A0A0B4J1H9,NotFound,A0A0B4J1H9_NotFound,A0A0B4J1H9,Igkv1-132,1,7,3,3,A0A0B4J1H9,MOUSE,13548.3,33.3,247,247.2,29.39,29.39,,120,Immunoglobulin kappa variable 1-132 (Fragment),,,,3,7,71600000,33.3%
Q80VA0-2,1.04681e-4,-1.261333333,46.37662405,4.784,2.30323e-5,9.294650662,-3.657,-2.751,-4.552,1.335,1.149,0.908,Q80VA0,Galnt7,Q80VA0-2_Galnt7,Q80VA0-2,Galnt7,1,25,11,11,Q80VA0-2|Q80VA0|Q80VA0-3,MOUSE,76183.4,14.3,248,248.1,106.19,106.19,,657,Isoform 2 of N-acetylgalactosaminyltransferase 7,Golgi membrane|membrane|integral component of membrane|extracellular exosome|,protein O-linked glycosylation|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,11,25,798000000,14.3%
Q8BI84,1.95315e-4,-0.8295,40.58294773,3.798333333,8.7439e-5,7.644190051,-3.556,-2.799,-1.831,1.039,0.998,1.172,Q8BI84,Mia3,Q8BI84_Mia3,Q8BI84,Mia3,1,26,11,11,Q8BI84|Q8BI84-2|J3KMH5|Q8BI84-3,MOUSE,214298.7,7,249,249.1,105.88,105.88,,1930,Transport and Golgi organization protein 1 homolog,endoplasmic reticulum membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|,chondrocyte development|positive regulation of leukocyte migration|exocytosis|negative regulation of cell adhesion|protein transport|collagen fibril organization|negative regulation of cell migration|positive regulation of bone mineralization|wound healing|,,11,26,8850000000,7.0%
Q02788,1.0426e-4,-1.0385,49.36578753,4.013,1.15723e-5,10.25835144,-3.324,-2.495,-3.316,0.941,0.926,1.037,Q02788,Col6a2,Q02788_Col6a2,Q02788,Col6a2,1,24,10,10,Q02788|D3Z7D5,MOUSE,111473.4,8.6,250,250.1,105.85,105.85,,1034,Collagen alpha-2(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular vesicle|extracellular matrix|,cell adhesion|response to glucose|protein heterotrimerization|,,10,24,872000000,8.6%
Q8C7G5,1.06884e-4,-1.003,45.91212208,4,2.56323e-5,9.152166285,-3.246,-2.281,-3.482,1.22,0.916,0.855,Q8C7G5,Apoa5,Q8C7G5_Apoa5,Q8C7G5,Apoa5,1,20,8,8,Q8C7G5|A0A1L1SQP3|A0A1L1SV61,MOUSE,41318.5,25,251,251.1,104.54,104.54,,368,Apolipoprotein A-V,extracellular region|extracellular space|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|blood microparticle|,triglyceride metabolic process|cholesterol biosynthetic process|lipid transport|response to hormone|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|positive regulation of very-low-density lipoprotein particle remodeling|triglyceride catabolic process|regulation of intestinal cholesterol absorption|organ regeneration|neuron projection regeneration|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|lipoprotein metabolic process|tissue regeneration|cholesterol homeostasis|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipid catabolic process|positive regulation of lipoprotein lipase activity|acylglycerol homeostasis|triglyceride homeostasis|,phospholipid binding|enzyme activator activity|heparin binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|lipase binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|lipase activator activity|lipoprotein lipase activator activity|lipoprotein particle receptor binding|,8,20,457000000,25.0%
Q9Z0M6,1.0426e-4,-0.946833333,47.29587624,4.171666667,1.86386e-5,9.582258867,-3.694,-2.516,-2.888,1.117,1.418,0.882,Q9Z0M6,Adgre5,Q9Z0M6_Adgre5,Q9Z0M6,Cd97,1,27,7,7,E9QJS7|Q9Z0M6|Q9Z0M6-3|E9QMJ5|Q9Z0M6-2|A0A0D9SEG8|Q9DC42,MOUSE,92922.2,10,252,252.1,103.98,103.98,,818,CD97 antigen,plasma membrane|focal adhesion|membrane|integral component of membrane|extracellular exosome|,cell adhesion|G-protein coupled receptor signaling pathway|positive regulation of synapse assembly|,transmembrane signaling receptor activity|G-protein coupled receptor activity|calcium ion binding|,7,27,443000000,10.0%
P47878,1.10858e-4,-1.0825,45.54423284,4.212333333,2.78982e-5,9.040646511,-3.058,-2.506,-4.002,0.944,1.173,0.954,P47878,Igfbp3,P47878_Igfbp3,P47878,Igfbp3,1,33,8,8,P47878,MOUSE,32713.3,29.1,253,253.1,103.17,103.17,,292,Insulin-like growth factor-binding protein 3,extracellular space|nucleus|insulin-like growth factor ternary complex|extracellular exosome|,regulation of cell growth|osteoblast differentiation|negative regulation of protein phosphorylation|protein phosphorylation|negative regulation of cell proliferation|regulation of glucose metabolic process|negative regulation of smooth muscle cell migration|regulation of growth|positive regulation of apoptotic process|positive regulation of catalytic activity|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|positive regulation of myoblast differentiation|negative regulation of smooth muscle cell proliferation|,fibronectin binding|insulin-like growth factor binding|protein tyrosine phosphatase activator activity|insulin-like growth factor I binding|insulin-like growth factor II binding|,8,33,14800000000,29.1%
Q01705,1.28279e-4,-0.676833333,43.88086299,3.380333333,4.09179e-5,8.550677112,-2.351,-1.895,-2.855,0.975,1.163,0.902,Q01705,Notch1,Q01705_Notch1,Q01705,Notch1,1,19,9,9,Q01705|Q01705-3|Q01705-4|Q01705-2,MOUSE,284808.6,4.3,254,254.1,101.34,101.34,,2531,Neurogenic locus notch homolog protein 1,Golgi membrane|acrosomal vesicle|ruffle|MAML1-RBP-Jkappa- ICN1 complex|extracellular region|nucleus|nucleoplasm|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|cytosol|cytoskeleton|plasma membrane|integral component of plasma membrane|cell surface|lamellipodium|cytoplasmic vesicle|receptor complex|cell periphery|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|cell fate specification|epithelial to mesenchymal transition|liver development|heart looping|sprouting angiogenesis|osteoblast fate commitment|positive regulation of neuroblast proliferation|inflammatory response to antigenic stimulus|endocardium development|endocardium morphogenesis|atrioventricular node development|coronary vein morphogenesis|aortic valve morphogenesis|atrioventricular valve morphogenesis|pulmonary valve morphogenesis|mitral valve formation|epithelial to mesenchymal transition involved in endocardial cushion formation|endocardial cushion morphogenesis|cardiac chamber formation|cardiac ventricle morphogenesis|cardiac atrium morphogenesis|cardiac right atrium morphogenesis|cardiac left ventricle morphogenesis|cardiac right ventricle formation|ventricular trabecula myocardium morphogenesis|growth involved in heart morphogenesis|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation|cell migration involved in endocardial cushion formation|pericardium morphogenesis|regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|humoral immune response|Notch signaling pathway|positive regulation of transcription of Notch receptor target|spermatogenesis|determination of left/right symmetry|compartment pattern specification|axonogenesis|foregut morphogenesis|endoderm development|heart development|positive regulation of cell proliferation|negative regulation of cell proliferation|epidermis development|regulation of Notch signaling pathway|auditory receptor cell fate commitment|glial cell differentiation|regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|negative regulation of myotube differentiation|mesenchymal cell development|regulation of somitogenesis|cell differentiation in spinal cord|neural tube development|cell differentiation|neuron differentiation|keratinocyte differentiation|negative regulation of ossification|lung development|embryonic limb morphogenesis|regulation of cell migration|positive regulation of cell migration|positive regulation of BMP signaling pathway|negative regulation of BMP signaling pathway|forebrain development|hair follicle morphogenesis|organ regeneration|response to corticosteroid|response to muramyl dipeptide|response to lipopolysaccharide|embryonic hindlimb morphogenesis|tube formation|skeletal muscle cell differentiation|cellular response to vascular endothelial growth factor stimulus|regulation of cell proliferation|tissue regeneration|positive regulation of apoptotic process|negative regulation of catalytic activity|cell fate commitment|negative regulation of cell differentiation|positive regulation of endothelial cell differentiation|regulation of auditory receptor cell differentiation|negative regulation of auditory receptor cell differentiation|positive regulation of keratinocyte differentiation|negative regulation of myoblast differentiation|negative regulation of neuron differentiation|negative regulation of osteoblast differentiation|positive regulation of Notch signaling pathway|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|negative regulation of calcium ion-dependent exocytosis|positive regulation of JAK-STAT cascade|negative regulation of photoreceptor cell differentiation|somatic stem cell division|neuron fate commitment|astrocyte differentiation|oligodendrocyte differentiation|positive regulation of astrocyte differentiation|negative regulation of oligodendrocyte differentiation|branching morphogenesis of an epithelial tube|regulation of epithelial cell proliferation|positive regulation of epithelial cell proliferation|regulation of neurogenesis|negative regulation of neurogenesis|cardiac muscle tissue morphogenesis|cardiac muscle cell proliferation|positive regulation of cardiac muscle cell proliferation|negative regulation of glial cell proliferation|cilium morphogenesis|cardiac epithelial to mesenchymal transition|cardiac septum morphogenesis|ventricular septum morphogenesis|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development|negative regulation of cell death|prostate gland epithelium morphogenesis|regulation of epithelial cell proliferation involved in prostate gland development|arterial endothelial cell differentiation|venous endothelial cell differentiation|cardiac vascular smooth muscle cell development|endocardial cell differentiation|vasculogenesis involved in coronary vascular morphogenesis|coronary artery morphogenesis|Notch signaling involved in heart development|regulation of cell adhesion involved in heart morphogenesis|heart trabecula morphogenesis|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia|left/right axis specification|cellular response to follicle-stimulating hormone stimulus|distal tubule development|collecting duct development|glomerular mesangial cell development|interleukin-4 secretion|negative regulation of cell migration involved in sprouting angiogenesis|negative regulation of canonical Wnt signaling pathway|neuronal stem cell maintenance|positive regulation of ephrin receptor signaling pathway|regulation of extracellular matrix assembly|apoptotic process involved in embryonic digit morphogenesis|negative regulation of stem cell differentiation|negative regulation of anoikis|negative regulation of pro-B cell differentiation|negative regulation of endothelial cell chemotaxis|",core promoter binding|RNA polymerase II transcription factor binding transcription activator activity|chromatin binding|sequence-specific DNA binding transcription factor activity|enzyme inhibitor activity|receptor activity|Notch binding|calcium ion binding|protein binding|enzyme binding|chromatin DNA binding|sequence-specific DNA binding|protein heterodimerization activity|,9,19,467000000,4.3%
Q8VC49,1.0426e-4,-0.981833333,52.36190838,4.193666667,5.80509e-6,11.31165461,-3.207,-2.719,-3.31,1.299,1.158,0.888,Q8VC49,Ifi27l2b,Q8VC49_Ifi27l2b,Q8VC49,Ifi27l2b,1,19,6,6,Q8VC49,MOUSE,27886.1,26.1,255,255.1,98.33,98.33,,283,Interferon alpha-inducible protein 27-like protein 2B,integral component of membrane|,,,6,19,12700000000,26.1%
O35664-3,2.41524e-4,-1.4475,39.0267212,5.163,1.2512e-4,7.357828443,-3.975,-2.636,-5.476,1.447,1.072,0.883,O35664,Ifnar2,O35664-3_Ifnar2,O35664-3,Ifnar2,1,48,7,7,O35664-3|O35664|O35664-2|F6XX07,MOUSE,28268.1,19.3,256,256.1,98.25,98.25,,513,Isoform 3 of Interferon alpha/beta receptor 2,extracellular space|plasma membrane|integral component of plasma membrane|integral component of membrane|,regulation of transcription from RNA polymerase II promoter|cell proliferation|cytokine-mediated signaling pathway|response to interferon-alpha|type I interferon signaling pathway|,type I interferon receptor activity|protein kinase binding|type I interferon binding|,7,48,15800000000,19.3%
Q9ET66,2.01782e-4,-1.268166667,40.33614018,4.488333333,9.2552e-5,7.579619062,-3.545,-2.348,-4.644,1.129,0.917,0.882,Q9ET66,Pi16,Q9ET66_Pi16,Q9ET66,Pi16,1,29,6,6,E9QNE5|Q9ET66|D3Z6T6|Q9ET66-2,MOUSE,53234.3,15.1,257,257.1,97.65,97.65,,489,Peptidase inhibitor 16,extracellular space|integral component of membrane|extracellular exosome|,negative regulation of peptidase activity|negative regulation of cell growth involved in cardiac muscle cell development|,peptidase inhibitor activity|,6,29,1820000000,15.1%
Q8R357,0.046536386,-3.771166667,13.7299376,9.631666667,0.042364905,2.482791491,-3.94,-3.069,-18.752,1.213,0.995,0.926,Q8R357,Olfm1,Q8R357_Olfm1,Q8R357,Olfm1,1,16,7,7,Q8R357|O88998|G3X9Q7|O88998-3|A3KGE4|O88998-2|O88998-4,MOUSE,55769.1,15.8,259,259.1,96.97,96.97,,485,Noelin,extracellular space|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|synaptic membrane|,atrioventricular valve formation|positive regulation of gene expression|negative regulation of gene expression|positive regulation of epithelial to mesenchymal transition|protein oligomerization|cardiac epithelial to mesenchymal transition|regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|negative regulation of neuron migration|,beta-amyloid binding|protein binding|,7,16,593000000,15.8%
Q8R0Z6,3.38676e-4,-0.423166667,37.01778533,3.194333333,1.98711e-4,6.752175671,-2.583,-2.288,-1.19,1.116,1.495,0.911,Q8R0Z6,Angptl6,Q8R0Z6_Angptl6,Q8R0Z6,Angptl6,1,18,8,8,Q8R0Z6,MOUSE,51493.9,20.5,262,262.1,94.92,94.92,,457,Angiopoietin-related protein 6,secretory granule|extracellular exosome|,angiogenesis|cell differentiation|,,8,18,628000000,20.5%
A0A075B5S2,2.34792e-4,-1.341833333,39.27826441,5.128333333,1.18079e-4,7.400515268,-3.799,-2.596,-5.323,1.038,1.697,0.932,A0A075B5S2,NotFound,A0A075B5S2_NotFound,A0A075B5S2,Ighv7-1,1,33,7,7,A0A075B5S2|P01791|P01794|P01788|P01787|P01790|P01793|P01792|P01789,MOUSE,13815.5,56.1,263,263.1,93.92,93.92,,121,Immunoglobulin heavy variable 7-1 (Fragment),,,,8,33,4340000000,56.1%
P01843,0.003427988,-2.189,25.67084057,6.621333333,0.002709667,4.547851919,-4.121,-3.184,-9.194,0.951,1.318,1.096,P01843,NotFound,P01843_NotFound,P01843,,1,35,5,5,A0A0G2JE99|P01843,MOUSE,11745.8,69.5,265,265.1,93.01,93.01,,105,Ig lambda-1 chain C region,plasma membrane|,,antigen binding|,5,35,16400000000,69.5%
P62827,5.59984e-4,-0.5165,34.33001009,3.124333333,3.68977e-4,6.133441465,-3.014,-1.829,-1.393,1.442,0.778,0.917,P62827,Ran,P62827_Ran,P62827,Ran,1,11,8,8,P62827|Q14AA6|Q61820,MOUSE,24593.8,33.3,266,266.1,91.77,91.77,,216,GTP-binding nuclear protein Ran,nucleus|nuclear envelope|nucleoplasm|nucleolus|cytoplasm|centriole|membrane|midbody|melanosome|RNA nuclear export complex|recycling endosome|extracellular exosome|chromatin|,"ribosomal subunit export from nucleus|ribosomal large subunit export from nucleus|ribosomal small subunit export from nucleus|protein import into nucleus, translocation|protein import into nucleus|protein export from nucleus|mitotic nuclear division|small GTPase mediated signal transduction|metabolic process|actin cytoskeleton organization|positive regulation of protein binding|cellular protein localization|cellular protein complex localization|cell division|protein localization to nucleolus|",GTPase activity|protein binding|GTP binding|GDP binding|poly(A) RNA binding|pre-miRNA binding|,8,11,4650000000,33.3%
Q9CZT5,2.0518e-4,-0.513166667,40.20634875,3.080333333,9.53598e-5,7.545837167,-2.541,-2.059,-1.56,1.314,0.818,0.949,Q9CZT5,Vasn,Q9CZT5_Vasn,Q9CZT5,Vasn,1,15,7,7,Q9CZT5,MOUSE,73401,12.3,267,267.1,90.74,90.74,,673,Vasorin,extracellular space|mitochondrion|lysosomal membrane|plasma membrane|cell surface|integral component of membrane|extracellular exosome|,negative regulation of epithelial to mesenchymal transition|negative regulation of transforming growth factor beta receptor signaling pathway|cellular response to hypoxia|cellular response to redox state|,protein binding|transforming growth factor beta binding|,7,15,304000000,12.3%
Q61646,0.043205203,-1.581333333,14.06919656,3.89,0.039181436,2.536462037,-0.01,-3.772,-6.797,0.749,0.329,0.013,Q61646,Hp,Q61646_Hp,Q61646,Hp,1,13,7,7,Q61646,MOUSE,39265.1,21.6,268,268.1,90.15,90.15,,347,Haptoglobin,extracellular space|endoplasmic reticulum|Golgi apparatus|haptoglobin-hemoglobin complex|extracellular exosome|blood microparticle|,response to hypoxia|liver development|immune system process|acute-phase response|Notch signaling pathway|spermatogenesis|response to heat|response to X-ray|response to lead ion|positive regulation of cell death|organ regeneration|response to magnesium ion|response to lipopolysaccharide|response to cobalamin|response to L-ascorbic acid|response to drug|response to hydrogen peroxide|defense response to bacterium|negative regulation of oxidoreductase activity|response to glucocorticoid|response to electrical stimulus|response to growth hormone|negative regulation of hydrogen peroxide catabolic process|,antioxidant activity|hemoglobin binding|protein homodimerization activity|,7,13,419000000,21.6%
E9QPU1,5.70588e-4,-0.861,34.20274368,4.028,3.79949e-4,6.105200433,-2.262,-1.975,-4.388,0.842,1.325,1.292,E9QPU1,Vwf,E9QPU1_Vwf,E9QPU1,Vwf,1,22,8,8,E9QPU1|Q8CIZ8|Q3TPE1|Q3TD35|Q8CIZ8-2,MOUSE,322558.9,2.8,269,269.1,90.12,90.12,,2813,von Willebrand factor,extracellular region|proteinaceous extracellular matrix|endoplasmic reticulum|external side of plasma membrane|extracellular matrix|Weibel-Palade body|extracellular exosome|,liver development|placenta development|cell adhesion|blood coagulation|hemostasis|platelet activation|cell-substrate adhesion|protein homooligomerization|platelet activation|,glycoprotein binding|protease binding|integrin binding|protein binding|collagen binding|immunoglobulin binding|identical protein binding|protein homodimerization activity|protein N-terminus binding|chaperone binding|,9,22,1300000000,2.8%
Q9QUM0,2.11828e-4,-0.957333333,39.8579597,4.435333333,1.03325e-4,7.455749563,-2.71,-2.383,-4.432,1.617,0.864,1.3,Q9QUM0,Itga2b,Q9QUM0_Itga2b,Q9QUM0,Itga2b,1,14,8,8,Q9QUM0,MOUSE,113760,10.1,270,270.1,90.02,90.02,,1033,Integrin alpha-IIb,focal adhesion|integrin complex|external side of plasma membrane|cell surface|extracellular exosome|blood microparticle|,positive regulation of leukocyte migration|cell-matrix adhesion|integrin-mediated signaling pathway|platelet aggregation|,identical protein binding|metal ion binding|extracellular matrix binding|fibrinogen binding|,8,14,293000000,10.1%
P01845,1.43093e-4,-0.9105,42.82829411,3.977,5.21399e-5,8.252271392,-3.825,-2.439,-2.433,0.963,0.991,1.28,P01845,NotFound,P01845_NotFound,P01845,Iglc3,1,25,5,2,P01845,MOUSE,11541.6,65.3,271,271.1,89.73,41.91,,104,Ig lambda-3 chain C region,plasma membrane|,,antigen binding|,5,25,10700000000,65.3%
P01844,1.0426e-4,-1.200166667,50.57915922,4.685,8.75153e-6,10.67388699,-3.835,-2.814,-3.979,0.901,1.335,1.191,P01844,NotFound,P01844_NotFound,P01844,Iglc2,1,17,5,3,P01844,MOUSE,11425.5,65.3,271,271.2,89.36,45.84,,104,Ig lambda-2 chain C region,plasma membrane|,,,3,17,3540000000,57.6%
Q9JHI0,1.0426e-4,-0.775166667,47.44434599,3.837,1.80121e-5,9.6294248,-3.111,-2.734,-2.236,1.421,1.115,0.894,Q9JHI0,Mmp19,Q9JHI0_Mmp19,Q9JHI0,Mmp19,1,9,7,7,Q9JHI0|Q3UW97,MOUSE,59349.2,18.4,273,273.1,88.72,88.72,,527,Matrix metalloproteinase-19,extracellular region|proteinaceous extracellular matrix|plasma membrane|anchored component of membrane|,angiogenesis|ovarian follicle development|ovulation from ovarian follicle|luteolysis|proteolysis|response to hormone|cell differentiation|collagen catabolic process|response to cAMP|,metalloendopeptidase activity|calcium ion binding|zinc ion binding|,7,9,66000000,18.4%
E9QKW2,0.001105008,-0.531666667,30.98937251,3.057333333,7.96274e-4,5.421348846,-3.109,-2.086,-0.986,1.182,0.937,0.872,E9QKW2,Smoc1,E9QKW2_Smoc1,E9QKW2,Smoc1,1,23,7,7,A0A0R4J1E4|E9QKW2|D3Z3A3|Q8BLY1|Q8BLY1-2,MOUSE,51031.9,18.1,274,274.1,87.71,87.71,,452,SPARC-related modular calcium-binding protein 1,basement membrane|,eye development|signal transduction|positive regulation of cell-substrate adhesion|extracellular matrix organization|regulation of osteoblast differentiation|limb development|,calcium ion binding|extracellular matrix binding|,7,23,5600000000,18.1%
Q9R100,1.0426e-4,-0.9285,50.35476002,4.011,9.21561e-6,10.59593152,-2.952,-2.545,-3.305,0.997,0.954,1.28,Q9R100,Cdh17,Q9R100_Cdh17,Q9R100,Cdh17,1,12,7,7,Q9R100|A2AKS7,MOUSE,92100.1,10.6,275,275.1,86.59,86.59,,827,Cadherin-17,plasma membrane|integral component of plasma membrane|basolateral plasma membrane|,oligopeptide transport|homophilic cell adhesion via plasma membrane adhesion molecules|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|oligopeptide transmembrane transport|,proton-dependent oligopeptide secondary active transmembrane transporter activity|calcium ion binding|protein binding|,7,12,313000000,10.6%
Q8BYB9,0.001658331,-0.758166667,29.07463998,3.483,0.001237474,5.075628179,-3.905,-2.495,-1.099,0.895,0.897,1.158,Q8BYB9,Poglut1,Q8BYB9_Poglut1,Q8BYB9,Poglut1,1,15,8,8,Q8BYB9,MOUSE,46892.1,21.4,276,276.1,86.26,86.26,,392,Protein O-glucosyltransferase 1,endoplasmic reticulum lumen|extracellular exosome|,protein O-linked glycosylation|regulation of Notch signaling pathway|cardiovascular system development|,protein xylosyltransferase activity|UDP-glucosyltransferase activity|UDP-xylosyltransferase activity|glucosyltransferase activity|,8,15,1130000000,21.4%
O08538,3.1214e-4,-0.798333333,37.45916299,3.507333333,1.79508e-4,6.858027462,-1.883,-2.229,-3.544,1.157,1.053,0.656,O08538,Angpt1,O08538_Angpt1,O08538,Angpt1,1,12,8,8,O08538,MOUSE,58088.5,16,277,277.1,85.68,85.68,,498,Angiopoietin-1,extracellular space|plasma membrane|microvillus|membrane raft|extracellular exosome|,angiogenesis|patterning of blood vessels|vasculogenesis|in utero embryonic development|negative regulation of protein phosphorylation|sprouting angiogenesis|positive regulation of receptor internalization|negative regulation of cytokine secretion involved in immune response|endocardium morphogenesis|negative regulation of cell adhesion|transmembrane receptor protein tyrosine kinase signaling pathway|activation of transmembrane receptor protein tyrosine kinase activity|endoderm development|positive regulation of endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase signaling|regulation of satellite cell proliferation|hemopoiesis|heparin biosynthetic process|positive regulation of vascular endothelial growth factor receptor signaling pathway|positive regulation of protein ubiquitination|cell-substrate adhesion|regulation of tumor necrosis factor production|positive regulation of peptidyl-serine phosphorylation|protein localization to cell surface|negative regulation of protein import into nucleus|negative regulation of apoptotic process|negative regulation of vascular permeability|regulation of I-kappaB kinase/NF-kappaB signaling|regulation of protein binding|negative regulation of neuron apoptotic process|positive regulation of blood vessel endothelial cell migration|positive regulation of cell adhesion|Tie signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|positive regulation of protein kinase B signaling|cardiac muscle tissue morphogenesis|vasculogenesis involved in coronary vascular morphogenesis|positive regulation of ERK1 and ERK2 cascade|glomerulus vasculature development|negative regulation of endothelial cell apoptotic process|regulation of macrophage migration inhibitory factor signaling pathway|,receptor binding|vascular endothelial growth factor receptor binding|receptor tyrosine kinase binding|,8,12,393000000,16.0%
P01869,1.0426e-4,-0.816666667,48.59528142,4.078,1.38188e-5,10.0019592,-3.049,-2.523,-2.995,0.905,1,1.762,P01869,NotFound,P01869_NotFound,P01869,Ighg1,1,25,5,5,P01869|P01868,MOUSE,44070.3,20.8,278,278.1,85.48,85.48,,393,"Ig gamma-1 chain C region, membrane-bound form",plasma membrane|integral component of membrane|,,antigen binding|immunoglobulin receptor binding|,5,25,2050000000,20.8%
A0A075B5R2,1.0426e-4,-0.7795,46.98083602,3.717666667,2.00409e-5,9.482838833,-2.185,-3.066,-2.664,1.178,0.85,1.21,A0A075B5R2,NotFound,A0A075B5R2_NotFound,A0A075B5R2,Ighv7-3,1,33,5,5,A0A075B5R2|A0A075B5R3|P01786,MOUSE,13628.3,41.6,279,279.1,84.67,84.67,,120,Immunoglobulin heavy variable 7-3 (Fragment),,,,5,33,1970000000,41.6%
P05366,0.072940189,-0.559666667,11.7175309,1.496,0.067335937,2.145067517,0.103,-2.771,-1.255,0.175,0.271,0.119,P05366,Saa1,P05366_Saa1,P05366,Saa1,1,30,6,5,P05366|P04918,MOUSE,13884.1,50,280,280.1,84.37,71.92,,122,Serum amyloid A-1 protein,extracellular space|cytosol|cytoplasmic microtubule|high-density lipoprotein particle|extracellular exosome|,acute-phase response|cholesterol metabolic process|positive chemotaxis|cell chemotaxis|,G-protein coupled receptor binding|protein binding|heparin binding|chemoattractant activity|,6,30,3330000000,50.0%
P05367,0.776086628,-0.0055,1.126250923,0.237666667,0.771569244,0.301422275,1.481,-0.006,-1.848,0.209,0.027,0.104,P05367,Saa2,P05367_Saa2,P05367,Saa2,1,14,6,5,P05367|A0A1B0GQV5,MOUSE,13736,46.7,280,280.2,60.4,47.95,,122,Serum amyloid A-2 protein,extracellular space|cytosol|cytoplasmic microtubule|high-density lipoprotein particle|extracellular exosome|,acute-phase response|response to stilbenoid|positive chemotaxis|cell chemotaxis|,G-protein coupled receptor binding|protein binding|chemoattractant activity|,5,14,574000000,38.5%
P26618,1.0426e-4,-0.861333333,50.987208270000004,3.87,7.96671e-6,10.81695215,-2.621,-2.668,-3.1,1.211,1.086,0.924,P26618,Pdgfra,P26618_Pdgfra,P26618,Pdgfra,1,13,8,8,P26618|P26618-2|A0A0J9YV87,MOUSE,123651.1,8.1,281,281.1,83.58,83.58,,1089,Platelet-derived growth factor receptor alpha,nucleus|cytoplasm|cytosol|integral component of plasma membrane|microvillus|external side of plasma membrane|cell surface|membrane|intrinsic component of plasma membrane|protein complex|,luteinization|in utero embryonic development|hematopoietic progenitor cell differentiation|positive regulation of cytosolic calcium ion concentration|estrogen metabolic process|positive regulation of cell proliferation|female gonad development|anatomical structure morphogenesis|organ morphogenesis|response to inorganic substance|negative regulation of platelet activation|positive regulation of phospholipase C activity|cell migration|peptidyl-tyrosine phosphorylation|signal transduction involved in regulation of gene expression|extracellular matrix organization|lung development|adrenal gland development|positive regulation of cell migration|male genitalia development|response to estradiol|Leydig cell differentiation|response to cytokine|cellular response to reactive oxygen species|platelet-derived growth factor receptor-alpha signaling pathway|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway|wound healing|gliogenesis|odontogenesis of dentin-containing tooth|positive regulation of phosphatidylinositol 3-kinase activity|positive regulation of DNA replication|protein autophosphorylation|platelet-derived growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of fibroblast proliferation|embryonic digestive tract morphogenesis|embryonic cranial skeleton morphogenesis|skeletal system morphogenesis|inner ear development|regulation of chemotaxis|cardiac myofibril assembly|response to hyperoxia|palate development|face morphogenesis|cell chemotaxis|retina vasculature development in camera-type eye|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to amino acid stimulus|metanephric glomerular capillary formation|regulation of mesenchymal stem cell differentiation|,protein kinase activity|transmembrane receptor protein tyrosine kinase activity|platelet-derived growth factor alpha-receptor activity|vascular endothelial growth factor-activated receptor activity|platelet-derived growth factor receptor binding|ATP binding|protein complex binding|vascular endothelial growth factor binding|protein homodimerization activity|phosphatidylinositol 3-kinase binding|platelet-derived growth factor binding|,8,13,219000000,8.1%
A0A140T8P5,1.34595e-4,-0.603333333,43.48599053,3.968,4.48127e-5,8.437696979,-2.725,-2.392,-2.645,0.996,2.259,0.887,A0A140T8P5,NotFound,A0A140T8P5_NotFound,A0A140T8P5,Igkv8-24,1,13,5,2,A0A140T8P5,MOUSE,13434.9,35.5,282,282.2,70.08,32.79,,121,Immunoglobulin kappa chain variable 8-24 (Fragment),,,,2,13,1890000000,17.3%
A0A140T8M4,4.34314e-4,-1.036833333,35.67024675,4.959666667,2.71004e-4,6.570333658,-3.493,-2.07,-4.987,0.882,1.344,2.103,A0A140T8M4,NotFound,A0A140T8M4_NotFound,A0A140T8M4,Igkv8-19,1,13,4,2,A0A140T8M4,MOUSE,11230.2,42.5,282,282.5,64.89,36.51,,101,Immunoglobulin kappa variable 8-19,,,,2,13,1580000000,26.7%
P08003,1.44347e-4,-0.961333333,42.72158453,3.702,5.34369e-5,8.222506643,-2.56,-2.261,-3.616,0.933,0.849,0.887,P08003,Pdia4,P08003_Pdia4,P08003,Pdia4,1,12,8,8,A0A0R4J0Z1|P08003,MOUSE,72323.4,11.7,283,283.1,80.8,80.8,,638,Protein disulfide-isomerase A4,endoplasmic reticulum|endoplasmic reticulum lumen|cell surface|endoplasmic reticulum chaperone complex|melanosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|chaperone-mediated protein folding|,protein disulfide isomerase activity|poly(A) RNA binding|,8,12,458000000,11.7%
Q61982,8.1812e-4,-0.5165,32.39420961,2.976333333,5.76208e-4,5.71358624,-1.961,-1.088,-2.965,1.088,0.893,0.934,Q61982,Notch3,Q61982_Notch3,Q61982,Notch3,1,18,7,7,Q61982,MOUSE,257423.3,3.3,284,284.1,79.46,79.46,,2318,Neurogenic locus notch homolog protein 3,nucleoplasm|cytoplasm|plasma membrane|integral component of plasma membrane|actin cytoskeleton|receptor complex|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|Notch signaling pathway|forebrain development|negative regulation of cell differentiation|negative regulation of neuron differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of smooth muscle cell proliferation|neuron fate commitment|artery morphogenesis|glomerular capillary formation|",calcium ion binding|protein binding|enzyme binding|,7,18,248000000,3.3%
P01645,0.00363885,-0.685,25.3988185,3.678666667,0.002884816,4.420663468,-4.153,-2.712,-0.708,0.926,1.622,0.915,P01645,NotFound,P01645_NotFound,P01645,,1,35,7,6,P01645|P01644|P01646|P01647|A0A140T8M1|P01648|P01643|P01649|A0A075B5L0,MOUSE,12068.2,65.7,285,285.1,79.25,67.02,,108,Ig kappa chain V-V region HP 93G7,,,antigen binding|,8,35,6570000000,65.7%
P97873,7.20125e-4,-0.633333333,33.05408902,3.529333333,4.94984e-4,5.8544085,-1.716,-1.787,-3.691,1.183,1.494,0.717,P97873,Loxl1,P97873_Loxl1,P97873,Loxl1,1,11,7,7,P97873|A0A0R4J0Q4,MOUSE,67189.7,12.8,286,286.1,79.09,79.09,,607,Lysyl oxidase homolog 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|,oxidation-reduction process|,"copper ion binding|protein binding|oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor|",7,11,811000000,12.8%
A0A075B5N3,6.05173e-4,-0.939666667,33.90937483,4.683333333,4.06502e-4,6.157922897,-2.729,-2.128,-4.987,0.863,1.418,1.925,A0A075B5N3,NotFound,A0A075B5N3_NotFound,A0A075B5N3,Igkv8-28,1,22,5,5,A0A075B5N3,MOUSE,11017,59.4,287,287.1,78.96,78.96,,101,Immunoglobulin kappa variable 8-28,,,,5,22,4330000000,59.4%
P16056,1.17305e-4,-1.035,44.7022601,4.167333333,3.38668e-5,8.789753673,-3.335,-2.259,-3.762,1.231,1.043,0.872,P16056,NotFound,P16056_NotFound,P16056,Met,1,12,7,7,P16056|F8VQL0,MOUSE,155885.1,6.9,288,288.1,78.71,78.71,,1379,Hepatocyte growth factor receptor,basal plasma membrane|cell surface|membrane|integral component of membrane|,activation of MAPK activity|endothelial cell morphogenesis|liver development|placenta development|synaptic transmission|brain development|muscle organ development|skeletal muscle tissue development|positive regulation of glucose transport|muscle cell migration|myotube differentiation|peptidyl-tyrosine phosphorylation|adult behavior|glucose homeostasis|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|hepatocyte growth factor receptor signaling pathway|branching morphogenesis of an epithelial tube|regulation of synaptic transmission|positive chemotaxis|myoblast proliferation|regulation of excitatory postsynaptic membrane potential|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling|semaphorin-plexin signaling pathway|negative regulation of hydrogen peroxide-mediated programmed cell death|positive regulation of endothelial cell chemotaxis|,protein kinase activity|hepatocyte growth factor-activated receptor activity|protein binding|ATP binding|protein phosphatase binding|,7,12,207000000,6.9%
P01631,1.0426e-4,-1.1605,49.44902379,4.973666667,1.13527e-5,10.28639229,-4.261,-3.033,-3.648,0.984,1.964,1.031,P01631,NotFound,P01631_NotFound,P01631,,1,48,5,5,P01631|A0A140T8M0|A0A0B4J1I0|A0A075B5K8|A0A140T8N1|A0A140T8M9|A0A075B5N0,MOUSE,12386.7,40.7,289,289.1,78.22,78.22,,113,Ig kappa chain V-II region 26-10,,,antigen binding|,7,48,71300000000,40.7%
P97464,1.0426e-4,-1.0635,50.78866302,4.161,8.33938e-6,10.74712843,-3.13,-2.722,-3.58,1.213,0.921,0.917,P97464,Ext1,P97464_Ext1,P97464,Ext1,1,16,7,7,P97464,MOUSE,87047.9,9.5,290,290.1,77.63,77.63,,746,Exostosin-1,Golgi membrane|endoplasmic reticulum|Golgi apparatus|integral component of endoplasmic reticulum membrane|,"ossification|glycosaminoglycan biosynthetic process|protein glycosylation|gastrulation|axon guidance|brain development|endoderm development|mesoderm development|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|olfactory bulb development|cellular polysaccharide biosynthetic process|embryonic skeletal joint development|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|",7,16,544000000,9.5%
Q8VI78,0.010085294,-0.418333333,20.67577093,2.809333333,0.008558998,3.573949008,-3.167,-2.326,0.024,1.197,0.885,0.877,Q8VI78,Pla1a,Q8VI78_Pla1a,Q8VI78,Pla1a,1,14,7,7,Q8VI78,MOUSE,50838.6,19.9,291,291.1,76.97,76.97,,456,Phospholipase A1 member A,acrosomal membrane|extracellular exosome|,lipid catabolic process|,phosphatidylcholine 1-acylhydrolase activity|,7,14,1480000000,19.9%
Q61171,2.39373e-4,-0.664333333,39.1146589,4.103333333,1.22612e-4,7.266378876,-3.22,-1.638,-3.29,1.74,0.772,1.65,Q61171,Prdx2,Q61171_Prdx2,Q61171,Prdx2,1,9,7,7,Q61171,MOUSE,21949.4,39.3,292,292.1,76.73,76.73,,198,Peroxiredoxin-2,mitochondrion|myelin sheath|extracellular exosome|,activation of MAPK activity|respiratory burst involved in inflammatory response|response to oxidative stress|regulation of hydrogen peroxide metabolic process|removal of superoxide radicals|positive regulation of blood coagulation|negative regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of NF-kappaB transcription factor activity|response to lipopolysaccharide|cellular response to oxidative stress|T cell proliferation|hydrogen peroxide metabolic process|hydrogen peroxide catabolic process|regulation of apoptotic process|negative regulation of T cell differentiation|thymus development|homeostasis of number of cells|oxidation-reduction process|negative regulation of reactive oxygen species metabolic process|negative regulation of extrinsic apoptotic signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,peroxidase activity|protein binding|thioredoxin peroxidase activity|selenium binding|antioxidant activity|,7,9,725000000,39.3%
Q769J6,0.00117386,-0.403666667,30.68496934,2.758,8.54089e-4,5.359338129,-2.634,-1.901,-0.813,0.913,1.124,0.889,Q769J6,Adamts13,Q769J6_Adamts13,Q769J6,Adamts13,1,16,7,7,Q769J6|A2ALB3,MOUSE,160032.5,7,293,293.1,76.43,76.43,,1426,A disintegrin and metalloproteinase with thrombospondin motifs 13,proteinaceous extracellular matrix|extracellular space|,proteolysis|blood coagulation|response to toxic substance|response to interferon-gamma|response to tumor necrosis factor|peptide catabolic process|response to interleukin-4|,endopeptidase activity|metalloendopeptidase activity|zinc ion binding|,7,16,165000000,7.0%
G3U9,0.002078288,-1.369666667,27.98722121,4.853333333,0.001589563,5.012113608,-2.785,-2.417,-6.187,1.233,0.938,1,G3U9,NotFound,G3U9_NotFound,G3U9,Atf6b,1,16,6,6,G3U9|A0A0A0MQ69|O35451,MOUSE,77389.6,12.1,294,294.1,75.17,75.17,,709,Cyclic AMP-dependent transcription factor ATF-6 beta,intracellular|nucleus|endoplasmic reticulum membrane|protein-DNA complex|,endoplasmic reticulum unfolded protein response|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|,sequence-specific DNA binding transcription factor activity|cAMP response element binding|sequence-specific DNA binding|transcription regulatory region DNA binding|,6,16,370000000,12.1%
A0A075B5S9,1.27982e-4,-0.8535,43.98717882,4.374333333,3.99284e-5,8.581310754,-2.861,-2.598,-3.663,0.949,2.166,0.886,A0A075B5S9,NotFound,A0A075B5S9_NotFound,A0A075B5S9,Ighv9-4,1,16,6,5,A0A075B5S9|A0A0B4J1J4|A0A075B5S1,MOUSE,11048.3,60.2,295,295.1,74.36,54.63,,98,Immunoglobulin heavy variable 9-4,,,,7,16,820000000,60.2%
Q8CBR6,0.001295084,-0.796333333,30.23044663,3.386666667,9.48321e-4,5.267589078,-2.306,-1.301,-3.862,1.033,0.922,0.736,Q8CBR6,Tsku,Q8CBR6_Tsku,Q8CBR6,Tsku,1,12,4,4,Q8CBR6,MOUSE,38760.8,16.6,296,296.1,74.15,74.15,,354,Tsukushin,extracellular space|,regulation of gene expression|corpus callosum morphogenesis|lateral ventricle development|anterior commissure morphogenesis|negative regulation of Wnt signaling pathway|camera-type eye development|ciliary body morphogenesis|,protein binding|,4,12,207000000,16.6%
O88325,7.45726e-4,-1.168166667,32.86167597,4.233666667,5.17407e-4,5.921600622,-2.941,-2.008,-4.906,0.944,0.982,0.92,O88325,Naglu,O88325_Naglu,O88325,Naglu,1,11,6,6,O88325,MOUSE,83165.4,11.5,297,297.1,74.03,74.03,,739,Alpha-N-acetylglucosaminidase,extracellular exosome|,lysosome organization|cerebellar Purkinje cell layer development|middle ear morphogenesis|locomotor rhythm|retinal rod cell development|inner ear receptor cell development|,,6,11,93900000,11.5%
E9QP56,3.06476e-4,-0.793333333,37.59763796,4.246666667,1.73875e-4,6.891493839,-2.884,-1.805,-4.061,1.756,1.417,0.817,E9QP56,Apoc3,E9QP56_Apoc3,E9QP56,Apoc3,1,46,4,4,E9QP56|P33622|A0A0R4J1N3,MOUSE,15162.8,36.4,298,298.1,72.24,72.24,,137,Apolipoprotein C-III,extracellular region|,triglyceride metabolic process|triglyceride mobilization|lipid transport|cholesterol metabolic process|triglyceride catabolic process|lipoprotein metabolic process|,lipid binding|,4,46,37200000000,36.4%
Q9Z1T2,0.00398198,-1.723333333,24.98203496,5.793333333,0.003175386,4.41480579,-2.958,-2.955,-7.947,0.979,1.574,0.967,Q9Z1T2,Thbs4,Q9Z1T2_Thbs4,Q9Z1T2,Thbs4,1,7,5,4,Q9Z1T2,MOUSE,109046.1,7.5,299,299.1,71.9,53.91,,963,Thrombospondin-4,basement membrane|extracellular space|endoplasmic reticulum|sarcoplasmic reticulum|extracellular matrix|extracellular exosome|,positive regulation of endothelial cell proliferation|response to unfolded protein|negative regulation of angiogenesis|regulation of tissue remodeling|response to endoplasmic reticulum stress|behavioral response to pain|tissue remodeling|positive regulation of peptidyl-tyrosine phosphorylation|myoblast migration|positive regulation of cell division|endothelial cell-cell adhesion|positive regulation of neutrophil chemotaxis|,integrin binding|calcium ion binding|protein binding|growth factor activity|heparin binding|,5,7,1010000000,7.5%
E9QP,1.0426e-4,-0.8865,46.95974693,3.844333333,2.01384e-5,9.47621553,-2.635,-2.399,-3.392,1.177,1.07,0.86,E9QP,Col18a1,E9QP_Col18a1,E9QP,Col18a1,1,20,5,5,E9QP|P39061|P39061-1|P39061-2,MOUSE,183320.5,3.4,300,300.1,71.8,71.8,,1774,Collagen alpha-1(XVIII) chain,collagen trimer|basement membrane|extracellular space|extracellular matrix|extracellular exosome|extracellular matrix|,angiogenesis|endothelial cell morphogenesis|cell adhesion|positive regulation of cell proliferation|extracellular matrix organization|positive regulation of cell migration|positive regulation of endothelial cell apoptotic process|,structural molecule activity|identical protein binding|,5,20,2920000000,3.4%
A0A075B5N7,1.0426e-4,-0.978666667,52.93835467,4.302,5.08352e-6,11.52508708,-3.467,-2.773,-3.149,0.964,1.252,1.301,A0A075B5N7,NotFound,A0A075B5N7_NotFound,A0A075B5N7,Igkv6-13,1,32,6,3,A0A075B5N7|A0A140T8P1,MOUSE,10554.5,56.8,302,302.1,69.71,39.67,,95,Immunoglobulin kappa variable 6-13,,,,7,32,10200000000,56.8%
Q9EPS3,1.0426e-4,-0.918333333,52.21822913,3.949333333,6.00036e-6,11.25901513,-3.044,-2.706,-2.929,1.263,0.92,0.986,Q9EPS3,Glce,Q9EPS3_Glce,Q9EPS3,Glce,1,12,7,7,Q9EPS3,MOUSE,70429.9,12.7,303,303.1,69.55,69.55,,618,D-glucuronyl C5-epimerase,Golgi membrane|Golgi apparatus|integral component of membrane|,heparan sulfate proteoglycan biosynthetic process|heparin biosynthetic process|,"racemase and epimerase activity, acting on carbohydrates and derivatives|heparosan-N-sulfate-glucuronate 5-epimerase activity|UDP-glucuronate 5'-epimerase activity|",7,12,78700000,12.7%
Q9R182,1.34728e-4,-1.001333333,43.32228383,4.071333333,4.65341e-5,8.39122329,-3.684,-3.306,-2.121,0.968,1.22,0.915,Q9R182,Angptl3,Q9R182_Angptl3,Q9R182,Angptl3,1,15,6,6,Q9R182,MOUSE,52770.3,15.3,304,304.1,69.55,69.55,,455,Angiopoietin-related protein 3,extracellular region|extracellular space|early endosome|Golgi apparatus|cell surface|,glycerol metabolic process|fatty acid metabolic process|triglyceride metabolic process|phospholipid metabolic process|cell-matrix adhesion|signal transduction|cholesterol metabolic process|phospholipid catabolic process|response to hormone|negative regulation of phospholipase activity|lipid storage|positive regulation of cell migration|cholesterol homeostasis|positive regulation of angiogenesis|positive regulation of lipid metabolic process|artery morphogenesis|positive regulation of lipid catabolic process|negative regulation of lipoprotein lipase activity|lipid homeostasis|acylglycerol homeostasis|phospholipid homeostasis|triglyceride homeostasis|,enzyme inhibitor activity|phospholipase inhibitor activity|integrin binding|growth factor activity|,6,15,815000000,15.3%
P09813,4.01427e-4,-0.9225,36.05710103,4.585,2.47908e-4,6.600061732,-2.683,-2.217,-4.745,1.786,1.498,0.826,P09813,Apoa2,P09813_Apoa2,P09813,Apoa2,1,33,4,4,P09813,MOUSE,11366,43.1,305,305.1,68.65,68.65,,102,Apolipoprotein A-II,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|,acute inflammatory response|negative regulation of cytokine secretion involved in immune response|protein folding|fatty acid metabolic process|phosphatidylcholine biosynthetic process|lipid transport|cholesterol metabolic process|phospholipid catabolic process|response to glucose|positive regulation of cholesterol esterification|negative regulation of very-low-density lipoprotein particle remodeling|beta-glucoside transport|protein oxidation|peptidyl-methionine modification|regulation of intestinal cholesterol absorption|organ regeneration|regulation of protein stability|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|high-density lipoprotein particle clearance|lipoprotein metabolic process|response to drug|cholesterol homeostasis|positive regulation of catalytic activity|response to estrogen|reverse cholesterol transport|positive regulation of interleukin-8 biosynthetic process|diacylglycerol catabolic process|negative regulation of lipid catabolic process|positive regulation of lipid catabolic process|response to glucocorticoid|negative regulation of lipase activity|negative regulation of cholesterol import|negative regulation of cholesterol transporter activity|,lipid transporter activity|phospholipid binding|high-density lipoprotein particle binding|lipid binding|cholesterol binding|phosphatidylcholine binding|apolipoprotein receptor binding|protein homodimerization activity|protein heterodimerization activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|cholesterol transporter activity|,4,33,75100000000,43.1%
Q9WUU7,1.0426e-4,-1.0425,48.9482296,4.544333333,1.27402e-5,10.11869758,-3.502,-2.602,-3.84,1.451,1.357,0.881,Q9WUU7,Ctsz,Q9WUU7_Ctsz,Q9WUU7,Ctsz,1,22,6,6,Q9WUU7,MOUSE,34680.3,18.9,307,307.1,68.03,68.03,,306,Cathepsin Z,extracellular space|lysosome|endoplasmic reticulum|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis involved in cellular protein catabolic process|epithelial tube branching involved in lung morphogenesis|,cysteine-type endopeptidase activity|,6,22,1790000000,18.9%
Q04592,1.50949e-4,-0.5595,42.37967421,2.922333333,5.78139e-5,8.127731018,-2.29,-2.038,-1.734,1.058,0.782,0.865,Q04592,Pcsk5,Q04592_Pcsk5,Q04592,Pcsk5,1,15,8,8,Q04592|Q04592-2,MOUSE,220321.6,4.8,310,310.1,67.23,67.23,,1877,Proprotein convertase subtilisin/kexin type 5,extracellular space|endoplasmic reticulum lumen|Golgi apparatus|integral component of membrane|secretory granule|,kidney development|renin secretion into blood stream|signal peptide processing|heart development|embryo implantation|anterior/posterior pattern specification|protein processing|peptide hormone processing|viral life cycle|respiratory tube development|limb morphogenesis|cytokine biosynthetic process|peptide biosynthetic process|embryonic digestive tract development|embryonic skeletal system development|,endopeptidase activity|serine-type endopeptidase activity|peptidase activity|peptide binding|,8,15,768000000,4.8%
O08742,2.59369e-4,-0.784333333,38.57316753,3.422,1.38894e-4,7.130805896,-2.95,-1.566,-2.97,1.028,0.79,0.962,O08742,NotFound,O08742_NotFound,O08742,Gp5,1,11,7,7,O08742,MOUSE,63980.2,10.5,312,312.1,66.65,66.65,,567,Platelet glycoprotein V,integral component of membrane|,cell adhesion|blood coagulation|,,7,11,9600000000,10.5%
Q09200,3.45278e-4,-0.570333333,36.89960914,3.005333333,2.04192e-4,6.724044407,-2.782,-2.043,-1.394,1.045,0.892,0.86,Q09200,B4galnt1,Q09200_B4galnt1,Q09200,B4galnt1,1,18,7,7,Q09200|A0A1W2P6F0,MOUSE,59610.2,12,313,313.1,66.51,66.51,,533,"Beta-1,4 N-acetylgalactosaminyltransferase 1",plasma membrane|integral component of Golgi membrane|,ganglioside biosynthetic process|protein glycosylation|glycosphingolipid metabolic process|spermatogenesis|lipid storage|lipid glycosylation|,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity|,7,18,269000000,12.0%
A0A075B5K2,2.07088e-4,-0.702,39.99789523,4.231333333,1.00048e-4,7.49183158,-2.26,-2.421,-3.772,1.198,2.181,0.862,A0A075B5K2,NotFound,A0A075B5K2_NotFound,A0A075B5K2,Igkv9-124,1,15,5,5,A0A075B5K2,MOUSE,10533.4,63.1,314,314.1,66.15,66.15,,95,Immunoglobulin kappa chain variable 9-124,,,,5,15,544000000,63.1%
Q6S5C2-2,2.19626e-4,-0.511166667,39.64324102,2.997666667,1.08562e-4,7.400651929,-2.591,-1.671,-1.768,1.209,0.872,0.882,Q6S5C2,Gnptg,Q6S5C2-2_Gnptg,Q6S5C2-2,Gnptg,1,9,5,5,Q6S5C2-2|A0A140T8R4|Q6S5C2|A0A0R4J0H5,MOUSE,35349.5,16.5,315,315.1,66.15,66.15,,307,Isoform 2 of N-acetylglucosamine-1-phosphotransferase subunit gamma,Golgi apparatus|extracellular exosome|,carbohydrate phosphorylation|,protein homodimerization activity|,5,9,560000000,16.5%
Q08879-2,4.70182e-4,-0.823,35.20575604,3.554666667,3.01595e-4,6.330302157,-2.026,-1.951,-3.824,1.089,0.859,0.915,Q08879,Fbln1,Q08879-2_Fbln1,Q08879-2,Fbln1,1,18,7,7,Q08879-2|Q08879,MOUSE,79390.4,10.8,316,316.1,65.28,65.28,,705,Isoform C of Fibulin-1,proteinaceous extracellular matrix|basement membrane|extracellular space|extracellular exosome|elastic fiber|fibrinogen complex|extracellular matrix|,"negative regulation of protein phosphorylation|negative regulation of cell adhesion|embryo implantation|positive regulation of gene expression|positive regulation of peptidase activity|extracellular matrix organization|positive regulation of fibroblast proliferation|negative regulation of ERK1 and ERK2 cascade|blood coagulation, fibrin clot formation|negative regulation of substrate adhesion-dependent cell spreading|negative regulation of transformation of host cell by virus|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of cell motility|negative regulation of stem cell proliferation|negative regulation of transforming growth factor-beta secretion|",fibronectin binding|integrin binding|extracellular matrix structural constituent|calcium ion binding|protein binding|protein C-terminus binding|peptidase activator activity|protein complex binding|identical protein binding|fibrinogen binding|,7,18,460000000,10.8%
Q8CG85,1.0426e-4,-0.893833333,47.90384623,3.932333333,1.62037e-5,9.776678855,-2.802,-2.371,-3.407,1,1.04,1.177,Q8CG85,Mamdc2,Q8CG85_Mamdc2,Q8CG85,Mamdc2,1,7,6,6,A0A0R4J0J7|Q8CG85,MOUSE,78406.9,9.3,317,317.1,64.38,64.38,,686,MAM domain-containing protein 2,proteinaceous extracellular matrix|interstitial matrix|endoplasmic reticulum|membrane|,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|,6,7,40700000,9.3%
P62983,0.067644599,-0.579,12.05583556,1.67,0.062289729,2.202072932,-1.687,0.276,-2.831,0.514,-0.005,0.259,P62983,Rps27a,P62983_Rps27a,P62983,Rps27a,1,16,7,7,P62983|P0CG50|P0CG49|P62984|A0A0A6YW67|E9QNP0|D3YYZ2,MOUSE,18292.9,44.8,318,318.1,64.13,64.13,,156,Ubiquitin-40S ribosomal protein S27a,nucleoplasm|nucleolus|cytoplasm|cytosol|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|myelin sheath|extracellular exosome|,translation|circadian rhythm|,structural constituent of ribosome|poly(A) RNA binding|metal ion binding|,7,16,219000000,44.8%
O09043,1.0426e-4,-1.251833333,49.79084722,4.825,1.04934e-5,10.40225792,-4.486,-3.173,-3.334,1.14,1.426,0.916,O09043,Napsa,O09043_Napsa,O09043,Napsa,1,15,4,4,O09043,MOUSE,45942.9,13.6,319,319.1,63.09,63.09,,419,Napsin-A,extracellular space|lysosome|extracellular exosome|alveolar lamellar body|,protein catabolic process|membrane protein proteolysis|surfactant homeostasis|,endopeptidase activity|aspartic-type endopeptidase activity|protein binding|peptidase activity|,4,15,854000000,13.6%
Q02596,1.0426e-4,-1.179666667,47.63487073,4.442666667,1.7239e-5,9.690245778,-3.769,-2.583,-3.851,1.291,0.9,0.934,Q02596,Glycam1,Q02596_Glycam1,Q02596,Glycam1,1,7,4,4,Q02596,MOUSE,16208.6,29.1,320,320.1,62.95,62.95,,151,Glycosylation-dependent cell adhesion molecule 1,extracellular region|plasma membrane|,cell adhesion|,sulfate binding|cell adhesion molecule binding|,4,7,576000000,29.1%
Q62351,1.74821e-4,-1.050833333,41.36186978,4.011666667,7.30824e-5,7.850871737,-3.219,-2.074,-3.877,0.943,1.014,0.908,Q62351,Tfrc,Q62351_Tfrc,Q62351,Tfrc,1,10,7,7,Q62351|Q8C872,MOUSE,86129.2,9.3,322,322.1,61.04,61.04,,763,Transferrin receptor protein 1,extracellular region|extracellular space|mitochondrion|endosome|plasma membrane|coated pit|external side of plasma membrane|cell surface|membrane|integral component of membrane|cytoplasmic membrane-bounded vesicle|melanosome|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|recycling endosome|recycling endosome membrane|extracellular exosome|blood microparticle|extracellular vesicle|HFE-transferrin receptor complex|,response to hypoxia|cellular iron ion homeostasis|receptor-mediated endocytosis|acute-phase response|aging|response to nutrient|response to manganese ion|osteoclast differentiation|cellular response to extracellular stimulus|response to retinoic acid|transferrin transport|iron ion transmembrane transport|cellular response to drug|positive regulation of bone resorption|response to copper ion|cellular response to iron ion|iron ion import|,glycoprotein binding|double-stranded RNA binding|transferrin receptor activity|iron ion transmembrane transporter activity|protein binding|Hsp70 protein binding|transferrin transmembrane transporter activity|identical protein binding|poly(A) RNA binding|chaperone binding|,7,10,310000000,9.3%
A0A075B5K0,1.41391e-4,-0.5465,42.94988213,3.959666667,5.07004e-5,8.286294468,-3.095,-2.192,-2.292,1.267,2.138,0.895,A0A075B5K0,NotFound,A0A075B5K0_NotFound,A0A075B5K0,Igkv14-126,1,37,4,2,A0A075B5K0|P01637,MOUSE,13228.7,41.8,323,323.1,60.63,37.43,,117,Immunoglobulin kappa variable 14-126 (Fragment),,,,5,37,15000000000,41.8%
Q6P542,0.011789794,-0.2235,19.93842502,1.388333333,0.010142792,3.416797116,-1.439,-0.861,-0.453,0.308,0.371,0.733,Q6P542,Abcf1,Q6P542_Abcf1,Q6P542,Abcf1,1,8,6,6,Q6P542,MOUSE,95400.1,6.2,326,326.1,59.23,59.23,,837,ATP-binding cassette sub-family F member 1,nuclear envelope|nucleoplasm|cytoplasm|membrane|polysomal ribosome|,translational initiation|positive regulation of translation|ribosome biogenesis|,ATP binding|translation activator activity|ATPase activity|ribosome binding|poly(A) RNA binding|,6,8,180000000,6.2%
Q9Z2L6,1.11935e-4,-1.249333333,45.20768694,4.726666667,3.01461e-5,8.939643301,-3.266,-2.911,-4.661,1.444,0.984,0.914,Q9Z2L6,Minpp1,Q9Z2L6_Minpp1,Q9Z2L6,Minpp1,1,10,5,5,Q9Z2L6,MOUSE,55164,11.6,327,327.1,58.66,58.66,,481,Multiple inositol polyphosphate phosphatase 1,endoplasmic reticulum lumen|plasma membrane|extracellular exosome|,dephosphorylation|,acid phosphatase activity|bisphosphoglycerate 3-phosphatase activity|inositol hexakisphosphate 2-phosphatase activity|,5,10,79400000,11.6%
Q3UFC6,2.54817e-4,-0.899333333,38.67191722,4.194,1.35771e-4,7.155382225,-2.787,-2.076,-4.126,1.059,0.821,1.713,Q3UFC6,Dsg3,Q3UFC6_Dsg3,Q3UFC6,Dsg3,1,11,6,6,Q3UFC6|O35902|O35902-2,MOUSE,109212.9,8.3,329,329.1,58.28,58.28,,993,Desmoglein-3,plasma membrane|integral component of membrane|extracellular exosome|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|,6,11,368000000,8.3%
A0A140T8P6,7.21107e-4,-1.3725,33.03671567,4.741,4.96968e-4,5.963910067,-3.727,-2.068,-5.434,1.099,1,0.895,A0A140T8P6,NotFound,A0A140T8P6_NotFound,A0A140T8P6,Igkv12-46,1,27,3,3,A0A140T8P6,MOUSE,12733.1,40.8,331,331.1,57.85,57.85,,115,Immunoglobulin kappa variable 12-46 (Fragment),,,,3,27,1850000000,40.8%
Q6T5E4,9.51723e-4,-1.328666667,31.6873127,5.013333333,6.78061e-4,5.746545864,-2.919,-2.632,-5.955,1.489,1.148,0.897,Q6T5E4,Gcnt2,Q6T5E4_Gcnt2,Q6T5E4,Gcnt2,1,7,5,5,Q6T5E4,MOUSE,46854.9,13.2,332,332.1,57.09,57.09,,401,"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme",membrane|,protein glycosylation|transforming growth factor beta receptor signaling pathway|posttranscriptional regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|positive regulation of cell migration|positive regulation of heterotypic cell-cell adhesion|maintenance of lens transparency|positive regulation of protein kinase B signaling|positive regulation of ERK1 and ERK2 cascade|,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity|",5,7,95600000,13.2%
A0A0A6YYE7,0.00398198,-0.831,24.98234711,4.116,0.003175158,4.41486559,-2.68,-1.03,-4.957,0.978,1.584,1.119,A0A0A6YYE7,NotFound,A0A0A6YYE7_NotFound,A0A0A6YYE7,Igkv4-57,1,13,3,3,A0A0A6YYE7|A0A075B5M4|A0A0B4J1I4|A0A0B4J1I3|A0A0A6YYE5|A0A075B5L8,MOUSE,12803.3,39.3,333,333.1,57.01,42.86,,117,Immunoglobulin kappa variable 4-57 (Fragment),,,,4,13,2260000000,39.3%
Q8BM72,1.24337e-4,-0.6455,44.26091283,3.654333333,3.74894e-5,8.660607014,-3.101,-2.278,-2.039,1.401,1.227,0.917,Q8BM72,Hspa13,Q8BM72_Hspa13,Q8BM72,Hspa13,1,12,5,5,Q8BM72|D3Z0Y0|Q8BM72-2,MOUSE,51765.4,10.8,335,335.1,56.35,56.35,,471,Heat shock 70 kDa protein 13,endoplasmic reticulum|extracellular exosome|,,ATP binding|,5,12,198000000,10.8%
Q62178,1.0426e-4,-0.789666667,50.13851627,4.308666667,9.68609e-6,10.52128855,-3.223,-2.507,-3.102,1.557,1.64,0.897,Q62178,Sema4a,Q62178_Sema4a,Q62178,Sema4a,1,9,5,5,Q62178|D3YWV5,MOUSE,84389.1,7.1,336,336.1,55.99,55.99,,760,Semaphorin-4A,plasma membrane|integral component of membrane|,angiogenesis|T cell differentiation involved in immune response|axonogenesis|regulation of cell shape|regulation of endothelial cell migration|negative regulation of angiogenesis|T-helper 1 cell differentiation|semaphorin-plexin signaling pathway|,,5,9,108000000,7.1%
A0A1Y7VJX7,1.54772e-4,-0.575333333,42.14219145,3.874,6.10634e-5,8.062430916,-2.004,-2.303,-3.23,1.444,0.818,1.823,A0A1Y7VJX7,NotFound,A0A1Y7VJX7_NotFound,A0A1Y7VJX7,Ighe,1,9,5,5,A0A1Y7VJX7|P06336,MOUSE,55752.3,13.7,337,337.1,55.96,55.96,,486,Immunoglobulin heavy constant epsilon (Fragment),,,,5,9,334000000,13.7%
Q9D1Q6,0.004860244,-1.7675,24.07229027,5.537,0.003915353,4.242362405,-3.373,-2.417,-7.818,1.13,1.015,0.858,Q9D1Q6,Erp44,Q9D1Q6_Erp44,Q9D1Q6,Erp44,1,10,5,5,Q9D1Q6,MOUSE,47251.5,11,338,338.1,55.78,55.78,,406,Endoplasmic reticulum resident protein 44,endoplasmic reticulum lumen|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|cell surface|extracellular exosome|,protein folding|response to unfolded protein|glycoprotein metabolic process|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|protein binding|,5,10,223000000,11.0%
A0A075B680,8.40727e-4,-0.4905,32.26865641,3.483,5.93109e-4,5.687054167,-3.323,-2.266,-1.107,0.922,1.82,1.011,A0A075B680,NotFound,A0A075B680_NotFound,A0A075B680,Ighv1-62-2,1,12,5,3,A0A075B680|A0A0G2JFL3,MOUSE,11338.5,53,339,339.1,54.86,38.72,,100,Immunoglobulin heavy variable 1-62-2,,,,5,12,3010000000,53.0%
Q922Q9,8.50293e-4,-0.560333333,32.21235871,3.118666667,6.00847e-4,5.67518412,-1.443,-1.65,-3.266,1.236,0.72,1.041,Q922Q9,Chid1,Q922Q9_Chid1,Q922Q9,Chid1,1,9,6,6,A0A0R4J242|Q922Q9|A0A0R4J058|Q922Q9-2|A0A1B0GSH5,MOUSE,45075.9,12.2,340,340.1,54.69,54.69,,393,Chitinase domain-containing protein 1,extracellular region|extracellular space|nucleus|lysosome|late endosome|trans-Golgi network|membrane|extracellular exosome|,carbohydrate metabolic process|chitin catabolic process|innate immune response|negative regulation of cytokine production involved in inflammatory response|,chitinase activity|chitin binding|oligosaccharide binding|,6,9,539000000,12.2%
Q9EQ21,1.95315e-4,-0.912333333,40.62972151,4.292666667,8.65023e-5,7.656476581,-2.934,-2.131,-4.111,1.618,1.218,0.866,Q9EQ21,Hamp,Q9EQ21_Hamp,Q9EQ21,Hamp,1,22,3,2,Q9EQ21,MOUSE,9865.4,45.7,341,341.1,54.27,42.54,,83,Hepcidin,extracellular region|extracellular space|nucleus|,negative regulation of transcription from RNA polymerase II promoter|myeloid cell homeostasis|cellular iron ion homeostasis|JAK-STAT cascade|cellular response to extracellular stimulus|membrane protein proteolysis|negative regulation of iron ion transmembrane transport|defense response to bacterium|positive regulation of macrophage activation|negative regulation of bone resorption|positive regulation of transcription from RNA polymerase II promoter|negative regulation of inflammatory response|defense response to fungus|iron ion homeostasis|cellular response to iron ion|positive regulation of cellular protein catabolic process|,hormone activity|copper ion binding|,3,22,774000000,45.7%
E9Q0F0,0.083955845,-0.841333333,11.0902916,2.229333333,0.077798431,2.068362864,-0.828,-0.387,-4.653,0.28,0.197,0.343,E9Q0F0,Krt78,E9Q0F0_Krt78,E9Q0F0,Krt78,1,34,3,3,E9Q0F0,MOUSE,114088.5,1.9,344,344.1,53.5,53.5,,1068,Keratin 78,extracellular space|keratin filament|extracellular exosome|,,structural molecule activity|,3,34,40100000000,1.9%
A0A140T8N3,1.0426e-4,-1.197,54.25699797,4.666666667,3.75232e-6,12.02711663,-3.927,-3.103,-3.561,0.914,1.343,1.152,A0A140T8N3,NotFound,A0A140T8N3_NotFound,A0A140T8N3,Igkv13-84,1,14,4,4,A0A140T8N3|A0A075B666,MOUSE,12788.3,37.3,345,345.1,53.07,53.07,,115,Immunoglobulin kappa chain variable 13-84 (Fragment),,,,4,14,2490000000,37.3%
Q8CAR0,2.88036e-4,-1.269833333,37.96940159,4.511666667,1.5961e-4,6.981955637,-2.813,-2.731,-5.033,1.051,1,0.907,Q8CAR0,Igf1,Q8CAR0_Igf1,Q8CAR0,Igf1,1,15,4,4,Q8CAR0|Q4VJB9|P05017-2|P05017|E9PU89|E9Q138,MOUSE,18872.4,25.4,346,346.1,52.96,52.96,,165,Insulin-like growth factor I,extracellular space|intracellular|insulin-like growth factor ternary complex|,"cell activation|regulation of protein phosphorylation|blood vessel remodeling|nervous system development|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|response to heat|glial cell differentiation|regulation of gene expression|positive regulation of glycoprotein biosynthetic process|positive regulation of cardiac muscle hypertrophy|phosphatidylinositol 3-kinase signaling|positive regulation of phosphatidylinositol 3-kinase signaling|skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration|muscle hypertrophy|myotube cell development|positive regulation of smooth muscle cell migration|positive regulation of cerebellar granule cell precursor proliferation|water homeostasis|proteoglycan biosynthetic process|lung development|positive regulation of cell migration|mammary gland development|exocrine pancreas development|regulation of establishment or maintenance of cell polarity|positive regulation of protein import into nucleus, translocation|negative regulation of smooth muscle cell apoptotic process|multicellular organism growth|bone mineralization involved in bone maturation|regulation of multicellular organism growth|positive regulation of activated T cell proliferation|positive regulation of tyrosine phosphorylation of Stat5 protein|negative regulation of apoptotic process|positive regulation of DNA binding|positive regulation of MAPK cascade|protein kinase B signaling|positive regulation of insulin-like growth factor receptor signaling pathway|myoblast differentiation|positive regulation of osteoblast differentiation|positive regulation of glycogen biosynthetic process|positive regulation of DNA replication|positive regulation of glycolytic process|positive regulation of mitotic nuclear division|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of glucose import|positive regulation of Ras protein signal transduction|insulin-like growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of fibroblast proliferation|lung alveolus development|cell development|positive regulation of smooth muscle cell proliferation|branching morphogenesis of an epithelial tube|inner ear development|chondroitin sulfate proteoglycan biosynthetic process|positive regulation of epithelial cell proliferation|positive regulation of protein secretion|positive regulation of peptidyl-tyrosine phosphorylation|protein stabilization|regulation of protein metabolic process|myoblast proliferation|positive regulation of protein kinase B signaling|negative regulation of oocyte development|lung vasculature development|lung lobe morphogenesis|Type I pneumocyte differentiation|Type II pneumocyte differentiation|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis|prostate gland growth|prostate gland epithelium morphogenesis|prostate gland stromal morphogenesis|negative regulation of androgen receptor signaling pathway|ERK1 and ERK2 cascade|negative regulation of ERK1 and ERK2 cascade|positive regulation of calcineurin-NFAT signaling cascade|extrinsic apoptotic signaling pathway in absence of ligand|positive regulation of trophectodermal cell proliferation|positive regulation of myoblast proliferation|negative regulation of extrinsic apoptotic signaling pathway|",insulin receptor binding|insulin-like growth factor receptor binding|integrin binding|hormone activity|protein binding|growth factor activity|,4,15,1120000000,25.4%
A0A087WPN7,1.72052e-4,-0.670833333,41.45664103,3.863666667,7.15049e-5,7.876322822,-3.281,-2.747,-1.78,0.921,1.666,1.196,A0A087WPN7,NotFound,A0A087WPN7_NotFound,A0A087WPN7,Ighv13-2,1,16,4,4,A0A087WPN7,MOUSE,11456.7,44,348,348.1,52.57,52.57,,100,Immunoglobulin heavy variable 13-2,,,,4,16,779000000,44.0%
O35622,1.0426e-4,-1.217333333,48.54594624,4.438,1.39767e-5,9.985735967,-4.018,-2.695,-3.596,1.172,0.949,0.884,O35622,Fgf15,O35622_Fgf15,O35622,Fgf15,1,10,5,5,O35622,MOUSE,25520.6,26.6,349,349.1,52.37,52.37,,218,Fibroblast growth factor 15,extracellular region|,neural crest cell migration|positive regulation of protein phosphorylation|heart development|positive regulation of cell proliferation|fibroblast growth factor receptor signaling pathway|negative regulation of gene expression|positive regulation of glucose import|positive regulation of JNK cascade|positive regulation of ERK1 and ERK2 cascade|negative regulation of bile acid biosynthetic process|,fibroblast growth factor receptor binding|growth factor activity|,5,10,219000000,26.6%
A0A075B5R9,2.46685e-4,-0.739333333,38.87674073,3.418666667,1.29517e-4,7.206566967,-3.354,-2.087,-1.905,1.075,0.87,0.965,A0A075B5R9,NotFound,A0A075B5R9_NotFound,A0A075B5R9,Ighv14-3,1,12,4,2,A0A075B5R9|A0A075B5R4|A0A075B5S3,MOUSE,13088.7,31.6,350,350.1,52.3,27.75,,117,Immunoglobulin heavy variable V14-3 (Fragment),,,,4,12,1030000000,31.6%
P01675,1.0426e-4,-0.8005,47.19491137,4.381666667,1.90769e-5,9.550298763,-3.693,-2.673,-2.608,0.933,1.777,1.461,P01675,NotFound,P01675_NotFound,P01675,,1,16,4,4,P01675|P01676|P01677|P01678|P01679|A0A075B5L5,MOUSE,11741,36.4,351,351.1,51.39,51.39,,107,Ig kappa chain V-VI region XRPC 44,,,antigen binding|,4,16,3990000000,36.4%
Q60805,9.4532e-4,-1.284833333,31.72372882,4.753,6.72399e-4,5.694276817,-2.952,-2.352,-5.68,1.158,1.234,0.883,Q60805,Mertk,Q60805_Mertk,Q60805,Mertk,1,12,6,6,Q60805,MOUSE,111239.5,4.6,352,352.1,51.09,51.09,,994,Tyrosine-protein kinase Mer,photoreceptor outer segment|extracellular space|cytoplasm|integral component of membrane|rhabdomere|,natural killer cell differentiation|phagocytosis|spermatogenesis|peptidyl-tyrosine phosphorylation|platelet activation|secretion by cell|substrate adhesion-dependent cell spreading|apoptotic cell clearance|protein kinase B signaling|positive regulation of phagocytosis|negative regulation of lymphocyte activation|retina development in camera-type eye|vagina development|negative regulation of leukocyte apoptotic process|,transmembrane receptor protein tyrosine kinase activity|ATP binding|,6,12,243000000,4.6%
O08807,3.35582e-4,-1.6345,37.08356611,5.454333333,1.95724e-4,6.915945145,-4.721,-2.543,-5.821,1.141,0.991,1.146,O08807,Prdx4,O08807_Prdx4,O08807,Prdx4,1,4,4,2,O08807,MOUSE,31280.1,16,353,353.2,44.57,21.96,,274,Peroxiredoxin-4,extracellular space|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|smooth endoplasmic reticulum|cytosol|extracellular exosome|,spermatogenesis|male gonad development|4-hydroxyproline metabolic process|protein maturation by protein folding|extracellular matrix organization|cell redox homeostasis|oxidation-reduction process|reactive oxygen species metabolic process|negative regulation of male germ cell proliferation|,peroxidase activity|protein homodimerization activity|peroxiredoxin activity|,2,4,18300000000,9.1%
A0A075B5M3,0.001833995,-1.555333333,28.60362593,5.756666667,0.001379232,5.140307604,-3.653,-2.567,-7.081,0.95,2.088,0.931,A0A075B5M3,NotFound,A0A075B5M3_NotFound,A0A075B5M3,Igkv4-58,1,17,4,3,A0A075B5M3|P01680|A0A075B5L2,MOUSE,10407.3,40.2,355,355.1,49.99,33.19,,97,Immunoglobulin kappa variable 4-58,,,,4,17,3950000000,40.2%
A0A0A6YXQ0,1.0426e-4,-1.098333333,51.27017881,4.271333333,7.46418e-6,10.91716671,-3.659,-2.713,-3.33,1.026,1.048,1.038,A0A0A6YXQ0,NotFound,A0A0A6YXQ0_NotFound,A0A0A6YXQ0,Ighv8-8,1,21,4,4,A0A0A6YXQ0,MOUSE,13299,26,357,357.1,49.33,49.33,,119,Immunoglobulin heavy variable 8-8 (Fragment),,,,4,21,3540000000,26.0%
G5E8D6,2.85081e-4,-0.411666667,38.08671628,2.784666667,1.55356e-4,7.010689359,-2.309,-1.332,-1.771,1.133,0.891,0.918,G5E8D6,Efemp2,G5E8D6_Efemp2,G5E8D6,Efemp2,1,15,4,4,G5E8D6|Q9WVJ9|E9Q3N9,MOUSE,53745,8.6,358,358.1,49.21,49.21,,462,EGF-containing fibulin-like extracellular matrix protein 2,proteinaceous extracellular matrix|extracellular exosome|extracellular vesicle|,,calcium ion binding|,4,15,1920000000,8.6%
P35454,1.0426e-4,-0.742333333,47.25186959,3.64,1.88284e-5,9.568317335,-2.121,-2.66,-2.906,1.235,1.064,0.934,P35454,Oxt,P35454_Oxt,P35454,Oxt,1,8,3,3,P35454|P35455,MOUSE,13934.7,36.8,360,360.1,48.18,48.18,,125,Oxytocin-neurophysin 1,extracellular region|extracellular space|cytoplasm|cytosol|secretory granule|terminal bouton|,response to amphetamine|regulation of heart rate|maternal aggressive behavior|positive regulation of cytosolic calcium ion concentration|heart development|female pregnancy|memory|grooming behavior|response to mechanical stimulus|response to sucrose|positive regulation of norepinephrine secretion|response to activity|sleep|response to food|positive regulation of prostaglandin secretion|response to estradiol|response to retinoic acid|response to progesterone|response to prostaglandin E|social behavior|negative regulation of urine volume|positive regulation of renal sodium excretion|response to cocaine|hyperosmotic salinity response|maternal behavior|sperm ejaculation|eating behavior|drinking behavior|response to external biotic stimulus|response to peptide hormone|response to ether|negative regulation of blood pressure|positive regulation of blood pressure|positive regulation of ossification|positive regulation of female receptivity|positive regulation of synaptic transmission|response to glucocorticoid|response to cAMP|response to electrical stimulus|regulation of sensory perception of pain|positive regulation of synapse assembly|male mating behavior|positive regulation of penile erection|positive regulation of hindgut contraction|negative regulation of gastric acid secretion|positive regulation of uterine smooth muscle contraction|,neurohypophyseal hormone activity|oxytocin receptor binding|,3,8,32000000,36.8%
A0A075B5R1,1.05478e-4,-0.943666667,46.10930165,4.566666667,2.44946e-5,9.212420219,-3.35,-2.443,-3.888,1.215,1.854,0.95,A0A075B5R1,NotFound,A0A075B5R1_NotFound,A0A075B5R1,Ighv5-17,1,10,3,2,A0A075B5R1|P18529|P18527,MOUSE,13075.8,35,361,361.1,48.09,33.47,,117,Immunoglobulin heavy variable 5-17 (Fragment),,,,4,10,670000000,35.0%
P18526,0.001130848,-0.349666667,30.86100998,3.574,8.20161e-4,5.395144071,-2.724,-2.965,-0.721,0.833,1.936,1.543,P18526,NotFound,P18526_NotFound,P18526,,1,6,3,2,P18526|A0A075B5Q0,MOUSE,13072.8,23.9,361,361.4,36.05,19.08,,117,Ig heavy chain V region 345,,,antigen binding|,2,6,246000000,9.4%
P15116,2.19626e-4,-1.3515,39.639202,4.843,1.08663e-4,7.399618585,-3.621,-2.53,-5.168,1.188,1.074,0.948,P15116,Cdh2,P15116_Cdh2,P15116,Cdh2,1,10,4,4,P15116|D3YYT0,MOUSE,100251,6.4,363,363.1,47.34,47.34,,906,Cadherin-2,cell-cell junction|adherens junction|cell-cell adherens junction|fascia adherens|focal adhesion|intercalated disc|membrane|integral component of membrane|basolateral plasma membrane|apical plasma membrane|catenin complex|lamellipodium|plasma membrane raft|synapse|extracellular exosome|cortical actin cytoskeleton|,cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|glial cell differentiation|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cell migration|regulation of myelination|regulation of Rho protein signal transduction|positive regulation of MAPK cascade|cell-cell adhesion mediated by cadherin|blood vessel morphogenesis|regulation of axonogenesis|striated muscle cell differentiation|protein heterooligomerization|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|neuroligin clustering involved in postsynaptic membrane assembly|neuronal stem cell maintenance|regulation of postsynaptic density protein 95 clustering|positive regulation of synaptic vesicle clustering|,calcium ion binding|protein binding|beta-catenin binding|enzyme binding|protein kinase binding|protein phosphatase binding|protein complex binding|alpha-catenin binding|gamma-catenin binding|nitric-oxide synthase binding|,4,10,187000000,6.4%
P47857-3,0.006352878,-0.9875,22.82217928,3.219666667,0.005221341,3.953151973,-3.333,-0.654,-3.805,0.955,0.285,0.627,P47857,Pfkm,P47857-3_Pfkm,P47857-3,Pfkm,1,4,3,2,P47857-3|P47857-2|P47857,MOUSE,103523.5,3.6,365,365.2,26.51,14.91,,780,"Isoform 3 of ATP-dependent 6-phosphofructokinase, muscle type",cytosol|6-phosphofructokinase complex|apical plasma membrane|extracellular exosome|sperm principal piece|,fructose 6-phosphate metabolic process|glycolytic process|positive regulation of insulin secretion|glucose homeostasis|muscle cell cellular homeostasis|carbohydrate phosphorylation|protein oligomerization|glycolytic process through fructose-6-phosphate|,6-phosphofructokinase activity|protein binding|ATP binding|protein C-terminus binding|phosphofructokinase activity|kinase binding|identical protein binding|protein homodimerization activity|metal ion binding|fructose binding|,2,4,9120000,2.6%
Q8CF98,1.24757e-4,-0.842833333,44.21286462,3.877666667,3.79065e-5,8.646643969,-3.387,-2.922,-2.036,1.126,1.248,0.914,Q8CF98,Colec10,Q8CF98_Colec10,Q8CF98,Colec10,1,16,4,4,Q8CF98,MOUSE,30922.6,15.1,367,367.1,46.6,46.6,,277,Collectin-10,extracellular region|collagen trimer|nucleus|cytoplasm|cytosol|,defense response|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|embryo development|,mannose binding|,4,16,476000000,15.1%
Q9EPL0,3.66377e-4,-0.807333333,36.56574403,3.573333333,2.20509e-4,6.645043197,-3.069,-1.47,-3.243,1.135,0.763,1.04,Q9EPL0,Xylt2,Q9EPL0_Xylt2,Q9EPL0,Xylt2,1,5,5,5,Q9EPL0|F2Z436,MOUSE,97608.3,7.2,368,368.1,46.03,46.03,,865,Xylosyltransferase 2,Golgi membrane|endoplasmic reticulum membrane|integral component of membrane|,glycosaminoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process|proteoglycan biosynthetic process|chondroitin sulfate biosynthetic process|heparin biosynthetic process|,acetylglucosaminyltransferase activity|protein xylosyltransferase activity|,5,5,27200000,7.2%
P01655,2.0518e-4,-0.674833333,40.15092704,3.741666667,9.65845e-5,7.531448609,-2.291,-1.855,-3.491,1.2,1.388,1,P01655,NotFound,P01655_NotFound,P01655,,1,15,3,1,P01655|P01654|P01656|A0A075B5P0|P01659|P01667|P01672|P01669|P01671|P01673,MOUSE,12168.4,51.7,369,369.1,45.96,12.77,,112,Ig kappa chain V-III region PC 7132,,,antigen binding|,4,15,712000000,51.7%
A0A075B5M1,1.34728e-4,-0.702833333,43.37746783,3.888333333,4.59466e-5,8.406865323,-3.37,-2.167,-2.404,1.675,1.18,0.869,A0A075B5M1,NotFound,A0A075B5M1_NotFound,A0A075B5M1,Igkv4-63,1,13,4,4,A0A075B5M1,MOUSE,10271.2,41,370,370.1,45.88,45.88,,95,Immunoglobulin kappa variable 4-63,,,,4,13,1130000000,41.0%
Q8K2I4,1.53223e-4,-1.030833333,42.22328896,3.991,5.99337e-5,8.084681659,-2.464,-2.604,-4.011,1.036,0.974,0.884,Q8K2I4,Manba,Q8K2I4_Manba,Q8K2I4,Manba,1,6,4,4,A0A0R4J092|Q8K2I4|D6RGR1,MOUSE,101513.6,5.6,371,371.1,44.29,44.29,,879,Beta-mannosidase,lysosome|intracellular membrane-bounded organelle|,carbohydrate metabolic process|glycoprotein catabolic process|mannan catabolic process|,beta-mannosidase activity|,4,6,59900000,5.6%
P07356,0.126624927,-0.844,9.208495516,1.888666667,0.119991491,1.77266305,0.023,-0.988,-4.4,0.116,0.087,0.098,P07356,Anxa2,P07356_Anxa2,P07356,Anxa2,1,5,3,3,P07356,MOUSE,38960.8,10.6,374,374.1,44.01,44.01,,339,Annexin A2,ruffle|basement membrane|extracellular space|nucleus|cytoplasm|lysosomal membrane|endosome|early endosome|lipid particle|cytosol|plasma membrane|cell cortex|cell surface|membrane|basolateral plasma membrane|extrinsic component of plasma membrane|midbody|late endosome membrane|vesicle|myelin sheath adaxonal region|sarcolemma|melanosome|Schmidt-Lanterman incisure|macropinosome|perinuclear region of cytoplasm|extracellular exosome|PCSK9-AnxA2 complex|membrane raft|,angiogenesis|membrane raft assembly|positive regulation of protein phosphorylation|negative regulation of receptor internalization|membrane budding|body fluid secretion|collagen fibril organization|positive regulation of vesicle fusion|negative regulation of low-density lipoprotein particle receptor catabolic process|osteoclast development|fibrinolysis|negative regulation of catalytic activity|positive regulation of fibroblast proliferation|positive regulation of binding|protein heterotetramerization|protein targeting to plasma membrane|negative regulation of receptor binding|positive regulation of receptor activity|,"calcium ion binding|protein binding|calcium-dependent phospholipid binding|phosphatidylinositol-4,5-bisphosphate binding|cytoskeletal protein binding|Rab GTPase binding|phospholipase A2 inhibitor activity|S100 protein binding|poly(A) RNA binding|calcium-dependent protein binding|receptor activator activity|",3,5,156000000,10.6%
P10854,0.494300123,-0.042833333,3.141748708,0.569666667,0.485093136,0.735655812,-1.297,1.552,-1.238,0.393,0.124,0.209,P10854,Hist1h2bm,P10854_Hist1h2bm,P10854,Hist1h2bm,1,18,5,5,P10854|Q64478|Q64525|Q6ZWY9|Q8CGP2-2|Q8CBB6|P70696|Q8CGP2|Q64475|P10853|Q8CGP1|Q9D2U9|Q64524|Q8CGP0,MOUSE,13935.9,31.7,375,375.1,43.45,43.45,,126,Histone H2B type 1-M,nuclear nucleosome|nucleus|nucleoplasm|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,5,18,6320000000,31.7%
H7BWY6,0.004927513,-0.9785,23.99380603,4.160333333,0.003986754,4.227654948,-2.032,-1.682,-5.462,1.535,0.854,0.916,H7BWY6,Rbp4,H7BWY6_Rbp4,H7BWY6,Rbp4,1,7,4,4,H7BWY6|Q00724,MOUSE,28746.7,12.6,378,378.1,41.44,41.44,,245,Retinol-binding protein 4,extracellular space|protein complex|extracellular exosome|,maintenance of gastrointestinal epithelium|positive regulation of insulin secretion|response to retinoic acid|retinol transport|retinol metabolic process|glucose homeostasis|response to ethanol|,retinol binding|retinol transporter activity|protein heterodimerization activity|,4,7,728000000,12.6%
P97333,0.03284076,-0.254333333,15.32218751,2.140666667,0.029361703,2.70757196,-2.91,-1.466,0.402,1.049,0.601,0.798,P97333,Nrp1,P97333_Nrp1,P97333,Nrp1,1,11,5,5,P97333,MOUSE,104253.4,6.5,380,380.1,40.68,40.68,,923,Neuropilin-1,extracellular space|early endosome|cytosol|neurofilament|plasma membrane|focal adhesion|integral component of membrane|axon|sorting endosome|,angiogenesis|patterning of blood vessels|neuron migration|sprouting angiogenesis|cell migration involved in sprouting angiogenesis|axon guidance|axonal fasciculation|heart development|motor neuron axon guidance|dendrite development|cell migration|facial nerve structural organization|trigeminal nerve morphogenesis|trigeminal nerve structural organization|vestibulocochlear nerve structural organization|nerve development|branchiomotor neuron axon guidance|gonadotrophin-releasing hormone neuronal migration to the hypothalamus|negative regulation of axon extension|retinal ganglion cell axon guidance|cellular response to hepatocyte growth factor stimulus|endothelial cell chemotaxis|cellular response to vascular endothelial growth factor stimulus|ventral trunk neural crest cell migration|VEGF-activated neuropilin signaling pathway|otic placode formation|negative regulation of neuron apoptotic process|platelet-derived growth factor receptor signaling pathway|vascular endothelial growth factor receptor signaling pathway|hepatocyte growth factor receptor signaling pathway|sympathetic nervous system development|neuron development|regulation of axon extension involved in axon guidance|positive regulation of axon extension involved in axon guidance|negative regulation of axon extension involved in axon guidance|artery morphogenesis|axon extension involved in axon guidance|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|axonogenesis involved in innervation|dichotomous subdivision of terminal units involved in salivary gland branching|angiogenesis involved in coronary vascular morphogenesis|cell migration involved in coronary vasculogenesis|coronary artery morphogenesis|retina vasculature morphogenesis in camera-type eye|renal artery morphogenesis|sympathetic ganglion development|trigeminal ganglion development|ganglion morphogenesis|positive regulation of ERK1 and ERK2 cascade|semaphorin-plexin signaling pathway|commissural neuron axon guidance|regulation of retinal ganglion cell axon guidance|sensory neuron axon guidance|sympathetic neuron projection extension|sympathetic neuron projection guidance|neural crest cell migration involved in autonomic nervous system development|toxin transport|semaphorin-plexin signaling pathway involved in neuron projection guidance|semaphorin-plexin signaling pathway involved in axon guidance|positive regulation of retinal ganglion cell axon guidance|VEGF-activated neuropilin signaling pathway involved in axon guidance|protein localization to early endosome|facioacoustic ganglion development|negative regulation of extrinsic apoptotic signaling pathway|,vascular endothelial growth factor-activated receptor activity|protein binding|heparin binding|semaphorin receptor activity|growth factor binding|vascular endothelial growth factor binding|metal ion binding|,5,11,73200000,6.5%
Q80W65,0.004922163,-1.048333333,24.00477665,3.672,0.003976695,4.195347658,-2.98,-0.978,-4.695,0.997,0.577,0.789,Q80W65,Pcsk9,Q80W65_Pcsk9,Q80W65,Pcsk9,1,5,4,4,Q80W65,MOUSE,76419.3,6.9,382,382.1,40.36,40.36,,694,Proprotein convertase subtilisin/kexin type 9,extracellular region|extracellular space|cytoplasm|lysosome|early endosome|late endosome|endoplasmic reticulum|endoplasmic reticulum lumen|rough endoplasmic reticulum|Golgi apparatus|plasma membrane|cell surface|ER to Golgi transport vesicle|perinuclear region of cytoplasm|PCSK9-LDLR complex|PCSK9-AnxA2 complex|,kidney development|liver development|negative regulation of receptor recycling|positive regulation of receptor internalization|triglyceride metabolic process|phospholipid metabolic process|apoptotic process|lysosomal transport|cholesterol metabolic process|cellular response to starvation|regulation of receptor activity|negative regulation of low-density lipoprotein particle clearance|protein autoprocessing|neurogenesis|neuron differentiation|low-density lipoprotein receptor particle metabolic process|low-density lipoprotein particle receptor catabolic process|regulation of low-density lipoprotein particle receptor catabolic process|positive regulation of low-density lipoprotein particle receptor catabolic process|cellular response to insulin stimulus|lipoprotein metabolic process|cholesterol homeostasis|regulation of neuron apoptotic process|positive regulation of neuron apoptotic process|negative regulation of receptor activity|negative regulation of sodium ion transmembrane transporter activity|,serine-type endopeptidase activity|sodium channel inhibitor activity|low-density lipoprotein particle binding|receptor inhibitor activity|apolipoprotein binding|very-low-density lipoprotein particle binding|apolipoprotein receptor binding|protein self-association|poly(A) RNA binding|low-density lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,4,5,136000000,6.9%
A0A0B4J1I8,1.0426e-4,-0.791833333,50.11221538,4.753666667,9.74492e-6,10.51224193,-3.346,-2.752,-3.408,0.889,2.088,1.778,A0A0B4J1I8,NotFound,A0A0B4J1I8_NotFound,A0A0B4J1I8,Igkv4-59,1,21,4,4,A0A0B4J1I8|P04944|P04940|P04941|A0A0B4J1I5|P04942|P04943|P70670|Q9JKC6|A0N8I8,MOUSE,12784.1,18.8,385,385.1,39.6,39.6,,117,Immunoglobulin kappa variable 4-59 (Fragment),,,,4,21,13600000000,18.8%
A0A075B5R0,1.19303e-4,-0.89,44.57668848,3.897333333,3.48603e-5,8.752845132,-2.846,-2.146,-3.524,0.952,1.093,1.131,A0A075B5R0,NotFound,A0A075B5R0_NotFound,A0A075B5R0,Ighv5-16,1,8,3,3,A0A075B5R0,MOUSE,13388.1,32.7,386,386.1,39.39,39.39,,116,Immunoglobulin heavy variable 5-16,,,,3,8,338000000,32.7%
P16014,0.01107556,-0.762833333,20.23931402,3.481,0.009463866,3.552590055,-1.852,-0.813,-4.845,1.251,0.69,0.992,P16014,Chgb,P16014_Chgb,P16014,Chgb,1,10,5,5,P16014,MOUSE,78081.7,6.9,387,387.1,39.08,39.08,,677,Secretogranin-1,extracellular region|secretory granule|,,protein binding|,5,10,86900000,6.9%
A2ASS6,0.00261173,-2.082166667,26.90990074,6.205,0.002037089,4.792852919,-3.858,-3.229,-8.467,0.946,1.049,1.066,A2ASS6,NotFound,A2ASS6_NotFound,A2ASS6,Ttn,1,19,7,7,A2ASS6|E9Q8K5|E9Q8N1|A2ASS6-2,MOUSE,3935740.7,0.2,388,388.1,38.81,38.81,,35213,Titin,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,7,19,133000000000,0.2%
A0A075B5T7,9.0976e-4,-0.4555,31.91162644,3.553,6.43928e-4,5.612056219,-3.323,-2.266,-1.107,0.964,2.041,0.958,A0A075B5T7,NotFound,A0A075B5T7_NotFound,A0A075B5T7,Ighv1-7,1,8,3,3,A0A075B5T7|A0A075B5T4,MOUSE,13273.8,29,391,391.1,38.29,38.29,,117,Immunoglobulin heavy variable V1-7 (Fragment),,,,3,8,2920000000,29.0%
P01634,1.0426e-4,-0.995166667,47.13821096,4.453666667,1.93276e-5,9.532390922,-3.832,-2.685,-3.149,0.898,0.975,1.822,P01634,NotFound,P01634_NotFound,P01634,,1,12,4,4,P01634|A0A140T8P2|A0A075B5N2|A0A075B5N1|P01632,MOUSE,15072.8,22.7,393,393.1,37.3,37.3,,136,Ig kappa chain V-V region MOPC 21,,,antigen binding|,4,12,3050000000,22.7%
A0A075B5Q6,0.002191317,-0.4205,27.72430027,2.997666667,0.001688768,4.778970007,-3.145,-1.892,-0.721,0.833,1.449,0.953,A0A075B5Q6,NotFound,A0A075B5Q6_NotFound,A0A075B5Q6,Ighv5-9-1,1,7,3,3,A0A075B5Q6,MOUSE,13238,28.4,394,394.1,37.2,37.2,,116,Immunoglobulin heavy variable 5-9-1,,,,3,7,357000000,28.4%
O35452,0.001183074,-0.644666667,30.63713627,2.917333333,8.63548e-4,5.349635351,-2.253,-1.02,-3.037,0.858,0.848,0.736,O35452,NotFound,O35452_NotFound,O35452,Tnxb,1,11,4,4,O35452|E9Q2T3,MOUSE,442488.3,1.1,397,397.1,36.46,36.46,,4006,Tenascin X,extracellular region|proteinaceous extracellular matrix|extracellular space|intracellular|extracellular exosome|fibrillar collagen trimer|extracellular matrix|,lipid metabolic process|fatty acid metabolic process|triglyceride metabolic process|cell-matrix adhesion|single organismal cell-cell adhesion|extracellular matrix organization|collagen fibril organization|collagen metabolic process|extracellular fibril organization|regulation of JUN kinase activity|elastic fiber assembly|phospholipid metabolic process|positive regulation of cell adhesion|,collagen binding|heparin binding|,4,11,77400000,1.1%
Q91V80,1.71582e-4,-0.991333333,41.48070734,4.07,7.11098e-5,7.882796513,-3.401,-1.97,-3.708,1,1.13,1.001,Q91V80,Apof,Q91V80_Apof,Q91V80,Apof,1,6,2,2,A0A0R4J0M4|Q91V80,MOUSE,34701.1,10.1,398,398.1,36.15,36.15,,315,Apolipoprotein F,low-density lipoprotein particle|high-density lipoprotein particle|,triglyceride metabolic process|cholesterol metabolic process|cholesterol efflux|,,2,6,277000000,10.1%
P63158,0.069371282,-0.079,11.94088262,0.757333333,0.063960484,2.172808884,-0.465,-0.222,-0.686,0.29,0.299,0.31,P63158,Hmgb1,P63158_Hmgb1,P63158,Hmgb1,1,10,4,4,P63158|A0A0J9YUD8|P30681,MOUSE,25064.5,12.5,399,399.1,35.82,35.82,,215,High mobility group protein B1,condensed chromosome|extracellular region|extracellular space|nucleus|cytoplasm|cell surface|transcriptional repressor complex|,"inflammatory response to antigenic stimulus|base-excision repair, DNA ligation|inflammatory response|negative regulation of RNA polymerase II transcriptional preinitiation complex assembly|DNA geometric change|V(D)J recombination|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of DNA binding|negative regulation of blood vessel endothelial cell migration|positive regulation of transcription from RNA polymerase II promoter|negative regulation of apoptotic cell clearance|","four-way junction DNA binding|bubble DNA binding|phosphatidylserine binding|sequence-specific DNA binding transcription factor activity|cytokine activity|protein binding|heparin binding|DNA binding, bending|poly(A) RNA binding|repressing transcription factor binding|supercoiled DNA binding|",4,10,537000000,12.5%
Q8K1I3,0.01230198,-0.177,19.73029342,1.549333333,0.010640711,3.382981814,-0.953,-0.256,-1.646,0.886,0.403,0.504,Q8K1I3,Spp2,Q8K1I3_Spp2,Q8K1I3,Spp2,1,10,3,3,Q8K1I3,MOUSE,23421,14.2,400,400.1,35.69,35.69,,203,Secreted phosphoprotein 24,extracellular exosome|,bone remodeling|,,3,10,588000000,14.2%
A0A0B4J1I1,1.0426e-4,-1.269333333,46.90525236,4.720666667,2.03927e-5,9.459119287,-3.954,-2.652,-4.283,0.912,1.177,1.184,A0A0B4J1I1,NotFound,A0A0B4J1I1_NotFound,A0A0B4J1I1,Igkv16-104,1,11,2,2,A0A0B4J1I1,MOUSE,13045.5,23.2,401,401.1,34.94,34.94,,116,Immunoglobulin kappa variable 16-104 (Fragment),,,,2,11,1240000000,23.2%
P10107,0.003812878,-0.223833333,25.18319564,3.198333333,0.00303166,4.367887627,-1.818,-0.727,-2.924,1.245,0.389,2.492,P10107,Anxa1,P10107_Anxa1,P10107,Anxa1,1,4,4,4,P10107,MOUSE,39018.9,12.7,402,402.1,34.86,34.86,,346,Annexin A1,cornified envelope|extracellular space|nucleus|cytoplasm|endosome|cytosol|plasma membrane|focal adhesion|cilium|cell surface|basolateral plasma membrane|mitochondrial membrane|vesicle|sarcolemma|mast cell granule|protein complex|extracellular exosome|,DNA strand renaturation|neutrophil homeostasis|signal transduction|cell surface receptor signaling pathway|response to X-ray|myoblast migration involved in skeletal muscle regeneration|peptide cross-linking|insulin secretion|keratinocyte differentiation|prostate gland development|endocrine pancreas development|positive regulation of vesicle fusion|positive regulation of prostaglandin biosynthetic process|response to estradiol|DNA duplex unwinding|positive regulation of neutrophil apoptotic process|DNA rewinding|gliogenesis|regulation of cell proliferation|response to drug|response to peptide hormone|estrous cycle|alpha-beta T cell differentiation|arachidonic acid secretion|cellular response to hydrogen peroxide|hepatocyte differentiation|prolactin secretion|response to interleukin-1|cellular response to glucocorticoid stimulus|neutrophil clearance|positive regulation of G1/S transition of mitotic cell cycle|negative regulation of phospholipase A2 activity|negative regulation of interleukin-8 secretion|,"single-stranded DNA binding|single-stranded RNA binding|helicase activity|structural molecule activity|calcium ion binding|protein binding|calcium-dependent phospholipid binding|phospholipase A2 inhibitor activity|protein binding, bridging|double-stranded DNA-dependent ATPase activity|annealing helicase activity|protein homodimerization activity|calcium-dependent protein binding|",4,4,40600000,12.7%
Q9EPK6,1.0426e-4,-0.9525,50.83833405,3.885,8.24454e-6,10.76455873,-2.543,-3.015,-3.127,1,0.902,1.068,Q9EPK6,Sil1,Q9EPK6_Sil1,Q9EPK6,Sil1,1,5,4,4,Q9EPK6,MOUSE,52771.3,10.5,403,403.1,34.76,34.76,,465,Nucleotide exchange factor SIL1,extracellular space|endoplasmic reticulum|endoplasmic reticulum lumen|,protein transport|,,4,5,51200000,10.5%
A6H6E2,2.1646e-4,-0.6655,39.73302309,3.572333333,1.0634e-4,7.423651143,-2.339,-1.731,-3.285,1.213,0.85,1.299,A6H6E2,Mmrn2,A6H6E2_Mmrn2,A6H6E2,Mmrn2,1,5,3,3,A6H6E2|A6H6E2-2,MOUSE,105832,4.2,404,404.1,34.61,34.61,,943,Multimerin-2,basement membrane|extracellular space|extracellular exosome|,negative regulation of vascular endothelial growth factor receptor signaling pathway|negative regulation of cell migration involved in sprouting angiogenesis|,,3,5,26700000,4.2%
Q61495,0.218314674,-0.228,6.789830247,1.034666667,0.209419431,1.377591052,-0.737,0.823,-2.322,0.346,0.222,0.3,Q61495,Dsg1a,Q61495_Dsg1a,Q61495,Dsg1a,1,8,5,5,Q61495|Q7TSF1|Q7TSF0,MOUSE,115622,3.9,407,407.1,33.67,33.67,,1057,Desmoglein-1-alpha,plasma membrane|cytoplasmic side of plasma membrane|integral component of membrane|desmosome|extracellular exosome|cell-cell junction|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|protein binding|gamma-catenin binding|,5,8,75600000,3.9%
P54818,2.0518e-4,-0.729833333,40.1814712,3.523666667,9.59076e-5,7.539375771,-3.058,-2.771,-1.646,1.261,0.901,0.934,P54818,Galc,P54818_Galc,P54818,Galc,1,7,4,4,P54818,MOUSE,77483.2,6.8,408,408.1,33.55,33.55,,684,Galactocerebrosidase,mitochondrion|lysosome|extracellular exosome|,carbohydrate metabolic process|galactosylceramide catabolic process|,galactosylceramidase activity|,4,7,486000000,6.8%
Q9D0F3,1.05478e-4,-1.050833333,46.17641484,4.252333333,2.4119e-5,9.233005895,-3.308,-2.411,-3.812,1,1.344,0.882,Q9D0F3,Lman1,Q9D0F3_Lman1,Q9D0F3,Lman1,1,7,4,4,Q9D0F3,MOUSE,58073,6.7,409,409.1,33.45,33.45,,517,Protein ERGIC-53,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|sarcomere|ER to Golgi transport vesicle|endoplasmic reticulum-Golgi intermediate compartment membrane|host cell perinuclear region of cytoplasm|extracellular exosome|,ER to Golgi vesicle-mediated transport|endoplasmic reticulum organization|Golgi organization|positive regulation of organelle organization|protein transport|,carbohydrate binding|metal ion binding|,4,7,316000000,6.7%
Q9Z0J1,1.53695e-4,-1.069,42.19704026,4.154666667,6.0297e-5,8.077474308,-2.77,-2.48,-4.189,1.026,1.134,0.865,Q9Z0J1,Reck,Q9Z0J1_Reck,Q9Z0J1,Reck,1,7,4,4,Q9Z0J1,MOUSE,111101,4.1,410,410.1,33.08,33.08,,971,Reversion-inducing cysteine-rich protein with Kazal motifs,plasma membrane|anchored component of membrane|,blood vessel maturation|embryo implantation|negative regulation of endopeptidase activity|extracellular matrix organization|embryonic forelimb morphogenesis|positive regulation of Notch signaling pathway|,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity|,4,7,207000000,4.1%
D3YTY6,0.007824594,-0.5235,21.85618329,3.502333333,0.006522013,3.836791234,-3.78,-2.946,-0.098,1.441,0.92,1.322,D3YTY6,NotFound,D3YTY6_NotFound,D3YTY6,Gm6096,1,27,3,1,D3YTY6,MOUSE,17281.2,13.9,411,411.1,32.83,10.56,,151,Predicted gene 6096,ribosome|,translation|,structural constituent of ribosome|,3,27,5940000000,13.9%
Q6GSS7,0.232177769,-0.173333333,6.511924828,0.978,0.22325825,1.332051235,-1.179,0.987,-1.795,0.699,-0.185,0.433,Q6GSS7,Hist2h2aa1,Q6GSS7_Hist2h2aa1,Q6GSS7,Hist2h2aa1,1,8,5,3,Q6GSS7|Q64523|Q8R1M2|A0A0N4SV66|P27661|Q8CGP5|Q8CGP7|C0HKE6|Q8BFU2|Q8CGP4|Q8CGP6|Q64522,MOUSE,14095.2,25.3,412,412.1,32.73,17.12,,130,Histone H2A type 2-A,nucleosome|nucleus|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,5,8,153000000,25.3%
Q9DC11,0.00183869,-0.733666667,28.58580259,3.734666667,0.001384904,5.020696523,-4.03,-2.807,-0.966,1.325,1.147,0.929,Q9DC11,Plxdc2,Q9DC11_Plxdc2,Q9DC11,Plxdc2,1,11,3,3,Q9DC11|B1AY85,MOUSE,60185.7,4.7,413,413.1,32.7,32.7,,530,Plexin domain-containing protein 2,plasma membrane|integral component of membrane|extracellular exosome|,,,3,11,231000000,4.7%
P27046,0.029863707,-0.427666667,15.75188013,3.228,0.026595734,2.805166529,-4.447,-2.24,0.562,1.345,1.289,0.925,P27046,Man2a1,P27046_Man2a1,P27046,Man2a1,1,3,2,2,P27046,MOUSE,132370.8,2.2,415,415.1,32.24,32.24,,1150,Alpha-mannosidase 2,Golgi membrane|Golgi apparatus|cis-Golgi network|membrane|integral component of membrane|extracellular exosome|,in utero embryonic development|liver development|mannose metabolic process|N-glycan processing|mitochondrion organization|vacuole organization|respiratory gaseous exchange|lung alveolus development|positive regulation of neurogenesis|retina morphogenesis in camera-type eye|,"mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity|zinc ion binding|mannosidase activity|hydrolase activity, hydrolyzing N-glycosyl compounds|carbohydrate binding|",2,3,16800000,2.2%
Q05D44,0.027311656,-0.166666667,16.15690159,1.463333333,0.024227569,2.817266437,-0.742,-1.851,-0.102,0.889,0.254,0.552,Q05D44,Eif5b,Q05D44_Eif5b,Q05D44,Eif5b,1,5,3,3,Q05D44,MOUSE,138069.9,3.6,418,418.1,31.12,31.12,,1216,Eukaryotic translation initiation factor 5B,cytoplasm|,translational initiation|regulation of translational initiation|,translation initiation factor activity|GTPase activity|GTP binding|poly(A) RNA binding|,3,5,68300000000,3.6%
P17742,0.279409276,-1.158833333,5.6815132,2.482333333,0.27030164,1.197914532,-2.085,2.095,-7.21,0.262,-0.229,0.214,P17742,Ppia,P17742_Ppia,P17742,Ppia,1,4,4,4,P17742|A0A1L1SST0|F8VPN3,MOUSE,18142.2,17.6,422,422.1,30.78,30.78,,164,Peptidyl-prolyl cis-trans isomerase A,extracellular space|nucleus|cytosol|focal adhesion|membrane|myelin sheath|extracellular exosome|,protein peptidyl-prolyl isomerization|protein folding|neuron differentiation|lipid particle organization|regulation of viral genome replication|positive regulation of viral genome replication|positive regulation of protein secretion|,peptidyl-prolyl cis-trans isomerase activity|peptide binding|poly(A) RNA binding|,4,4,41400000,17.6%
A0A0B4J1H6,3.06476e-4,-1.239333333,37.58287647,5.259333333,1.74467e-4,7.041304193,-3.123,-2.914,-5.57,0.916,1.933,1.322,A0A0B4J1H6,NotFound,A0A0B4J1H6_NotFound,A0A0B4J1H6,Igkv2-137,1,12,2,2,A0A0B4J1H6|P01630,MOUSE,13302,20,423,423.1,30.41,30.41,,120,Immunoglobulin kappa chain variable 2-137 (Fragment),,,,2,12,15800000000,20.0%
P97467,1.99681e-4,-0.863666667,40.44823697,3.928,9.01937e-5,7.608892221,-3.874,-2.428,-2.181,1.204,1.194,0.903,P97467,Pam,P97467_Pam,P97467,Pam,1,4,3,3,P97467|F8VQA4|E9Q704,MOUSE,109816.4,3.8,427,427.1,29.67,29.67,,979,Peptidyl-glycine alpha-amidating monooxygenase,cytosol|integral component of plasma membrane|membrane|transport vesicle membrane|extracellular exosome|,peptide amidation|peptide metabolic process|oxidation-reduction process|,peptidylglycine monooxygenase activity|peptidylamidoglycolate lyase activity|copper ion binding|zinc ion binding|L-ascorbic acid binding|,3,4,124000000,3.8%
P17182,0.089984544,-0.867833333,10.75650876,2.115,0.084013509,2.016082635,-1.513,0.103,-4.366,0.395,-0.111,0.285,P17182,Eno1,P17182_Eno1,P17182,Eno1,1,7,4,4,P17182,MOUSE,47482.3,6.9,428,428.1,29.62,29.62,,434,Alpha-enolase,phosphopyruvate hydratase complex|plasma membrane|myelin sheath|,glycolytic process|,magnesium ion binding|phosphopyruvate hydratase activity|,4,7,30900000000,6.9%
Q9QUK9,0.017247992,-0.105833333,18.1988328,1.103,0.015139681,3.137333519,-0.373,-0.75,-0.849,0.502,0.399,0.436,Q9QUK9,Try5,Q9QUK9_Try5,Q9QUK9,Try5,1,7,3,3,Q9QUK9|Q9R0T7|Q9Z1R9|Q792Y9|Q792Z0|Q792Y8,MOUSE,26961,15.4,429,429.1,29.6,29.6,,246,MCG15083,extracellular space|extracellular exosome|,proteolysis|digestion|,serine-type endopeptidase activity|calcium ion binding|serine-type peptidase activity|,3,7,385000000,15.4%
Q59IW6,3.06476e-4,-0.601,37.61829023,2.845333333,1.7305e-4,6.896495644,-2.371,-1.364,-2.336,0.828,0.816,0.821,Q59IW6,Abi3bp,Q59IW6_Abi3bp,Q59IW6,Abi3bp,1,7,3,3,Q59IW6|Q59IW5|Q59IW9|E9Q8E3,MOUSE,130163.5,2,430,430.1,29.4,29.4,,1179,"ABI gene family, member 3 (NESH)-binding protein",proteinaceous extracellular matrix|interstitial matrix|extracellular space|,positive regulation of cell-substrate adhesion|extracellular matrix organization|,collagen binding|glycosaminoglycan binding|heparin binding|,3,7,148000000,2.0%
A6H584,4.45305e-4,-0.598166667,35.54553194,3.034333333,2.78899e-4,6.407890973,-2.158,-1.308,-2.88,1.032,0.846,0.879,A6H584,Col6a5,A6H584_Col6a5,A6H584,Col6a5,1,6,4,4,A0A140T8W1|A6H584|A0A140T8T7|E9Q6A6|Q8C6K9|Q8C6K9-2,MOUSE,291566.4,1.8,431,431.1,29.36,29.36,,2640,Collagen alpha-5(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|,cell adhesion|,,4,6,44700000,1.8%
P55104,0.00484084,-0.541666667,24.09594372,3.157333333,0.003894087,4.169633791,-3.627,-2.264,-0.47,1.2,0.961,0.95,P55104,Inhbc,P55104_Inhbc,P55104,Inhbc,1,6,4,4,P55104,MOUSE,40085.3,9.9,434,434.1,29.11,29.11,,352,Inhibin beta C chain,extracellular space|extracellular exosome|,positive regulation of pathway-restricted SMAD protein phosphorylation|regulation of apoptotic process|regulation of MAPK cascade|cell development|SMAD protein signal transduction|,cytokine activity|transforming growth factor beta receptor binding|hormone activity|growth factor activity|,4,6,51200000,9.9%
Q9DBH5,1.0426e-4,-0.882833333,50.71584962,3.975,8.48037e-6,10.72162262,-3.136,-2.585,-2.89,1.385,1.055,0.874,Q9DBH5,Lman2,Q9DBH5_Lman2,Q9DBH5,Lman2,1,5,3,3,Q9DBH5,MOUSE,40771.4,6.9,435,435.1,29.05,29.05,,358,Vesicular integral-membrane protein VIP36,Golgi membrane|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of plasma membrane|cell surface|extracellular exosome|,"retrograde vesicle-mediated transport, Golgi to ER|protein transport|positive regulation of phagocytosis|",glycoprotein binding|mannose binding|carbohydrate binding|heat shock protein binding|metal ion binding|,3,5,23200000,6.9%
E9Q401,1.65117e-4,-1.168166667,41.70893636,4.441,6.74693e-5,7.944403398,-4.601,-2.78,-2.785,0.96,0.979,1.218,E9Q401,Ryr2,E9Q401_Ryr2,E9Q401,Ryr2,1,16,4,4,E9Q401|F6U7V1|Q80ZZ5,MOUSE,570001.1,0.9,439,439.1,28.37,28.37,,4966,Ryanodine receptor 2,smooth endoplasmic reticulum|membrane|integral component of membrane|sarcoplasmic reticulum|sarcomere|Z disc|sarcoplasmic reticulum membrane|calcium channel complex|protein complex|extracellular exosome|,response to hypoxia|regulation of heart rate|embryonic heart tube morphogenesis|left ventricular cardiac muscle tissue morphogenesis|cardiac muscle hypertrophy|detection of calcium ion|calcium ion transport|cellular calcium ion homeostasis|positive regulation of heart rate|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion|regulation of cardiac muscle contraction by calcium ion signaling|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|response to muscle activity|calcium-mediated signaling|BMP signaling pathway|response to caffeine|calcium-mediated signaling using intracellular calcium source|response to muscle stretch|release of sequestered calcium ion into cytosol|positive regulation of sequestering of calcium ion|response to redox state|regulation of cardiac muscle contraction|cardiac muscle contraction|canonical Wnt signaling pathway|cytosolic calcium ion transport|calcium ion transport into cytosol|calcium ion transmembrane transport|cellular response to caffeine|cellular response to epinephrine stimulus|establishment of protein localization to endoplasmic reticulum|ventricular cardiac muscle cell action potential|Purkinje myocyte to ventricular cardiac muscle cell signaling|type B pancreatic cell apoptotic process|positive regulation of the force of heart contraction|regulation of AV node cell action potential|regulation of SA node cell action potential|regulation of atrial cardiac muscle cell action potential|regulation of ventricular cardiac muscle cell action potential|positive regulation of calcium-transporting ATPase activity|,intracellular ligand-gated calcium channel activity|ryanodine-sensitive calcium-release channel activity|calcium channel activity|calcium ion binding|protein binding|calmodulin binding|calcium-release channel activity|enzyme binding|protein kinase binding|protein kinase A catalytic subunit binding|protein kinase A regulatory subunit binding|identical protein binding|protein self-association|suramin binding|calcium-induced calcium release activity|organic cyclic compound binding|,4,16,27900000000,0.9%
P24270,0.011227272,-0.5025,20.16841101,2.245666667,0.009619642,3.454291272,-1.853,-0.241,-2.782,0.934,0.351,0.576,P24270,Cat,P24270_Cat,P24270,Cat,1,6,3,3,P24270|A2AL20,MOUSE,60079.5,5.1,442,442.1,28.02,28.02,,527,Catalase,extracellular space|mitochondrion|mitochondrial intermembrane space|lysosome|peroxisome|peroxisomal membrane|endoplasmic reticulum|Golgi apparatus|cytosol|plasma membrane|focal adhesion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,response to reactive oxygen species|osteoblast differentiation|ureteric bud development|response to hypoxia|triglyceride metabolic process|response to oxidative stress|aging|cholesterol metabolic process|aerobic respiration|response to toxic substance|response to light intensity|UV protection|response to ozone|response to lead ion|positive regulation of phosphatidylinositol 3-kinase signaling|response to activity|response to inactivity|hemoglobin metabolic process|negative regulation of NF-kappaB transcription factor activity|response to estradiol|response to insulin|response to vitamin A|response to vitamin E|response to L-ascorbic acid|response to drug|hydrogen peroxide catabolic process|negative regulation of apoptotic process|response to ethanol|response to cadmium ion|positive regulation of NF-kappaB transcription factor activity|protein tetramerization|protein homotetramerization|positive regulation of cell division|response to hyperoxia|response to fatty acid|cellular response to growth factor stimulus|response to phenylpropanoid|,"aminoacylase activity|catalase activity|receptor binding|antioxidant activity|oxidoreductase activity, acting on peroxide as acceptor|enzyme binding|heme binding|protein homodimerization activity|metal ion binding|NADP binding|",3,6,340000000,5.1%
Q0VBK2,0.014486706,-0.796,18.99121934,2.082,0.012614733,3.263760177,-1.159,-1.047,-3.305,0.401,0.049,0.285,Q0VBK2,Krt80,Q0VBK2_Krt80,Q0VBK2,Krt80,1,3,2,2,Q0VBK2,MOUSE,51173.1,5,443,443.1,27.93,27.93,,452,"Keratin, type II cytoskeletal 80",cytoplasm|intermediate filament|keratin filament|,,structural molecule activity|,2,3,87000000,5.0%
Q923,2.48458e-4,-0.556,38.83018578,3.266,1.30913e-4,7.194908155,-2.797,-2.312,-1.458,1.367,0.864,1,Q923,Adgrl4,Q923_Adgrl4,Q923,Adgrl4,1,3,2,2,Q923,MOUSE,84526.8,4.6,445,445.1,27.52,27.52,,739,Adhesion G protein-coupled receptor L4,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|,G-protein coupled receptor activity|calcium ion binding|,2,3,23400000,4.6%
Q792Z1,0.033876694,-0.048166667,15.17601417,0.996333333,0.030366769,2.665901071,-0.246,-0.416,-0.977,0.399,0.389,0.562,Q792Z1,Try10,Q792Z1_Try10,Q792Z1,Try10,1,7,2,2,Q792Z1,MOUSE,26905,7.3,446,446.1,27.46,27.46,,246,MCG140784,extracellular space|extracellular exosome|blood microparticle|,proteolysis|digestion|,serine-type endopeptidase activity|,2,7,485000000,7.3%
Q9Z126,1.0426e-4,-0.807,47.35546299,3.740666667,1.83846e-5,9.601164298,-3.062,-2.734,-2.236,1.312,0.874,1.004,Q9Z126,Pf4,Q9Z126_Pf4,Q9Z126,Pf4,1,9,3,3,Q9Z126|A0A0J9YTR7,MOUSE,11471.5,25.7,447,447.1,27.38,27.38,,105,Platelet factor 4,extracellular space|platelet alpha granule|protein complex|,positive regulation of leukocyte chemotaxis|protein complex assembly|inflammatory response|immune response|G-protein coupled receptor signaling pathway|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|negative regulation of angiogenesis|cytokine-mediated signaling pathway|platelet activation|leukocyte chemotaxis|positive regulation of cAMP metabolic process|response to lipopolysaccharide|positive regulation of tumor necrosis factor production|regulation of cell proliferation|positive regulation of cAMP-mediated signaling|negative regulation of MHC class II biosynthetic process|positive regulation of macrophage differentiation|negative regulation of megakaryocyte differentiation|negative regulation of cytolysis|positive regulation of transcription from RNA polymerase II promoter|chemokine-mediated signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,chemokine activity|heparin binding|CXCR chemokine receptor binding|CXCR3 chemokine receptor binding|,3,9,149000000,25.7%
P09581,1.0426e-4,-0.862833333,49.25375901,3.865,1.18747e-5,10.22071743,-3.216,-2.711,-2.459,1.148,1.176,0.885,P09581,Csf1r,P09581_Csf1r,P09581,Csf1r,1,3,3,3,P09581,MOUSE,110375.4,2.9,448,448.1,27.36,27.36,,977,Macrophage colony-stimulating factor 1 receptor,intracellular|plasma membrane|cell surface|integral component of membrane|CSF1-CSF1R complex|,positive regulation of protein phosphorylation|inflammatory response|transmembrane receptor protein tyrosine kinase signaling pathway|axon guidance|skeletal muscle tissue development|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|regulation of cell shape|peptidyl-tyrosine phosphorylation|cytokine-mediated signaling pathway|olfactory bulb development|forebrain neuron differentiation|hemopoiesis|osteoclast differentiation|positive regulation of cell migration|ruffle organization|cellular response to macrophage colony-stimulating factor stimulus|macrophage colony-stimulating factor signaling pathway|positive regulation of tyrosine phosphorylation of Stat3 protein|negative regulation of apoptotic process|innate immune response|regulation of bone resorption|cell-cell junction maintenance|positive regulation of osteoclast differentiation|phosphatidylinositol metabolic process|protein autophosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein tyrosine kinase activity|positive regulation of ERK1 and ERK2 cascade|cellular response to cytokine stimulus|positive regulation of protein serine/threonine kinase activity|positive regulation of chemokine secretion|positive regulation of cell motility|regulation of actin cytoskeleton reorganization|,macrophage colony-stimulating factor receptor activity|protein binding|ATP binding|protein phosphatase binding|cytokine binding|protein homodimerization activity|,3,3,28700000,2.9%
F8WID5,0.514614645,-0.120833333,2.961685763,0.551666667,0.505628359,0.700289367,-1.505,1.387,-1.072,0.324,-0.503,0.644,F8WID5,NotFound,F8WID5_NotFound,F8WID5,Tpm1,1,4,2,2,F8WID5|E9Q454|E9Q450|Q8BP43|E9Q448|P58771-2|Q8BSH3|P58771|B7ZNL3|E9Q452|E9Q455|G5E8R2|E9Q456|G5E8R1|E9Q453|G5E8R0|E9Q5J9|P21107|A0A0R4J1P2|P21107-2|D3Z2H9|D3Z6I8|E9Q7Q3|P58774|S4R2U0,MOUSE,37469.2,5.5,452,452.1,26.26,13.92,,326,Tropomyosin alpha-1 chain,cytoplasm|muscle thin filament tropomyosin|myofibril|filamentous actin|,in utero embryonic development|,structural constituent of cytoskeleton|,3,4,70700000,5.5%
P47911,5.29183e-4,-0.232666667,34.62198851,2.926666667,3.44986e-4,6.198582545,-1.969,-2.082,-1.037,1.05,1.839,0.803,P47911,Rpl6,P47911_Rpl6,P47911,Rpl6,1,3,3,3,P47911,MOUSE,33566.1,9.7,453,453.1,25.85,25.85,,296,60S ribosomal protein L6,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|cytoplasmic ribonucleoprotein granule|,translation|,structural constituent of ribosome|poly(A) RNA binding|,3,3,29900000,9.7%
E9Q1W3,2.13447e-4,-0.650166667,39.81454266,3.877666667,1.04363e-4,7.444582563,-3.323,-2.733,-1.711,1.821,1.144,0.901,E9Q1W3,Neb,E9Q1W3_Neb,E9Q1W3,Neb,1,11,4,4,E9Q1W3|A2AQA9|B2RUJ5|B2RUJ5-3,MOUSE,831956.2,0.6,454,454.1,25.46,25.46,,7152,Nebulin,striated muscle thin filament|Z disc|protein complex|contractile fiber|extracellular exosome|,regulation of actin filament length|sarcomere organization|,actin binding|protein binding|,4,11,19500000000,0.6%
P01662,7.94876e-4,-1.215666667,32.54097422,4.374,5.57061e-4,5.850556778,-2.487,-2.521,-5.2,0.83,1.145,0.939,P01662,NotFound,P01662_NotFound,P01662,,1,5,2,2,P01662|P01663,MOUSE,12155.2,21.6,455,455.1,25.28,25.28,,111,Ig kappa chain V-III region ABPC 22/PC 9245,,,antigen binding|,2,5,167000000,21.6%
A0A075B5Q3,1.46405e-4,-0.849166667,42.60582287,4.399666667,5.48805e-5,8.190317006,-3.953,-3.08,-2.114,0.917,1.61,1.525,A0A075B5Q3,NotFound,A0A075B5Q3_NotFound,A0A075B5Q3,Ighv2-5,1,11,2,2,A0A075B5Q3,MOUSE,12727.5,16.5,456,456.1,25.26,25.26,,115,Immunoglobulin heavy variable 2-5,,,,2,11,5620000000,16.5%
Q00612,4.56873e-4,-0.256,35.40198809,2.945333333,2.88271e-4,6.375028644,-2.282,-1.815,-1.089,1.54,0.696,1.414,Q00612,G6pdx,Q00612_G6pdx,Q00612,G6pdx,1,5,4,4,Q00612|P97324|G3UWD6,MOUSE,59717.9,8.1,458,458.1,24.62,24.62,,515,Glucose-6-phosphate 1-dehydrogenase X,cytoplasm|centrosome|microtubule organizing center|cytosol|cytoplasmic side of plasma membrane|membrane|intracellular membrane-bounded organelle|extracellular exosome|,"cytokine production|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|vasodilation by angiotensin involved in regulation of systemic arterial blood pressure|glucose metabolic process|pentose-phosphate shunt|cholesterol biosynthetic process|NADP metabolic process|NADPH regeneration|NADP biosynthetic process|glutathione metabolic process|response to oxidative stress|pentose-phosphate shunt, oxidative branch|negative regulation of protein glutathionylation|pentose biosynthetic process|interleukin-10 production|interleukin-12 production|cellular response to oxidative stress|regulation of multicellular organism growth|erythrocyte maturation|ribose phosphate biosynthetic process|erythrocyte development|glucose 6-phosphate metabolic process|oxidation-reduction process|",glucose-6-phosphate dehydrogenase activity|glucose binding|identical protein binding|protein homodimerization activity|NADP binding|,4,5,1880000000,8.1%
P08032,0.059879344,-0.609833333,12.60741399,1.898333333,0.054860353,2.289778622,-2.132,-2.918,0.373,0.772,-0.065,0.311,P08032,Spta1,P08032_Spta1,P08032,Spta1,1,3,3,3,P08032,MOUSE,281001,1.5,461,461.1,24.51,24.51,,2415,"Spectrin alpha chain, erythrocytic 1",spectrin|spectrin-associated cytoskeleton|membrane|cortical cytoskeleton|cuticular plate|,porphyrin-containing compound biosynthetic process|plasma membrane organization|regulation of cell shape|actin cytoskeleton organization|hemopoiesis|positive regulation of protein binding|positive regulation of T cell proliferation|actin filament capping|,actin binding|calcium ion binding|protein heterodimerization activity|,3,3,98300000,1.5%
A0A075B5L4,3.32638e-4,-0.889,37.13051021,4.204666667,1.93619e-4,6.779091562,-2.699,-1.954,-4.321,1.152,1,1.488,A0A075B5L4,NotFound,A0A075B5L4_NotFound,A0A075B5L4,Igkv12-89,1,13,2,2,A0A075B5L4,MOUSE,12138.5,24.3,462,462.1,24.27,24.27,,111,Immunoglobulin kappa chain variable 12-89,,,,2,13,3190000000,24.3%
F6R7E8,0.006879967,-0.151166667,22.45148445,1.345666667,0.005686585,3.834415397,-0.535,-0.965,-0.972,0.546,0.525,0.494,F6R7E8,Gm2663,F6R7E8_Gm2663,F6R7E8,Gm2663,1,10,3,3,F6R7E8|Q9CPN7,MOUSE,27260.6,16.1,465,465.1,24.07,24.07,,247,Predicted gene 2663,extracellular space|,proteolysis|,serine-type endopeptidase activity|,3,10,1890000000,16.1%
P97927,0.020132881,-1.147166667,17.51565434,3.997666667,0.017718811,3.092696771,-2.145,-0.942,-6.351,0.75,1.19,0.615,P97927,Lama4,P97927_Lama4,P97927,Lama4,1,4,2,2,P97927,MOUSE,204497.2,0.8,466,466.1,23.95,23.95,,1816,Laminin subunit alpha-4,extracellular region|basement membrane|basal lamina|extracellular exosome|,blood vessel development|cell adhesion|regulation of cell adhesion|regulation of cell migration|regulation of embryonic development|brown fat cell differentiation|,receptor binding|,2,4,17800000,0.8%
Q9ES89,4.40674e-4,-0.607333333,35.59901523,3.206666667,2.75485e-4,6.420166675,-3.04,-1.313,-2.279,1.155,0.963,0.87,Q9ES89,Extl2,Q9ES89_Extl2,Q9ES89,Extl2,1,11,2,2,Q9ES89|Q3TSR0,MOUSE,37618.1,4.2,468,468.1,23.78,23.78,,330,Exostosin-like 2,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|extracellular exosome|,glycosaminoglycan biosynthetic process|N-acetylglucosamine metabolic process|heparan sulfate proteoglycan biosynthetic process|UDP-N-acetylgalactosamine metabolic process|,"glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|alpha-1,4-N-acetylgalactosaminyltransferase activity|metal ion binding|",2,11,504000000,4.2%
P60335,3.48752e-4,-0.598,36.82206215,3.138,2.07871e-4,6.705632523,-2.561,-1.315,-2.625,0.799,0.878,1.236,P60335,Pcbp1,P60335_Pcbp1,P60335,Pcbp1,1,2,2,2,P60335,MOUSE,38010.7,6.1,469,469.1,23.68,23.68,,356,Poly(rC)-binding protein 1,nucleoplasm|cytoplasm|membrane|ribonucleoprotein complex|intracellular membrane-bounded organelle|extracellular exosome|,mRNA processing|positive regulation of translation|,single-stranded DNA binding|RNA binding|protein binding|translation activator activity|poly(A) RNA binding|,2,2,144000000,6.1%
P62242,0.033273476,-0.371833333,15.25968647,1.421,0.029787315,2.678764022,-1.908,-1.3,-0.039,0.153,0.312,0.551,P62242,Rps8,P62242_Rps8,P62242,Rps8,1,3,2,2,P62242,MOUSE,24490,9.6,471,471.1,23.5,23.5,,208,40S ribosomal protein S8,nucleus|cytoplasm|focal adhesion|membrane|cytosolic small ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|translation|",structural constituent of ribosome|poly(A) RNA binding|,2,3,2520000000,9.6%
Q8BKH7,1.4484e-4,-1.097666667,42.69312801,4.33,5.37882e-5,8.214584154,-3.102,-2.399,-4.287,1.141,0.91,1.151,Q8BKH7,Mapkap1,Q8BKH7_Mapkap1,Q8BKH7,Mapkap1,1,9,3,3,Q8BKH7|Q8BKH7-2|Q8BKH7-3,MOUSE,59521.1,4.7,472,472.1,23.4,23.4,,522,Target of rapamycin complex 2 subunit MAPKAP1,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|cytoplasmic membrane-bounded vesicle|,substantia nigra development|negative regulation of Ras protein signal transduction|,"protein binding|phosphatidylinositol-4,5-bisphosphate binding|phosphatidylinositol-3,4,5-trisphosphate binding|Ras GTPase binding|protein kinase binding|phosphatidylinositol-3,4-bisphosphate binding|phosphatidic acid binding|phosphatidylinositol-3,5-bisphosphate binding|",3,9,13900000000,4.7%
A0A075B5X8,1.0426e-4,-1.328833333,47.98075441,4.773,1.59193e-5,9.801515735,-3.405,-3.097,-4.644,0.933,0.982,1.258,A0A075B5X8,NotFound,A0A075B5X8_NotFound,A0A075B5X8,Ighv8-12,1,11,3,3,A0A075B5X8,MOUSE,11636.9,20,473,473.1,23.36,23.36,,105,Immunoglobulin heavy variable V8-12,,,,3,11,3310000000,20.0%
E9QLL8,0.002423571,-0.334833333,27.24760888,2.506333333,0.001884686,4.689165849,-2.503,-1.706,-0.555,0.912,0.804,1.039,E9QLL8,Serpina11,E9QLL8_Serpina11,E9QLL8,Serpina11,1,3,3,3,E9QLL8|E9QK54|Q8CIE0,MOUSE,47783.4,7.9,474,474.1,23.07,23.07,,427,Serpin A11,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,3,3,171000000,7.9%
A0A087WRT4,5.92518e-4,-0.712166667,34.01623641,3.582333333,3.96622e-4,6.06397939,-3.616,-2.549,-1.345,1.239,0.868,1.13,A0A087WRT4,Fat1,A0A087WRT4_Fat1,A0A087WRT4,Fat1,1,5,3,3,A0A1L1SQU7|A0A087WRT4|F2Z4A3,MOUSE,511001.9,0.5,475,475.1,22.84,22.84,,4602,FAT atypical cadherin 1,nucleus|plasma membrane|cell-cell junction|focal adhesion|lamellipodium|cell junction|filopodium|perinuclear region of cytoplasm|extracellular exosome|,actin filament organization|homophilic cell adhesion via plasma membrane adhesion molecules|establishment or maintenance of cell polarity|single organismal cell-cell adhesion|,calcium ion binding|protein binding|,3,5,323000000,0.5%
Q8BYC6,1.27982e-4,-1.641,44.01479169,5.414,3.96754e-5,8.589282071,-4.581,-2.992,-5.471,1.063,1.211,0.924,Q8BYC6,Taok3,Q8BYC6_Taok3,Q8BYC6,Taok3,1,27,3,3,Q8BYC6|Q3V3K3,MOUSE,105790.3,4,477,477.1,22.66,22.66,,898,Serine/threonine-protein kinase TAO3,nucleus|cytoplasm|,MAPK cascade|activation of MAPKK activity|DNA repair|protein phosphorylation|cellular response to DNA damage stimulus|mitotic G2 DNA damage checkpoint|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|positive regulation of stress-activated MAPK cascade|regulation of apoptotic process|positive regulation of JUN kinase activity|negative regulation of JNK cascade|positive regulation of JNK cascade|protein autophosphorylation|,protein serine/threonine kinase activity|MAP kinase kinase kinase activity|ATP binding|transferase activity|,3,27,58600000000,4.0%
D3YZ61,3.38676e-4,-0.505166667,37.01831146,2.981,1.98687e-4,6.752301111,-1.772,-1.542,-2.673,1.364,0.792,0.8,D3YZ61,C1qtnf3,D3YZ61_C1qtnf3,D3YZ61,C1qtnf3,1,5,2,2,D3YZ61|Q9ES30,MOUSE,35268.9,5.9,478,478.1,22.31,22.31,,319,Complement C1q tumor necrosis factor-related protein 3,extracellular region|collagen trimer|extracellular space|cell|membrane|extracellular exosome|,negative regulation of gene expression|cellular triglyceride homeostasis|negative regulation of NF-kappaB import into nucleus|glucose homeostasis|negative regulation of gluconeogenesis|positive regulation of cytokine secretion|negative regulation of inflammatory response|protein oligomerization|positive regulation of protein kinase B signaling|positive regulation of adiponectin secretion|protein trimerization|positive regulation of ERK1 and ERK2 cascade|negative regulation of monocyte chemotactic protein-1 production|negative regulation of interleukin-6 secretion|,identical protein binding|,2,5,83100000,5.9%
A2AQH1,0.001072082,-0.062666667,31.13480166,2.262666667,7.70052e-4,5.451136553,-1.338,-0.904,-1.34,1.6,0.551,1.055,A2AQH1,Cerkl,A2AQH1_Cerkl,A2AQH1,Cerkl,1,6,4,4,A2AQH1,MOUSE,59694.4,7.2,479,479.1,22.26,22.26,,525,Ceramide kinase-like,nucleolus|cytoplasm|endoplasmic reticulum|Golgi apparatus|,phosphorylation|negative regulation of apoptotic process|,kinase activity|,4,6,346000000,7.2%
Q80UM7,0.038708207,-0.193166667,14.5801062,1.611,0.03483288,2.574519897,-2.37,-0.34,-0.286,0.869,0.16,0.808,Q80UM7,Mogs,Q80UM7_Mogs,Q80UM7,Mogs,1,5,3,3,Q80UM7,MOUSE,92000.8,3.1,480,480.1,22.18,22.18,,834,Mannosyl-oligosaccharide glucosidase,endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,protein N-linked glycosylation|oligosaccharide metabolic process|,mannosyl-oligosaccharide glucosidase activity|,3,5,828000000,3.1%
Q7TNC4,0.002128191,-0.418333333,27.87097108,2.101333333,0.001632687,4.806795395,-1.594,-2.02,-0.793,0.903,0.521,0.473,Q7TNC4,Luc7l2,Q7TNC4_Luc7l2,Q7TNC4,Luc7l2,1,2,2,2,Q7TNC4|Q7TNC4-4|Q05CX5|Q7TNC4-3|Q7TNC4-2|E9Q715|Q9CYI4|A0A0R4J047|Q9CYI4-2,MOUSE,46981.6,6.3,482,482.1,22.03,22.03,,392,Putative RNA-binding protein Luc7-like 2,U1 snRNP|nuclear speck|,mRNA splice site selection|,mRNA binding|enzyme binding|poly(A) RNA binding|,2,2,40400000,6.3%
Q9CQV8,0.034265931,-0.4315,15.12076255,1.520333333,0.030755567,2.657411792,-1.865,0.011,-1.721,0.327,-0.011,0.67,Q9CQV8,Ywhab,Q9CQV8_Ywhab,Q9CQV8,Ywhab,1,3,2,2,Q9CQV8|P68254|P68254-2|Q9CQV8-2|P63101,MOUSE,28200,6.9,484,484.1,21.45,21.45,,246,14-3-3 protein beta/alpha,nucleus|cytoplasm|cytosol|focal adhesion|membrane|transcriptional repressor complex|cytoplasmic vesicle membrane|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"protein targeting|negative regulation of protein dephosphorylation|positive regulation of catalytic activity|negative regulation of transcription, DNA-templated|cytoplasmic sequestering of protein|protein heterooligomerization|",transcription corepressor activity|protein binding|protein C-terminus binding|enzyme binding|protein domain specific binding|protein complex binding|histone deacetylase binding|phosphoserine binding|phosphoprotein binding|,2,3,12400000,6.9%
Q9WTL4,0.239069493,0.0605,6.379634945,-0.753666667,0.230163528,-1.306633814,0.864,0.999,-0.551,-0.237,-1.059,0.347,Q9WTL4,Insrr,Q9WTL4_Insrr,Q9WTL4,Insrr,1,8,2,2,Q9WTL4,MOUSE,147382.5,1.3,485,485.1,21.23,21.23,,1300,Insulin receptor-related protein,integral component of plasma membrane|receptor complex|,transmembrane receptor protein tyrosine kinase signaling pathway|peptidyl-tyrosine phosphorylation|male sex determination|actin cytoskeleton reorganization|protein autophosphorylation|cellular response to alkaline pH|,transmembrane receptor protein tyrosine kinase activity|ATP binding|phosphatidylinositol 3-kinase binding|insulin receptor substrate binding|,2,8,1740000000,1.3%
P13707,0.005083339,-0.473666667,23.85234868,3.082,0.004118747,4.125843879,-2.153,-0.641,-3.25,2.039,0.442,0.721,P13707,Gpd1,P13707_Gpd1,P13707,Gpd1,1,3,2,2,P13707|E0CXN5,MOUSE,38199.6,6,486,486.1,21.13,21.13,,349,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",mitochondrion|cytosol|glycerol-3-phosphate dehydrogenase complex|extracellular exosome|,glycerol-3-phosphate metabolic process|gluconeogenesis|NADH oxidation|glycerophosphate shuttle|positive regulation of glycolytic process|glycerol-3-phosphate catabolic process|glycerolipid metabolic process|cellular response to cAMP|cellular response to tumor necrosis factor|,glycerol-3-phosphate dehydrogenase [NAD+] activity|glycerol-3-phosphate dehydrogenase activity|protein homodimerization activity|NAD binding|,2,3,17400000,6.0%
Q64700,0.002173552,0.042666667,27.76621697,1.89,0.001672547,4.786912762,-0.457,-1.408,-0.842,1.114,0.849,1,Q64700,Rbl2,Q64700_Rbl2,Q64700,Rbl2,1,4,4,4,Q64700|A0A1B0GR06|A0A1B0GRM0,MOUSE,128966.4,2.9,488,488.1,20.96,20.96,,1135,Retinoblastoma-like protein 2,nucleus|transcription factor complex|nucleolus|cytoplasm|extracellular exosome|,"transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|cell cycle|chromatin modification|regulation of lipid kinase activity|regulation of cell cycle|",DNA binding|protein binding|,4,4,3780000000,2.9%
P19639,0.438546128,-0.245666667,3.67698597,0.732666667,0.428846039,0.839182182,-1.966,1.496,-1.366,0.372,-0.126,0.116,P19639,Gstm3,P19639_Gstm3,P19639,Gstm3,1,2,2,2,G5E8M7|P19639|P15626|Q80W21|O35660|D3YVP5|D3YX76|D3YVP6,MOUSE,25929.4,8.7,490,490.1,20.81,20.81,,218,Glutathione S-transferase Mu 3,cytoplasm|,metabolic process|cellular response to drug|cellular response to organic cyclic compound|,glutathione transferase activity|protein homodimerization activity|,2,2,72800000,8.7%
Q63836,7.80419e-4,-0.411666667,32.6312146,2.196666667,5.45605e-4,5.763897192,-1.443,-1.148,-1.939,0.769,0.497,0.794,Q63836,Selenbp2,Q63836_Selenbp2,Q63836,Selenbp2,1,2,2,2,Q63836|P17563|D6RHN2|A0A0R4J135|G3UYY2,MOUSE,53179.6,5.9,494,494.1,20.25,20.25,,472,Selenium-binding protein 2,extracellular space|nucleolus|cytosol|membrane|extracellular exosome|,protein transport|,selenium binding|,2,2,10100000,5.9%
A2ARZ3,0.158018719,-0.074333333,8.220007254,0.967333333,0.150660455,1.601429623,-1.725,0.339,-0.288,1.038,0.09,0.1,A2ARZ3,NotFound,A2ARZ3_NotFound,A2ARZ3,Fsip2,1,5,3,3,A2ARZ3,MOUSE,790434.4,0.2,496,496.1,20.15,20.15,,6995,Fibrous sheath-interacting protein 2,mitochondrion|motile cilium|,,protein binding|,3,5,276000000,0.2%
O88569,1.0426e-4,-1.235666667,52.82377212,4.56,5.21943e-6,11.48237466,-3.877,-2.956,-3.714,1.134,1.095,0.904,O88569,Hnrnpa2b1,O88569_Hnrnpa2b1,O88569,Hnrnpa2b1,1,4,2,2,O88569|Q5EBP8|O88569-2|P49312|O88569-3|P49312-2,MOUSE,37459.1,5,497,497.1,20.04,20.04,,353,Heterogeneous nuclear ribonucleoproteins A2/B1,nucleus|nucleoplasm|spliceosomal complex|cytoplasm|membrane|ribonucleoprotein complex|catalytic step 2 spliceosome|,"negative regulation of transcription from RNA polymerase II promoter|mRNA processing|RNA splicing|negative regulation of mRNA splicing, via spliceosome|RNA transport|",nucleotide binding|RNA binding|single-stranded telomeric DNA binding|poly(A) RNA binding|pre-mRNA intronic binding|,2,4,35000000,5.0%
G3X9D6,0.002397641,-0.538833333,27.30083204,2.889666667,0.00186173,4.699145222,-1.74,-0.955,-3.256,1.052,0.507,1.159,G3X9D6,Apon,G3X9D6_Apon,G3X9D6,Apon,1,2,2,2,G3X9D6,MOUSE,28249.3,11.1,502,502.1,19.5,19.5,,251,Apolipoprotein N,extracellular space|cytoplasm|,,,2,2,125000000,11.1%
Q3U492,9.9414e-4,-0.746833333,31.49085303,3.201666667,7.09438e-4,5.524512493,-1.91,-1.514,-3.619,0.876,0.798,0.888,Q3U492,Kcp,Q3U492_Kcp,Q3U492,Kcp,1,4,2,2,Q3U492|Q3U492-2|E9QNB3,MOUSE,178777.4,1.5,504,504.1,19.29,19.29,,1550,Kielin/chordin-like protein,extracellular space|,hematopoietic progenitor cell differentiation|positive regulation of BMP signaling pathway|,protein binding|,2,4,9430000,1.5%
E9PZ36,0.00484084,-0.587333333,24.09703996,3.423333333,0.003893104,4.181242687,-3.559,-3.013,-0.325,1,1.015,1.358,E9PZ36,Pkhd1,E9PZ36_Pkhd1,E9PZ36,Pkhd1,1,6,3,3,E9PZ36,MOUSE,450351.1,1.1,505,505.1,19.15,19.15,,4059,Polycystic kidney and hepatic disease 1,cytoplasm|centrosome|apical plasma membrane|ciliary basal body|perinuclear region of cytoplasm|extracellular exosome|primary cilium|mitotic spindle|,kidney development|cellular calcium ion homeostasis|positive regulation of cell proliferation|regulation of centrosome duplication|regulation of TOR signaling|negative regulation of NF-kappaB transcription factor activity|cilium assembly|negative regulation of apoptotic process|negative regulation of protein kinase B signaling|regulation of ERK1 and ERK2 cascade|,protein binding|,3,6,4320000000,1.1%
P15535,0.013735941,-1.951833333,19.2281413,5.817666667,0.011944992,3.37930254,-2.951,-2.332,-9.299,1.053,0.938,0.88,P15535,B4galt1,P15535_B4galt1,P15535,B4galt1,1,3,2,2,P15535|P15535-2|B1AXY5,MOUSE,44809.7,7,507,507.1,19.03,19.03,,399,"Beta-1,4-galactosyltransferase 1",Golgi trans cisterna|extracellular space|Golgi apparatus|plasma membrane|external side of plasma membrane|cell surface|membrane|integral component of membrane|basolateral plasma membrane|desmosome|glycocalyx|filopodium|brush border membrane|Golgi cisterna membrane|extracellular exosome|,epithelial cell development|acute inflammatory response|lactose biosynthetic process|galactose metabolic process|protein glycosylation|protein N-linked glycosylation|cell adhesion|binding of sperm to zona pellucida|penetration of zona pellucida|negative regulation of cell proliferation|glycoprotein biosynthetic process|oligosaccharide biosynthetic process|extracellular matrix organization|mammary gland development|wound healing|regulation of cell proliferation|positive regulation of apoptotic process|development of secondary sexual characteristics|branching morphogenesis of an epithelial tube|leukocyte migration|regulation of cellular component movement|regulation of acrosome reaction|positive regulation of epithelial cell proliferation involved in wound healing|angiogenesis involved in wound healing|positive regulation of apoptotic process involved in mammary gland involution|,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity|N-acetyllactosamine synthase activity|lactose synthase activity|protein binding|cytoskeletal protein binding|galactosyltransferase activity|protein kinase binding|manganese ion binding|UDP-galactosyltransferase activity|protein homodimerization activity|alpha-tubulin binding|beta-tubulin binding|",2,3,36300000,7.0%
E9Q5P0,2.53142e-4,-0.653333333,38.71828869,3.459333333,1.34329e-4,7.166945532,-2.963,-2.728,-1.458,1.009,1.248,0.972,E9Q5P0,Hpn,E9Q5P0_Hpn,E9Q5P0,Hpn,1,3,2,2,E9Q5P0|O35453|O35453-2|G3UWE8,MOUSE,48900.6,5.1,509,509.1,18.93,18.93,,445,Serine protease hepsin,endoplasmic reticulum membrane|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extracellular exosome|nuclear membrane|,proteolysis|sensory perception of sound|regulation of cell shape|negative regulation of alkaline phosphatase activity|negative regulation of epithelial to mesenchymal transition|positive regulation of plasminogen activation|positive regulation of cell growth|basement membrane disassembly|cholesterol homeostasis|negative regulation of apoptotic process|positive regulation by host of viral transcription|negative regulation of epithelial cell proliferation|positive regulation of hepatocyte proliferation|,serine-type endopeptidase activity|peptidase activity|serine-type peptidase activity|serine-type exopeptidase activity|,2,3,33100000,5.1%
Q3U515,0.090665153,0.016333333,10.71296716,0.990666667,0.08486005,1.986032054,-1.267,-0.288,0.118,0.755,-0.074,0.854,Q3U515,Vwce,Q3U515_Vwce,Q3U515,Vwce,1,3,2,2,Q3U515,MOUSE,103029.8,2.9,511,511.1,18.81,18.81,,929,von Willebrand factor C and EGF domain-containing protein,extracellular region|,positive regulation of cell proliferation|regulation of signal transduction|,calcium ion binding|,2,3,12000000,2.9%
Q9QZ25,4.65715e-4,-0.593833333,35.25549325,3.128333333,2.98161e-4,6.341617023,-2.939,-2.222,-1.313,1.245,0.709,0.957,Q9QZ25,Vnn3,Q9QZ25_Vnn3,Q9QZ25,Vnn3,1,2,2,2,Q9QZ25,MOUSE,56931.6,3.6,513,513.1,18.61,18.61,,500,Vascular non-inflammatory molecule 3,extracellular space|plasma membrane|anchored component of membrane|,pantothenate metabolic process|,pantetheine hydrolase activity|,2,2,30300000,3.6%
P30412,0.002381866,-0.357333333,27.33601645,2.514666667,0.001846709,4.705748814,-2.513,-0.697,-1.634,1.029,0.468,1.203,P30412,Ppic,P30412_Ppic,P30412,Ppic,1,3,2,2,P30412,MOUSE,22907.8,10.3,516,516.1,18.41,18.41,,212,Peptidyl-prolyl cis-trans isomerase C,cytoplasm|extracellular exosome|,protein peptidyl-prolyl isomerization|protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein binding|cyclosporin A binding|,2,3,243000000,10.3%
Q7TQ48,0.001780596,-1.230333333,28.73868021,4.255333333,0.001337002,5.068592109,-2.883,-1.851,-5.34,0.896,1.006,0.79,Q7TQ48,Srl,Q7TQ48_Srl,Q7TQ48,Srl,1,6,3,3,Q7TQ48|Q7TQ48-2,MOUSE,99581.6,3,517,517.1,18.37,18.37,,910,Sarcalumenin,sarcoplasmic reticulum lumen|,,GTP binding|,3,6,148000000,3.0%
D3Z623,1.78163e-4,-0.801666667,41.19451939,4.240666667,7.59535e-5,7.806091637,-2.431,-2.249,-4.086,1.33,1.348,1.278,D3Z623,9330159F19Rik,D3Z623_9330159F19Rik,D3Z623,9330159F19Rik,1,3,3,3,D3Z623|A0A1L1SS16,MOUSE,74697,5.2,518,518.1,18.33,18.33,,648,"MCG7194, isoform CRA_a",,,,3,3,6620000000,5.2%
Q8BMJ2,0.652789861,-0.0665,1.913363533,-0.207666667,0.643670561,-0.481929462,0.009,-0.209,0.312,0.028,-0.831,0.292,Q8BMJ2,Lars,Q8BMJ2_Lars,Q8BMJ2,Lars,1,9,3,3,Q8BMJ2,MOUSE,135445.1,2.4,520,520.1,18.18,18.18,,1178,"Leucine--tRNA ligase, cytoplasmic",nucleus|cytoplasm|cytosol|,leucyl-tRNA aminoacylation|regulation of translational fidelity|methionyl-tRNA aminoacylation|,aminoacyl-tRNA editing activity|leucine-tRNA ligase activity|ATP binding|methionine-tRNA ligase activity|,3,9,25700000000,2.4%
E9PZQ0,1.0426e-4,-0.8445,50.87739448,3.881,8.17072e-6,10.77828333,-2.638,-3.112,-2.605,1.039,0.995,1.254,E9PZQ0,Ryr1,E9PZQ0_Ryr1,E9PZQ0,Ryr1,1,7,3,3,A0A1L1SQG7|E9PZQ0|K3W4M2|Q5DTZ6|Q5DTZ6-2|Q5DTZ6-3|Q99MV7|Q8CFI7|Q99MV7-3|P18293|Q3UFM5|Q8K4B0|E9PX23|F8WHY8|Q9R190|Q8BKV1|F8WHY9|M0QWK4|H3BLK0|Q3URK1|E0CXM8|Q99N20|E0CZ80,MOUSE,570734.5,0.3,521,521.1,18.14,18.14,,5035,Ryanodine receptor 1,cytoplasm|smooth endoplasmic reticulum|plasma membrane|cell cortex|membrane|integral component of membrane|sarcoplasmic reticulum|junctional membrane complex|T-tubule|I band|sarcoplasmic reticulum membrane|protein complex|extracellular exosome|,response to hypoxia|outflow tract morphogenesis|calcium ion transport|muscle contraction|regulation of muscle contraction|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|skin development|ossification involved in bone maturation|skeletal muscle fiber development|release of sequestered calcium ion into cytosol|calcium ion transmembrane transport|cellular response to caffeine|,protease binding|ryanodine-sensitive calcium-release channel activity|voltage-gated calcium channel activity|calcium channel activity|protein binding|calmodulin binding|enzyme binding|,4,7,9350000000,0.3%
Q3UHI0-2,1.0426e-4,-1.392333333,47.69134448,4.847333333,1.70163e-5,9.708337818,-3.598,-3.071,-4.779,0.956,1.06,1.078,Q3UHI0,Ccser2,Q3UHI0-2_Ccser2,Q3UHI0-2,Ccser2,1,16,2,2,Q3UHI0-2|Q3UHI0,MOUSE,115944.3,1.9,527,527.1,17.71,17.71,,833,Isoform 2 of Serine-rich coiled-coil domain-containing protein 2,microtubule cytoskeleton|,,microtubule binding|,2,16,1550000000000,1.9%
A0A140LIJ4,2.06954e-4,-0.697,40.04277716,4.056,9.90199e-5,7.503433496,-3.63,-1.88,-2.665,1.822,0.84,1.331,A0A140LIJ4,NotFound,A0A140LIJ4_NotFound,A0A140LIJ4,Dnah14,1,6,3,3,A0A140LIJ4,MOUSE,521611.8,0.9,528,528.1,17.68,17.68,,4489,"Dynein, axonemal, heavy chain 14",,,,3,6,300000000,0.9%
Q9WU60,0.001130848,-1.0535,30.86106282,4.061,8.20151e-4,5.487916834,-2.579,-1.856,-4.817,1.032,0.99,0.909,Q9WU60,Atrn,Q9WU60_Atrn,Q9WU60,Atrn,1,4,2,2,Q9WU60,MOUSE,163133.2,1.4,529,529.1,17.68,17.68,,1428,Attractin,extracellular space|cytoplasm|plasma membrane|integral component of membrane|extracellular exosome|,inflammatory response|response to oxidative stress|cerebellum development|regulation of multicellular organism growth|myelination|pigmentation|,receptor activity|protein binding|carbohydrate binding|,2,4,24700000,1.4%
Q99MN9,0.00193635,-0.413,28.32096166,2.412666667,0.001471987,4.892744396,-1.166,-1.123,-2.569,1.064,0.602,0.714,Q99MN9,Pccb,Q99MN9_Pccb,Q99MN9,Pccb,1,2,2,2,Q99MN9|E9Q1J7,MOUSE,59035.6,4.6,532,532.1,17.58,17.58,,541,"Propionyl-CoA carboxylase beta chain, mitochondrial",mitochondrion|mitochondrial matrix|,metabolic process|,propionyl-CoA carboxylase activity|ATP binding|,2,2,6580000,4.6%
P09411,1.84037e-4,-1.156666667,40.97379517,4.378,7.99136e-5,7.747344753,-3.121,-2.415,-4.501,1.247,0.957,0.893,P09411,Pgk1,P09411_Pgk1,P09411,Pgk1,1,7,3,3,P09411|S4R2M7,MOUSE,44949.1,7.1,538,538.1,17.01,17.01,,417,Phosphoglycerate kinase 1,cytoplasm|,glycolytic process|phosphorylation|,phosphoglycerate kinase activity|ATP binding|,3,7,1290000000,7.1%
Q7TNB8,0.010582956,-0.262833333,20.45468811,1.897,0.009005984,3.501154775,-0.403,-2.329,-0.902,0.659,0.831,0.567,Q7TNB8,Sbno2,Q7TNB8_Sbno2,Q7TNB8,Sbno2,1,3,3,3,Q7TNB8|Q7TNB8-2,MOUSE,150546.2,3.1,539,539.1,16.97,16.97,,1349,Protein strawberry notch homolog 2,,"macrophage activation involved in immune response|transcription, DNA-templated|bone mineralization|osteoclast differentiation|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|regulation of inflammatory response|bone trabecula morphogenesis|multinuclear osteoclast differentiation|osteoclast fusion|",protein binding|,3,3,15300000000,3.1%
P43274,0.003437957,-0.178833333,25.65183765,1.771666667,0.002721549,4.395295386,-1.304,-1.082,-0.808,1.242,0.356,0.523,P43274,Hist1h1e,P43274_Hist1h1e,P43274,Hist1h1e,1,2,2,2,P43274|P43277|P43275|P15864,MOUSE,21976.9,11.8,542,542.1,16.61,16.61,,219,Histone H1.4,nucleosome|nucleus|nuclear heterochromatin|extracellular exosome|nucleolus|,negative regulation of transcription from RNA polymerase II promoter|nucleosome assembly|nucleosome positioning|,DNA binding|protein binding|chromatin DNA binding|poly(A) RNA binding|,2,2,35000000,11.8%
P68433,0.012027283,-0.149333333,19.83421713,1.481333333,0.010389109,3.399852754,-0.604,-0.665,-1.401,1.154,0.262,0.358,P68433,Hist1h3g,P68433_Hist1h3g,P68433,Hist1h3a,1,3,2,2,A0A1W2P768|P68433|P84228|P84244|P02301|F8WI35,MOUSE,15517.9,10.2,552,552.1,15.4,15.4,,136,Histone H3.1,nuclear nucleosome|nucleoplasm|membrane|extracellular exosome|,chromatin silencing at rDNA|DNA replication-dependent nucleosome assembly|protein heterotetramerization|regulation of gene silencing|,DNA binding|protein binding|histone binding|protein heterodimerization activity|,2,3,118000000,10.2%
Q6ZPY7,0.002494376,-0.618,27.11605049,3.835333333,0.001942652,4.744444765,-4.198,-2.567,-0.842,1.541,0.879,1.479,Q6ZPY7,NotFound,Q6ZPY7_NotFound,Q6ZPY7,Kdm3b,1,21,2,2,B9EKS2|Q6ZPY7,MOUSE,172583.6,1.2,554,554.1,15.33,15.33,,1562,Lysine-specific demethylase 3B,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|oxidation-reduction process|",metal ion binding|dioxygenase activity|,2,21,18300000000,1.2%
Q91VS8,0.020770643,-0.0565,17.37067229,1.073666667,0.018320308,3.006602728,-0.457,-0.481,-0.842,0.714,0.38,0.347,Q91VS8,Farp2,Q91VS8_Farp2,Q91VS8,Farp2,1,3,2,2,Q91VS8,MOUSE,122248.2,1.6,559,559.1,15.11,15.11,,1065,"FERM, ARHGEF and pleckstrin domain-containing protein 2",cytoplasm|cytosol|cytoskeleton|extrinsic component of membrane|,cell adhesion|neuron remodeling|Rac protein signal transduction|osteoclast differentiation|actin cytoskeleton reorganization|regulation of integrin activation|regulation of Rho protein signal transduction|positive regulation of GTPase activity|semaphorin-plexin signaling pathway|podosome assembly|,Rho guanyl-nucleotide exchange factor activity|cytoskeletal protein binding|Rac guanyl-nucleotide exchange factor activity|,2,3,370000000,1.6%
P08228,0.01286764,-0.587833333,19.52337999,2.141,0.011159944,3.349471378,-2.524,-0.21,-2.241,0.619,0.183,0.646,P08228,Sod1,P08228_Sod1,P08228,Sod1,1,3,3,3,P08228,MOUSE,16113.6,22.7,560,560.1,15.09,15.09,,154,Superoxide dismutase [Cu-Zn],extracellular space|nucleus|nucleoplasm|cytoplasm|mitochondrion|mitochondrial intermembrane space|lysosome|peroxisome|cytosol|extracellular matrix|dense core granule|cytoplasmic vesicle|dendrite cytoplasm|neuronal cell body|myelin sheath|protein complex|extracellular exosome|plasma membrane|,activation of MAPK activity|response to reactive oxygen species|response to superoxide|ovarian follicle development|positive regulation of cytokine production|retina homeostasis|response to amphetamine|myeloid cell homeostasis|glutathione metabolic process|superoxide metabolic process|cellular iron ion homeostasis|response to oxidative stress|spermatogenesis|embryo implantation|aging|cell aging|sensory perception of sound|locomotory behavior|anterograde axon cargo transport|retrograde axon cargo transport|regulation of blood pressure|response to heat|response to organic substance|transmission of nerve impulse|removal of superoxide radicals|response to nutrient levels|peripheral nervous system myelin maintenance|positive regulation of superoxide anion generation|response to carbon monoxide|cellular response to potassium ion|regulation of multicellular organism growth|response to drug|response to hydrogen peroxide|superoxide anion generation|negative regulation of apoptotic process|positive regulation of catalytic activity|regulation of GTPase activity|negative regulation of neuron apoptotic process|response to ethanol|negative regulation of cholesterol biosynthetic process|regulation of protein kinase activity|response to antibiotic|response to copper ion|muscle cell cellular homeostasis|response to axon injury|hydrogen peroxide biosynthetic process|regulation of mitochondrial membrane potential|oxidation-reduction process|heart contraction|neurofilament cytoskeleton organization|relaxation of vascular smooth muscle|auditory receptor cell stereocilium organization|cellular response to cadmium ion|cellular response to ATP|reactive oxygen species metabolic process|response to antipsychotic drug|positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,superoxide dismutase activity|copper ion binding|protein binding|zinc ion binding|protein phosphatase 2B binding|identical protein binding|Rac GTPase binding|chaperone binding|,3,3,197000000,22.7%
P10639,0.029679853,-0.825666667,15.78438056,2.764,0.026397448,2.810404734,-2.12,-0.164,-4.339,0.849,0.144,0.676,P10639,Txn1,P10639_Txn1,P10639,Txn,1,3,2,2,P10639,MOUSE,12017.6,19,561,561.1,15.06,15.06,,105,Thioredoxin,nucleus|cytoplasm|mitochondrion|cytosol|extracellular exosome|,"sulfate assimilation|negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|protein folding|glycerol ether metabolic process|response to radiation|positive regulation of peptidyl-serine phosphorylation|regulation of protein import into nucleus, translocation|cellular response to oxidative stress|positive regulation of DNA binding|cell redox homeostasis|negative regulation of protein export from nucleus|oxidation-reduction process|negative regulation of hydrogen peroxide-induced cell death|","protein binding|protein disulfide oxidoreductase activity|peptide disulfide oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|poly(A) RNA binding|",2,3,15200000,19.0%
Q3UGX2,0.413416536,-0.136333333,3.938433594,0.570666667,0.403791005,0.884957627,-1.475,-0.78,0.99,0.262,-0.184,0.369,Q3UGX2,Sptb,Q3UGX2_Sptb,Q3UGX2,Sptb,1,2,2,2,Q3UGX2|E9Q397|P15508,MOUSE,268999.3,0.9,564,564.1,14.95,14.95,,2329,Spectrin beta chain,cytoplasm|plasma membrane|spectrin|cell surface|spectrin-associated cytoskeleton|membrane|cortical cytoskeleton|protein complex|,porphyrin-containing compound biosynthetic process|plasma membrane organization|hemopoiesis|,actin binding|structural constituent of cytoskeleton|phospholipid binding|ankyrin binding|protein heterodimerization activity|actin filament binding|,2,2,23100000,0.9%
Q9CSN1,1.0426e-4,-1.593333333,53.35862513,5.52,4.61464e-6,11.68298429,-5.194,-3.723,-4.143,1.392,1.16,0.948,Q9CSN1,Snw1,Q9CSN1_Snw1,Q9CSN1,Snw1,1,15,2,2,Q9CSN1|A0A0B4J1E2,MOUSE,61531.4,2.6,565,565.1,14.89,14.89,,536,SNW domain-containing protein 1,nucleus|nucleoplasm|spliceosomal complex|nuclear matrix|catalytic step 2 spliceosome|positive transcription elongation factor complex b|SMAD3-SMAD4 protein complex|,"negative regulation of transcription from RNA polymerase II promoter|mRNA splicing, via spliceosome|transcription, DNA-templated|positive regulation of transforming growth factor beta receptor signaling pathway|skeletal muscle cell differentiation|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|positive regulation by host of viral transcription|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of mRNA splicing, via spliceosome|retinoic acid receptor signaling pathway|regulation of retinoic acid receptor signaling pathway|positive regulation of neurogenesis|positive regulation of histone H3-K4 methylation|regulation of vitamin D receptor signaling pathway|positive regulation of vitamin D receptor signaling pathway|cellular response to retinoic acid|",transcription coactivator activity|transcription corepressor activity|Notch binding|protein binding|nuclear hormone receptor binding|vitamin D receptor binding|retinoic acid receptor binding|poly(A) RNA binding|SMAD binding|,2,15,455000000000,2.6%
P16460,0.248231101,-0.377166667,6.211066332,1.223666667,0.239272819,1.287394487,-2.71,1.197,-1.454,0.716,-0.127,0.115,P16460,Ass1,P16460_Ass1,P16460,Ass1,1,2,2,2,P16460,MOUSE,46868.9,4.8,567,567.1,14.82,14.82,,412,Argininosuccinate synthase,cytoplasm|mitochondrion|myelin sheath|extracellular exosome|,urea cycle|citrulline metabolic process|argininosuccinate metabolic process|arginine biosynthetic process|aspartate metabolic process|positive regulation of nitric oxide biosynthetic process|cellular response to laminar fluid shear stress|negative regulation of leukocyte cell-cell adhesion|,argininosuccinate synthase activity|ATP binding|amino acid binding|identical protein binding|poly(A) RNA binding|,2,2,6590000,4.8%
Q8C2E4,3.06476e-4,-0.960666667,37.58486173,3.965333333,1.74387e-4,6.888400923,-2.52,-2.135,-4.175,1.284,0.842,0.94,Q8C2E4,Ptcd1,Q8C2E4_Ptcd1,Q8C2E4,Ptcd1,1,3,3,3,Q8C2E4,MOUSE,78334.7,6,569,569.1,14.75,14.75,,695,"Pentatricopeptide repeat-containing protein 1, mitochondrial",mitochondrial matrix|,tRNA 3'-end processing|,,3,3,105000000,6.0%
B2RQ80,0.090273065,-0.1845,10.7371943,1.283666667,0.084387976,1.989726036,-1.654,0.527,-1.352,1.093,0.076,0.203,B2RQ80,Tnik,B2RQ80_Tnik,B2RQ80,Tnik,1,3,2,2,B2RQ80|B9EKN8|E9PUL9|P83510|E0CY98|E0CXD6|P83510-2|E0CZD7|E0CZF8|Q9JM52-3|G3X9G2|Q5SXG3|Q5SXG1|Q9JM52|E9PVG7|A0A0A6YW53|Q9JM52-2|A0A0A6YWM8|F8VPL5|A0A0A6YWR8|P97820|B2RUE8|B7ZNR9,MOUSE,155455.9,1.4,574,574.1,14.66,14.66,,1360,Tnik protein,nucleus|nucleoplasm|cytoplasm|cytoskeleton|apical plasma membrane|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|,MAPK cascade|positive regulation of protein phosphorylation|positive regulation of defense response to virus by host|protein phosphorylation|cytoskeleton organization|activation of JNKK activity|regulation of mitotic cell cycle|microvillus assembly|stress-activated protein kinase signaling cascade|actin cytoskeleton reorganization|activation of protein kinase activity|intracellular signal transduction|regulation of apoptotic process|protein autophosphorylation|neuron projection morphogenesis|regulation of dendrite morphogenesis|protein localization to plasma membrane|,protein kinase activity|protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity|,2,3,166000000,1.4%
Q61884,0.001329554,-0.281666667,30.09570182,1.911333333,9.78205e-4,5.240581234,-1.048,-1.035,-1.629,0.612,0.682,0.728,Q61884,Mns1,Q61884_Mns1,Q61884,Mns1,1,9,2,2,Q61884,MOUSE,60291.8,2.8,578,578.1,14.56,14.56,,491,Meiosis-specific nuclear structural protein 1,nuclear envelope|intermediate filament|axoneme|sperm flagellum|,spermatogenesis|cilium organization|positive regulation of cilium assembly|meiotic cell cycle|left/right axis specification|,identical protein binding|,2,9,698000000,2.8%
Q8CE64,0.009161764,-0.195833333,21.1287577,2.316333333,0.00771124,3.612373063,-2.311,-0.028,-1.723,1.175,0.37,1.342,Q8CE64,Zfp276,Q8CE64_Zfp276,Q8CE64,Znf276,1,2,2,2,Q8CE64,MOUSE,68935.4,2.4,579,579.1,14.56,14.56,,614,Zinc finger protein 276,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|zinc ion binding|,2,2,56600000,2.4%
H3BKH6,2.48458e-4,-0.2255,38.82641694,3.274333333,1.31026e-4,7.193964961,-1.393,-1.832,-2.363,1.713,0.782,1.74,H3BKH6,Esd,H3BKH6_Esd,H3BKH6,Esd,1,3,2,2,H3BKH6|Q9R0P3|H3BJL6|H3BLJ9,MOUSE,33399.4,8.4,588,588.1,14.48,14.48,,295,S-formylglutathione hydrolase,nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|extracellular exosome|,formaldehyde catabolic process|,"hydrolase activity, acting on ester bonds|S-formylglutathione hydrolase activity|",2,3,19500000,8.4%
Q99MY8,1.74821e-4,-1.202833333,41.3029763,4.753666667,7.40802e-5,7.83508926,-4.067,-2.27,-4.402,1.197,1.508,0.817,Q99MY8,Ash1l,Q99MY8_Ash1l,Q99MY8,Ash1l,1,4,3,3,Q99MY8,MOUSE,334864.7,1,589,589.1,14.41,14.41,,2958,Histone-lysine N-methyltransferase ASH1L,nucleoplasm|chromosome|cytoplasm|Golgi apparatus|bicellular tight junction|extracellular exosome|,"negative regulation of acute inflammatory response|transcription, DNA-templated|interleukin-6 production|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of MAPK cascade|positive regulation of transcription from RNA polymerase II promoter|negative regulation of inflammatory response|histone H3-K4 methylation|",DNA binding|chromatin binding|zinc ion binding|histone methyltransferase activity (H3-K4 specific)|,3,4,54300000,1.0%
Q6P9P0,0.006069829,-2.174333333,23.03861377,6.779333333,0.004967509,4.050732287,-3.533,-3.282,-9.877,1.381,1.341,0.924,Q6P9P0,Slf2,Q6P9P0_Slf2,Q6P9P0,Slf2,1,14,2,2,Q6P9P0|E9Q839|K4JR88|K4JBS4|K4JR71,MOUSE,144937.3,1,597,597.1,14.12,14.12,,1278,SMC5-SMC6 complex localization factor protein 2,chromatin|extracellular space|nucleus|intracellular membrane-bounded organelle|,,,2,14,328000000000,1.0%
E9Q3M9,0.015598642,-1.5275,18.64688532,4.605666667,0.013655621,3.281104185,-2.751,-1.398,-7.342,0.77,0.696,0.86,E9Q3M9,2010300C02Rik,E9Q3M9_2010300C02Rik,E9Q3M9,2010300C02Rik,1,5,2,2,E9Q3M9|Q3UHU5|Q3UHU5-3|Q3TYL0,MOUSE,126478.6,1.1,598,598.1,14.11,14.11,,1175,RIKEN cDNA 2010300C02 gene,,,,2,5,657000000,1.1%
P10166,2.86085e-4,-0.906333333,38.02636793,3.930666667,1.5753e-4,6.995897036,-4.009,-2.69,-1.916,1.226,0.975,0.976,P10166,Mycl,P10166_Mycl,P10166,Mycl,1,12,2,2,P10166,MOUSE,41361,2.9,599,599.1,14.1,14.1,,368,Protein L-Myc,nucleus|,"regulation of transcription, DNA-templated|",DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|protein dimerization activity|,2,12,9130000000,2.9%
A2AQB2,1.0426e-4,-0.709833333,48.26257154,4.015,1.49191e-5,9.892997289,-2.829,-2.545,-2.778,1.886,1.119,0.888,A2AQB2,NotFound,A2AQB2_NotFound,A2AQB2,Neb,1,9,2,2,A2AQB2,MOUSE,354700.3,0.4,603,603.1,13.88,13.88,,3044,Nebulin,striated muscle thin filament|Z disc|protein complex|contractile fiber|extracellular exosome|,regulation of actin filament length|sarcomere organization|,actin binding|protein binding|,2,9,19300000000,0.4%
P14576,0.02337878,-0.482166667,16.84929535,3.456333333,0.020657153,2.983244187,-4.848,-1.52,-0.263,1.537,0.222,1.979,P14576,Srp54a,P14576_Srp54a,P14576,Srp54,1,2,2,2,P14576,MOUSE,56005.1,3.5,604,604.1,13.85,13.85,,504,Signal recognition particle 54 kDa protein,"signal recognition particle, endoplasmic reticulum targeting|nuclear speck|",SRP-dependent cotranslational protein targeting to membrane|metabolic process|,GTPase activity|GTP binding|7S RNA binding|,2,2,73400000,3.5%
Q9WVB3,2.01694e-4,-0.633333333,40.36014507,3.400666667,9.20419e-5,7.585880181,-2.958,-1.921,-2.122,0.723,1.567,0.911,Q9WVB3,Tle6,Q9WVB3_Tle6,Q9WVB3,Tle6,1,2,2,2,Q9WVB3|D3Z5E1,MOUSE,65970.1,4.4,609,609.1,13.69,13.69,,581,Transducin-like enhancer protein 6,nucleus|cell cortex|protein complex|,positive regulation of neuron differentiation|positive regulation of neurogenesis|,protein binding|,2,2,226000000,4.4%
P26040,1.33659e-4,-0.778833333,43.56207905,3.286333333,4.40344e-5,8.459369991,-2.811,-2.452,-2.003,0.979,1.019,0.595,P26040,Ezr,P26040_Ezr,P26040,Ezr,1,5,2,2,P26040|P26041|P26043|Q7TSG6,MOUSE,69519.7,4,610,610.1,13.63,13.63,,586,Ezrin,ruffle|uropod|extracellular space|intracellular|nucleolus|cytoplasm|endosome|cytosol|actin filament|plasma membrane|microvillus|brush border|focal adhesion|cell cortex|actin cytoskeleton|membrane|basolateral plasma membrane|apical plasma membrane|extrinsic component of membrane|filopodium|T-tubule|microvillus membrane|vesicle|ruffle membrane|ciliary basal body|myelin sheath|cell body|microspike|membrane raft|apical part of cell|cell tip|extracellular exosome|cell periphery|astrocyte projection|Schwann cell microvillus|cytoplasmic side of apical plasma membrane|focal adhesion|,intestinal D-glucose absorption|sphingosine-1-phosphate signaling pathway|leukocyte cell-cell adhesion|regulation of cell shape|positive regulation of gene expression|membrane to membrane docking|actin cytoskeleton reorganization|receptor internalization|regulation of microvillus length|establishment or maintenance of apical/basal cell polarity|positive regulation of multicellular organism growth|filopodium assembly|phosphatidylinositol-mediated signaling|positive regulation of protein secretion|actin filament bundle assembly|establishment of endothelial barrier|positive regulation of establishment of protein localization to plasma membrane|regulation of organelle assembly|terminal web assembly|positive regulation of protein localization to early endosome|positive regulation of cellular protein catabolic process|positive regulation of early endosome to late endosome transport|microvillus assembly|,protein binding|protein domain specific binding|poly(A) RNA binding|cell adhesion molecule binding|actin filament binding|,3,5,170000000,4.0%
K3W4R5,1.12332e-4,-1.103666667,45.16133389,4.054666667,3.04696e-5,8.925807319,-3.298,-2.341,-3.754,1.03,0.891,0.85,K3W4R5,Ckap5,K3W4R5_Ckap5,K3W4R5,Ckap5,1,3,2,2,K3W4R5|A2AGT5|A0A0R4J0K2|A2AGT5-3|Z4YL78|A2AGT5-2,MOUSE,227286.2,0.7,611,611.1,13.56,13.56,,2032,Cytoskeleton-associated protein 5,spindle pole|cytoplasm|centrosome|membrane|protein complex|gamma-tubulin complex|microtubule plus-end|,spindle organization|establishment or maintenance of microtubule cytoskeleton polarity|centrosome organization|,microtubule binding|ribonucleoprotein complex binding|,2,3,795000000,0.7%
Q8C257,5.32138e-4,-1.172333333,34.59005739,4.594666667,3.47532e-4,6.315028686,-3.714,-1.884,-4.811,1.492,0.965,0.918,Q8C257,Il18r1,Q8C257_Il18r1,Q8C257,Il18r1,1,4,2,2,Q8C257,MOUSE,43230.5,4.5,612,612.1,13.45,13.45,,372,Il18r1 protein,,natural killer cell activation|positive regulation of interferon-gamma production|interleukin-18-mediated signaling pathway|positive regulation of NF-kappaB import into nucleus|T-helper 1 cell differentiation|,interleukin-18 receptor activity|,2,4,622000000,4.5%
E9Q9F7,0.023984758,-2.674666667,16.73244235,8.076666667,0.021220507,2.964158376,-3.717,-2.63,-13.792,0.874,1.696,1.521,E9Q9F7,Ccdc146,E9Q9F7_Ccdc146,E9Q9F7,Ccdc146,1,2,2,2,E9Q9F7|Q8R422|Q6P1H4|Q9WVL6|G3X8Z3|Q9R0S0|Q9Z111,MOUSE,115632.1,1.2,613,613.1,13.43,13.43,,977,Coiled-coil domain-containing 146,centriole|,,,2,2,197000000,1.2%
Q9ESG6,5.73296e-4,-0.497833333,34.1745947,3.276333333,3.8242e-4,6.098966459,-3.177,-1.954,-1.277,1.371,0.877,1.173,Q9ESG6,P2ry14,Q9ESG6_P2ry14,Q9ESG6,P2ry14,1,5,2,2,A0A0G2JEW9|Q9ESG6,MOUSE,39259.9,6.5,614,614.1,13.42,13.42,,338,P2Y purinoceptor 14,integral component of plasma membrane|,G-protein coupled receptor signaling pathway|G-protein coupled purinergic nucleotide receptor signaling pathway|,G-protein coupled purinergic nucleotide receptor activity|,2,5,43000000000,6.5%
Q99PT9,1.82834e-4,-0.9225,41.05700886,4.190333333,7.83969e-5,7.769450557,-3.13,-2.034,-3.889,0.867,1.575,1.076,Q99PT9,Kif19a,Q99PT9_Kif19a,Q99PT9,Kif19,1,8,2,2,Q99PT9|A2AC95,MOUSE,112127.5,2,616,616.1,13.33,13.33,,997,Kinesin-like protein KIF19,kinesin complex|microtubule|cilium|axoneme|,microtubule-based movement|metabolic process|axonemal microtubule depolymerization|plus-end specific microtubule depolymerization|,"ATP binding|microtubule binding|ATP-dependent microtubule motor activity, plus-end-directed|",2,8,1190000000,2.0%
A9Z1V5,0.002010159,-0.132166667,28.14521448,1.941,0.001532776,4.859071565,-0.704,-1.095,-1.509,0.471,1.084,0.96,A9Z1V5,Vwa5b1,A9Z1V5_Vwa5b1,A9Z1V5,Vwa5b1,1,9,2,2,A9Z1V5,MOUSE,135567.6,2.2,617,617.1,13.33,13.33,,1215,von Willebrand factor A domain-containing protein 5B1,extracellular region|,,,2,9,10500000000,2.2%
Q3U2I3,6.72532e-4,-1.04,33.37642318,3.9,4.59576e-4,5.924049791,-2.881,-1.708,-4.381,0.845,0.905,0.98,Q3U2I3,Fam160a2,Q3U2I3_Fam160a2,Q3U2I3,Fam160a2,1,2,2,2,A0A1C7CYU5|Q3U2I3|Q3U2I3-2|F8WHJ1|Q3U2I3-3,MOUSE,107509.4,1.7,619,619.1,13.24,13.24,,975,FTS and Hook-interacting protein,FHF complex|,endosome organization|lysosome organization|endosome to lysosome transport|protein transport|early endosome to late endosome transport|,,2,2,242000000,1.7%
P04919,0.98508589,0.280833333,0.075382435,0.026333333,0.982792325,0.02235806,-1.975,-0.045,2.823,1.184,-0.66,0.358,P04919,Slc4a1,P04919_Slc4a1,P04919,Slc4a1,1,2,2,2,P04919|P04919-2,MOUSE,103475.9,2.3,622,622.1,13.22,13.22,,929,Band 3 anion transport protein,integral component of plasma membrane|membrane|basolateral plasma membrane|Z disc|cortical cytoskeleton|extracellular exosome|blood microparticle|,anion transport|chloride transport|bicarbonate transport|regulation of intracellular pH|anion transmembrane transport|chloride transmembrane transport|,actin binding|inorganic anion exchanger activity|protein binding|protein C-terminus binding|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity|anion:anion antiporter activity|ankyrin binding|protein homodimerization activity|,2,2,9650000,2.3%
Q5FW60,3.31784e-4,-0.992,37.15037614,4.699333333,1.92736e-4,6.85224678,-4.459,-3.631,-1.935,1.11,2.017,0.946,Q5FW60,Mup20,Q5FW60_Mup20,Q5FW60,Mup20,1,6,2,2,Q5FW60,MOUSE,21157.8,13.2,623,623.1,13.21,13.21,,181,Major urinary protein 20,extracellular region|extracellular space|nucleus|cytosol|,"energy reserve metabolic process|transport|insulin receptor signaling pathway|olfactory learning|aerobic respiration|positive regulation of gene expression|negative regulation of lipid storage|positive regulation of glucose metabolic process|heat generation|glucose homeostasis|locomotor rhythm|negative regulation of gluconeogenesis|positive regulation of lipid metabolic process|negative regulation of transcription, DNA-templated|negative regulation of lipid biosynthetic process|positive regulation of protein kinase B signaling|negative regulation of insulin secretion involved in cellular response to glucose stimulus|mitochondrion morphogenesis|cellular response to lipid|",mating pheromone activity|insulin-activated receptor activity|transporter activity|pheromone binding|small molecule binding|,2,6,647000000,13.2%
P21550,0.086857059,-0.851833333,10.93729724,2.147,0.080587981,2.044403176,-1.513,0.103,-4.366,0.395,-0.111,0.381,P21550,Eno3,P21550_Eno3,P21550,Eno3,1,5,2,2,P21550,MOUSE,47366.4,2.9,625,625.1,13.12,13.12,,434,Beta-enolase,phosphopyruvate hydratase complex|extracellular space|cytoplasm|plasma membrane|extracellular exosome|,glycolytic process|aging|response to drug|skeletal muscle tissue regeneration|,magnesium ion binding|phosphopyruvate hydratase activity|protein homodimerization activity|protein heterodimerization activity|,2,5,30800000000,2.9%
E9PUR0,0.396166454,-0.016333333,4.128714466,-0.356666667,0.386481361,-0.919723209,0.033,0.487,-0.034,-0.038,-0.615,0.069,E9PUR0,Ankhd1,E9PUR0_Ankhd1,E9PUR0,Ankhd1,1,3,2,2,E9PUR0|E9Q1M6|A0A0A6Y7|Q9CWU0|E1BKR4|Q5RJG1|Q9ET22,MOUSE,271726.3,0.5,631,631.1,12.98,12.98,,2548,Ankyrin repeat and KH domain-containing 1,,,poly(A) RNA binding|,2,3,115000000,0.5%
Q8VHI3,0.001696908,-0.160333333,28.96123952,2.363333333,0.001270212,5.016576734,-2.041,-1.28,-0.705,1.4,0.588,1.076,Q8VHI3,Pofut2,Q8VHI3_Pofut2,Q8VHI3,Pofut2,1,2,2,2,Q8VHI3,MOUSE,49770.7,3.9,632,632.1,12.97,12.97,,429,GDP-fucose protein O-fucosyltransferase 2,endoplasmic reticulum|Golgi apparatus|,mesoderm formation|fucose metabolic process|regulation of gene expression|regulation of epithelial to mesenchymal transition|fucosylation|protein O-linked fucosylation|regulation of secretion|,fucosyltransferase activity|peptide-O-fucosyltransferase activity|,2,2,38100000,3.9%
E9PUN6,0.006504658,-0.111333333,22.70735419,1.572,0.005361232,3.877983275,-1.036,-1.257,-0.399,0.94,0.336,0.748,E9PUN6,Adamts9,E9PUN6_Adamts9,E9PUN6,Adamts9,1,3,2,2,E9PUN6|E9PYV8,MOUSE,223166.7,1.7,638,638.1,12.76,12.76,,1931,"A disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9",proteinaceous extracellular matrix|extracellular space|,proteolysis|positive regulation of melanocyte differentiation|regulation of developmental pigmentation|,endopeptidase activity|metalloendopeptidase activity|metallopeptidase activity|zinc ion binding|,2,3,82300000,1.7%
Q9DBN5,7.69362e-4,-0.95,32.71161383,3.906,5.35598e-4,5.80211566,-2.265,-1.97,-4.474,1.179,1,0.83,Q9DBN5,Lonp2,Q9DBN5_Lonp2,Q9DBN5,Lonp2,1,5,2,2,Q9DBN5|Q9DBN5-3|Q8BK80,MOUSE,95038.2,3.5,639,639.1,12.74,12.74,,852,"Lon protease homolog 2, peroxisomal",nucleus|cytoplasm|peroxisome|peroxisomal matrix|membrane|,misfolded or incompletely synthesized protein catabolic process|protein targeting to peroxisome|response to organic cyclic compound|protein processing|protein import into peroxisome matrix|regulation of fatty acid beta-oxidation|,protease binding|ATP-dependent peptidase activity|serine-type endopeptidase activity|receptor binding|protein binding|ATP binding|peptidase activity|enzyme binding|,2,5,3570000000,3.5%
K7N784,1.42093e-4,-0.627166667,42.87266391,3.155,5.161e-5,8.264673681,-2.672,-1.969,-1.973,1.116,0.94,0.795,K7N784,NotFound,K7N784_NotFound,K7N784,Vmn2r4,1,2,2,2,K7N784|E9Q277|E9PYL5|H3BK29|E9PZ74|L7N478,MOUSE,104813.9,4.3,642,642.1,12.51,12.51,,913,"Vomeronasal 2, receptor 4",plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|,G-protein coupled receptor activity|,2,2,111000000,4.3%
Q80Z25,0.361014585,0.391,4.54262139,0.733333333,0.351348304,0.996063869,-0.453,-0.418,0.944,-0.011,0.011,2.273,Q80Z25,Ofd1,Q80Z25_Ofd1,Q80Z25,Ofd1,1,2,2,2,A2AEG2|Q80Z25,MOUSE,117799.6,1.4,645,645.1,12.44,12.44,,1017,Oral-facial-digital syndrome 1 protein homolog,nucleus|centrosome|centriole|cilium|microtubule cytoskeleton|membrane|centriolar satellite|ciliary basal body|,embryonic body morphogenesis|axoneme assembly|cilium morphogenesis|epithelial cilium movement involved in determination of left/right asymmetry|negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation|mitotic nuclear division|centriole replication|mitotic spindle assembly|,alpha-tubulin binding|gamma-tubulin binding|,2,2,5370000000,1.4%
F8VQD1,0.032004484,-0.507833333,15.43986975,2.484333333,0.028576762,2.753927529,0.184,-1.79,-3.644,0.619,0.967,0.617,F8VQD1,Pbrm1,F8VQD1_Pbrm1,F8VQD1,Pbrm1,1,2,2,2,F8VQD1|E9Q4Y5|D3Z1N4|Q8BSQ9|E9Q7L2|Q8BSQ9-2|E9Q7L3|D3Z1W6|D6RI94|D6RIL0,MOUSE,195966.4,1.1,654,654.1,12.29,12.29,,1704,Protein polybromo-1,kinetochore|nucleus|BAF-type complex|,placenta development|heart development|negative regulation of cell proliferation|,chromatin binding|,2,2,1870000000,1.1%
P21836,2.97846e-4,-0.312,37.78113314,2.410666667,1.66681e-4,6.936031607,-1.409,-1.64,-1.503,1.094,0.713,0.873,P21836,Ache,P21836_Ache,P21836,Ache,1,3,2,2,P21836|A0A0G2JDM6,MOUSE,68566.6,2.7,657,657.1,12.23,12.23,,614,Acetylcholinesterase,extracellular region|basal lamina|extracellular space|Golgi apparatus|plasma membrane|cell surface|membrane|cell junction|anchored component of membrane|neuromuscular junction|synapse|perinuclear region of cytoplasm|,regulation of receptor recycling|osteoblast development|acetylcholine catabolic process|cell adhesion|receptor internalization|neurotransmitter receptor biosynthetic process|protein tetramerization|retina development in camera-type eye|,acetylcholinesterase activity|cholinesterase activity|protein binding|collagen binding|hydrolase activity|serine hydrolase activity|acetylcholine binding|protein homodimerization activity|laminin binding|protein self-association|,2,3,13600000,2.7%
Q80YA7,0.016326353,-0.446666667,18.44308993,2.4,0.014311693,3.204562614,-2.632,-2.461,0.153,0.814,0.581,0.865,Q80YA7,Dpp8,Q80YA7_Dpp8,Q80YA7,Dpp8,1,2,2,2,Q80YA7|A0A1L1STG9,MOUSE,102868.7,1.4,672,672.1,11.75,11.75,,892,Dipeptidyl peptidase 8,nucleoplasm|cytoplasm|membrane|,proteolysis|,aminopeptidase activity|serine-type peptidase activity|,2,2,5470000,1.4%
Q03717,0.001662693,-0.089333333,29.05646014,2.749333333,0.001242665,5.035150039,-2.411,-0.994,-0.987,1.625,0.583,1.648,Q03717,Kcnb1,Q03717_Kcnb1,Q03717,Kcnb1,1,5,2,2,Q03717,MOUSE,96445.6,2.2,673,673.1,11.71,11.71,,857,Potassium voltage-gated channel subfamily B member 1,intracellular|plasma membrane|voltage-gated potassium channel complex|integral component of membrane|lateral plasma membrane|cell junction|axon|dendrite|dendrite membrane|neuronal cell body membrane|sarcolemma|perikaryon|postsynaptic membrane|,action potential|potassium ion transport|vesicle docking involved in exocytosis|glutamate receptor signaling pathway|positive regulation of norepinephrine secretion|cellular response to nutrient levels|positive regulation of catecholamine secretion|regulation of ion transmembrane transport|glucose homeostasis|positive regulation of calcium ion-dependent exocytosis|negative regulation of insulin secretion|protein homooligomerization|cellular response to glucose stimulus|potassium ion transmembrane transport|protein targeting to plasma membrane|positive regulation of protein targeting to membrane|regulation of action potential|positive regulation of long term synaptic depression|regulation of motor neuron apoptotic process|,voltage-gated potassium channel activity|delayed rectifier potassium channel activity|protein binding|outward rectifier potassium channel activity|ubiquitin-like protein binding|ion channel binding|protein heterodimerization activity|protein N-terminus binding|,2,5,63800000,2.2%
P50544,0.006494231,-1.047333333,22.72046004,4.971333333,0.005345077,3.992631016,-3.227,-1.233,-6.139,2.821,0.655,0.839,P50544,Acadvl,P50544_Acadvl,P50544,Acadvl,1,6,2,2,P50544|B1AR28,MOUSE,71273.6,4.2,675,675.1,11.65,11.65,,656,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial",nucleus|nucleolus|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|,temperature homeostasis|epithelial cell differentiation|fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of fatty acid biosynthetic process|negative regulation of fatty acid oxidation|regulation of cholesterol metabolic process|,acyl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|,2,6,209000000,4.2%
Q6DFV5-3,3.23709e-4,-1.139666667,37.28357367,4.233333333,1.86914e-4,6.815768531,-3.727,-1.865,-4.177,0.787,1.012,1.132,Q6DFV5,Helz,Q6DFV5-3_Helz,Q6DFV5-3,Helz,1,3,2,2,Q6DFV5-3|A0A0R4J0Y3|Q6DFV5|A2AAU3|Q6DFV5-2,MOUSE,221802.9,0.6,679,679.1,11.57,11.57,,1964,Isoform 3 of Probable helicase with zinc finger domain,nucleus|membrane|,metabolic process|,helicase activity|protein binding|ATP binding|poly(A) RNA binding|metal ion binding|,2,3,111000000,0.6%
G3X9L9,0.590895196,-0.0735,2.351123413,0.609,0.581952661,0.577364256,-1.736,2.187,-1.585,0.282,-0.353,0.764,G3X9L9,Pde4dip,G3X9L9_Pde4dip,G3X9L9,Pde4dip,1,2,2,2,G3X9L9|E9Q1A0|Q80YT7|Q80YT7-2,MOUSE,279214.5,0.5,685,685.1,11.48,11.48,,2463,Myomegalin,nucleus|cytoplasm|centrosome|,,protein binding|,2,2,45200000,0.5%
Q8R418,0.001915758,-0.304666667,28.37404953,2.288666667,0.001454103,4.902942567,-2.264,-1.241,-0.842,1.033,0.909,0.577,Q8R418,NotFound,Q8R418_NotFound,Q8R418,Dicer1,1,2,2,2,Q8R418|F8VQ54,MOUSE,219555.4,0.9,687,687.1,11.47,11.47,,1916,Endoribonuclease Dicer,nucleus|cytoplasm|RISC complex|micro-ribonucleoprotein complex|RISC-loading complex|,"negative regulation of transcription from RNA polymerase II promoter|meiotic spindle organization|angiogenesis|regulation of protein phosphorylation|hair follicle development|apoptotic DNA fragmentation|RNA processing|cell proliferation|regulation of Notch signaling pathway|post-embryonic development|zygote asymmetric cell division|regulation of gene expression|negative regulation of Schwann cell proliferation|positive regulation of gene expression|regulation of muscle cell apoptotic process|positive regulation of Schwann cell differentiation|myoblast differentiation involved in skeletal muscle regeneration|rRNA catabolic process|stem cell maintenance|spinal cord motor neuron differentiation|nerve development|olfactory bulb interneuron differentiation|cerebral cortex development|lung development|embryonic limb morphogenesis|production of siRNA involved in RNA interference|targeting of mRNA for destruction involved in RNA interference|pre-miRNA processing|hair follicle morphogenesis|regulation of myelination|positive regulation of myelination|peripheral nervous system myelin formation|conversion of ds siRNA to ss siRNA involved in RNA interference|siRNA loading onto RISC involved in RNA interference|embryonic hindlimb morphogenesis|production of miRNAs involved in gene silencing by miRNA|multicellular organism growth|miRNA loading onto RISC involved in gene silencing by miRNA|conversion of ds siRNA to ss siRNA|regulation of odontogenesis of dentin-containing tooth|regulation of viral genome replication|regulation of cell differentiation|regulation of neuron differentiation|positive regulation of transcription from RNA polymerase II promoter|mRNA stabilization|spleen development|digestive tract development|reproductive structure development|regulation of oligodendrocyte differentiation|epidermis morphogenesis|branching morphogenesis of an epithelial tube|neuron projection morphogenesis|anatomical structure development|regulation of neurogenesis|cartilage development|spindle assembly|regulation of RNA metabolic process|defense response to virus|regulation of cell cycle|cardiac muscle cell development|inner ear receptor cell development|negative regulation of glial cell proliferation|intestinal epithelial cell development|cardiac neural crest cell development involved in outflow tract morphogenesis|ganglion development|regulation of enamel mineralization|hair follicle cell proliferation|RNA phosphodiester bond hydrolysis|RNA phosphodiester bond hydrolysis, endonucleolytic|regulation of miRNA metabolic process|positive regulation of miRNA metabolic process|",double-stranded RNA binding|helicase activity|endoribonuclease activity|ribonuclease III activity|deoxyribonuclease I activity|protein binding|ATP binding|protein domain specific binding|siRNA binding|miRNA binding|metal ion binding|pre-miRNA binding|pre-miRNA binding|,2,2,376000000,0.9%
E9Q048,0.012027283,-0.254,19.8348465,1.332,0.010387603,3.399955009,-0.645,-0.646,-1.469,0.508,0.355,0.373,E9Q048,Ermard,E9Q048_Ermard,E9Q048,Ermard,1,3,2,2,E9Q048|Q3TVE4,MOUSE,71714.1,1.9,689,689.1,11.41,11.41,,622,ER membrane-associated RNA degradation,,,,2,3,88600000,1.9%
Q02357-6,0.729729551,0.303333333,1.403916353,0.463333333,0.723782977,0.368099093,-0.923,-2.001,3.139,1.035,-0.13,0.7,Q02357,Ank1,Q02357-6_Ank1,Q02357-6,Ank1,1,2,2,2,Q02357-6|A0A0R4J1N7|Q02357-4|Q0VGY9|D3Z5M4|D3YTV8|Q02357-3|G8JL84|Q02357|E9QNT8|B7ZW98|Q02357-2|G5E8J2|Q02357-5,MOUSE,210742.6,1.6,701,701.1,11.12,11.12,,1862,Isoform 6 of Ankyrin-1,plasma membrane|spectrin-associated cytoskeleton|membrane|sarcoplasmic reticulum|cortical cytoskeleton|,porphyrin-containing compound biosynthetic process|ER to Golgi vesicle-mediated transport|signal transduction|monovalent inorganic cation transport|erythrocyte development|iron ion homeostasis|protein targeting to plasma membrane|,cytoskeletal adaptor activity|enzyme binding|spectrin binding|ATPase binding|,2,2,6660000,1.6%
Q9Z0X4,1.0426e-4,-0.786166667,46.79912758,3.709666667,2.08972e-5,9.4259018,-3.125,-2.481,-2.317,1.005,1.336,0.865,Q9Z0X4,Pde3a,Q9Z0X4_Pde3a,Q9Z0X4,Pde3a,1,3,2,2,Q9Z0X4,MOUSE,125994,2,708,708.1,10.99,10.99,,1141,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",cytosol|membrane|integral component of membrane|,oocyte maturation|cAMP catabolic process|diterpenoid metabolic process|cAMP-mediated signaling|cGMP-mediated signaling|regulation of meiotic nuclear division|response to drug|negative regulation of apoptotic process|negative regulation of vascular permeability|positive regulation of vascular permeability|response to cAMP|positive regulation of oocyte development|cellular response to cGMP|cellular response to transforming growth factor beta stimulus|,"3',5'-cyclic-AMP phosphodiesterase activity|cGMP-inhibited cyclic-nucleotide phosphodiesterase activity|cAMP binding|metal ion binding|",2,3,71800000,2.0%
Q01853,5.63553e-4,-1.056166667,34.27945873,3.965,3.73297e-4,6.122212846,-2.682,-1.944,-4.49,0.929,1,0.85,Q01853,Vcp,Q01853_Vcp,Q01853,Vcp,1,8,2,2,Q01853,MOUSE,90004.9,3.7,721,721.1,10.82,10.82,,806,Transitional endoplasmic reticulum ATPase,proteasome complex|Hrd1p ubiquitin ligase complex|nucleus|nucleoplasm|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|lipid particle|cytosol|VCP-NPL4-UFD1 AAA ATPase complex|site of double-strand break|myelin sheath|protein complex|perinuclear region of cytoplasm|extracellular exosome|VCP-NSFL1C complex|,"double-strand break repair|ubiquitin-dependent protein catabolic process|ER to Golgi vesicle-mediated transport|activation of cysteine-type endopeptidase activity involved in apoptotic process|cellular response to DNA damage stimulus|protein ubiquitination|protein N-linked glycosylation via asparagine|viral genome replication|translesion synthesis|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|positive regulation of protein complex assembly|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|protein hexamerization|positive regulation of protein catabolic process|ATP metabolic process|protein homooligomerization|aggresome assembly|ER-associated misfolded protein catabolic process|positive regulation of protein K63-linked deubiquitination|positive regulation of Lys63-specific deubiquitinase activity|",protein binding|ATP binding|lipid binding|ATPase activity|protein phosphatase binding|protein domain specific binding|polyubiquitin binding|protein complex binding|deubiquitinase activator activity|K48-linked polyubiquitin binding|MHC class I protein binding|identical protein binding|ADP binding|ubiquitin-like protein ligase binding|poly(A) RNA binding|ubiquitin-specific protease binding|,2,8,944000000,3.7%
